SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'PHE'


List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1A4L_A_DCFA353_1
(ADENOSINE DEAMINASE)		 1zef ALKALINE PHOSPHATASE
(Homo
sapiens) 		5 / 12 HIS A 320
HIS A 317
ASP A 273
HIS A 432
ASP A 316
 ZN  A 901 ( 3.3A)
PHE  A 802 (-4.0A)
None
ZN  A 901 ( 3.2A)
ZN  A 901 ( 1.9A)
 1.13A 1a4lA-1zefA:
undetectable		 1a4lA-1zefA:
20.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1BKF_A_FK5A108_1
(FK506 BINDING
PROTEIN)		 5wpi HSVA
(Erwinia
amylovora) 		5 / 9 TYR A 296
PHE A  58
VAL A  40
ILE A  38
PHE A 345
 TYR  A 296 ( 1.3A)
PHE  A  58 ( 1.3A)
VAL  A  40 ( 0.5A)
ILE  A  38 ( 0.7A)
PHE  A 345 ( 1.3A)
 1.41A 1bkfA-5wpiA:
undetectable		 1bkfA-5wpiA:
16.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C8L_A_CFFA940_1
(PROTEIN (GLYCOGEN
PHOSPHORYLASE))		 1omo ALANINE
DEHYDROGENASE
(Archaeoglobus
fulgidus) 		4 / 6 ASN A 214
PHE A 288
ALA A 117
GLY A 114
 ASN  A 214 ( 0.6A)
PHE  A 288 ( 1.3A)
ALA  A 117 ( 0.0A)
GLY  A 114 ( 0.0A)
 1.08A 1c8lA-1omoA:
undetectable		 1c8lA-1omoA:
18.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C8L_A_CFFA940_1
(PROTEIN (GLYCOGEN
PHOSPHORYLASE))		 1zef ALKALINE PHOSPHATASE
(Homo
sapiens) 		4 / 6 ASN A  84
PHE A 107
ALA A  94
GLY A  93
 None
PHE  A 802 (-4.4A)
None
SEP  A  92 ( 2.4A)
 1.03A 1c8lA-1zefA:
undetectable		 1c8lA-1zefA:
20.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C9S_A_TRPA81_0
(TRP RNA-BINDING
ATTENUATION PROTEIN)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.42A 1c9sA-3l4gA:
undetectable
1c9sK-3l4gA:
undetectable		 1c9sA-3l4gA:
9.81
1c9sK-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C9S_B_TRPB81_0
(TRP RNA-BINDING
ATTENUATION PROTEIN)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.43A 1c9sA-3l4gA:
undetectable
1c9sB-3l4gA:
undetectable		 1c9sA-3l4gA:
9.81
1c9sB-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C9S_D_TRPD81_0
(TRP RNA-BINDING
ATTENUATION PROTEIN)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.44A 1c9sC-3l4gA:
undetectable
1c9sD-3l4gA:
undetectable		 1c9sC-3l4gA:
9.81
1c9sD-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C9S_E_TRPE81_0
(TRP RNA-BINDING
ATTENUATION PROTEIN)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 1c9sD-3l4gA:
undetectable
1c9sE-3l4gA:
undetectable		 1c9sD-3l4gA:
9.81
1c9sE-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C9S_F_TRPF81_0
(TRP RNA-BINDING
ATTENUATION PROTEIN)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.43A 1c9sE-3l4gA:
undetectable
1c9sF-3l4gA:
undetectable		 1c9sE-3l4gA:
9.81
1c9sF-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C9S_G_TRPG81_0
(TRP RNA-BINDING
ATTENUATION PROTEIN)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.43A 1c9sF-3l4gA:
undetectable
1c9sG-3l4gA:
undetectable		 1c9sF-3l4gA:
9.81
1c9sG-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C9S_H_TRPH81_0
(TRP RNA-BINDING
ATTENUATION PROTEIN)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.43A 1c9sG-3l4gA:
undetectable
1c9sH-3l4gA:
undetectable		 1c9sG-3l4gA:
9.81
1c9sH-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C9S_I_TRPI81_0
(TRP RNA-BINDING
ATTENUATION PROTEIN)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.43A 1c9sH-3l4gA:
undetectable
1c9sI-3l4gA:
undetectable		 1c9sH-3l4gA:
9.81
1c9sI-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C9S_K_TRPK81_0
(TRP RNA-BINDING
ATTENUATION PROTEIN)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 1c9sJ-3l4gA:
undetectable
1c9sK-3l4gA:
undetectable		 1c9sJ-3l4gA:
9.81
1c9sK-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C9S_L_TRPL81_0
(TRP RNA-BINDING
ATTENUATION PROTEIN)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.46A 1c9sL-3l4gA:
undetectable
1c9sM-3l4gA:
undetectable		 1c9sL-3l4gA:
9.81
1c9sM-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C9S_M_TRPM81_0
(TRP RNA-BINDING
ATTENUATION PROTEIN)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.45A 1c9sM-3l4gA:
undetectable
1c9sN-3l4gA:
undetectable		 1c9sM-3l4gA:
9.81
1c9sN-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C9S_O_TRPO81_0
(TRP RNA-BINDING
ATTENUATION PROTEIN)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.45A 1c9sO-3l4gA:
undetectable
1c9sP-3l4gA:
undetectable		 1c9sO-3l4gA:
9.81
1c9sP-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C9S_S_TRPS81_0
(TRP RNA-BINDING
ATTENUATION PROTEIN)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.45A 1c9sS-3l4gA:
undetectable
1c9sT-3l4gA:
undetectable		 1c9sS-3l4gA:
9.81
1c9sT-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CMA_B_SAMB105_0
(PROTEIN (MET
REPRESSOR))		 4egs RIBOSE 5-PHOSPHATE
ISOMERASE RPIB
(Caldanaerobacter
subterraneus) 		5 / 11 LEU A  83
LEU A 135
ALA A  17
PHE A  21
GLY A  19
 LEU  A  83 ( 0.6A)
LEU  A 135 ( 0.6A)
ALA  A  17 ( 0.0A)
PHE  A  21 ( 1.3A)
GLY  A  19 ( 0.0A)
 1.14A 1cmaA-4egsA:
undetectable
1cmaB-4egsA:
undetectable		 1cmaA-4egsA:
21.20
1cmaB-4egsA:
21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CMC_A_SAMA105_0
(MET REPRESSOR)		 4egs RIBOSE 5-PHOSPHATE
ISOMERASE RPIB
(Caldanaerobacter
subterraneus) 		5 / 10 ALA A  17
PHE A  21
GLY A  19
LEU A  83
LEU A 135
 ALA  A  17 ( 0.0A)
PHE  A  21 ( 1.3A)
GLY  A  19 ( 0.0A)
LEU  A  83 ( 0.6A)
LEU  A 135 ( 0.6A)
 1.11A 1cmcA-4egsA:
undetectable
1cmcB-4egsA:
undetectable		 1cmcA-4egsA:
21.20
1cmcB-4egsA:
21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CMC_B_SAMB105_0
(MET REPRESSOR)		 4egs RIBOSE 5-PHOSPHATE
ISOMERASE RPIB
(Caldanaerobacter
subterraneus) 		5 / 10 LEU A  83
LEU A 135
ALA A  17
PHE A  21
GLY A  19
 LEU  A  83 ( 0.6A)
LEU  A 135 ( 0.6A)
ALA  A  17 ( 0.0A)
PHE  A  21 ( 1.3A)
GLY  A  19 ( 0.0A)
 1.15A 1cmcA-4egsA:
undetectable
1cmcB-4egsA:
undetectable		 1cmcA-4egsA:
21.20
1cmcB-4egsA:
21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1DRB_B_MTXB361_1
(DIHYDROFOLATE
REDUCTASE)		 3eqz RESPONSE REGULATOR
(Colwellia
psychrerythraea) 		5 / 12 LEU A 114
PHE A 117
ILE A  48
LEU A 121
ILE A 102
 LEU  A 114 ( 0.6A)
PHE  A 117 ( 1.3A)
ILE  A  48 ( 0.7A)
LEU  A 121 ( 0.6A)
ILE  A 102 ( 0.7A)
 0.87A 1drbB-3eqzA:
undetectable		 1drbB-3eqzA:
17.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1DTL_A_BEPA204_1
(CARDIAC TROPONIN C)		 4gow CALMODULIN
(Homo
sapiens) 		8 / 11 PHE D  19
ILE D  27
LEU D  32
MET D  36
LEU D  39
MET D  51
VAL D  55
MET D  71
 PHE  D  19 ( 1.3A)
ILE  D  27 ( 0.7A)
LEU  D  32 ( 0.6A)
MET  D  36 ( 0.0A)
LEU  D  39 ( 0.5A)
MET  D  51 ( 0.0A)
VAL  D  55 ( 0.6A)
MET  D  71 ( 0.0A)
 0.74A 1dtlA-4gowD:
12.2		 1dtlA-4gowD:
53.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1DTL_A_BEPA204_1
(CARDIAC TROPONIN C)		 4gow CALMODULIN
(Homo
sapiens) 		6 / 11 PHE D  92
ILE D 100
LEU D 105
LEU D 112
MET D 124
MET D 144
 PHE  D  92 ( 1.3A)
ILE  D 100 ( 0.7A)
LEU  D 105 ( 0.6A)
LEU  D 112 ( 0.6A)
MET  D 124 ( 0.0A)
MET  D 144 ( 0.0A)
 0.79A 1dtlA-4gowD:
12.2		 1dtlA-4gowD:
53.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1DTL_A_BEPA204_1
(CARDIAC TROPONIN C)		 4gow CALMODULIN
(Homo
sapiens) 		6 / 11 PHE D  92
ILE D 100
LEU D 105
LEU D 112
MET D 124
MET D 145
 PHE  D  92 ( 1.3A)
ILE  D 100 ( 0.7A)
LEU  D 105 ( 0.6A)
LEU  D 112 ( 0.6A)
MET  D 124 ( 0.0A)
MET  D 145 ( 0.0A)
 1.26A 1dtlA-4gowD:
12.2		 1dtlA-4gowD:
53.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1DTL_A_BEPA204_1
(CARDIAC TROPONIN C)		 4gow CALMODULIN
(Homo
sapiens) 		6 / 11 PHE D  92
ILE D 100
LEU D 105
LEU D 112
MET D 145
LEU D  18
 PHE  D  92 ( 1.3A)
ILE  D 100 ( 0.7A)
LEU  D 105 ( 0.6A)
LEU  D 112 ( 0.6A)
MET  D 145 ( 0.0A)
LEU  D  18 ( 0.6A)
 1.29A 1dtlA-4gowD:
12.2		 1dtlA-4gowD:
53.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1DZ4_A_CAMA502_0
(CYTOCHROME P450-CAM)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		4 / 6 PHE C 251
LEU C 280
VAL C 289
ASP C 273
 PHE  C 251 ( 1.3A)
LEU  C 280 ( 0.5A)
VAL  C 289 ( 0.5A)
ASP  C 273 ( 0.6A)
 0.99A 1dz4A-5lmxC:
undetectable		 1dz4A-5lmxC:
22.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1DZ4_B_CAMB502_0
(CYTOCHROME P450-CAM)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		4 / 6 PHE C 251
LEU C 280
VAL C 289
ASP C 273
 PHE  C 251 ( 1.3A)
LEU  C 280 ( 0.5A)
VAL  C 289 ( 0.5A)
ASP  C 273 ( 0.6A)
 0.97A 1dz4B-5lmxC:
undetectable		 1dz4B-5lmxC:
22.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1E71_M_ASCM995_0
(MYROSINASE MA1)		 5c05 PUTATIVE
GAMMA-TERPINENE
SYNTHASE
(Thymus
vulgaris) 		4 / 7 ILE A 204
ARG A 161
PHE A 157
PHE A 183
 ILE  A 204 ( 0.7A)
ARG  A 161 (-0.6A)
PHE  A 157 ( 1.3A)
PHE  A 183 ( 1.3A)
 1.09A 1e71M-5c05A:
undetectable		 1e71M-5c05A:
22.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1E72_M_ASCM995_0
(MYROSINASE MA1)		 5c05 PUTATIVE
GAMMA-TERPINENE
SYNTHASE
(Thymus
vulgaris) 		4 / 7 ILE A 204
ARG A 161
PHE A 157
PHE A 183
 ILE  A 204 ( 0.7A)
ARG  A 161 (-0.6A)
PHE  A 157 ( 1.3A)
PHE  A 183 ( 1.3A)
 1.12A 1e72M-5c05A:
undetectable		 1e72M-5c05A:
22.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1E73_M_ASCM995_0
(MYROSINASE MA1)		 5c05 PUTATIVE
GAMMA-TERPINENE
SYNTHASE
(Thymus
vulgaris) 		4 / 6 ILE A 204
ARG A 161
PHE A 157
PHE A 183
 ILE  A 204 ( 0.7A)
ARG  A 161 (-0.6A)
PHE  A 157 ( 1.3A)
PHE  A 183 ( 1.3A)
 1.07A 1e73M-5c05A:
undetectable		 1e73M-5c05A:
22.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1E7A_A_PFLA4002_1
(SERUM ALBUMIN)		 2nvv ACETYL-COA
HYDROLASE/TRANSFERAS
E FAMILY PROTEIN
(Porphyromonas
gingivalis) 		3 / 3 PHE A  26
LEU A 330
SER A 308
 PHE  A  26 ( 1.3A)
LEU  A 330 ( 0.6A)
SER  A 308 ( 0.0A)
 0.92A 1e7aA-2nvvA:
undetectable		 1e7aA-2nvvA:
20.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1E7A_A_PFLA4002_1
(SERUM ALBUMIN)		 3r9r PHOSPHORIBOSYLAMINOI
MIDAZOLE-SUCCINOCARB
OXAMIDE SYNTHASE
(Mycobacteroides
abscessus) 		3 / 3 PHE A  29
LEU A  70
SER A  57
 PHE  A  29 ( 1.3A)
LEU  A  70 ( 0.6A)
SER  A  57 ( 0.0A)
 0.81A 1e7aA-3r9rA:
undetectable		 1e7aA-3r9rA:
18.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1E7A_B_PFLB4002_1
(SERUM ALBUMIN)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 6 PHE A 258
LEU A 322
VAL A 278
VAL A 263
 PHE  A 258 ( 1.3A)
LEU  A 322 ( 0.6A)
VAL  A 278 ( 0.6A)
VAL  A 263 ( 0.6A)
 0.89A 1e7aB-4flxA:
undetectable		 1e7aB-4flxA:
22.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1E9L_A_GCSA800_1
(YM1 SECRETORY
PROTEIN)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		8 / 9 TYR A 156
PHE A 184
GLY A 267
ASP A 306
MET A 381
TYR A 383
ASP A 384
TRP A 532
 TYR  A 156 ( 1.3A)
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
ASP  A 306 ( 0.5A)
MET  A 381 ( 0.0A)
TYR  A 383 ( 1.3A)
ASP  A 384 ( 0.5A)
TRP  A 532 ( 0.5A)
 0.84A 1e9lA-5gprA:
42.6		 1e9lA-5gprA:
23.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1EPB_A_9CRA165_2
(EPIDIDYMAL RETINOIC
ACID-BINDING PROTEIN)		 3gle PILIN
(Streptococcus
pyogenes) 		4 / 7 PHE A 194
ALA A 227
VAL A 210
VAL A 245
 PHE  A 194 ( 1.3A)
ALA  A 227 ( 0.0A)
VAL  A 210 ( 0.6A)
VAL  A 245 ( 0.5A)
 0.60A 1epbA-3gleA:
undetectable		 1epbA-3gleA:
23.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1EPB_B_9CRB165_2
(EPIDIDYMAL RETINOIC
ACID-BINDING PROTEIN)		 3gle PILIN
(Streptococcus
pyogenes) 		4 / 8 PHE A 194
ALA A 227
VAL A 210
VAL A 245
 PHE  A 194 ( 1.3A)
ALA  A 227 ( 0.0A)
VAL  A 210 ( 0.6A)
VAL  A 245 ( 0.5A)
 0.63A 1epbB-3gleA:
undetectable		 1epbB-3gleA:
23.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1EQB_A_FFOA1293_1
(SERINE
HYDROXYMETHYLTRANSFE
RASE)		 4urs DIGUANYLATE CYCLASE
(Thermotoga
maritima) 		3 / 3 GLU A 170
TYR A 166
PHE A 124
 GLU  A 170 ( 0.6A)
TYR  A 166 ( 1.3A)
PHE  A 124 ( 1.3A)
 0.92A 1eqbB-4ursA:
undetectable		 1eqbB-4ursA:
16.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1EQB_B_FFOB2293_0
(SERINE
HYDROXYMETHYLTRANSFE
RASE)		 4urs DIGUANYLATE CYCLASE
(Thermotoga
maritima) 		3 / 3 GLU A 170
TYR A 166
PHE A 124
 GLU  A 170 ( 0.6A)
TYR  A 166 ( 1.3A)
PHE  A 124 ( 1.3A)
 0.92A 1eqbA-4ursA:
undetectable		 1eqbA-4ursA:
16.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1EQB_C_FFOC3293_2
(SERINE
HYDROXYMETHYLTRANSFE
RASE)		 4urs DIGUANYLATE CYCLASE
(Thermotoga
maritima) 		3 / 3 GLU A 170
TYR A 166
PHE A 124
 GLU  A 170 ( 0.6A)
TYR  A 166 ( 1.3A)
PHE  A 124 ( 1.3A)
 0.92A 1eqbD-4ursA:
undetectable		 1eqbD-4ursA:
16.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1EQB_D_FFOD4293_0
(SERINE
HYDROXYMETHYLTRANSFE
RASE)		 4urs DIGUANYLATE CYCLASE
(Thermotoga
maritima) 		3 / 3 GLU A 170
TYR A 166
PHE A 124
 GLU  A 170 ( 0.6A)
TYR  A 166 ( 1.3A)
PHE  A 124 ( 1.3A)
 0.93A 1eqbC-4ursA:
undetectable		 1eqbC-4ursA:
16.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FDS_A_ESTA350_1
(17-BETA-HYDROXYSTERO
ID-DEHYDROGENASE)		 5xlu GAMMA GLUTAMYL
TRANSPEPTIDASE
(Bacillus
licheniformis) 		5 / 12 LEU A 150
GLY A  86
SER A 233
PHE A 236
MET A 162
 LEU  A 150 ( 0.6A)
GLY  A  86 ( 0.0A)
SER  A 233 ( 0.0A)
PHE  A 236 ( 1.3A)
MET  A 162 ( 0.0A)
 1.42A 1fdsA-5xluA:
undetectable		 1fdsA-5xluA:
13.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FDU_C_ESTC353_1
(17-BETA-HYDROXYSTERO
ID DEHYDROGENASE)		 5ve2 ENOYL-COA HYDRATASE
(Pseudoalteromona
s
atlantica) 		5 / 12 LEU A  35
TYR A  32
GLY A 107
PHE A  60
VAL A  51
 LEU  A  35 ( 0.6A)
TYR  A  32 ( 1.3A)
GLY  A 107 ( 0.0A)
PHE  A  60 ( 1.3A)
VAL  A  51 ( 0.6A)
 1.10A 1fduC-5ve2A:
undetectable		 1fduC-5ve2A:
24.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GFZ_A_CFFA940_1
(GLYCOGEN
PHOSPHORYLASE)		 1omo ALANINE
DEHYDROGENASE
(Archaeoglobus
fulgidus) 		4 / 6 ASN A 214
PHE A 288
ALA A 117
GLY A 114
 ASN  A 214 ( 0.6A)
PHE  A 288 ( 1.3A)
ALA  A 117 ( 0.0A)
GLY  A 114 ( 0.0A)
 1.09A 1gfzA-1omoA:
undetectable		 1gfzA-1omoA:
18.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GFZ_A_CFFA940_1
(GLYCOGEN
PHOSPHORYLASE)		 1zef ALKALINE PHOSPHATASE
(Homo
sapiens) 		4 / 6 ASN A  84
PHE A 107
ALA A  94
GLY A  93
 None
PHE  A 802 (-4.4A)
None
SEP  A  92 ( 2.4A)
 1.04A 1gfzA-1zefA:
undetectable		 1gfzA-1zefA:
20.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GSE_B_EAAB224_1
(GLUTATHIONE
TRANSFERASE)		 2vbf BRANCHED-CHAIN
ALPHA-KETOACID
DECARBOXYLASE
(Lactococcus
lactis) 		6 / 12 ARG A 134
PRO A 159
VAL A  93
LEU A  83
ALA A  79
PHE A  68
 ARG  A 134 ( 0.6A)
PRO  A 159 ( 1.1A)
VAL  A  93 ( 0.6A)
LEU  A  83 ( 0.6A)
ALA  A  79 ( 0.0A)
PHE  A  68 ( 1.3A)
 1.44A 1gseB-2vbfA:
undetectable		 1gseB-2vbfA:
19.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GSF_C_EAAC223_1
(GLUTATHIONE
TRANSFERASE A1-1)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		4 / 8 PHE A 379
GLY A 528
LEU A 549
PHE A 530
 PHE  A 379 ( 1.3A)
GLY  A 528 ( 0.0A)
LEU  A 549 ( 0.6A)
PHE  A 530 ( 1.3A)
 1.02A 1gsfC-5gprA:
undetectable		 1gsfC-5gprA:
17.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GTF_A_TRPA81_0
(TRP RNA-BINDING
ATTENUATION PROTEIN
(TRAP))		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.43A 1gtfA-3l4gA:
undetectable
1gtfK-3l4gA:
undetectable		 1gtfA-3l4gA:
9.81
1gtfK-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GTF_B_TRPB81_0
(TRP RNA-BINDING
ATTENUATION PROTEIN
(TRAP))		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 1gtfA-3l4gA:
undetectable
1gtfB-3l4gA:
undetectable		 1gtfA-3l4gA:
9.81
1gtfB-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GTF_C_TRPC81_0
(TRP RNA-BINDING
ATTENUATION PROTEIN
(TRAP))		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 1gtfB-3l4gA:
undetectable
1gtfC-3l4gA:
undetectable		 1gtfB-3l4gA:
9.81
1gtfC-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GTF_F_TRPF81_0
(TRP RNA-BINDING
ATTENUATION PROTEIN
(TRAP))		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.45A 1gtfE-3l4gA:
undetectable
1gtfF-3l4gA:
undetectable		 1gtfE-3l4gA:
9.81
1gtfF-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GTF_G_TRPG81_0
(TRP RNA-BINDING
ATTENUATION PROTEIN
(TRAP))		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.43A 1gtfF-3l4gA:
undetectable
1gtfG-3l4gA:
undetectable		 1gtfF-3l4gA:
9.81
1gtfG-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GTF_H_TRPH81_0
(TRP RNA-BINDING
ATTENUATION PROTEIN
(TRAP))		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.43A 1gtfG-3l4gA:
undetectable
1gtfH-3l4gA:
undetectable		 1gtfG-3l4gA:
9.81
1gtfH-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GTF_J_TRPJ81_0
(TRP RNA-BINDING
ATTENUATION PROTEIN
(TRAP))		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.44A 1gtfI-3l4gA:
undetectable
1gtfJ-3l4gA:
undetectable		 1gtfI-3l4gA:
9.81
1gtfJ-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GTF_O_TRPO81_0
(TRP RNA-BINDING
ATTENUATION PROTEIN
(TRAP))		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.46A 1gtfO-3l4gA:
undetectable
1gtfP-3l4gA:
undetectable		 1gtfO-3l4gA:
9.81
1gtfP-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GTF_P_TRPP81_0
(TRP RNA-BINDING
ATTENUATION PROTEIN
(TRAP))		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.45A 1gtfP-3l4gA:
undetectable
1gtfQ-3l4gA:
undetectable		 1gtfP-3l4gA:
9.81
1gtfQ-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GTN_A_TRPA81_0
(TRP RNA-BINDING
ATTENUATION PROTEIN)		 3lkv UNCHARACTERIZED
CONSERVED DOMAIN
PROTEIN
(Vibrio
cholerae) 		4 / 7 GLY A 266
ALA A 116
THR A 269
ILE A 265
 None
PHE  A 601 (-4.6A)
None
None
 0.81A 1gtnA-3lkvA:
undetectable
1gtnK-3lkvA:
undetectable		 1gtnA-3lkvA:
13.76
1gtnK-3lkvA:
13.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GTN_B_TRPB81_0
(TRP RNA-BINDING
ATTENUATION PROTEIN)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 8 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.38A 1gtnA-3l4gA:
undetectable
1gtnB-3l4gA:
undetectable		 1gtnA-3l4gA:
9.81
1gtnB-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GTN_P_TRPP81_0
(TRP RNA-BINDING
ATTENUATION PROTEIN)		 3lkv UNCHARACTERIZED
CONSERVED DOMAIN
PROTEIN
(Vibrio
cholerae) 		4 / 8 GLY A 266
ALA A 116
THR A 269
ILE A 265
 None
PHE  A 601 (-4.6A)
None
None
 0.82A 1gtnP-3lkvA:
undetectable
1gtnQ-3lkvA:
undetectable		 1gtnP-3lkvA:
13.76
1gtnQ-3lkvA:
13.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GTN_R_TRPR81_0
(TRP RNA-BINDING
ATTENUATION PROTEIN)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.45A 1gtnR-3l4gA:
undetectable
1gtnS-3l4gA:
undetectable		 1gtnR-3l4gA:
9.81
1gtnS-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1H4O_A_BEZA1162_0
(PEROXIREDOXIN 5)		 2ogs THERMOSTABLE
CARBOXYLESTERASE
EST50
(Geobacillus
stearothermophil
us) 		5 / 10 THR A 135
GLY A 115
LEU A 413
PHE A 417
GLY A 107
 THR  A 135 ( 0.8A)
GLY  A 115 ( 0.0A)
LEU  A 413 ( 0.6A)
PHE  A 417 ( 1.3A)
GLY  A 107 ( 0.0A)
 1.40A 1h4oA-2ogsA:
undetectable
1h4oB-2ogsA:
undetectable		 1h4oA-2ogsA:
15.29
1h4oB-2ogsA:
15.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1H4O_A_BEZA1162_0
(PEROXIREDOXIN 5)		 4kqn D-HYDANTOINASE
(Bacillus
sp.
AR9) 		5 / 10 PRO A  57
LEU A 375
PHE A 376
THR A 311
GLY A 261
 PRO  A  57 ( 1.1A)
LEU  A 375 ( 0.6A)
PHE  A 376 ( 1.3A)
THR  A 311 ( 0.8A)
GLY  A 261 ( 0.0A)
 0.92A 1h4oA-4kqnA:
undetectable
1h4oB-4kqnA:
undetectable		 1h4oA-4kqnA:
17.39
1h4oB-4kqnA:
17.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1H8S_A_AICA1000_1
(MUTANT AL2 6E7P9G)		 5gru DIABODY PROTEIN
(Homo
sapiens;
Mus
musculus) 		6 / 12 TYR H 170
GLN H 223
PHE H 232
ASN L  36
ALA L  97
TRP L 106
 TYR  H 170 ( 1.3A)
GLN  H 223 ( 0.6A)
PHE  H 232 ( 1.3A)
ASN  L  36 ( 0.6A)
ALA  L  97 ( 0.0A)
TRP  L 106 ( 0.5A)
 0.74A 1h8sA-5gruH:
21.4		 1h8sA-5gruH:
29.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1H8S_A_AICA1000_1
(MUTANT AL2 6E7P9G)		 5gru DIABODY PROTEIN
(Homo
sapiens;
Mus
musculus) 		6 / 12 TYR L 157
GLN L 210
PHE L 219
VAL H  37
ALA H  97
TRP H 119
 TYR  L 157 ( 1.3A)
GLN  L 210 ( 0.6A)
PHE  L 219 ( 1.3A)
VAL  H  37 ( 0.6A)
ALA  H  97 ( 0.0A)
TRP  H 119 ( 0.5A)
 0.72A 1h8sA-5gruL:
13.9		 1h8sA-5gruL:
26.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HVY_C_D16C416_1
(THYMIDYLATE SYNTHASE)		 3ab7 PUTATIVE
UNCHARACTERIZED
PROTEIN TTHA0350
(Thermus
thermophilus) 		5 / 11 ILE A 257
ASN A 259
ASP A 124
GLY A 125
PHE A 126
 ILE  A 257 ( 0.6A)
ASN  A 259 ( 0.6A)
ASP  A 124 ( 0.6A)
GLY  A 125 ( 0.0A)
PHE  A 126 ( 1.3A)
 1.34A 1hvyC-3ab7A:
undetectable		 1hvyC-3ab7A:
21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ICU_D_NIOD223_1
(OXYGEN-INSENSITIVE
NAD(P)H
NITROREDUCTASE)		 2vbf BRANCHED-CHAIN
ALPHA-KETOACID
DECARBOXYLASE
(Lactococcus
lactis) 		4 / 5 PHE A 381
GLY A 397
SER A 244
PHE A 395
 PHE  A 381 ( 1.3A)
GLY  A 397 ( 0.0A)
SER  A 244 ( 0.0A)
PHE  A 395 ( 1.3A)
 1.34A 1icuC-2vbfA:
undetectable
1icuD-2vbfA:
undetectable		 1icuC-2vbfA:
18.27
1icuD-2vbfA:
18.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JB0_B_PQNB2002_1
(PHOTOSYSTEM I P700
CHLOROPHYLL A
APOPROTEIN A2)		 6c0w HISTONE H3-LIKE
CENTROMERIC PROTEIN
A
HISTONE H4
(Homo
sapiens) 		5 / 11 PHE A 106
ARG B  36
ALA B  33
LEU B  37
ALA B  38
 PHE  A 106 ( 1.3A)
ARG  B  36 ( 0.6A)
ALA  B  33 ( 0.0A)
LEU  B  37 ( 0.6A)
ALA  B  38 ( 0.0A)
 1.33A 1jb0B-6c0wA:
undetectable		 1jb0B-6c0wA:
5.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1KIA_C_SAMC2293_0
(GLYCINE
N-METHYLTRANSFERASE)		 3lkv UNCHARACTERIZED
CONSERVED DOMAIN
PROTEIN
(Vibrio
cholerae) 		5 / 12 GLY A  94
VAL A 117
ALA A  31
GLY A 138
LEU A 277
 None
PHE  A 601 (-3.7A)
None
None
None
 1.08A 1kiaC-3lkvA:
undetectable		 1kiaC-3lkvA:
23.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1KIJ_A_NOVA400_2
(DNA GYRASE SUBUNIT B)		 2pnn TRANSIENT RECEPTOR
POTENTIAL CATION
CHANNEL SUBFAMILY V
MEMBER 1
(Rattus
norvegicus) 		3 / 3 ASN A 301
PHE A 245
VAL A 294
 ASN  A 301 ( 0.6A)
PHE  A 245 ( 1.3A)
VAL  A 294 ( 0.5A)
 0.81A 1kijA-2pnnA:
undetectable		 1kijA-2pnnA:
21.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1KQB_D_BEZD523_0
(OXYGEN-INSENSITIVE
NAD(P)H
NITROREDUCTASE)		 1v0f ENDO-ALPHA-SIALIDASE
(Enterobacteria
phage
K1F) 		4 / 6 PHE A 718
GLU A 721
GLY A 720
SER A 700
 PHE  A 718 ( 1.3A)
GLU  A 721 ( 0.6A)
GLY  A 720 ( 0.0A)
SER  A 700 ( 0.0A)
 1.16A 1kqbC-1v0fA:
undetectable
1kqbD-1v0fA:
undetectable		 1kqbC-1v0fA:
14.61
1kqbD-1v0fA:
14.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L5Q_A_CFFA863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)		 1omo ALANINE
DEHYDROGENASE
(Archaeoglobus
fulgidus) 		4 / 6 ASN A 214
PHE A 288
ALA A 117
GLY A 114
 ASN  A 214 ( 0.6A)
PHE  A 288 ( 1.3A)
ALA  A 117 ( 0.0A)
GLY  A 114 ( 0.0A)
 1.06A 1l5qA-1omoA:
0.3		 1l5qA-1omoA:
17.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L5Q_A_CFFA863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)		 1zef ALKALINE PHOSPHATASE
(Homo
sapiens) 		4 / 6 ASN A  84
PHE A 107
ALA A  94
GLY A  93
 None
PHE  A 802 (-4.4A)
None
SEP  A  92 ( 2.4A)
 0.98A 1l5qA-1zefA:
undetectable		 1l5qA-1zefA:
21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L5Q_B_CFFB1863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)		 1omo ALANINE
DEHYDROGENASE
(Archaeoglobus
fulgidus) 		4 / 6 ASN A 214
PHE A 288
ALA A 117
GLY A 114
 ASN  A 214 ( 0.6A)
PHE  A 288 ( 1.3A)
ALA  A 117 ( 0.0A)
GLY  A 114 ( 0.0A)
 1.07A 1l5qB-1omoA:
undetectable		 1l5qB-1omoA:
17.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L5Q_B_CFFB1863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)		 1zef ALKALINE PHOSPHATASE
(Homo
sapiens) 		4 / 6 ASN A  84
PHE A 107
ALA A  94
GLY A  93
 None
PHE  A 802 (-4.4A)
None
SEP  A  92 ( 2.4A)
 0.98A 1l5qB-1zefA:
undetectable		 1l5qB-1zefA:
21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L7X_A_CFFA863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)		 1omo ALANINE
DEHYDROGENASE
(Archaeoglobus
fulgidus) 		4 / 6 ASN A 214
PHE A 288
ALA A 117
GLY A 114
 ASN  A 214 ( 0.6A)
PHE  A 288 ( 1.3A)
ALA  A 117 ( 0.0A)
GLY  A 114 ( 0.0A)
 1.02A 1l7xA-1omoA:
undetectable		 1l7xA-1omoA:
17.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L7X_A_CFFA863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)		 1zef ALKALINE PHOSPHATASE
(Homo
sapiens) 		4 / 6 ASN A  84
PHE A 107
ALA A  94
GLY A  93
 None
PHE  A 802 (-4.4A)
None
SEP  A  92 ( 2.4A)
 0.99A 1l7xA-1zefA:
undetectable		 1l7xA-1zefA:
21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L7X_B_CFFB1863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)		 1omo ALANINE
DEHYDROGENASE
(Archaeoglobus
fulgidus) 		4 / 6 ASN A 214
PHE A 288
ALA A 117
GLY A 114
 ASN  A 214 ( 0.6A)
PHE  A 288 ( 1.3A)
ALA  A 117 ( 0.0A)
GLY  A 114 ( 0.0A)
 1.01A 1l7xB-1omoA:
undetectable		 1l7xB-1omoA:
17.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L7X_B_CFFB1863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)		 1zef ALKALINE PHOSPHATASE
(Homo
sapiens) 		4 / 6 ASN A  84
PHE A 107
ALA A  94
GLY A  93
 None
PHE  A 802 (-4.4A)
None
SEP  A  92 ( 2.4A)
 1.03A 1l7xB-1zefA:
undetectable		 1l7xB-1zefA:
21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1LHV_A_NOGA301_1
(SEX HORMONE-BINDING
GLOBULIN)		 1aoa T-FIMBRIN
(Homo
sapiens) 		4 / 8 THR A 354
ASP A 357
PHE A 352
ASN A 362
 THR  A 354 ( 0.8A)
ASP  A 357 ( 0.6A)
PHE  A 352 ( 1.3A)
ASN  A 362 ( 0.6A)
 0.97A 1lhvA-1aoaA:
undetectable		 1lhvA-1aoaA:
23.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1LIN_A_TFPA155_1
(CALMODULIN)		 4hne PHOSPHATIDYLINOSITOL
4-KINASE TYPE
2-ALPHA
(Homo
sapiens) 		4 / 7 GLN A 261
GLU A 193
PHE A 364
ALA A 343
 GLN  A 261 (-0.6A)
GLU  A 193 ( 0.5A)
PHE  A 364 ( 1.3A)
ALA  A 343 ( 0.0A)
 1.36A 1linA-4hneA:
undetectable		 1linA-4hneA:
16.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1LQT_A_ACTA1871_0
(FPRA)		 1gc7 RADIXIN
(Mus
musculus) 		4 / 7 PRO A  86
ALA A  82
PHE A  45
PHE A  44
 PRO  A  86 ( 1.1A)
ALA  A  82 ( 0.0A)
PHE  A  45 ( 1.3A)
PHE  A  44 ( 1.3A)
 1.19A 1lqtA-1gc7A:
undetectable		 1lqtA-1gc7A:
22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1LQU_A_ACTA1428_0
(FPRA)		 1gc7 RADIXIN
(Mus
musculus) 		4 / 7 PRO A  86
ALA A  82
PHE A  45
PHE A  44
 PRO  A  86 ( 1.1A)
ALA  A  82 ( 0.0A)
PHE  A  45 ( 1.3A)
PHE  A  44 ( 1.3A)
 1.19A 1lquA-1gc7A:
undetectable		 1lquA-1gc7A:
22.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1LXF_C_BEPC92_1
(TROPONIN C, SLOW
SKELETAL AND CARDIAC
MUSCLES)		 4gow CALMODULIN
(Homo
sapiens) 		7 / 12 PHE D  92
ILE D 100
LEU D 105
MET D 124
ILE D 125
VAL D 136
MET D 145
 PHE  D  92 ( 1.3A)
ILE  D 100 ( 0.7A)
LEU  D 105 ( 0.6A)
MET  D 124 ( 0.0A)
ILE  D 125 ( 0.4A)
VAL  D 136 ( 0.6A)
MET  D 145 ( 0.0A)
 0.78A 1lxfC-4gowD:
9.8		 1lxfC-4gowD:
67.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1LXF_C_BEPC92_1
(TROPONIN C, SLOW
SKELETAL AND CARDIAC
MUSCLES)		 4gow CALMODULIN
(Homo
sapiens) 		6 / 12 PHE D  92
LEU D 105
MET D 124
ILE D 125
GLU D 127
VAL D 136
 PHE  D  92 ( 1.3A)
LEU  D 105 ( 0.6A)
MET  D 124 ( 0.0A)
ILE  D 125 ( 0.4A)
GLU  D 127 ( 0.6A)
VAL  D 136 ( 0.6A)
 0.94A 1lxfC-4gowD:
9.8		 1lxfC-4gowD:
67.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MCN_P_DHIP1_0
(IMMUNOGLOBULIN
LAMBDA DIMER MCG
(LIGHT CHAIN)
PEPTIDE
N-ACETYL-D-HIS-L-PRO
-NH2)		 3sag EXOSOME COMPONENT 10
(Homo
sapiens) 		3 / 3 PHE A 198
TYR A 382
PRO A 200
 PHE  A 198 ( 1.3A)
TYR  A 382 ( 1.3A)
PRO  A 200 ( 1.1A)
 1.15A 1mcnA-3sagA:
undetectable
1mcnB-3sagA:
undetectable
1mcnP-3sagA:
undetectable		 1mcnA-3sagA:
17.45
1mcnB-3sagA:
17.45
1mcnP-3sagA:
2.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MCN_P_DHIP1_0
(IMMUNOGLOBULIN
LAMBDA DIMER MCG
(LIGHT CHAIN)
PEPTIDE
N-ACETYL-D-HIS-L-PRO
-NH2)		 6gef TYPE IV SECRETION
SYSTEM PROTEIN DOTB
(Yersinia
pseudotuberculos
is) 		3 / 3 PHE A  21
TYR A  15
PRO A  18
 PHE  A  21 ( 1.3A)
TYR  A  15 ( 1.3A)
PRO  A  18 ( 1.1A)
 1.09A 1mcnA-6gefA:
undetectable
1mcnB-6gefA:
undetectable
1mcnP-6gefA:
undetectable		 1mcnA-6gefA:
undetectable
1mcnB-6gefA:
undetectable
1mcnP-6gefA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MJ2_A_SAMA2200_0
(PROTEIN (METHIONINE
REPRESSOR))		 4egs RIBOSE 5-PHOSPHATE
ISOMERASE RPIB
(Caldanaerobacter
subterraneus) 		5 / 12 ALA A  17
PHE A  21
GLY A  19
LEU A  83
LEU A 135
 ALA  A  17 ( 0.0A)
PHE  A  21 ( 1.3A)
GLY  A  19 ( 0.0A)
LEU  A  83 ( 0.6A)
LEU  A 135 ( 0.6A)
 1.15A 1mj2A-4egsA:
undetectable
1mj2B-4egsA:
undetectable		 1mj2A-4egsA:
21.20
1mj2B-4egsA:
21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MJ2_A_SAMA2201_1
(PROTEIN (METHIONINE
REPRESSOR))		 1wha KIAA0147 PROTEIN
(Homo
sapiens) 		4 / 4 HIS A  76
ALA A  25
PHE A  41
GLY A  27
 HIS  A  76 ( 1.0A)
ALA  A  25 ( 0.0A)
PHE  A  41 ( 1.3A)
GLY  A  27 ( 0.0A)
 1.21A 1mj2B-1whaA:
undetectable		 1mj2B-1whaA:
23.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MJ2_C_SAMC1200_1
(PROTEIN (METHIONINE
REPRESSOR))		 1wha KIAA0147 PROTEIN
(Homo
sapiens) 		4 / 4 HIS A  76
ALA A  25
PHE A  41
GLY A  27
 HIS  A  76 ( 1.0A)
ALA  A  25 ( 0.0A)
PHE  A  41 ( 1.3A)
GLY  A  27 ( 0.0A)
 1.20A 1mj2D-1whaA:
undetectable		 1mj2D-1whaA:
23.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MJ2_C_SAMC2199_0
(PROTEIN (METHIONINE
REPRESSOR))		 4egs RIBOSE 5-PHOSPHATE
ISOMERASE RPIB
(Caldanaerobacter
subterraneus) 		5 / 12 ALA A  17
PHE A  21
GLY A  19
LEU A  83
LEU A 135
 ALA  A  17 ( 0.0A)
PHE  A  21 ( 1.3A)
GLY  A  19 ( 0.0A)
LEU  A  83 ( 0.6A)
LEU  A 135 ( 0.6A)
 1.10A 1mj2C-4egsA:
undetectable
1mj2D-4egsA:
undetectable		 1mj2C-4egsA:
21.20
1mj2D-4egsA:
21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MJO_A_SAMA199_1
(METHIONINE REPRESSOR)		 1wha KIAA0147 PROTEIN
(Homo
sapiens) 		4 / 4 HIS A  76
ALA A  25
PHE A  41
GLY A  27
 HIS  A  76 ( 1.0A)
ALA  A  25 ( 0.0A)
PHE  A  41 ( 1.3A)
GLY  A  27 ( 0.0A)
 1.20A 1mjoB-1whaA:
undetectable		 1mjoB-1whaA:
23.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MJO_B_SAMB200_0
(METHIONINE REPRESSOR)		 1wha KIAA0147 PROTEIN
(Homo
sapiens) 		4 / 4 HIS A  76
ALA A  25
PHE A  41
GLY A  27
 HIS  A  76 ( 1.0A)
ALA  A  25 ( 0.0A)
PHE  A  41 ( 1.3A)
GLY  A  27 ( 0.0A)
 1.24A 1mjoA-1whaA:
undetectable		 1mjoA-1whaA:
23.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MJO_C_SAMC200_0
(METHIONINE REPRESSOR)		 4egs RIBOSE 5-PHOSPHATE
ISOMERASE RPIB
(Caldanaerobacter
subterraneus) 		5 / 12 ALA A  17
PHE A  21
GLY A  19
LEU A  83
LEU A 135
 ALA  A  17 ( 0.0A)
PHE  A  21 ( 1.3A)
GLY  A  19 ( 0.0A)
LEU  A  83 ( 0.6A)
LEU  A 135 ( 0.6A)
 1.10A 1mjoC-4egsA:
undetectable
1mjoD-4egsA:
undetectable		 1mjoC-4egsA:
21.20
1mjoD-4egsA:
21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MJO_D_SAMD200_1
(METHIONINE REPRESSOR)		 1wha KIAA0147 PROTEIN
(Homo
sapiens) 		4 / 4 HIS A  76
ALA A  25
PHE A  41
GLY A  27
 HIS  A  76 ( 1.0A)
ALA  A  25 ( 0.0A)
PHE  A  41 ( 1.3A)
GLY  A  27 ( 0.0A)
 1.19A 1mjoD-1whaA:
undetectable		 1mjoD-1whaA:
23.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MJQ_A_SAMA200_0
(METHIONINE REPRESSOR)		 4egs RIBOSE 5-PHOSPHATE
ISOMERASE RPIB
(Caldanaerobacter
subterraneus) 		5 / 11 LEU A  83
LEU A 135
ALA A  17
PHE A  21
GLY A  19
 LEU  A  83 ( 0.6A)
LEU  A 135 ( 0.6A)
ALA  A  17 ( 0.0A)
PHE  A  21 ( 1.3A)
GLY  A  19 ( 0.0A)
 1.06A 1mjqA-4egsA:
undetectable
1mjqB-4egsA:
undetectable		 1mjqA-4egsA:
21.20
1mjqB-4egsA:
21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MJQ_C_SAMC199_0
(METHIONINE REPRESSOR)		 4egs RIBOSE 5-PHOSPHATE
ISOMERASE RPIB
(Caldanaerobacter
subterraneus) 		5 / 10 LEU A  83
LEU A 135
ALA A  17
PHE A  21
GLY A  19
 LEU  A  83 ( 0.6A)
LEU  A 135 ( 0.6A)
ALA  A  17 ( 0.0A)
PHE  A  21 ( 1.3A)
GLY  A  19 ( 0.0A)
 1.10A 1mjqC-4egsA:
undetectable
1mjqD-4egsA:
undetectable		 1mjqC-4egsA:
21.20
1mjqD-4egsA:
21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MJQ_D_SAMD200_0
(METHIONINE REPRESSOR)		 4egs RIBOSE 5-PHOSPHATE
ISOMERASE RPIB
(Caldanaerobacter
subterraneus) 		5 / 12 ALA A  17
PHE A  21
GLY A  19
LEU A  83
LEU A 135
 ALA  A  17 ( 0.0A)
PHE  A  21 ( 1.3A)
GLY  A  19 ( 0.0A)
LEU  A  83 ( 0.6A)
LEU  A 135 ( 0.6A)
 1.12A 1mjqC-4egsA:
undetectable
1mjqD-4egsA:
undetectable		 1mjqC-4egsA:
21.20
1mjqD-4egsA:
21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MJQ_I_SAMI199_0
(METHIONINE REPRESSOR)		 4egs RIBOSE 5-PHOSPHATE
ISOMERASE RPIB
(Caldanaerobacter
subterraneus) 		5 / 11 LEU A  83
LEU A 135
ALA A  17
PHE A  21
GLY A  19
 LEU  A  83 ( 0.6A)
LEU  A 135 ( 0.6A)
ALA  A  17 ( 0.0A)
PHE  A  21 ( 1.3A)
GLY  A  19 ( 0.0A)
 1.11A 1mjqI-4egsA:
undetectable
1mjqJ-4egsA:
undetectable		 1mjqI-4egsA:
21.20
1mjqJ-4egsA:
21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MJQ_J_SAMJ200_0
(METHIONINE REPRESSOR)		 4egs RIBOSE 5-PHOSPHATE
ISOMERASE RPIB
(Caldanaerobacter
subterraneus) 		5 / 12 ALA A  17
PHE A  21
GLY A  19
LEU A  83
LEU A 135
 ALA  A  17 ( 0.0A)
PHE  A  21 ( 1.3A)
GLY  A  19 ( 0.0A)
LEU  A  83 ( 0.6A)
LEU  A 135 ( 0.6A)
 1.12A 1mjqI-4egsA:
undetectable
1mjqJ-4egsA:
undetectable		 1mjqI-4egsA:
21.20
1mjqJ-4egsA:
21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MX1_D_THAD4_2
(LIVER
CARBOXYLESTERASE I)		 2vbf BRANCHED-CHAIN
ALPHA-KETOACID
DECARBOXYLASE
(Lactococcus
lactis) 		3 / 3 PHE A 318
LEU A 303
MET A 300
 PHE  A 318 ( 1.3A)
LEU  A 303 ( 0.6A)
MET  A 300 ( 0.0A)
 0.77A 1mx1D-2vbfA:
undetectable		 1mx1D-2vbfA:
22.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MX1_D_THAD4_2
(LIVER
CARBOXYLESTERASE I)		 4kqn D-HYDANTOINASE
(Bacillus
sp.
AR9) 		3 / 3 PHE A 418
LEU A 270
MET A 275
 PHE  A 418 ( 1.3A)
LEU  A 270 ( 0.6A)
MET  A 275 ( 0.0A)
 0.84A 1mx1D-4kqnA:
undetectable		 1mx1D-4kqnA:
23.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MXD_A_ACRA733_1
(ALPHA AMYLASE)		 3pco PHENYLALANYL-TRNA
SYNTHETASE, ALPHA
SUBUNIT
(Escherichia
coli) 		4 / 6 SER A 171
THR A 170
ASN A 139
LEU A 165
 PHE  A 980 (-3.5A)
None
None
None
 1.34A 1mxdA-3pcoA:
undetectable		 1mxdA-3pcoA:
19.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1NBH_B_SAMB1293_0
(GLYCINE
N-METHYLTRANSFERASE)		 3lkv UNCHARACTERIZED
CONSERVED DOMAIN
PROTEIN
(Vibrio
cholerae) 		5 / 12 GLY A  94
VAL A 117
ALA A  31
GLY A 138
LEU A 277
 None
PHE  A 601 (-3.7A)
None
None
None
 1.09A 1nbhB-3lkvA:
undetectable		 1nbhB-3lkvA:
23.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1O76_B_CAMB1420_0
(CYTOCHROME P450-CAM)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		4 / 8 PHE C 251
LEU C 280
VAL C 289
ASP C 273
 PHE  C 251 ( 1.3A)
LEU  C 280 ( 0.5A)
VAL  C 289 ( 0.5A)
ASP  C 273 ( 0.6A)
 0.96A 1o76B-5lmxC:
undetectable		 1o76B-5lmxC:
22.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1O86_A_LPRA702_1
(ANGIOTENSIN
CONVERTING ENZYME)		 4kqn D-HYDANTOINASE
(Bacillus
sp.
AR9) 		5 / 12 GLU A 262
HIS A 239
PHE A  65
HIS A 183
TYR A 155
 GLU  A 262 ( 0.6A)
HIS  A 239 (-1.0A)
PHE  A  65 ( 1.3A)
HIS  A 183 (-1.0A)
TYR  A 155 ( 1.3A)
 1.42A 1o86A-4kqnA:
undetectable		 1o86A-4kqnA:
22.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ONI_B_BEZB504_0
(14.5 KDA
TRANSLATIONAL
INHIBITOR PROTEIN)		 1amu GRAMICIDIN
SYNTHETASE 1
(Brevibacillus
brevis) 		4 / 7 LEU A 110
ILE A 106
ALA A 185
ILE A 330
 None
None
None
PHE  A 566 (-4.6A)
 0.96A 1oniB-1amuA:
0.0
1oniC-1amuA:
0.0		 1oniB-1amuA:
14.59
1oniC-1amuA:
14.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1P33_A_MTXA351_1
(PTERIDINE REDUCTASE
1)		 5hfi UNCHARACTERIZED
PROTEIN, CYTOSOLIC
DISULFIDE REDUCTASE
DSBM
(Pseudomonas
aeruginosa) 		5 / 12 PHE A 206
LEU A 191
TYR A 196
LEU A  33
LEU A 211
 PHE  A 206 ( 1.3A)
LEU  A 191 ( 0.6A)
TYR  A 196 ( 1.3A)
LEU  A  33 ( 0.6A)
LEU  A 211 ( 0.6A)
 1.34A 1p33A-5hfiA:
undetectable		 1p33A-5hfiA:
22.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1P33_B_MTXB352_1
(PTERIDINE REDUCTASE
1)		 5hfi UNCHARACTERIZED
PROTEIN, CYTOSOLIC
DISULFIDE REDUCTASE
DSBM
(Pseudomonas
aeruginosa) 		5 / 12 PHE A 206
LEU A 191
TYR A 196
LEU A  33
LEU A 211
 PHE  A 206 ( 1.3A)
LEU  A 191 ( 0.6A)
TYR  A 196 ( 1.3A)
LEU  A  33 ( 0.6A)
LEU  A 211 ( 0.6A)
 1.33A 1p33B-5hfiA:
undetectable		 1p33B-5hfiA:
22.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1P33_C_MTXC353_1
(PTERIDINE REDUCTASE
1)		 5hfi UNCHARACTERIZED
PROTEIN, CYTOSOLIC
DISULFIDE REDUCTASE
DSBM
(Pseudomonas
aeruginosa) 		5 / 12 PHE A 206
LEU A 191
TYR A 196
LEU A  33
LEU A 211
 PHE  A 206 ( 1.3A)
LEU  A 191 ( 0.6A)
TYR  A 196 ( 1.3A)
LEU  A  33 ( 0.6A)
LEU  A 211 ( 0.6A)
 1.29A 1p33C-5hfiA:
undetectable		 1p33C-5hfiA:
22.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1P7R_A_NCTA440_1
(CYTOCHROME P450-CAM)		 1fxj UDP-N-ACETYLGLUCOSAM
INE
PYROPHOSPHORYLASE
(Escherichia
coli) 		4 / 7 PHE A 260
VAL A 284
VAL A 272
ILE A 274
 PHE  A 260 ( 1.3A)
VAL  A 284 ( 0.6A)
VAL  A 272 ( 0.6A)
ILE  A 274 ( 0.7A)
 0.96A 1p7rA-1fxjA:
0.0		 1p7rA-1fxjA:
22.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1P93_A_DEXA1999_1
(GLUCOCORTICOID
RECEPTOR)		 2nvv ACETYL-COA
HYDROLASE/TRANSFERAS
E FAMILY PROTEIN
(Porphyromonas
gingivalis) 		5 / 12 LEU A 307
LEU A 330
GLY A 304
MET A 281
MET A 294
 LEU  A 307 ( 0.6A)
LEU  A 330 ( 0.6A)
GLY  A 304 ( 0.0A)
PHE  A 279 ( 3.6A)
ILE  A 328 ( 3.9A)
 1.48A 1p93A-2nvvA:
undetectable		 1p93A-2nvvA:
18.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1Q23_A_FUAA702_1
(CHLORAMPHENICOL
ACETYLTRANSFERASE)		 5hxk ZINC-DEPENDENT
PEPTIDASE
(Thermus
thermophilus) 		5 / 12 PHE A  98
LEU A  11
VAL A  13
ALA A 349
ALA A 185
 PHE  A  98 ( 1.3A)
LEU  A  11 ( 0.5A)
VAL  A  13 ( 0.6A)
ALA  A 349 ( 0.0A)
ALA  A 185 ( 0.0A)
 1.28A 1q23A-5hxkA:
undetectable
1q23B-5hxkA:
undetectable		 1q23A-5hxkA:
18.01
1q23B-5hxkA:
18.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1Q97_B_ADNB486_1
(SR PROTEIN KINASE)		 5nks DIHYDROPYRIMIDINASE-
RELATED PROTEIN 4
(Homo
sapiens) 		4 / 4 VAL A 328
ALA A 388
LEU A 105
PHE A 392
 VAL  A 328 ( 0.6A)
ALA  A 388 ( 0.0A)
LEU  A 105 ( 0.6A)
PHE  A 392 ( 1.3A)
 1.06A 1q97B-5nksA:
undetectable		 1q97B-5nksA:
21.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1R5L_A_VIVA301_0
(PROTEIN
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN))		 3r64 NAD DEPENDENT
BENZALDEHYDE
DEHYDROGENASE
(Corynebacterium
glutamicum) 		5 / 12 PHE A   7
ILE A 181
ILE A  92
ILE A 166
ILE A 111
 PHE  A   7 ( 1.3A)
ILE  A 181 ( 0.7A)
ILE  A  92 ( 0.7A)
ILE  A 166 ( 0.7A)
ILE  A 111 ( 0.7A)
 1.21A 1r5lA-3r64A:
undetectable		 1r5lA-3r64A:
19.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RA2_A_FOLA161_0
(DIHYDROFOLATE
REDUCTASE)		 3eqz RESPONSE REGULATOR
(Colwellia
psychrerythraea) 		5 / 12 LEU A 114
PHE A 117
ILE A  48
LEU A 121
ILE A 102
 LEU  A 114 ( 0.6A)
PHE  A 117 ( 1.3A)
ILE  A  48 ( 0.7A)
LEU  A 121 ( 0.6A)
ILE  A 102 ( 0.7A)
 0.87A 1ra2A-3eqzA:
undetectable		 1ra2A-3eqzA:
17.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RA8_A_FOLA161_0
(DIHYDROFOLATE
REDUCTASE)		 3eqz RESPONSE REGULATOR
(Colwellia
psychrerythraea) 		5 / 12 LEU A 114
PHE A 117
ILE A  48
LEU A 121
ILE A 102
 LEU  A 114 ( 0.6A)
PHE  A 117 ( 1.3A)
ILE  A  48 ( 0.7A)
LEU  A 121 ( 0.6A)
ILE  A 102 ( 0.7A)
 0.88A 1ra8A-3eqzA:
undetectable		 1ra8A-3eqzA:
17.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RB2_A_FOLA161_0
(DIHYDROFOLATE
REDUCTASE)		 3eqz RESPONSE REGULATOR
(Colwellia
psychrerythraea) 		5 / 12 LEU A 114
PHE A 117
ILE A  48
LEU A 121
ILE A 102
 LEU  A 114 ( 0.6A)
PHE  A 117 ( 1.3A)
ILE  A  48 ( 0.7A)
LEU  A 121 ( 0.6A)
ILE  A 102 ( 0.7A)
 0.87A 1rb2A-3eqzA:
undetectable		 1rb2A-3eqzA:
17.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RD7_A_FOLA161_0
(DIHYDROFOLATE
REDUCTASE)		 3eqz RESPONSE REGULATOR
(Colwellia
psychrerythraea) 		5 / 12 LEU A 114
PHE A 117
ILE A  48
LEU A 121
ILE A 102
 LEU  A 114 ( 0.6A)
PHE  A 117 ( 1.3A)
ILE  A  48 ( 0.7A)
LEU  A 121 ( 0.6A)
ILE  A 102 ( 0.7A)
 0.90A 1rd7A-3eqzA:
undetectable		 1rd7A-3eqzA:
17.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RLB_E_REAE176_1
(RETINOL BINDING
PROTEIN)		 3i4k MUCONATE LACTONIZING
ENZYME
(Corynebacterium
glutamicum) 		5 / 10 LEU A 305
ALA A 143
LEU A 330
ASP A 251
PHE A  26
 LEU  A 305 ( 0.6A)
ALA  A 143 ( 0.0A)
LEU  A 330 ( 0.6A)
ASP  A 251 ( 0.6A)
PHE  A  26 ( 1.3A)
 1.30A 1rlbE-3i4kA:
undetectable		 1rlbE-3i4kA:
18.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RMT_C_ADNC1503_1
(CLASS B ACID
PHOSPHATASE)		 1aoa T-FIMBRIN
(Homo
sapiens) 		4 / 8 PHE A 369
LEU A 341
GLY A 348
ASP A 345
 PHE  A 369 ( 1.3A)
LEU  A 341 ( 0.6A)
GLY  A 348 ( 0.0A)
ASP  A 345 ( 0.6A)
 1.02A 1rmtC-1aoaA:
undetectable		 1rmtC-1aoaA:
20.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RTS_A_D16A309_1
(THYMIDYLATE SYNTHASE)		 1omo ALANINE
DEHYDROGENASE
(Archaeoglobus
fulgidus) 		4 / 8 PHE A 288
ILE A 268
ASP A 277
GLY A 278
 PHE  A 288 ( 1.3A)
ILE  A 268 ( 0.3A)
ASP  A 277 ( 0.5A)
GLY  A 278 ( 0.0A)
 0.86A 1rtsA-1omoA:
undetectable		 1rtsA-1omoA:
21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RU9_H_ACTH611_0
(IMMUNOGLOBULIN
IGG2A, HEAVY CHAIN
IMMUNOGLOBULIN
IGG2A, LIGHT CHAIN)		 3h8m EPHRIN TYPE-A
RECEPTOR 7
(Homo
sapiens) 		4 / 6 LEU A 952
TRP A 931
LEU A 932
PHE A 944
 LEU  A 952 ( 0.5A)
TRP  A 931 ( 0.5A)
LEU  A 932 ( 0.6A)
PHE  A 944 ( 1.4A)
 1.30A 1ru9H-3h8mA:
undetectable
1ru9L-3h8mA:
undetectable		 1ru9H-3h8mA:
14.41
1ru9L-3h8mA:
16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RUK_L_ACTL611_0
(IMMUNOGLOBULIN
IGG2A, HEAVY CHAIN
IMMUNOGLOBULIN
IGG2A, LIGHT CHAIN)		 3h8m EPHRIN TYPE-A
RECEPTOR 7
(Homo
sapiens) 		4 / 6 LEU A 952
TRP A 931
LEU A 932
PHE A 944
 LEU  A 952 ( 0.5A)
TRP  A 931 ( 0.5A)
LEU  A 932 ( 0.6A)
PHE  A 944 ( 1.4A)
 1.35A 1rukH-3h8mA:
undetectable
1rukL-3h8mA:
undetectable		 1rukH-3h8mA:
14.41
1rukL-3h8mA:
16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RV7_B_AB1B1001_1
(PROTEASE)		 3td9 BRANCHED CHAIN AMINO
ACID ABC
TRANSPORTER,
PERIPLASMIC AMINO
ACID-BINDING PROTEIN
(Thermotoga
maritima) 		5 / 11 ALA A  35
ILE A  44
THR A 114
PRO A 115
ALA A 116
 None
None
None
None
PHE  A 400 (-3.6A)
 1.13A 1rv7A-3td9A:
undetectable
1rv7B-3td9A:
undetectable		 1rv7A-3td9A:
17.54
1rv7B-3td9A:
17.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RX2_A_FOLA161_0
(DIHYDROFOLATE
REDUCTASE)		 3eqz RESPONSE REGULATOR
(Colwellia
psychrerythraea) 		5 / 12 LEU A 114
PHE A 117
ILE A  48
LEU A 121
ILE A 102
 LEU  A 114 ( 0.6A)
PHE  A 117 ( 1.3A)
ILE  A  48 ( 0.7A)
LEU  A 121 ( 0.6A)
ILE  A 102 ( 0.7A)
 0.92A 1rx2A-3eqzA:
undetectable		 1rx2A-3eqzA:
17.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SBR_A_VIBA502_1
(YKOF)		 4g9k ROTENONE-INSENSITIVE
NADH-UBIQUINONE
OXIDOREDUCTASE
(Saccharomyces
cerevisiae) 		4 / 6 PHE A  68
ALA A  65
LEU A  69
ILE A  81
 PHE  A  68 ( 1.3A)
ALA  A  65 ( 0.0A)
LEU  A  69 ( 0.6A)
ILE  A  81 ( 0.4A)
 1.08A 1sbrA-4g9kA:
undetectable
1sbrB-4g9kA:
undetectable		 1sbrA-4g9kA:
17.93
1sbrB-4g9kA:
17.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SKX_A_RFPA1_2
(ORPHAN NUCLEAR
RECEPTOR PXR)		 3gnr OS03G0212800 PROTEIN
(Oryza
sativa) 		4 / 5 PHE A 442
LEU A 486
MET A  79
LEU A 120
 PHE  A 442 ( 1.3A)
LEU  A 486 ( 0.6A)
MET  A  79 ( 0.0A)
LEU  A 120 ( 0.6A)
 1.10A 1skxA-3gnrA:
undetectable		 1skxA-3gnrA:
20.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1T85_A_CAMA422_0
(CYTOCHROME P450-CAM)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		4 / 7 PHE C 251
LEU C 280
VAL C 289
ASP C 273
 PHE  C 251 ( 1.3A)
LEU  C 280 ( 0.5A)
VAL  C 289 ( 0.5A)
ASP  C 273 ( 0.6A)
 1.01A 1t85A-5lmxC:
undetectable		 1t85A-5lmxC:
22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1T87_A_CAMA1422_0
(CYTOCHROME P450-CAM)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		4 / 7 PHE C 251
LEU C 280
VAL C 289
ASP C 273
 PHE  C 251 ( 1.3A)
LEU  C 280 ( 0.5A)
VAL  C 289 ( 0.5A)
ASP  C 273 ( 0.6A)
 1.00A 1t87A-5lmxC:
undetectable		 1t87A-5lmxC:
22.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1T88_A_CAMA1422_0
(CYTOCHROME P450-CAM)		 4kqn D-HYDANTOINASE
(Bacillus
sp.
AR9) 		4 / 7 PHE A 396
VAL A 354
GLY A 353
VAL A 423
 PHE  A 396 ( 1.3A)
VAL  A 354 ( 0.6A)
GLY  A 353 ( 0.0A)
VAL  A 423 ( 0.5A)
 0.80A 1t88A-4kqnA:
undetectable		 1t88A-4kqnA:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1T9W_A_NFNA6002_1
(ACRIFLAVINE
RESISTANCE PROTEIN B)		 1omo ALANINE
DEHYDROGENASE
(Archaeoglobus
fulgidus) 		4 / 7 GLN A 140
ALA A 117
PHE A 130
ARG A 145
 GLN  A 140 ( 0.6A)
ALA  A 117 ( 0.0A)
PHE  A 130 ( 1.3A)
ARG  A 145 ( 0.6A)
 1.22A 1t9wA-1omoA:
undetectable		 1t9wA-1omoA:
15.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1U72_A_MTXA188_1
(DIHYDROFOLATE
REDUCTASE)		 4w65 GLYCOSYL HYDROLASE
FAMILY PROTEIN
(Mycolicibacteriu
m
fortuitum) 		5 / 12 ALA A 139
LEU A 250
PHE A  57
SER A 127
ASN A  66
 ALA  A 139 ( 0.0A)
LEU  A 250 ( 0.6A)
PHE  A  57 ( 1.3A)
SER  A 127 ( 0.0A)
ASN  A  66 ( 0.6A)
 1.23A 1u72A-4w65A:
undetectable		 1u72A-4w65A:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1U72_A_MTXA188_1
(DIHYDROFOLATE
REDUCTASE)		 4w65 GLYCOSYL HYDROLASE
FAMILY PROTEIN
(Mycolicibacteriu
m
fortuitum) 		5 / 12 ALA A 139
LEU A 250
PHE A  57
SER A 127
VAL A 278
 ALA  A 139 ( 0.0A)
LEU  A 250 ( 0.6A)
PHE  A  57 ( 1.3A)
SER  A 127 ( 0.0A)
VAL  A 278 ( 0.6A)
 1.29A 1u72A-4w65A:
undetectable		 1u72A-4w65A:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UHO_A_VDNA1000_1
(CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		6 / 10 TYR A 159
HIS A 160
PHE A 340
GLN A 369
GLY A 371
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
PHE  A 340 (-1.3A)
GLN  A 369 (-0.6A)
GLY  A 371 ( 0.0A)
PHE  A 372 (-1.3A)
 0.37A 1uhoA-3sl5A:
36.4		 1uhoA-3sl5A:
28.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UTD_A_TRPA81_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.42A 1utdA-3l4gA:
undetectable
1utdB-3l4gA:
undetectable		 1utdA-3l4gA:
9.81
1utdB-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UTD_B_TRPB81_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 8 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.43A 1utdB-3l4gA:
undetectable
1utdC-3l4gA:
undetectable		 1utdB-3l4gA:
9.81
1utdC-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UTD_C_TRPC81_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.44A 1utdC-3l4gA:
undetectable
1utdD-3l4gA:
undetectable		 1utdC-3l4gA:
9.81
1utdD-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UTD_D_TRPD81_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.44A 1utdD-3l4gA:
undetectable
1utdE-3l4gA:
undetectable		 1utdD-3l4gA:
9.81
1utdE-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UTD_F_TRPF81_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 8 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.44A 1utdF-3l4gA:
undetectable
1utdG-3l4gA:
undetectable		 1utdF-3l4gA:
9.81
1utdG-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UTD_G_TRPG81_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.47A 1utdG-3l4gA:
undetectable
1utdH-3l4gA:
undetectable		 1utdG-3l4gA:
9.81
1utdH-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UTD_J_TRPJ81_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 8 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.45A 1utdJ-3l4gA:
undetectable
1utdK-3l4gA:
undetectable		 1utdJ-3l4gA:
9.81
1utdK-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UTD_K_TRPK81_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.44A 1utdA-3l4gA:
undetectable
1utdK-3l4gA:
undetectable		 1utdA-3l4gA:
9.81
1utdK-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UTD_N_TRPN81_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.45A 1utdN-3l4gA:
undetectable
1utdO-3l4gA:
undetectable		 1utdN-3l4gA:
9.81
1utdO-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UTD_R_TRPR81_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.45A 1utdR-3l4gA:
undetectable
1utdS-3l4gA:
undetectable		 1utdR-3l4gA:
9.81
1utdS-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UW6_A_NCTA1208_1
(ACETYLCHOLINE-BINDIN
G PROTEIN)		 3td9 BRANCHED CHAIN AMINO
ACID ABC
TRANSPORTER,
PERIPLASMIC AMINO
ACID-BINDING PROTEIN
(Thermotoga
maritima) 		4 / 8 TYR A 166
THR A 263
CYH A 133
LEU A 296
 PHE  A 400 (-3.8A)
EDO  A 403 ( 4.2A)
None
None
 1.40A 1uw6A-3td9A:
undetectable
1uw6B-3td9A:
undetectable		 1uw6A-3td9A:
19.62
1uw6B-3td9A:
19.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UW6_D_NCTD1208_1
(ACETYLCHOLINE-BINDIN
G PROTEIN)		 3td9 BRANCHED CHAIN AMINO
ACID ABC
TRANSPORTER,
PERIPLASMIC AMINO
ACID-BINDING PROTEIN
(Thermotoga
maritima) 		4 / 8 TYR A 166
THR A 263
CYH A 133
LEU A 296
 PHE  A 400 (-3.8A)
EDO  A 403 ( 4.2A)
None
None
 1.41A 1uw6D-3td9A:
undetectable
1uw6E-3td9A:
undetectable		 1uw6D-3td9A:
19.62
1uw6E-3td9A:
19.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UW6_G_NCTG1206_1
(ACETYLCHOLINE-BINDIN
G PROTEIN)		 3td9 BRANCHED CHAIN AMINO
ACID ABC
TRANSPORTER,
PERIPLASMIC AMINO
ACID-BINDING PROTEIN
(Thermotoga
maritima) 		4 / 8 TYR A 166
THR A 263
CYH A 133
LEU A 296
 PHE  A 400 (-3.8A)
EDO  A 403 ( 4.2A)
None
None
 1.41A 1uw6G-3td9A:
undetectable
1uw6H-3td9A:
undetectable		 1uw6G-3td9A:
19.62
1uw6H-3td9A:
19.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UW6_P_NCTP1206_1
(ACETYLCHOLINE-BINDIN
G PROTEIN)		 3td9 BRANCHED CHAIN AMINO
ACID ABC
TRANSPORTER,
PERIPLASMIC AMINO
ACID-BINDING PROTEIN
(Thermotoga
maritima) 		4 / 8 TYR A 166
THR A 263
CYH A 133
LEU A 296
 PHE  A 400 (-3.8A)
EDO  A 403 ( 4.2A)
None
None
 1.37A 1uw6P-3td9A:
undetectable
1uw6Q-3td9A:
undetectable		 1uw6P-3td9A:
19.62
1uw6Q-3td9A:
19.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UW6_T_NCTT1208_1
(ACETYLCHOLINE-BINDIN
G PROTEIN)		 3td9 BRANCHED CHAIN AMINO
ACID ABC
TRANSPORTER,
PERIPLASMIC AMINO
ACID-BINDING PROTEIN
(Thermotoga
maritima) 		4 / 8 LEU A 296
TYR A 166
THR A 263
CYH A 133
 None
PHE  A 400 (-3.8A)
EDO  A 403 ( 4.2A)
None
 1.42A 1uw6P-3td9A:
undetectable
1uw6T-3td9A:
undetectable		 1uw6P-3td9A:
19.62
1uw6T-3td9A:
19.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UWJ_B_BAXB1723_2
(B-RAF PROTO-ONCOGENE
SERINE/THREONINE-PRO
TEIN KINASE)		 5cdn DNA GYRASE SUBUNIT A
(Staphylococcus
aureus) 		3 / 3 ILE A 230
ASP A 217
PHE A 218
 ILE  A 230 ( 0.7A)
ASP  A 217 ( 0.5A)
PHE  A 218 ( 1.3A)
 0.57A 1uwjB-5cdnA:
1.8		 1uwjB-5cdnA:
19.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UYU_B_CAMB1416_0
(CYTOCHROME P450-CAM)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		4 / 8 PHE C 251
LEU C 280
VAL C 289
ASP C 273
 PHE  C 251 ( 1.3A)
LEU  C 280 ( 0.5A)
VAL  C 289 ( 0.5A)
ASP  C 273 ( 0.6A)
 0.93A 1uyuB-5lmxC:
undetectable		 1uyuB-5lmxC:
22.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1V54_C_CHDC3271_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE III
CYTOCHROME C OXIDASE
POLYPEPTIDE
VIIA-HEART)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 8 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.91A 1v54C-4flxA:
2.6
1v54J-4flxA:
undetectable		 1v54C-4flxA:
13.49
1v54J-4flxA:
6.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1V54_C_CHDC3271_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE III
CYTOCHROME C OXIDASE
POLYPEPTIDE
VIIA-HEART)		 5d7w SERRALYSIN
(Serratia
marcescens) 		4 / 8 LYS A  57
LEU A  58
PHE A  60
LEU A 182
 LYS  A  57 ( 0.0A)
LEU  A  58 ( 0.6A)
PHE  A  60 ( 1.3A)
LEU  A 182 ( 0.6A)
 0.89A 1v54C-5d7wA:
undetectable
1v54J-5d7wA:
undetectable		 1v54C-5d7wA:
19.92
1v54J-5d7wA:
8.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1V54_P_CHDP4271_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE III
CYTOCHROME C OXIDASE
POLYPEPTIDE
VIIA-HEART)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 8 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.91A 1v54P-4flxA:
undetectable
1v54W-4flxA:
undetectable		 1v54P-4flxA:
13.49
1v54W-4flxA:
6.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1V55_C_CHDC3271_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE III
CYTOCHROME C OXIDASE
POLYPEPTIDE
VIIA-HEART)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 7 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.95A 1v55C-4flxA:
2.6
1v55J-4flxA:
undetectable		 1v55C-4flxA:
13.49
1v55J-4flxA:
6.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1V55_C_CHDC3271_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE III
CYTOCHROME C OXIDASE
POLYPEPTIDE
VIIA-HEART)		 5d7w SERRALYSIN
(Serratia
marcescens) 		4 / 7 LYS A  57
LEU A  58
PHE A  60
LEU A 182
 LYS  A  57 ( 0.0A)
LEU  A  58 ( 0.6A)
PHE  A  60 ( 1.3A)
LEU  A 182 ( 0.6A)
 0.95A 1v55C-5d7wA:
undetectable
1v55J-5d7wA:
undetectable		 1v55C-5d7wA:
19.92
1v55J-5d7wA:
8.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1WRL_B_TFPB203_1
(TROPONIN C, SLOW
SKELETAL AND CARDIAC
MUSCLES)		 5w0a GLUCANASE
(Trichoderma
harzianum) 		4 / 6 PHE A 359
VAL A 357
LEU A 137
PHE A 130
 PHE  A 359 ( 1.3A)
VAL  A 357 ( 0.6A)
LEU  A 137 ( 0.6A)
PHE  A 130 ( 1.3A)
 1.00A 1wrlB-5w0aA:
undetectable		 1wrlB-5w0aA:
22.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1WRL_C_TFPC208_1
(TROPONIN C, SLOW
SKELETAL AND CARDIAC
MUSCLES)		 2loe 6-CYSTEINE PROTEIN,
PUTATIVE
(Plasmodium
falciparum) 		4 / 5 PHE A 109
LEU A  99
PHE A 123
SER A  17
 PHE  A 109 ( 1.4A)
LEU  A  99 ( 0.6A)
PHE  A 123 ( 1.4A)
SER  A  17 ( 0.0A)
 1.20A 1wrlC-2loeA:
undetectable		 1wrlC-2loeA:
17.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1WRL_C_TFPC208_1
(TROPONIN C, SLOW
SKELETAL AND CARDIAC
MUSCLES)		 4gow CALMODULIN
(Homo
sapiens) 		4 / 5 PHE D  92
LEU D 112
PHE D 141
MET D 145
 PHE  D  92 ( 1.3A)
LEU  D 112 ( 0.6A)
PHE  D 141 ( 1.3A)
MET  D 145 ( 0.0A)
 1.05A 1wrlC-4gowD:
11.4		 1wrlC-4gowD:
67.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1WSV_A_THHA3001_0
(AMINOMETHYLTRANSFERA
SE)		 1wsv AMINOMETHYLTRANSFERA
SE
(Homo
sapiens) 		12 / 12 MET A  56
THR A  87
LEU A  88
ILE A 103
VAL A 115
ASN A 117
PHE A 176
MET A 177
TYR A 197
ARG A 233
LEU A 242
TRP A 262
 MET  A  56 (-0.0A)
THR  A  87 ( 0.8A)
LEU  A  88 (-0.6A)
ILE  A 103 (-0.7A)
VAL  A 115 (-0.6A)
ASN  A 117 (-0.6A)
PHE  A 176 (-1.3A)
MET  A 177 (-0.0A)
TYR  A 197 (-1.3A)
ARG  A 233 (-0.6A)
LEU  A 242 (-0.6A)
TRP  A 262 ( 0.5A)
 0.02A 1wsvA-1wsvA:
66.6		 1wsvA-1wsvA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1WSV_A_THHA3001_0
(AMINOMETHYLTRANSFERA
SE)		 6gef TYPE IV SECRETION
SYSTEM PROTEIN DOTB
(Yersinia
pseudotuberculos
is) 		5 / 12 THR A 200
LEU A 199
ILE A 246
VAL A 270
PHE A 228
 THR  A 200 ( 0.8A)
LEU  A 199 ( 0.5A)
ILE  A 246 ( 0.7A)
VAL  A 270 ( 0.6A)
PHE  A 228 ( 1.3A)
 1.22A 1wsvA-6gefA:
undetectable		 1wsvA-6gefA:
undetectable
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1WSV_B_THHB4001_0
(AMINOMETHYLTRANSFERA
SE)		 1wsv AMINOMETHYLTRANSFERA
SE
(Homo
sapiens) 		11 / 12 MET A  56
THR A  87
LEU A  88
ILE A 103
VAL A 115
ASN A 117
PHE A 176
MET A 177
TYR A 197
LEU A 242
TRP A 262
 MET  A  56 (-0.0A)
THR  A  87 ( 0.8A)
LEU  A  88 (-0.6A)
ILE  A 103 (-0.7A)
VAL  A 115 (-0.6A)
ASN  A 117 (-0.6A)
PHE  A 176 (-1.3A)
MET  A 177 (-0.0A)
TYR  A 197 (-1.3A)
LEU  A 242 (-0.6A)
TRP  A 262 ( 0.5A)
 0.19A 1wsvB-1wsvA:
62.3		 1wsvB-1wsvA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1WSV_B_THHB4001_0
(AMINOMETHYLTRANSFERA
SE)		 6gef TYPE IV SECRETION
SYSTEM PROTEIN DOTB
(Yersinia
pseudotuberculos
is) 		5 / 12 THR A 200
LEU A 199
ILE A 246
VAL A 270
PHE A 228
 THR  A 200 ( 0.8A)
LEU  A 199 ( 0.5A)
ILE  A 246 ( 0.7A)
VAL  A 270 ( 0.6A)
PHE  A 228 ( 1.3A)
 1.23A 1wsvB-6gefA:
undetectable		 1wsvB-6gefA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1X70_A_715A801_1
(DIPEPTIDYL PEPTIDASE
IV)		 1szb MANNOSE BINDING
LECTIN-ASSOCIATED
SERINE PROTEASE-2
RELATED PROTEIN,
MAP19 (19KDA)
(Homo
sapiens) 		5 / 12 GLU A  52
SER A  54
PHE A  61
TYR A  24
ASN A 108
 GLU  A  52 (-0.6A)
SER  A  54 ( 0.0A)
PHE  A  61 ( 1.3A)
TYR  A  24 ( 1.3A)
ASN  A 108 (-0.6A)
 1.05A 1x70A-1szbA:
undetectable		 1x70A-1szbA:
11.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1X8V_A_ESLA471_1
(CYTOCHROME P450 51)		 1tza APAG PROTEIN
(Shewanella
oneidensis) 		4 / 8 TYR A  28
PHE A  30
ALA A  56
LEU A 124
 TYR  A  28 ( 1.3A)
PHE  A  30 ( 1.3A)
ALA  A  56 ( 0.0A)
LEU  A 124 ( 0.6A)
 1.14A 1x8vA-1tzaA:
undetectable		 1x8vA-1tzaA:
14.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XDK_B_9CRB600_2
(RETINOIC ACID
RECEPTOR, BETA)		 2qv2 INOSITOL
POLYPHOSPHATE
5-PHOSPHATASE OCRL-1
(Homo
sapiens) 		3 / 3 LEU A 310
PHE A 331
ARG A 274
 LEU  A 310 ( 0.6A)
PHE  A 331 ( 1.3A)
ARG  A 274 ( 0.6A)
 0.72A 1xdkB-2qv2A:
undetectable		 1xdkB-2qv2A:
21.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XDK_B_9CRB600_2
(RETINOIC ACID
RECEPTOR, BETA)		 3bpo INTERLEUKIN-13
RECEPTOR ALPHA-1
CHAIN
(Homo
sapiens) 		3 / 3 LEU C 258
PHE C 253
ARG C 225
 LEU  C 258 ( 0.5A)
PHE  C 253 ( 1.3A)
ARG  C 225 ( 0.6A)
 0.76A 1xdkB-3bpoC:
undetectable		 1xdkB-3bpoC:
19.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XDK_F_9CRF1600_2
(RETINOIC ACID
RECEPTOR, BETA)		 2qv2 INOSITOL
POLYPHOSPHATE
5-PHOSPHATASE OCRL-1
(Homo
sapiens) 		3 / 3 LEU A 310
PHE A 331
ARG A 274
 LEU  A 310 ( 0.6A)
PHE  A 331 ( 1.3A)
ARG  A 274 ( 0.6A)
 0.72A 1xdkF-2qv2A:
undetectable		 1xdkF-2qv2A:
21.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XDK_F_9CRF1600_2
(RETINOIC ACID
RECEPTOR, BETA)		 3bpo INTERLEUKIN-13
RECEPTOR ALPHA-1
CHAIN
(Homo
sapiens) 		3 / 3 LEU C 258
PHE C 253
ARG C 225
 LEU  C 258 ( 0.5A)
PHE  C 253 ( 1.3A)
ARG  C 225 ( 0.6A)
 0.76A 1xdkF-3bpoC:
undetectable		 1xdkF-3bpoC:
19.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XKK_A_FMMA91_1
(EPIDERMAL GROWTH
FACTOR RECEPTOR)		 5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE
(Homo
sapiens) 		5 / 12 ALA A  52
GLY A 111
LEU A 160
ASP A 171
PHE A 172
 ALA  A  52 (-0.0A)
GLY  A 111 (-0.0A)
LEU  A 160 (-0.6A)
ASP  A 171 ( 0.5A)
PHE  A 172 ( 1.3A)
 0.51A 1xkkA-5d7aA:
24.8		 1xkkA-5d7aA:
25.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XLX_A_CIOA101_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		12 / 12 TYR A 159
HIS A 160
HIS A 204
MET A 273
LEU A 319
ASN A 321
THR A 333
ILE A 336
MET A 337
SER A 368
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
HIS  A 204 ( 1.0A)
MET  A 273 (-0.0A)
LEU  A 319 ( 0.6A)
ASN  A 321 (-0.6A)
THR  A 333 ( 0.8A)
ILE  A 336 ( 0.4A)
MET  A 337 ( 0.0A)
SER  A 368 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.54A 1xlxA-3sl5A:
51.0		 1xlxA-3sl5A:
84.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XLX_B_CIOB102_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		10 / 12 TYR A 159
HIS A 160
HIS A 204
MET A 273
ILE A 336
MET A 337
PHE A 340
MET A 357
SER A 368
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
HIS  A 204 ( 1.0A)
MET  A 273 (-0.0A)
ILE  A 336 ( 0.4A)
MET  A 337 ( 0.0A)
PHE  A 340 (-1.3A)
MET  A 357 (-0.0A)
SER  A 368 (-0.0A)
PHE  A 372 (-1.3A)
 0.74A 1xlxB-3sl5A:
51.1		 1xlxB-3sl5A:
84.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XLX_B_CIOB102_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		11 / 12 TYR A 159
HIS A 160
HIS A 204
MET A 273
THR A 333
ILE A 336
MET A 337
PHE A 340
MET A 357
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
HIS  A 204 ( 1.0A)
MET  A 273 (-0.0A)
THR  A 333 ( 0.8A)
ILE  A 336 ( 0.4A)
MET  A 337 ( 0.0A)
PHE  A 340 (-1.3A)
MET  A 357 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.54A 1xlxB-3sl5A:
51.1		 1xlxB-3sl5A:
84.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XMU_A_ROFA101_0
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		12 / 12 TYR A 159
HIS A 160
ASP A 318
LEU A 319
PRO A 322
TYR A 329
TRP A 332
ILE A 336
PHE A 340
MET A 357
SER A 368
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
ASP  A 318 (-0.5A)
LEU  A 319 ( 0.6A)
PRO  A 322 (-1.1A)
TYR  A 329 (-1.3A)
TRP  A 332 ( 0.5A)
ILE  A 336 ( 0.4A)
PHE  A 340 (-1.3A)
MET  A 357 (-0.0A)
SER  A 368 (-0.0A)
PHE  A 372 (-1.3A)
 0.61A 1xmuA-3sl5A:
51.4		 1xmuA-3sl5A:
84.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XMU_B_ROFB102_0
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		12 / 12 TYR A 159
HIS A 160
MET A 273
ASP A 318
LEU A 319
PRO A 322
TYR A 329
TRP A 332
ILE A 336
PHE A 340
MET A 357
SER A 368
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 273 (-0.0A)
ASP  A 318 (-0.5A)
LEU  A 319 ( 0.6A)
PRO  A 322 (-1.1A)
TYR  A 329 (-1.3A)
TRP  A 332 ( 0.5A)
ILE  A 336 ( 0.4A)
PHE  A 340 (-1.3A)
MET  A 357 (-0.0A)
SER  A 368 (-0.0A)
 0.44A 1xmuB-3sl5A:
51.1		 1xmuB-3sl5A:
84.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XMU_B_ROFB102_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		5 / 5 ASN A 321
THR A 333
MET A 337
GLN A 369
PHE A 372
 ASN  A 321 (-0.6A)
THR  A 333 ( 0.8A)
MET  A 337 ( 0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.51A 1xmuB-3sl5A:
51.1		 1xmuB-3sl5A:
84.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XOM_A_CIOA603_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		6 / 12 TYR A 159
ASP A 201
ILE A 336
MET A 337
PHE A 340
MET A 357
 TYR  A 159 (-1.3A)
ASP  A 201 ( 0.5A)
ILE  A 336 ( 0.4A)
MET  A 337 ( 0.0A)
PHE  A 340 (-1.3A)
MET  A 357 (-0.0A)
 1.47A 1xomA-3sl5A:
53.0		 1xomA-3sl5A:
94.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XOM_A_CIOA603_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		12 / 12 TYR A 159
HIS A 160
MET A 273
ASP A 318
LEU A 319
ILE A 336
MET A 337
PHE A 340
MET A 357
SER A 368
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 273 (-0.0A)
ASP  A 318 (-0.5A)
LEU  A 319 ( 0.6A)
ILE  A 336 ( 0.4A)
MET  A 337 ( 0.0A)
PHE  A 340 (-1.3A)
MET  A 357 (-0.0A)
SER  A 368 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.57A 1xomA-3sl5A:
53.0		 1xomA-3sl5A:
94.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XOM_B_CIOB601_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		12 / 12 TYR A 159
HIS A 160
MET A 273
LEU A 319
THR A 333
ILE A 336
MET A 337
PHE A 340
MET A 357
SER A 368
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 273 (-0.0A)
LEU  A 319 ( 0.6A)
THR  A 333 ( 0.8A)
ILE  A 336 ( 0.4A)
MET  A 337 ( 0.0A)
PHE  A 340 (-1.3A)
MET  A 357 (-0.0A)
SER  A 368 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.59A 1xomB-3sl5A:
52.8		 1xomB-3sl5A:
94.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XOQ_A_ROFA502_0
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		11 / 12 TYR A 159
HIS A 160
MET A 273
ASP A 318
LEU A 319
PRO A 322
TYR A 329
THR A 333
ILE A 336
SER A 368
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 273 (-0.0A)
ASP  A 318 (-0.5A)
LEU  A 319 ( 0.6A)
PRO  A 322 (-1.1A)
TYR  A 329 (-1.3A)
THR  A 333 ( 0.8A)
ILE  A 336 ( 0.4A)
SER  A 368 (-0.0A)
PHE  A 372 (-1.3A)
 0.52A 1xoqA-3sl5A:
53.5		 1xoqA-3sl5A:
94.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XOQ_B_ROFB501_0
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		11 / 12 TYR A 159
HIS A 160
ASP A 318
LEU A 319
PRO A 322
TYR A 329
TRP A 332
THR A 333
ILE A 336
SER A 368
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
ASP  A 318 (-0.5A)
LEU  A 319 ( 0.6A)
PRO  A 322 (-1.1A)
TYR  A 329 (-1.3A)
TRP  A 332 ( 0.5A)
THR  A 333 ( 0.8A)
ILE  A 336 ( 0.4A)
SER  A 368 (-0.0A)
PHE  A 372 (-1.3A)
 0.50A 1xoqB-3sl5A:
53.4		 1xoqB-3sl5A:
94.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XOS_A_VIAA1_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		11 / 12 TYR A 159
HIS A 160
MET A 273
ASP A 318
LEU A 319
MET A 337
PHE A 340
MET A 357
GLN A 369
PHE A 372
ILE A 376
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 273 (-0.0A)
ASP  A 318 (-0.5A)
LEU  A 319 ( 0.6A)
MET  A 337 ( 0.0A)
PHE  A 340 (-1.3A)
MET  A 357 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
ILE  A 376 (-0.6A)
 0.48A 1xosA-3sl5A:
51.3		 1xosA-3sl5A:
84.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XOS_A_VIAA1_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		10 / 12 TYR A 159
HIS A 160
MET A 273
ASP A 318
LEU A 319
MET A 337
PHE A 340
SER A 355
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 273 (-0.0A)
ASP  A 318 (-0.5A)
LEU  A 319 ( 0.6A)
MET  A 337 ( 0.0A)
PHE  A 340 (-1.3A)
SER  A 355 ( 0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 1.02A 1xosA-3sl5A:
51.3		 1xosA-3sl5A:
84.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XOT_A_VDNA101_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		12 / 12 TYR A 159
HIS A 160
MET A 273
LEU A 319
ILE A 336
MET A 337
SER A 355
MET A 357
SER A 368
GLN A 369
PHE A 372
ILE A 376
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 273 (-0.0A)
LEU  A 319 ( 0.6A)
ILE  A 336 ( 0.4A)
MET  A 337 ( 0.0A)
SER  A 355 ( 0.0A)
MET  A 357 (-0.0A)
SER  A 368 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
ILE  A 376 (-0.6A)
 0.74A 1xotA-3sl5A:
50.9		 1xotA-3sl5A:
84.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XOT_B_VDNB102_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		11 / 12 TYR A 159
HIS A 160
MET A 273
LEU A 319
ASN A 321
ILE A 336
MET A 337
SER A 355
MET A 357
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 273 (-0.0A)
LEU  A 319 ( 0.6A)
ASN  A 321 (-0.6A)
ILE  A 336 ( 0.4A)
MET  A 337 ( 0.0A)
SER  A 355 ( 0.0A)
MET  A 357 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.59A 1xotB-3sl5A:
50.9		 1xotB-3sl5A:
84.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XOT_B_VDNB102_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		11 / 12 TYR A 159
HIS A 160
MET A 273
LEU A 319
ASN A 321
ILE A 336
MET A 337
SER A 355
MET A 357
SER A 368
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 273 (-0.0A)
LEU  A 319 ( 0.6A)
ASN  A 321 (-0.6A)
ILE  A 336 ( 0.4A)
MET  A 337 ( 0.0A)
SER  A 355 ( 0.0A)
MET  A 357 (-0.0A)
SER  A 368 (-0.0A)
PHE  A 372 (-1.3A)
 0.73A 1xotB-3sl5A:
50.9		 1xotB-3sl5A:
84.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1YC2_A_NCAA506_0
(NAD-DEPENDENT
DEACETYLASE 2)		 1it2 HEMOGLOBIN
(Eptatretus
burgeri) 		4 / 6 ALA A  48
SER A  51
PHE A  45
ILE A 112
 ALA  A  48 ( 0.0A)
SER  A  51 (-0.0A)
PHE  A  45 ( 1.3A)
ILE  A 112 ( 0.4A)
 1.01A 1yc2A-1it2A:
undetectable		 1yc2A-1it2A:
20.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1YC2_E_NCAE507_0
(NAD-DEPENDENT
DEACETYLASE 2)		 1amu GRAMICIDIN
SYNTHETASE 1
(Brevibacillus
brevis) 		4 / 7 ILE A 352
PHE A 214
LEU A 218
ILE A 330
 None
None
None
PHE  A 566 (-4.6A)
 0.74A 1yc2E-1amuA:
undetectable		 1yc2E-1amuA:
18.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1YKI_D_NFZD4219_1
(OXYGEN-INSENSITIVE
NAD(P)H
NITROREDUCTASE)		 4mwt LYSOSOMAL PROTECTIVE
PROTEIN
(Homo
sapiens) 		4 / 8 TYR A 367
PHE A 377
GLU A 149
GLY A 177
 TYR  A 367 ( 1.3A)
PHE  A 377 ( 1.3A)
GLU  A 149 ( 0.5A)
GLY  A 177 ( 0.0A)
 0.98A 1ykiC-4mwtA:
undetectable
1ykiD-4mwtA:
undetectable		 1ykiC-4mwtA:
16.78
1ykiD-4mwtA:
16.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1YRC_A_CAMA420_0
(CYTOCHROME P450-CAM)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		4 / 7 PHE C 251
LEU C 280
VAL C 289
ASP C 273
 PHE  C 251 ( 1.3A)
LEU  C 280 ( 0.5A)
VAL  C 289 ( 0.5A)
ASP  C 273 ( 0.6A)
 0.99A 1yrcA-5lmxC:
undetectable		 1yrcA-5lmxC:
22.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1YRD_A_CAMA420_0
(CYTOCHROME P450-CAM)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		4 / 7 PHE C 251
LEU C 280
VAL C 289
ASP C 273
 PHE  C 251 ( 1.3A)
LEU  C 280 ( 0.5A)
VAL  C 289 ( 0.5A)
ASP  C 273 ( 0.6A)
 0.97A 1yrdA-5lmxC:
undetectable		 1yrdA-5lmxC:
22.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZLQ_A_ACTA1507_0
(NICKEL-BINDING
PERIPLASMIC PROTEIN)		 3pco PHENYLALANYL-TRNA
SYNTHETASE, ALPHA
SUBUNIT
(Escherichia
coli) 		3 / 3 GLN A 169
HIS A 155
ARG A 152
 PHE  A 980 (-3.5A)
None
None
 0.99A 1zlqA-3pcoA:
undetectable		 1zlqA-3pcoA:
20.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZZ1_A_SHHA2452_1
(HISTONE
DEACETYLASE-LIKE
AMIDOHYDROLASE)		 1wsv AMINOMETHYLTRANSFERA
SE
(Homo
sapiens) 		5 / 11 LEU A 152
ILE A 219
HIS A  14
PHE A  13
GLY A 229
 LEU  A 152 ( 0.6A)
ILE  A 219 ( 0.7A)
HIS  A  14 ( 1.0A)
PHE  A  13 ( 1.3A)
GLY  A 229 ( 0.0A)
 0.99A 1zz1A-1wsvA:
undetectable		 1zz1A-1wsvA:
22.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZZ1_C_SHHC2652_1
(HISTONE
DEACETYLASE-LIKE
AMIDOHYDROLASE)		 1wsv AMINOMETHYLTRANSFERA
SE
(Homo
sapiens) 		5 / 12 LEU A 152
ILE A 219
HIS A  14
PHE A  13
GLY A 229
 LEU  A 152 ( 0.6A)
ILE  A 219 ( 0.7A)
HIS  A  14 ( 1.0A)
PHE  A  13 ( 1.3A)
GLY  A 229 ( 0.0A)
 0.97A 1zz1C-1wsvA:
undetectable		 1zz1C-1wsvA:
22.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A1M_B_CAMB2422_0
(CYTOCHROME P450-CAM)		 4kqn D-HYDANTOINASE
(Bacillus
sp.
AR9) 		4 / 8 PHE A 396
VAL A 354
GLY A 353
VAL A 423
 PHE  A 396 ( 1.3A)
VAL  A 354 ( 0.6A)
GLY  A 353 ( 0.0A)
VAL  A 423 ( 0.5A)
 0.74A 2a1mB-4kqnA:
undetectable		 2a1mB-4kqnA:
21.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A1O_A_CAMA1422_0
(CYTOCHROME P450-CAM)		 4kqn D-HYDANTOINASE
(Bacillus
sp.
AR9) 		4 / 8 PHE A 396
VAL A 354
GLY A 353
VAL A 423
 PHE  A 396 ( 1.3A)
VAL  A 354 ( 0.6A)
GLY  A 353 ( 0.0A)
VAL  A 423 ( 0.5A)
 0.77A 2a1oA-4kqnA:
undetectable		 2a1oA-4kqnA:
21.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3A_A_TEPA1433_1
(CHITINASE)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		10 / 11 TYR A 156
PHE A 184
GLY A 267
ASP A 306
GLU A 308
MET A 381
TYR A 383
ASP A 384
TYR A 437
TRP A 532
 TYR  A 156 ( 1.3A)
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
ASP  A 306 ( 0.5A)
GLU  A 308 ( 0.6A)
MET  A 381 ( 0.0A)
TYR  A 383 ( 1.3A)
ASP  A 384 ( 0.5A)
TYR  A 437 ( 1.3A)
TRP  A 532 ( 0.5A)
 0.39A 2a3aA-5gprA:
12.4		 2a3aA-5gprA:
27.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3A_A_TEPA1433_1
(CHITINASE)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		8 / 11 TYR A 156
PHE A 184
GLY A 267
TRP A 268
ASP A 306
GLU A 308
MET A 381
TRP A 532
 TYR  A 156 ( 1.3A)
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
TRP  A 268 ( 0.5A)
ASP  A 306 ( 0.5A)
GLU  A 308 ( 0.6A)
MET  A 381 ( 0.0A)
TRP  A 532 ( 0.5A)
 0.65A 2a3aA-5gprA:
12.4		 2a3aA-5gprA:
27.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3A_A_TEPA1436_1
(CHITINASE)		 1txu RAB5 GDP/GTP
EXCHANGE FACTOR
(Homo
sapiens) 		3 / 3 ASP A 279
PHE A 224
ARG A 330
 ASP  A 279 ( 0.6A)
PHE  A 224 ( 1.3A)
ARG  A 330 ( 0.6A)
 0.82A 2a3aA-1txuA:
undetectable		 2a3aA-1txuA:
18.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3A_A_TEPA1436_1
(CHITINASE)		 3r9r PHOSPHORIBOSYLAMINOI
MIDAZOLE-SUCCINOCARB
OXAMIDE SYNTHASE
(Mycobacteroides
abscessus) 		3 / 3 ASP A  48
PHE A 289
ARG A  51
 ASP  A  48 ( 0.6A)
PHE  A 289 ( 1.3A)
ARG  A  51 ( 0.6A)
 0.85A 2a3aA-3r9rA:
undetectable		 2a3aA-3r9rA:
22.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3A_B_TEPB2433_1
(CHITINASE)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		8 / 9 PHE A 184
GLY A 267
GLU A 308
MET A 381
TYR A 383
ASP A 384
TYR A 437
TRP A 532
 PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
GLU  A 308 ( 0.6A)
MET  A 381 ( 0.0A)
TYR  A 383 ( 1.3A)
ASP  A 384 ( 0.5A)
TYR  A 437 ( 1.3A)
TRP  A 532 ( 0.5A)
 0.47A 2a3aB-5gprA:
43.1		 2a3aB-5gprA:
27.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_A_CFFA1435_1
(CHITINASE)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		9 / 11 TYR A 156
PHE A 184
GLY A 267
TRP A 268
ASP A 306
GLU A 308
MET A 381
TYR A 383
TRP A 532
 TYR  A 156 ( 1.3A)
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
TRP  A 268 ( 0.5A)
ASP  A 306 ( 0.5A)
GLU  A 308 ( 0.6A)
MET  A 381 ( 0.0A)
TYR  A 383 ( 1.3A)
TRP  A 532 ( 0.5A)
 0.78A 2a3bA-5gprA:
43.0		 2a3bA-5gprA:
27.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_A_CFFA1435_1
(CHITINASE)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		10 / 11 TYR A 156
PHE A 184
GLY A 267
TRP A 268
ASP A 306
MET A 381
TYR A 383
ASP A 384
TYR A 437
TRP A 532
 TYR  A 156 ( 1.3A)
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
TRP  A 268 ( 0.5A)
ASP  A 306 ( 0.5A)
MET  A 381 ( 0.0A)
TYR  A 383 ( 1.3A)
ASP  A 384 ( 0.5A)
TYR  A 437 ( 1.3A)
TRP  A 532 ( 0.5A)
 0.57A 2a3bA-5gprA:
43.0		 2a3bA-5gprA:
27.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_B_CFFB2435_1
(CHITINASE)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		9 / 10 PHE A 184
GLY A 267
ASP A 306
GLU A 308
MET A 381
TYR A 383
ASP A 384
TYR A 437
TRP A 532
 PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
ASP  A 306 ( 0.5A)
GLU  A 308 ( 0.6A)
MET  A 381 ( 0.0A)
TYR  A 383 ( 1.3A)
ASP  A 384 ( 0.5A)
TYR  A 437 ( 1.3A)
TRP  A 532 ( 0.5A)
 0.67A 2a3bB-5gprA:
43.1		 2a3bB-5gprA:
27.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3C_A_PNXA1434_1
(CHITINASE)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		9 / 12 TYR A 156
TRP A 160
PHE A 184
GLY A 267
ASP A 306
GLU A 308
MET A 381
TYR A 383
TRP A 532
 TYR  A 156 ( 1.3A)
TRP  A 160 ( 0.5A)
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
ASP  A 306 ( 0.5A)
GLU  A 308 ( 0.6A)
MET  A 381 ( 0.0A)
TYR  A 383 ( 1.3A)
TRP  A 532 ( 0.5A)
 0.72A 2a3cA-5gprA:
12.4		 2a3cA-5gprA:
27.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3C_A_PNXA1434_1
(CHITINASE)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		10 / 12 TYR A 156
TRP A 160
PHE A 184
GLY A 267
ASP A 306
MET A 381
TYR A 383
ASP A 384
TYR A 437
TRP A 532
 TYR  A 156 ( 1.3A)
TRP  A 160 ( 0.5A)
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
ASP  A 306 ( 0.5A)
MET  A 381 ( 0.0A)
TYR  A 383 ( 1.3A)
ASP  A 384 ( 0.5A)
TYR  A 437 ( 1.3A)
TRP  A 532 ( 0.5A)
 0.44A 2a3cA-5gprA:
12.4		 2a3cA-5gprA:
27.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3C_A_PNXA1435_1
(CHITINASE)		 4c9g ADP, ATP CARRIER
PROTEIN 2
(Saccharomyces
cerevisiae) 		4 / 6 TYR A 177
GLY A 192
PHE A 193
ARG A 252
 TYR  A 177 ( 1.3A)
GLY  A 192 (-0.0A)
PHE  A 193 (-1.3A)
ARG  A 252 (-0.6A)
 1.38A 2a3cA-4c9gA:
undetectable		 2a3cA-4c9gA:
23.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3C_B_PNXB2433_1
(CHITINASE)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		11 / 12 TRP A 160
PHE A 184
GLY A 267
THR A 269
ASP A 306
GLU A 308
MET A 381
TYR A 383
ASP A 384
TYR A 437
TRP A 532
 TRP  A 160 ( 0.5A)
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
THR  A 269 ( 0.8A)
ASP  A 306 ( 0.5A)
GLU  A 308 ( 0.6A)
MET  A 381 ( 0.0A)
TYR  A 383 ( 1.3A)
ASP  A 384 ( 0.5A)
TYR  A 437 ( 1.3A)
TRP  A 532 ( 0.5A)
 0.71A 2a3cB-5gprA:
43.1		 2a3cB-5gprA:
27.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2AOU_A_CQAA403_0
(HISTAMINE
N-METHYLTRANSFERASE)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		4 / 8 LYS A 243
GLY A 247
PHE A 299
ASP A 127
 LYS  A 243 ( 0.0A)
GLY  A 247 ( 0.0A)
PHE  A 299 ( 1.3A)
ASP  A 127 ( 0.5A)
 1.03A 2aouA-5gprA:
undetectable		 2aouA-5gprA:
19.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2AVD_A_SAMA501_0
(CATECHOL-O-METHYLTRA
NSFERASE)		 5d7w SERRALYSIN
(Serratia
marcescens) 		5 / 12 GLY A   5
PHE A 359
ALA A   3
ALA A   8
ASP A  11
 GLY  A   5 ( 0.0A)
PHE  A 359 ( 1.3A)
ALA  A   3 ( 0.0A)
ALA  A   8 ( 0.0A)
ASP  A  11 ( 0.5A)
 1.29A 2avdA-5d7wA:
undetectable		 2avdA-5d7wA:
19.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2AXN_A_EDTA737_0
(6-PHOSPHOFRUCTO-2-KI
NASE/FRUCTOSE-2,6-BI
PHOSPHATASE 3
(6PF-2-K/FRU-
2,6-P2ASE
BRAIN/PLACENTA-TYPE
ISOZYME) (IPFK-2)
[INCLUDES: 6-
PHOSPHOFRUCTO-2-KINA
SE (EC 2.7.1.105)
FRUCTOSE-2,6-BISPHO
SPHATASE (EC
3.1.3.46)])		 1amu GRAMICIDIN
SYNTHETASE 1
(Brevibacillus
brevis) 		5 / 12 THR A 282
GLY A 302
ALA A 304
THR A 305
TYR A 319
 None
PHE  A 566 ( 3.6A)
AMP  A 567 (-4.1A)
None
None
 1.30A 2axnA-1amuA:
2.3		 2axnA-1amuA:
22.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BJF_A_DXCA330_0
(CHOLOYLGLYCINE
HYDROLASE)		 2qc5 STREPTOGRAMIN B
LACTONASE
(Staphylococcus
cohnii) 		5 / 12 PHE A 145
ASN A  75
ILE A  63
ILE A 112
THR A  73
 PHE  A 145 ( 1.3A)
ASN  A  75 ( 0.6A)
ILE  A  63 ( 0.4A)
ILE  A 112 ( 0.7A)
THR  A  73 ( 0.8A)
 1.30A 2bjfA-2qc5A:
undetectable		 2bjfA-2qc5A:
20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BJF_A_DXCA330_0
(CHOLOYLGLYCINE
HYDROLASE)		 4ikn AP-3 COMPLEX SUBUNIT
MU-1
(Rattus
norvegicus) 		5 / 12 MET A 314
PHE A 282
ASN A 372
THR A 418
LEU A 373
 MET  A 314 ( 0.0A)
PHE  A 282 ( 1.3A)
ASN  A 372 ( 0.6A)
THR  A 418 ( 0.8A)
LEU  A 373 ( 0.5A)
 1.19A 2bjfA-4iknA:
undetectable		 2bjfA-4iknA:
21.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BM9_A_SAMA301_1
(CEPHALOSPORIN
HYDROXYLASE CMCI)		 1c1d L-PHENYLALANINE
DEHYDROGENASE
(Rhodococcus
sp.) 		3 / 3 LYS A  66
ASP A  55
ASN A 262
 PHE  A 361 (-2.6A)
None
PHE  A 361 ( 3.1A)
 1.12A 2bm9A-1c1dA:
3.6		 2bm9A-1c1dA:
20.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BXE_B_1FLB2002_1
(SERUM ALBUMIN)		 5e37 EF-HAND
DOMAIN-CONTAINING
THIOREDOXIN
(Chlamydomonas
reinhardtii) 		5 / 11 PHE A 261
ALA A 203
LEU A 220
ALA A 223
VAL A 229
 PHE  A 261 ( 1.3A)
ALA  A 203 ( 0.0A)
LEU  A 220 ( 0.6A)
ALA  A 223 ( 0.0A)
VAL  A 229 ( 0.6A)
 1.02A 2bxeB-5e37A:
undetectable		 2bxeB-5e37A:
21.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2CC8_A_RBFA1067_1
(VNG1446H)		 3ghg FIBRINOGEN GAMMA
CHAIN
(Homo
sapiens) 		3 / 3 PHE C 290
VAL C 248
TRP C 369
 PHE  C 290 ( 1.3A)
VAL  C 248 ( 0.6A)
TRP  C 369 ( 0.5A)
 0.89A 2cc8A-3ghgC:
undetectable		 2cc8A-3ghgC:
11.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2CC8_A_RBFA1067_1
(VNG1446H)		 4mtp RNA DEPENDENT RNA
POLYMERASE
(Japanese
encephalitis
virus) 		3 / 3 PHE A 401
VAL A 428
TRP A 434
 PHE  A 401 ( 1.3A)
VAL  A 428 ( 0.6A)
TRP  A 434 ( 0.5A)
 0.81A 2cc8A-4mtpA:
undetectable		 2cc8A-4mtpA:
9.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2CC8_A_RBFA1067_1
(VNG1446H)		 5ec3 4-HYDROXYPHENYLPYRUV
ATE DIOXYGENASE
(Homo
sapiens) 		3 / 3 PHE A 364
VAL A 212
TRP A 210
 PHE  A 364 ( 1.3A)
VAL  A 212 ( 0.6A)
TRP  A 210 ( 0.5A)
 0.86A 2cc8A-5ec3A:
undetectable		 2cc8A-5ec3A:
11.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2CCB_A_RBFA1067_1
(VNG1446H)		 3ghg FIBRINOGEN GAMMA
CHAIN
(Homo
sapiens) 		3 / 3 PHE C 290
VAL C 248
TRP C 369
 PHE  C 290 ( 1.3A)
VAL  C 248 ( 0.6A)
TRP  C 369 ( 0.5A)
 0.87A 2ccbA-3ghgC:
undetectable		 2ccbA-3ghgC:
11.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2CCB_A_RBFA1067_1
(VNG1446H)		 4mtp RNA DEPENDENT RNA
POLYMERASE
(Japanese
encephalitis
virus) 		3 / 3 PHE A 401
VAL A 428
TRP A 434
 PHE  A 401 ( 1.3A)
VAL  A 428 ( 0.6A)
TRP  A 434 ( 0.5A)
 0.83A 2ccbA-4mtpA:
undetectable		 2ccbA-4mtpA:
9.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2CCB_A_RBFA1067_1
(VNG1446H)		 5ec3 4-HYDROXYPHENYLPYRUV
ATE DIOXYGENASE
(Homo
sapiens) 		3 / 3 PHE A 364
VAL A 212
TRP A 210
 PHE  A 364 ( 1.3A)
VAL  A 212 ( 0.6A)
TRP  A 210 ( 0.5A)
 0.85A 2ccbA-5ec3A:
undetectable		 2ccbA-5ec3A:
11.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2CPP_A_CAMA422_0
(CYTOCHROME P450-CAM)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		4 / 7 PHE C 251
LEU C 280
VAL C 289
ASP C 273
 PHE  C 251 ( 1.3A)
LEU  C 280 ( 0.5A)
VAL  C 289 ( 0.5A)
ASP  C 273 ( 0.6A)
 0.98A 2cppA-5lmxC:
undetectable		 2cppA-5lmxC:
22.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2D0K_B_FOLB2161_0
(DIHYDROFOLATE
REDUCTASE)		 3eqz RESPONSE REGULATOR
(Colwellia
psychrerythraea) 		5 / 12 LEU A 114
PHE A 117
ILE A  48
LEU A 121
ILE A 102
 LEU  A 114 ( 0.6A)
PHE  A 117 ( 1.3A)
ILE  A  48 ( 0.7A)
LEU  A 121 ( 0.6A)
ILE  A 102 ( 0.7A)
 0.95A 2d0kB-3eqzA:
undetectable		 2d0kB-3eqzA:
20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2DG3_A_RAPA501_1
(FK506-BINDING
PROTEIN 1A)		 5wpi HSVA
(Erwinia
amylovora) 		5 / 11 PHE A  58
VAL A  40
ILE A  38
ILE A  73
PHE A 345
 PHE  A  58 ( 1.3A)
VAL  A  40 ( 0.5A)
ILE  A  38 ( 0.7A)
ILE  A  73 ( 0.6A)
PHE  A 345 ( 1.3A)
 1.25A 2dg3A-5wpiA:
undetectable		 2dg3A-5wpiA:
16.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2DG3_A_RAPA501_1
(FK506-BINDING
PROTEIN 1A)		 5wpi HSVA
(Erwinia
amylovora) 		5 / 11 TYR A 296
PHE A  58
VAL A  40
ILE A  38
PHE A 345
 TYR  A 296 ( 1.3A)
PHE  A  58 ( 1.3A)
VAL  A  40 ( 0.5A)
ILE  A  38 ( 0.7A)
PHE  A 345 ( 1.3A)
 1.31A 2dg3A-5wpiA:
undetectable		 2dg3A-5wpiA:
16.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2DR2_A_TRPA479_0
(TRYPTOPHANYL-TRNA
SYNTHETASE)		 5gru DIABODY PROTEIN
DIABODY PROTEIN
(Homo
sapiens;
Mus
musculus) 		5 / 11 GLY L 109
THR L  93
GLN L  40
GLN H 172
PHE H 221
 GLY  L 109 ( 0.0A)
THR  L  93 ( 0.8A)
GLN  L  40 ( 0.6A)
GLN  H 172 ( 0.6A)
PHE  H 221 ( 1.3A)
 1.38A 2dr2A-5gruL:
undetectable		 2dr2A-5gruL:
19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2DTT_C_H4BC1002_1
(HYPOTHETICAL PROTEIN
PH0634)		 3ulk KETOL-ACID
REDUCTOISOMERASE
(Escherichia
coli) 		4 / 6 ASP A 356
PHE A 355
THR A 260
GLU A 351
 ASP  A 356 ( 0.6A)
PHE  A 355 ( 1.3A)
THR  A 260 ( 0.8A)
GLU  A 351 ( 0.5A)
 1.48A 2dttB-3ulkA:
undetectable
2dttC-3ulkA:
undetectable		 2dttB-3ulkA:
14.26
2dttC-3ulkA:
14.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2DYR_C_CHDC271_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE
VIIA-HEART
CYTOCHROME C OXIDASE
SUBUNIT 3)		 5d7w SERRALYSIN
(Serratia
marcescens) 		4 / 8 LYS A  57
LEU A  58
PHE A  60
LEU A 182
 LYS  A  57 ( 0.0A)
LEU  A  58 ( 0.6A)
PHE  A  60 ( 1.3A)
LEU  A 182 ( 0.6A)
 0.89A 2dyrC-5d7wA:
undetectable
2dyrJ-5d7wA:
undetectable		 2dyrC-5d7wA:
19.92
2dyrJ-5d7wA:
8.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2DYR_P_CHDP1271_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE
VIIA-HEART
CYTOCHROME C OXIDASE
SUBUNIT 3)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 8 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.91A 2dyrP-4flxA:
2.6
2dyrW-4flxA:
undetectable		 2dyrP-4flxA:
13.49
2dyrW-4flxA:
6.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2DYS_P_CHDP310_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE
VIIA-HEART
CYTOCHROME C OXIDASE
SUBUNIT 3)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 7 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.98A 2dysP-4flxA:
2.6
2dysW-4flxA:
undetectable		 2dysP-4flxA:
13.49
2dysW-4flxA:
6.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2DYS_P_CHDP310_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE
VIIA-HEART
CYTOCHROME C OXIDASE
SUBUNIT 3)		 5d7w SERRALYSIN
(Serratia
marcescens) 		4 / 7 LYS A  57
LEU A  58
PHE A  60
LEU A 182
 LYS  A  57 ( 0.0A)
LEU  A  58 ( 0.6A)
PHE  A  60 ( 1.3A)
LEU  A 182 ( 0.6A)
 0.87A 2dysP-5d7wA:
undetectable
2dysW-5d7wA:
undetectable		 2dysP-5d7wA:
19.92
2dysW-5d7wA:
8.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2E1Q_B_SALB3006_1
(XANTHINE
DEHYDROGENASE/OXIDAS
E)		 1wsv AMINOMETHYLTRANSFERA
SE
(Homo
sapiens) 		4 / 4 ARG A 233
PHE A  51
THR A 198
ALA A 153
 ARG  A 233 (-0.6A)
PHE  A  51 ( 1.3A)
THR  A 198 ( 0.8A)
ALA  A 153 ( 0.0A)
 1.28A 2e1qB-1wsvA:
0.7		 2e1qB-1wsvA:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2E5D_B_NCAB1502_0
(NICOTINAMIDE
PHOSPHORIBOSYLTRANSF
ERASE)		 2ogs THERMOSTABLE
CARBOXYLESTERASE
EST50
(Geobacillus
stearothermophil
us) 		4 / 7 ASP A 486
PHE A 488
ALA A 474
ARG A 393
 ASP  A 486 ( 0.6A)
PHE  A 488 ( 1.3A)
ALA  A 474 ( 0.0A)
ARG  A 393 ( 0.6A)
 1.08A 2e5dA-2ogsA:
undetectable
2e5dB-2ogsA:
undetectable		 2e5dA-2ogsA:
21.26
2e5dB-2ogsA:
21.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2EIJ_C_CHDC271_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE
VIIA-HEART
CYTOCHROME C OXIDASE
SUBUNIT 3)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 7 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.94A 2eijC-4flxA:
2.6
2eijJ-4flxA:
undetectable		 2eijC-4flxA:
13.49
2eijJ-4flxA:
6.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2EIJ_C_CHDC271_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE
VIIA-HEART
CYTOCHROME C OXIDASE
SUBUNIT 3)		 5d7w SERRALYSIN
(Serratia
marcescens) 		4 / 7 LYS A  57
LEU A  58
PHE A  60
LEU A 182
 LYS  A  57 ( 0.0A)
LEU  A  58 ( 0.6A)
PHE  A  60 ( 1.3A)
LEU  A 182 ( 0.6A)
 0.90A 2eijC-5d7wA:
undetectable
2eijJ-5d7wA:
undetectable		 2eijC-5d7wA:
19.92
2eijJ-5d7wA:
8.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2EIK_C_CHDC271_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE
VIIA-HEART
CYTOCHROME C OXIDASE
SUBUNIT 3)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 7 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.95A 2eikC-4flxA:
2.6
2eikJ-4flxA:
undetectable		 2eikC-4flxA:
13.49
2eikJ-4flxA:
6.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2EIK_J_CHDJ60_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE
VIIA-HEART
CYTOCHROME C OXIDASE
SUBUNIT 1)		 3o96 RAC-ALPHA
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		4 / 7 LEU A 379
PHE A 407
ARG A 249
MET A 343
 LEU  A 379 ( 0.6A)
PHE  A 407 ( 1.3A)
ARG  A 249 ( 0.6A)
MET  A 343 ( 0.0A)
 1.01A 2eikA-3o96A:
0.5
2eikJ-3o96A:
undetectable		 2eikA-3o96A:
19.89
2eikJ-3o96A:
9.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2EIL_C_CHDC271_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE
VIIA-HEART
CYTOCHROME C OXIDASE
SUBUNIT 3)		 5d7w SERRALYSIN
(Serratia
marcescens) 		4 / 8 LYS A  57
LEU A  58
PHE A  60
LEU A 182
 LYS  A  57 ( 0.0A)
LEU  A  58 ( 0.6A)
PHE  A  60 ( 1.3A)
LEU  A 182 ( 0.6A)
 0.86A 2eilC-5d7wA:
undetectable
2eilJ-5d7wA:
undetectable		 2eilC-5d7wA:
19.92
2eilJ-5d7wA:
8.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2EIM_W_CHDW1271_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE
VIIA-HEART
CYTOCHROME C OXIDASE
SUBUNIT 3)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 7 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.97A 2eimP-4flxA:
2.6
2eimW-4flxA:
undetectable		 2eimP-4flxA:
13.49
2eimW-4flxA:
6.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2EIM_W_CHDW1271_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE
VIIA-HEART
CYTOCHROME C OXIDASE
SUBUNIT 3)		 5d7w SERRALYSIN
(Serratia
marcescens) 		4 / 7 LYS A  57
LEU A  58
PHE A  60
LEU A 182
 LYS  A  57 ( 0.0A)
LEU  A  58 ( 0.6A)
PHE  A  60 ( 1.3A)
LEU  A 182 ( 0.6A)
 0.91A 2eimP-5d7wA:
undetectable
2eimW-5d7wA:
undetectable		 2eimP-5d7wA:
19.92
2eimW-5d7wA:
8.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2EIN_C_CHDC271_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE
VIIA-HEART
CYTOCHROME C OXIDASE
SUBUNIT 3)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 7 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.99A 2einC-4flxA:
2.4
2einJ-4flxA:
undetectable		 2einC-4flxA:
13.49
2einJ-4flxA:
6.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2EIN_P_CHDP1271_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE
VIIA-HEART
CYTOCHROME C OXIDASE
SUBUNIT 3)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 6 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 1.04A 2einP-4flxA:
2.4
2einW-4flxA:
undetectable		 2einP-4flxA:
13.49
2einW-4flxA:
6.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2F7F_A_NIOA601_1
(NICOTINATE
PHOSPHORIBOSYLTRANSF
ERASE, PUTATIVE)		 1ted PKS18
(Mycobacterium
tuberculosis) 		4 / 6 PHE A 354
ARG A 343
GLY A  41
THR A  42
 PHE  A 354 ( 1.3A)
ARG  A 343 ( 0.6A)
GLY  A  41 ( 0.0A)
THR  A  42 ( 0.8A)
 1.26A 2f7fA-1tedA:
undetectable		 2f7fA-1tedA:
22.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FEU_B_CAMB1421_0
(CYTOCHROME P450-CAM)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		4 / 7 PHE C 251
LEU C 280
VAL C 289
ASP C 273
 PHE  C 251 ( 1.3A)
LEU  C 280 ( 0.5A)
VAL  C 289 ( 0.5A)
ASP  C 273 ( 0.6A)
 1.04A 2feuB-5lmxC:
undetectable		 2feuB-5lmxC:
22.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FQY_A_ADNA400_1
(MEMBRANE LIPOPROTEIN
TMPC)		 4ki5 MURINE MONOCLONAL
G99 FAB HEAVY CHAIN
(Mus
musculus) 		5 / 12 ASP E  90
PHE E  64
MET E  81
PHE E  70
GLY E  66
 ASP  E  90 ( 0.6A)
PHE  E  64 ( 1.3A)
MET  E  81 ( 0.0A)
PHE  E  70 ( 1.3A)
GLY  E  66 ( 0.0A)
 1.27A 2fqyA-4ki5E:
undetectable		 2fqyA-4ki5E:
20.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2G72_B_SAMB2002_1
(PHENYLETHANOLAMINE
N-METHYLTRANSFERASE)		 3td9 BRANCHED CHAIN AMINO
ACID ABC
TRANSPORTER,
PERIPLASMIC AMINO
ACID-BINDING PROTEIN
(Thermotoga
maritima) 		4 / 7 TYR A 213
GLY A 140
TYR A 166
ASP A 368
 None
None
PHE  A 400 (-3.8A)
None
 0.97A 2g72B-3td9A:
undetectable		 2g72B-3td9A:
21.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2GSS_A_EAAA0_1
(GLUTATHIONE
S-TRANSFERASE P1-1)		 1c1d L-PHENYLALANINE
DEHYDROGENASE
(Rhodococcus
sp.) 		4 / 8 PHE A 137
ILE A 106
TYR A 113
GLY A  39
 None
None
None
PHE  A 361 (-3.7A)
 0.92A 2gssA-1c1dA:
undetectable		 2gssA-1c1dA:
21.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2GSS_B_EAAB0_1
(GLUTATHIONE
S-TRANSFERASE P1-1)		 1c1d L-PHENYLALANINE
DEHYDROGENASE
(Rhodococcus
sp.) 		4 / 8 PHE A 137
ILE A 106
TYR A 113
GLY A  39
 None
None
None
PHE  A 361 (-3.7A)
 0.92A 2gssB-1c1dA:
undetectable		 2gssB-1c1dA:
21.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2H42_A_VIAA901_1
(CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		5 / 11 TYR A 159
HIS A 160
PHE A 340
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
PHE  A 340 (-1.3A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.50A 2h42A-3sl5A:
36.2		 2h42A-3sl5A:
29.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2H42_C_VIAC903_1
(CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		5 / 12 TYR A 159
LEU A 319
PHE A 340
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
LEU  A 319 ( 0.6A)
PHE  A 340 (-1.3A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.43A 2h42C-3sl5A:
35.9		 2h42C-3sl5A:
29.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HJH_B_NCAB901_0
(NAD-DEPENDENT
HISTONE DEACETYLASE
SIR2)		 3r64 NAD DEPENDENT
BENZALDEHYDE
DEHYDROGENASE
(Corynebacterium
glutamicum) 		4 / 5 ILE A 181
PRO A 183
PHE A 223
VAL A 212
 ILE  A 181 ( 0.7A)
PRO  A 183 ( 1.1A)
PHE  A 223 ( 1.3A)
VAL  A 212 ( 0.6A)
 1.39A 2hjhB-3r64A:
undetectable		 2hjhB-3r64A:
20.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HYY_B_STIB600_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE
(Homo
sapiens) 		6 / 12 VAL A  39
ALA A  52
GLU A  69
PHE A 107
GLY A 111
LEU A 160
 VAL  A  39 (-0.6A)
ALA  A  52 (-0.0A)
GLU  A  69 ( 0.6A)
PHE  A 107 ( 1.3A)
GLY  A 111 (-0.0A)
LEU  A 160 (-0.6A)
 0.75A 2hyyB-5d7aA:
24.2		 2hyyB-5d7aA:
23.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2I30_A_SALA1100_1
(SERUM ALBUMIN)		 2nvv ACETYL-COA
HYDROLASE/TRANSFERAS
E FAMILY PROTEIN
(Porphyromonas
gingivalis) 		4 / 6 PHE A 323
ARG A 298
GLY A 297
LYS A 296
 PHE  A 323 ( 1.3A)
ARG  A 298 ( 0.6A)
GLY  A 297 ( 0.0A)
LYS  A 296 ( 0.0A)
 1.14A 2i30A-2nvvA:
undetectable		 2i30A-2nvvA:
20.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2IJ7_C_TPFC2471_1
(CYTOCHROME P450 121)		 5d7w SERRALYSIN
(Serratia
marcescens) 		4 / 8 VAL A 445
VAL A 457
PHE A 407
ALA A 380
 VAL  A 445 ( 0.6A)
VAL  A 457 ( 0.6A)
PHE  A 407 ( 1.3A)
ALA  A 380 ( 0.0A)
 1.16A 2ij7C-5d7wA:
undetectable		 2ij7C-5d7wA:
24.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2IYF_A_ERYA1400_0
(OLEANDOMYCIN
GLYCOSYLTRANSFERASE)		 3r6y ASPARTASE
(Bacillus
sp.
YM55-1) 		5 / 11 HIS A 150
ASN A 359
PHE A 366
ASN A 226
ASP A 266
 HIS  A 150 ( 1.0A)
ASN  A 359 ( 0.6A)
PHE  A 366 ( 1.3A)
ASN  A 226 ( 0.6A)
ASP  A 266 ( 0.6A)
 1.22A 2iyfA-3r6yA:
undetectable		 2iyfA-3r6yA:
20.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2J5M_A_ACTA1321_0
(CHLOROPEROXIDASE)		 4yba REGULATORY PROTEIN C
(Klebsiella
pneumoniae) 		4 / 6 LEU A  20
PHE A  68
ILE A  13
ALA A  16
 LEU  A  20 ( 0.6A)
PHE  A  68 ( 1.3A)
ILE  A  13 ( 0.7A)
ALA  A  16 ( 0.0A)
 1.01A 2j5mA-4ybaA:
undetectable		 2j5mA-4ybaA:
15.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JJP_A_KLNA413_1
(CYTOCHROME P450
113A1)		 1xqw PROLINE
IMINOPEPTIDASE
(Thermoplasma
acidophilum) 		5 / 12 MET A 141
ALA A 111
LEU A 112
ALA A 113
MET A 208
 PHE  A 300 ( 4.9A)
None
None
None
None
 1.30A 2jjpA-1xqwA:
undetectable		 2jjpA-1xqwA:
21.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JJP_A_KLNA413_1
(CYTOCHROME P450
113A1)		 5wpi HSVA
(Erwinia
amylovora) 		5 / 12 PRO A  17
ALA A 352
ALA A 119
PHE A 149
ILE A 152
 PRO  A  17 ( 1.1A)
ALA  A 352 ( 0.0A)
ALA  A 119 ( 0.0A)
PHE  A 149 ( 1.3A)
ILE  A 152 ( 0.6A)
 1.30A 2jjpA-5wpiA:
undetectable		 2jjpA-5wpiA:
20.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JKC_A_TRPA1520_0
(FLAVIN-DEPENDENT
TRYPTOPHAN
HALOGENASE PRNA)		 1amu GRAMICIDIN
SYNTHETASE 1
(Brevibacillus
brevis) 		5 / 10 ILE A 188
PRO A 118
ILE A 330
TYR A 123
ASN A 515
 None
None
PHE  A 566 (-4.6A)
None
None
 1.42A 2jkcA-1amuA:
1.1		 2jkcA-1amuA:
21.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JN3_A_JN3A131_2
(FATTY ACID-BINDING
PROTEIN, LIVER)		 3gnr OS03G0212800 PROTEIN
(Oryza
sativa) 		4 / 6 LEU A 313
ASN A 319
GLN A 270
PHE A 281
 LEU  A 313 ( 0.5A)
ASN  A 319 ( 0.6A)
GLN  A 270 ( 0.6A)
PHE  A 281 ( 1.3A)
 1.21A 2jn3A-3gnrA:
undetectable		 2jn3A-3gnrA:
13.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2KOT_A_ANWA99_0
(PROTEIN S100-A13)		 5d7w SERRALYSIN
(Serratia
marcescens) 		4 / 7 THR A 103
PHE A 104
THR A 105
LYS A  90
 THR  A 103 ( 0.8A)
PHE  A 104 ( 1.3A)
THR  A 105 ( 0.8A)
LYS  A  90 ( 0.0A)
 1.02A 2kotA-5d7wA:
undetectable		 2kotA-5d7wA:
11.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2KOT_B_ANWB99_0
(PROTEIN S100-A13)		 1ted PKS18
(Mycobacterium
tuberculosis) 		4 / 8 ALA A 176
VAL A 383
THR A 382
PHE A 377
 ALA  A 176 ( 0.0A)
VAL  A 383 ( 0.6A)
THR  A 382 ( 0.8A)
PHE  A 377 ( 1.3A)
 1.21A 2kotB-1tedA:
0.0		 2kotB-1tedA:
12.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2LH6_A_NIOA155_1
(LEGHEMOGLOBIN A
(NICOTINATE MET))		 3r9r PHOSPHORIBOSYLAMINOI
MIDAZOLE-SUCCINOCARB
OXAMIDE SYNTHASE
(Mycobacteroides
abscessus) 		4 / 5 PHE A 201
PHE A 199
PHE A 216
VAL A  66
 PHE  A 201 ( 1.3A)
PHE  A 199 ( 1.3A)
PHE  A 216 ( 1.3A)
VAL  A  66 ( 0.6A)
 1.16A 2lh6A-3r9rA:
undetectable		 2lh6A-3r9rA:
20.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2LH6_A_NIOA155_1
(LEGHEMOGLOBIN A
(NICOTINATE MET))		 5jja SERINE/THREONINE-PRO
TEIN PHOSPHATASE 2A
56 KDA REGULATORY
SUBUNIT GAMMA
ISOFORM
(Homo
sapiens) 		4 / 5 PHE A 144
PHE A 150
PHE A 193
VAL A  96
 PHE  A 144 ( 1.3A)
PHE  A 150 ( 1.3A)
PHE  A 193 ( 1.3A)
VAL  A  96 ( 0.6A)
 1.16A 2lh6A-5jjaA:
undetectable		 2lh6A-5jjaA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2M2P_B_DHIB24_0
(INSULIN B CHAIN)		 5d7w SERRALYSIN
(Serratia
marcescens) 		3 / 3 TYR A 297
GLY A 334
PHE A 294
 TYR  A 297 ( 1.3A)
GLY  A 334 (-0.0A)
PHE  A 294 ( 1.3A)
 0.67A 2m2pB-5d7wA:
undetectable		 2m2pB-5d7wA:
4.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Q6K_A_ADNA699_1
(CHLORINASE)		 3pu5 EXTRACELLULAR
SOLUTE-BINDING
PROTEIN
(Bordetella
parapertussis) 		4 / 7 PHE A 285
TYR A  87
TYR A  36
THR A  65
 PHE  A 285 ( 1.3A)
TYR  A  87 ( 1.3A)
TYR  A  36 (-1.3A)
THR  A  65 ( 0.8A)
 1.28A 2q6kA-3pu5A:
undetectable		 2q6kA-3pu5A:
24.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Q72_A_IXXA802_1
(TRANSPORTER)		 3r6y ASPARTASE
(Bacillus
sp.
YM55-1) 		4 / 6 ILE A 291
ARG A 296
ILE A 309
PHE A 201
 ILE  A 291 ( 0.7A)
ARG  A 296 ( 0.6A)
ILE  A 309 ( 0.7A)
PHE  A 201 ( 1.3A)
 1.14A 2q72A-3r6yA:
undetectable		 2q72A-3r6yA:
21.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QEI_A_CXXA802_1
(TRANSPORTER)		 2qv2 INOSITOL
POLYPHOSPHATE
5-PHOSPHATASE OCRL-1
(Homo
sapiens) 		4 / 6 ARG A 274
PHE A 277
ILE A 244
PHE A 331
 ARG  A 274 ( 0.6A)
PHE  A 277 ( 1.3A)
ILE  A 244 ( 0.7A)
PHE  A 331 ( 1.3A)
 1.28A 2qeiA-2qv2A:
undetectable		 2qeiA-2qv2A:
20.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QWX_B_ML1B233_1
(RIBOSYLDIHYDRONICOTI
NAMIDE DEHYDROGENASE
[QUINONE])		 1rrv GLYCOSYLTRANSFERASE
GTFD
(Amycolatopsis
orientalis) 		4 / 7 GLY A 310
GLY A 275
PHE A 296
PHE A 300
 GLY  A 310 ( 0.0A)
GLY  A 275 ( 0.0A)
PHE  A 296 (-1.3A)
PHE  A 300 ( 1.3A)
 0.96A 2qwxA-1rrvA:
5.3
2qwxB-1rrvA:
5.5		 2qwxA-1rrvA:
21.53
2qwxB-1rrvA:
21.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QWX_B_ML1B233_1
(RIBOSYLDIHYDRONICOTI
NAMIDE DEHYDROGENASE
[QUINONE])		 2vbf BRANCHED-CHAIN
ALPHA-KETOACID
DECARBOXYLASE
(Lactococcus
lactis) 		4 / 7 GLY A 289
GLY A 242
PHE A 381
PHE A 382
 GLY  A 289 ( 0.0A)
GLY  A 242 ( 0.0A)
PHE  A 381 ( 1.3A)
PHE  A 382 ( 1.3A)
 0.96A 2qwxA-2vbfA:
undetectable
2qwxB-2vbfA:
undetectable		 2qwxA-2vbfA:
16.35
2qwxB-2vbfA:
16.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QX6_A_ML1A233_1
(RIBOSYLDIHYDRONICOTI
NAMIDE DEHYDROGENASE
[QUINONE])		 1wly 2-HALOACRYLATE
REDUCTASE
(Burkholderia
sp.
WS) 		4 / 6 PHE A 306
ILE A 327
GLY A 320
GLY A 319
 PHE  A 306 ( 1.3A)
ILE  A 327 ( 0.6A)
GLY  A 320 ( 0.0A)
GLY  A 319 ( 0.0A)
 0.81A 2qx6A-1wlyA:
3.4
2qx6B-1wlyA:
3.4		 2qx6A-1wlyA:
24.24
2qx6B-1wlyA:
24.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2TSR_D_D16D609_1
(THYMIDYLATE SYNTHASE)		 3td9 BRANCHED CHAIN AMINO
ACID ABC
TRANSPORTER,
PERIPLASMIC AMINO
ACID-BINDING PROTEIN
(Thermotoga
maritima) 		5 / 9 PHE A  36
ASP A 299
LEU A 296
GLY A 297
THR A 118
 PHE  A 400 (-3.7A)
None
None
None
PHE  A 400 (-2.8A)
 1.33A 2tsrD-3td9A:
undetectable		 2tsrD-3td9A:
22.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2UY4_A_AZMA1311_1
(ENDOCHITINASE)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		6 / 9 TYR A 156
PHE A 184
GLY A 267
ASP A 306
TYR A 383
TRP A 532
 TYR  A 156 ( 1.3A)
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
ASP  A 306 ( 0.5A)
TYR  A 383 ( 1.3A)
TRP  A 532 ( 0.5A)
 0.93A 2uy4A-5gprA:
18.4		 2uy4A-5gprA:
19.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2UY4_A_AZMA1311_1
(ENDOCHITINASE)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		6 / 9 TYR A 156
PHE A 184
GLY A 267
GLU A 308
TYR A 383
TRP A 532
 TYR  A 156 ( 1.3A)
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
GLU  A 308 ( 0.6A)
TYR  A 383 ( 1.3A)
TRP  A 532 ( 0.5A)
 0.52A 2uy4A-5gprA:
18.4		 2uy4A-5gprA:
19.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		 4zke SUPERKILLER PROTEIN
7
(Saccharomyces
cerevisiae) 		4 / 7 PHE A 364
LEU A 382
ILE A 442
GLY A 274
 PHE  A 364 ( 1.3A)
LEU  A 382 ( 0.6A)
ILE  A 442 ( 0.7A)
GLY  A 274 ( 0.0A)
 1.01A 2v0mC-4zkeA:
undetectable		 2v0mC-4zkeA:
22.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		 5jja SERINE/THREONINE-PRO
TEIN PHOSPHATASE 2A
56 KDA REGULATORY
SUBUNIT GAMMA
ISOFORM
(Homo
sapiens) 		4 / 7 PHE A 163
PHE A 140
SER A 147
PHE A  42
 PHE  A 163 ( 1.3A)
PHE  A 140 ( 1.3A)
SER  A 147 ( 0.0A)
PHE  A  42 ( 1.3A)
 0.93A 2v0mC-5jjaA:
undetectable		 2v0mC-5jjaA:
22.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V7B_A_BEZA1529_0
(BENZOATE-COENZYME A
LIGASE)		 1amu GRAMICIDIN
SYNTHETASE 1
(Brevibacillus
brevis) 		5 / 9 PHE A 234
ALA A 301
GLY A 302
GLY A 324
LYS A 517
 PHE  A 566 ( 4.5A)
PHE  A 566 (-3.4A)
PHE  A 566 ( 3.6A)
PHE  A 566 (-4.7A)
AMP  A 567 ( 2.8A)
 0.64A 2v7bA-1amuA:
45.7		 2v7bA-1amuA:
25.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V7B_A_BEZA1529_0
(BENZOATE-COENZYME A
LIGASE)		 1rrv GLYCOSYLTRANSFERASE
GTFD
(Amycolatopsis
orientalis) 		5 / 9 PHE A 121
ALA A 114
ALA A 107
GLY A 189
GLY A 109
 PHE  A 121 ( 1.3A)
ALA  A 114 ( 0.0A)
ALA  A 107 ( 0.0A)
GLY  A 189 ( 0.0A)
GLY  A 109 ( 0.0A)
 1.37A 2v7bA-1rrvA:
4.1		 2v7bA-1rrvA:
25.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V7B_B_BEZB1529_0
(BENZOATE-COENZYME A
LIGASE)		 1amu GRAMICIDIN
SYNTHETASE 1
(Brevibacillus
brevis) 		5 / 9 PHE A 234
ALA A 301
GLY A 302
GLY A 324
LYS A 517
 PHE  A 566 ( 4.5A)
PHE  A 566 (-3.4A)
PHE  A 566 ( 3.6A)
PHE  A 566 (-4.7A)
AMP  A 567 ( 2.8A)
 0.65A 2v7bB-1amuA:
45.7		 2v7bB-1amuA:
25.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VH3_B_DAHB2_1
(RANASMURFIN)		 3td9 BRANCHED CHAIN AMINO
ACID ABC
TRANSPORTER,
PERIPLASMIC AMINO
ACID-BINDING PROTEIN
(Thermotoga
maritima) 		4 / 8 ALA A  94
SER A  98
GLY A  91
ALA A 116
 PHE  A 400 (-4.3A)
None
None
PHE  A 400 (-3.6A)
 0.83A 2vh3B-3td9A:
undetectable		 2vh3B-3td9A:
13.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VUF_A_FUAA2002_1
(SERUM ALBUMIN)		 1zx3 HYPOTHETICAL PROTEIN
NE0241
(Nitrosomonas
europaea) 		4 / 9 PHE A  53
ALA A  54
VAL A  57
GLU A  58
 PHE  A  53 ( 1.4A)
ALA  A  54 ( 0.0A)
VAL  A  57 ( 0.6A)
GLU  A  58 ( 0.5A)
 0.49A 2vufA-1zx3A:
undetectable		 2vufA-1zx3A:
9.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VUF_A_FUAA2002_1
(SERUM ALBUMIN)		 5wm9 RV0078
(Mycobacterium
tuberculosis) 		4 / 9 ILE A 113
PHE A  62
VAL A  66
GLU A  67
 ILE  A 113 ( 0.7A)
PHE  A  62 ( 1.3A)
VAL  A  66 ( 0.6A)
GLU  A  67 ( 0.6A)
 0.82A 2vufA-5wm9A:
4.0		 2vufA-5wm9A:
8.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VX9_A_RBFA1064_1
(DODECIN)		 3ghg FIBRINOGEN GAMMA
CHAIN
(Homo
sapiens) 		3 / 3 PHE C 290
VAL C 248
TRP C 369
 PHE  C 290 ( 1.3A)
VAL  C 248 ( 0.6A)
TRP  C 369 ( 0.5A)
 0.87A 2vx9A-3ghgC:
undetectable		 2vx9A-3ghgC:
11.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VX9_A_RBFA1064_1
(DODECIN)		 4mtp RNA DEPENDENT RNA
POLYMERASE
(Japanese
encephalitis
virus) 		3 / 3 PHE A 401
VAL A 428
TRP A 434
 PHE  A 401 ( 1.3A)
VAL  A 428 ( 0.6A)
TRP  A 434 ( 0.5A)
 0.82A 2vx9A-4mtpA:
undetectable		 2vx9A-4mtpA:
11.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VX9_A_RBFA1064_1
(DODECIN)		 5ec3 4-HYDROXYPHENYLPYRUV
ATE DIOXYGENASE
(Homo
sapiens) 		3 / 3 PHE A 364
VAL A 212
TRP A 210
 PHE  A 364 ( 1.3A)
VAL  A 212 ( 0.6A)
TRP  A 210 ( 0.5A)
 0.84A 2vx9A-5ec3A:
undetectable		 2vx9A-5ec3A:
12.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2W3B_A_FOLA401_0
(DIHYDROFOLATE
REDUCTASE)		 5fii PHENYLALANINE-4-HYDR
OXYLASE
(Homo
sapiens) 		5 / 12 ILE A  94
LEU A  41
PHE A  55
ILE A  65
LEU A  62
 None
None
None
PHE  A 901 ( 4.3A)
PHE  A 901 (-3.6A)
 1.11A 2w3bA-5fiiA:
undetectable		 2w3bA-5fiiA:
21.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2W3B_B_FOLB401_0
(DIHYDROFOLATE
REDUCTASE)		 5fii PHENYLALANINE-4-HYDR
OXYLASE
(Homo
sapiens) 		5 / 12 ILE A  94
LEU A  41
PHE A  55
ILE A  65
LEU A  62
 None
None
None
PHE  A 901 ( 4.3A)
PHE  A 901 (-3.6A)
 1.10A 2w3bB-5fiiA:
undetectable		 2w3bB-5fiiA:
21.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2W3M_A_FOLA1188_0
(DIHYDROFOLATE
REDUCTASE)		 5fii PHENYLALANINE-4-HYDR
OXYLASE
(Homo
sapiens) 		5 / 12 ILE A  94
LEU A  41
PHE A  55
ILE A  65
LEU A  62
 None
None
None
PHE  A 901 ( 4.3A)
PHE  A 901 (-3.6A)
 1.09A 2w3mA-5fiiA:
undetectable		 2w3mA-5fiiA:
21.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2W3V_A_TOPA1169_1
(DIHYDROFOLATE
REDUCTASE)		 2nvv ACETYL-COA
HYDROLASE/TRANSFERAS
E FAMILY PROTEIN
(Porphyromonas
gingivalis) 		5 / 12 VAL A 428
ILE A 350
LEU A 239
PHE A 238
SER A 386
 VAL  A 428 ( 0.6A)
ILE  A 350 ( 0.6A)
LEU  A 239 ( 0.6A)
PHE  A 238 ( 1.3A)
SER  A 386 ( 0.0A)
 1.11A 2w3vA-2nvvA:
undetectable		 2w3vA-2nvvA:
15.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2W9S_A_TOPA1160_1
(DIHYDROFOLATE
REDUCTASE TYPE 1
FROM TN4003)		 2rci TYPE-2BA CYTOLYTIC
DELTA-ENDOTOXIN
(Bacillus
thuringiensis) 		5 / 11 ILE A 111
ALA A 138
ILE A 114
ILE A 193
PHE A 143
 ILE  A 111 ( 0.7A)
ALA  A 138 ( 0.0A)
ILE  A 114 ( 0.7A)
ILE  A 193 ( 0.6A)
PHE  A 143 ( 1.3A)
 1.07A 2w9sA-2rciA:
undetectable		 2w9sA-2rciA:
22.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2W9S_B_TOPB1160_1
(DIHYDROFOLATE
REDUCTASE TYPE 1
FROM TN4003)		 2rci TYPE-2BA CYTOLYTIC
DELTA-ENDOTOXIN
(Bacillus
thuringiensis) 		5 / 11 ILE A 111
ALA A 138
ILE A 114
ILE A 193
PHE A 143
 ILE  A 111 ( 0.7A)
ALA  A 138 ( 0.0A)
ILE  A 114 ( 0.7A)
ILE  A 193 ( 0.6A)
PHE  A 143 ( 1.3A)
 1.08A 2w9sB-2rciA:
undetectable		 2w9sB-2rciA:
22.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2W9S_C_TOPC1160_1
(DIHYDROFOLATE
REDUCTASE TYPE 1
FROM TN4003)		 2rci TYPE-2BA CYTOLYTIC
DELTA-ENDOTOXIN
(Bacillus
thuringiensis) 		5 / 10 ILE A 111
ALA A 138
ILE A 114
ILE A 193
PHE A 143
 ILE  A 111 ( 0.7A)
ALA  A 138 ( 0.0A)
ILE  A 114 ( 0.7A)
ILE  A 193 ( 0.6A)
PHE  A 143 ( 1.3A)
 1.08A 2w9sC-2rciA:
undetectable		 2w9sC-2rciA:
22.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2WEK_A_DIFA1373_1
(ZINC-BINDING ALCOHOL
DEHYDROGENASE
DOMAIN-CONTAINING
PROTEIN 2)		 3td9 BRANCHED CHAIN AMINO
ACID ABC
TRANSPORTER,
PERIPLASMIC AMINO
ACID-BINDING PROTEIN
(Thermotoga
maritima) 		4 / 8 VAL A 348
TYR A 166
PHE A 261
ASN A 351
 None
PHE  A 400 (-3.8A)
EDO  A 403 (-4.4A)
EDO  A 403 (-4.0A)
 1.27A 2wekA-3td9A:
6.9		 2wekA-3td9A:
23.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2WEK_B_DIFB1373_1
(ZINC-BINDING ALCOHOL
DEHYDROGENASE
DOMAIN-CONTAINING
PROTEIN 2)		 3td9 BRANCHED CHAIN AMINO
ACID ABC
TRANSPORTER,
PERIPLASMIC AMINO
ACID-BINDING PROTEIN
(Thermotoga
maritima) 		4 / 8 VAL A 348
TYR A 166
PHE A 261
ASN A 351
 None
PHE  A 400 (-3.8A)
EDO  A 403 (-4.4A)
EDO  A 403 (-4.0A)
 1.22A 2wekB-3td9A:
6.8		 2wekB-3td9A:
23.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2WEY_A_EV1A1771_1
(CAMP AND
CAMP-INHIBITED CGMP
3', 5'-CYCLIC
PHOSPHODIESTERASE)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		8 / 12 TYR A 159
HIS A 160
LEU A 319
ILE A 336
GLU A 339
MET A 357
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
LEU  A 319 ( 0.6A)
ILE  A 336 ( 0.4A)
GLU  A 339 ( 0.5A)
MET  A 357 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 1.01A 2weyA-3sl5A:
37.9		 2weyA-3sl5A:
27.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2WEY_A_EV1A1771_1
(CAMP AND
CAMP-INHIBITED CGMP
3', 5'-CYCLIC
PHOSPHODIESTERASE)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		8 / 12 TYR A 159
HIS A 160
LEU A 319
ILE A 336
GLU A 339
PHE A 340
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
LEU  A 319 ( 0.6A)
ILE  A 336 ( 0.4A)
GLU  A 339 ( 0.5A)
PHE  A 340 (-1.3A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.83A 2weyA-3sl5A:
37.9		 2weyA-3sl5A:
27.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2WEY_B_EV1B1771_1
(CAMP AND
CAMP-INHIBITED CGMP
3', 5'-CYCLIC
PHOSPHODIESTERASE)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		4 / 8 ILE A 336
MET A 357
GLN A 369
PHE A 372
 ILE  A 336 ( 0.4A)
MET  A 357 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.86A 2weyB-3sl5A:
37.4		 2weyB-3sl5A:
27.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2WEY_B_EV1B1771_1
(CAMP AND
CAMP-INHIBITED CGMP
3', 5'-CYCLIC
PHOSPHODIESTERASE)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		4 / 8 ILE A 336
PHE A 340
GLN A 369
PHE A 372
 ILE  A 336 ( 0.4A)
PHE  A 340 (-1.3A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.54A 2weyB-3sl5A:
37.4		 2weyB-3sl5A:
27.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2WSC_B_PQNB1773_1
(PHOTOSYSTEM I P700
CHLOROPHYLL A
APOPROTEIN A2)		 6c0w HISTONE H3-LIKE
CENTROMERIC PROTEIN
A
HISTONE H4
(Homo
sapiens) 		5 / 10 PHE A 106
ARG B  36
ALA B  33
LEU B  37
ALA B  38
 PHE  A 106 ( 1.3A)
ARG  B  36 ( 0.6A)
ALA  B  33 ( 0.0A)
LEU  B  37 ( 0.6A)
ALA  B  38 ( 0.0A)
 1.30A 2wscB-6c0wA:
undetectable		 2wscB-6c0wA:
7.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2WSE_B_PQNB1774_1
(PHOTOSYSTEM I P700
CHLOROPHYLL A
APOPROTEIN A2)		 6c0w HISTONE H3-LIKE
CENTROMERIC PROTEIN
A
HISTONE H4
(Homo
sapiens) 		5 / 10 PHE A 106
ARG B  36
ALA B  33
LEU B  37
ALA B  38
 PHE  A 106 ( 1.3A)
ARG  B  36 ( 0.6A)
ALA  B  33 ( 0.0A)
LEU  B  37 ( 0.6A)
ALA  B  38 ( 0.0A)
 1.31A 2wseB-6c0wA:
undetectable		 2wseB-6c0wA:
7.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2WSF_B_PQNB1773_1
(PHOTOSYSTEM I P700
CHLOROPHYLL A
APOPROTEIN A2)		 6c0w HISTONE H3-LIKE
CENTROMERIC PROTEIN
A
HISTONE H4
(Homo
sapiens) 		5 / 9 PHE A 106
ARG B  36
ALA B  33
LEU B  37
ALA B  38
 PHE  A 106 ( 1.3A)
ARG  B  36 ( 0.6A)
ALA  B  33 ( 0.0A)
LEU  B  37 ( 0.6A)
ALA  B  38 ( 0.0A)
 1.32A 2wsfB-6c0wA:
undetectable		 2wsfB-6c0wA:
7.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X2I_B_QPSB1060_1
(ALPHA-1,4-GLUCAN
LYASE ISOZYME 1)		 4yzr POLYKETIDE
BIOSYNTHESIS
CYTOCHROME P450 PKSS
(Bacillus
subtilis) 		5 / 10 PHE A 345
SER A 344
SER A 286
GLY A 362
ALA A 358
 PHE  A 345 (-1.3A)
SER  A 344 (-0.0A)
SER  A 286 ( 0.0A)
GLY  A 362 ( 0.0A)
ALA  A 358 (-0.0A)
 1.31A 2x2iB-4yzrA:
undetectable		 2x2iB-4yzrA:
16.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X91_A_LPRA1615_2
(ANGIOTENSIN
CONVERTING ENZYME)		 5gru DIABODY PROTEIN
(Mus
musculus) 		3 / 3 SER L 215
THR L 218
PHE L 192
 SER  L 215 ( 0.0A)
THR  L 218 ( 0.8A)
PHE  L 192 ( 1.3A)
 0.64A 2x91A-5gruL:
undetectable		 2x91A-5gruL:
16.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XF3_A_J01A600_1
(ORF12)		 5hiu GTPASE
ACTIVATOR-LIKE
PROTEIN
(Chaetomium
thermophilum) 		5 / 11 SER A 384
ALA A 382
GLY A 381
SER A 323
PHE A 359
 SER  A 384 ( 0.0A)
ALA  A 382 ( 0.0A)
GLY  A 381 ( 0.0A)
SER  A 323 ( 0.0A)
PHE  A 359 ( 1.3A)
 1.37A 2xf3A-5hiuA:
undetectable		 2xf3A-5hiuA:
22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XF3_B_J01B600_1
(ORF12)		 5hiu GTPASE
ACTIVATOR-LIKE
PROTEIN
(Chaetomium
thermophilum) 		5 / 11 SER A 384
ALA A 382
GLY A 381
SER A 323
PHE A 359
 SER  A 384 ( 0.0A)
ALA  A 382 ( 0.0A)
GLY  A 381 ( 0.0A)
SER  A 323 ( 0.0A)
PHE  A 359 ( 1.3A)
 1.36A 2xf3B-5hiuA:
undetectable		 2xf3B-5hiuA:
22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XTK_A_AZMA1339_1
(CLASS III CHITINASE
CHIA1)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		6 / 11 TYR A 156
PHE A 184
GLY A 267
GLU A 308
TYR A 383
TRP A 532
 TYR  A 156 ( 1.3A)
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
GLU  A 308 ( 0.6A)
TYR  A 383 ( 1.3A)
TRP  A 532 ( 0.5A)
 0.74A 2xtkA-5gprA:
19.8		 2xtkA-5gprA:
20.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XTK_B_AZMB1339_1
(CLASS III CHITINASE
CHIA1)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		6 / 10 TYR A 156
PHE A 184
GLY A 267
ASP A 306
TYR A 383
TRP A 532
 TYR  A 156 ( 1.3A)
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
ASP  A 306 ( 0.5A)
TYR  A 383 ( 1.3A)
TRP  A 532 ( 0.5A)
 0.96A 2xtkB-5gprA:
19.7		 2xtkB-5gprA:
20.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XTK_B_AZMB1339_1
(CLASS III CHITINASE
CHIA1)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		6 / 10 TYR A 156
PHE A 184
GLY A 267
GLU A 308
TYR A 383
TRP A 532
 TYR  A 156 ( 1.3A)
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
GLU  A 308 ( 0.6A)
TYR  A 383 ( 1.3A)
TRP  A 532 ( 0.5A)
 0.56A 2xtkB-5gprA:
19.7		 2xtkB-5gprA:
20.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XZ5_E_ACHE1211_0
(SOLUBLE
ACETYLCHOLINE
RECEPTOR)		 3td9 BRANCHED CHAIN AMINO
ACID ABC
TRANSPORTER,
PERIPLASMIC AMINO
ACID-BINDING PROTEIN
(Thermotoga
maritima) 		4 / 7 ILE A 214
SER A 192
TYR A 166
TYR A 217
 None
None
PHE  A 400 (-3.8A)
PHE  A 400 (-4.8A)
 1.29A 2xz5D-3td9A:
undetectable
2xz5E-3td9A:
undetectable		 2xz5D-3td9A:
19.89
2xz5E-3td9A:
19.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y6R_A_CTCA1385_0
(TETX2 PROTEIN)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		5 / 10 PHE A 309
ASN A 316
GLY A 312
GLY A 266
MET A 381
 PHE  A 309 ( 1.3A)
ASN  A 316 ( 0.6A)
GLY  A 312 ( 0.0A)
GLY  A 266 ( 0.0A)
MET  A 381 ( 0.0A)
 1.21A 2y6rA-5gprA:
undetectable		 2y6rA-5gprA:
22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y7K_A_SALA1303_1
(LYSR-TYPE REGULATORY
PROTEIN)		 3wd7 TYPE III POLYKETIDE
SYNTHASES ACRIDONE
SYNTHASE
(Citrus
x
microcarpa) 		4 / 7 PHE A 275
ILE A 309
PRO A 375
GLY A 374
 PHE  A 275 ( 1.3A)
ILE  A 309 ( 0.7A)
PRO  A 375 ( 1.1A)
GLY  A 374 ( 0.0A)
 0.92A 2y7kA-3wd7A:
undetectable		 2y7kA-3wd7A:
20.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZAW_A_CAMA422_0
(CYTOCHROME P450-CAM)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		4 / 6 PHE C 251
LEU C 280
VAL C 289
ASP C 273
 PHE  C 251 ( 1.3A)
LEU  C 280 ( 0.5A)
VAL  C 289 ( 0.5A)
ASP  C 273 ( 0.6A)
 0.94A 2zawA-5lmxC:
undetectable		 2zawA-5lmxC:
23.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZAX_A_CAMA422_0
(CYTOCHROME P450-CAM)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		4 / 7 PHE C 251
LEU C 280
VAL C 289
ASP C 273
 PHE  C 251 ( 1.3A)
LEU  C 280 ( 0.5A)
VAL  C 289 ( 0.5A)
ASP  C 273 ( 0.6A)
 0.97A 2zaxA-5lmxC:
undetectable		 2zaxA-5lmxC:
23.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZI9_A_CL9A401_2
(DEOXYCYTIDINE KINASE)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		3 / 3 ASP A 212
PHE A 216
LEU A 220
 ASP  A 212 ( 0.6A)
PHE  A 216 ( 1.3A)
LEU  A 220 ( 0.6A)
 0.69A 2zi9A-4flxA:
undetectable		 2zi9A-4flxA:
18.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZIF_A_SAMA298_0
(PUTATIVE
MODIFICATION
METHYLASE)		 3ulk KETOL-ACID
REDUCTOISOMERASE
(Escherichia
coli) 		5 / 12 ALA A 488
PRO A 154
PHE A 169
GLY A 199
THR A 198
 ALA  A 488 ( 0.0A)
PRO  A 154 (-1.1A)
PHE  A 169 ( 1.3A)
GLY  A 199 ( 0.0A)
THR  A 198 ( 0.8A)
 1.04A 2zifA-3ulkA:
undetectable		 2zifA-3ulkA:
20.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZSE_A_PAUA600_0
(PANTOTHENATE KINASE)		 3sag EXOSOME COMPONENT 10
(Homo
sapiens) 		4 / 7 TYR A 382
PHE A 198
ILE A 202
ASN A 353
 TYR  A 382 ( 1.3A)
PHE  A 198 ( 1.3A)
ILE  A 202 ( 0.7A)
ASN  A 353 ( 0.6A)
 1.24A 2zseA-3sagA:
undetectable		 2zseA-3sagA:
22.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZWT_A_CAMA422_0
(CAMPHOR
5-MONOOXYGENASE)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		4 / 7 PHE C 251
LEU C 280
VAL C 289
ASP C 273
 PHE  C 251 ( 1.3A)
LEU  C 280 ( 0.5A)
VAL  C 289 ( 0.5A)
ASP  C 273 ( 0.6A)
 0.97A 2zwtA-5lmxC:
undetectable		 2zwtA-5lmxC:
23.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZWU_A_CAMA422_0
(CAMPHOR
5-MONOOXYGENASE)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		4 / 7 PHE C 251
LEU C 280
VAL C 289
ASP C 273
 PHE  C 251 ( 1.3A)
LEU  C 280 ( 0.5A)
VAL  C 289 ( 0.5A)
ASP  C 273 ( 0.6A)
 0.98A 2zwuA-5lmxC:
undetectable		 2zwuA-5lmxC:
23.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZXW_C_CHDC271_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE 7A1
CYTOCHROME C OXIDASE
SUBUNIT 3)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 7 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.96A 2zxwC-4flxA:
2.6
2zxwJ-4flxA:
undetectable		 2zxwC-4flxA:
13.49
2zxwJ-4flxA:
6.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZXW_P_CHDP1271_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE 7A1
CYTOCHROME C OXIDASE
SUBUNIT 3)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 6 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.97A 2zxwP-4flxA:
2.6
2zxwW-4flxA:
undetectable		 2zxwP-4flxA:
13.49
2zxwW-4flxA:
6.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZXW_W_CHDW1060_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE 7A1
CYTOCHROME C OXIDASE
SUBUNIT 1)		 3o96 RAC-ALPHA
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		4 / 7 LEU A 379
PHE A 407
ARG A 249
MET A 343
 LEU  A 379 ( 0.6A)
PHE  A 407 ( 1.3A)
ARG  A 249 ( 0.6A)
MET  A 343 ( 0.0A)
 1.01A 2zxwN-3o96A:
undetectable
2zxwW-3o96A:
undetectable		 2zxwN-3o96A:
19.89
2zxwW-3o96A:
9.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZZN_B_SAMB402_0
(UNCHARACTERIZED
PROTEIN MJ0883)		 2p5d UPF0310 PROTEIN
MJECL36
(Methanocaldococc
us
jannaschii) 		5 / 12 PHE A 102
TYR A  60
PHE A 108
ILE A 144
ASP A 140
 PHE  A 102 ( 1.3A)
TYR  A  60 ( 1.3A)
PHE  A 108 ( 1.3A)
ILE  A 144 ( 0.7A)
ASP  A 140 ( 0.6A)
 1.33A 2zznB-2p5dA:
undetectable		 2zznB-2p5dA:
20.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZZN_B_SAMB402_0
(UNCHARACTERIZED
PROTEIN MJ0883)		 3qvi HISTO-ASPARTIC
PROTEASE
(Plasmodium
falciparum) 		5 / 12 LEU A 140
PHE A  29
GLY A 122
ASN A  37
PHE A  27
 LEU  A 140 ( 0.6A)
PHE  A  29 ( 1.3A)
GLY  A 122 ( 0.0A)
ASN  A  37 ( 0.6A)
PHE  A  27 ( 1.3A)
 1.40A 2zznB-3qviA:
undetectable		 2zznB-3qviA:
22.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZZN_B_SAMB402_0
(UNCHARACTERIZED
PROTEIN MJ0883)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		5 / 12 PHE A 217
PHE A 293
ILE A 193
ASP A 195
PHE A 204
 PHE  A 217 ( 1.3A)
PHE  A 293 ( 1.3A)
ILE  A 193 ( 0.4A)
ASP  A 195 ( 0.6A)
PHE  A 204 ( 1.3A)
 1.23A 2zznB-5gprA:
undetectable		 2zznB-5gprA:
20.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ABK_J_CHDJ60_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE 7A1
CYTOCHROME C OXIDASE
SUBUNIT 1)		 3h7a SHORT CHAIN
DEHYDROGENASE
(Rhodopseudomonas
palustris) 		4 / 8 ILE A 135
PHE A 137
THR A  70
LEU A  73
 ILE  A 135 ( 0.6A)
PHE  A 137 ( 1.3A)
THR  A  70 ( 0.8A)
LEU  A  73 ( 0.5A)
 0.89A 3abkA-3h7aA:
undetectable
3abkJ-3h7aA:
undetectable		 3abkA-3h7aA:
18.89
3abkJ-3h7aA:
11.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ABK_P_CHDP1271_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE 7A1
CYTOCHROME C OXIDASE
SUBUNIT 3)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 6 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.86A 3abkP-4flxA:
undetectable
3abkW-4flxA:
undetectable		 3abkP-4flxA:
13.49
3abkW-4flxA:
6.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ABL_W_CHDW1060_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE 7A1
CYTOCHROME C OXIDASE
SUBUNIT 1)		 3h7a SHORT CHAIN
DEHYDROGENASE
(Rhodopseudomonas
palustris) 		4 / 8 ILE A 135
PHE A 137
THR A  70
LEU A  73
 ILE  A 135 ( 0.6A)
PHE  A 137 ( 1.3A)
THR  A  70 ( 0.8A)
LEU  A  73 ( 0.5A)
 0.82A 3ablN-3h7aA:
undetectable
3ablW-3h7aA:
undetectable		 3ablN-3h7aA:
18.89
3ablW-3h7aA:
11.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ABM_W_CHDW1060_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE 7A1
CYTOCHROME C OXIDASE
SUBUNIT 1)		 3h7a SHORT CHAIN
DEHYDROGENASE
(Rhodopseudomonas
palustris) 		4 / 8 ILE A 135
PHE A 137
THR A  70
LEU A  73
 ILE  A 135 ( 0.6A)
PHE  A 137 ( 1.3A)
THR  A  70 ( 0.8A)
LEU  A  73 ( 0.5A)
 0.86A 3abmN-3h7aA:
undetectable
3abmW-3h7aA:
undetectable		 3abmN-3h7aA:
18.89
3abmW-3h7aA:
11.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AG1_B_CHDB1085_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 2
CYTOCHROME C OXIDASE
SUBUNIT 6A2)		 2nvv ACETYL-COA
HYDROLASE/TRANSFERAS
E FAMILY PROTEIN
(Porphyromonas
gingivalis) 		5 / 11 GLY A 143
THR A  63
ARG A 113
PHE A  58
GLY A  22
 GLY  A 143 ( 0.0A)
THR  A  63 ( 0.8A)
ARG  A 113 ( 0.6A)
PHE  A  58 ( 1.3A)
GLY  A  22 ( 0.0A)
 0.95A 3ag1A-2nvvA:
0.0
3ag1B-2nvvA:
0.0
3ag1T-2nvvA:
0.0		 3ag1A-2nvvA:
22.39
3ag1B-2nvvA:
18.90
3ag1T-2nvvA:
10.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AG1_C_CHDC271_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE 7A1
CYTOCHROME C OXIDASE
SUBUNIT 3)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 6 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.91A 3ag1C-4flxA:
2.5
3ag1J-4flxA:
undetectable		 3ag1C-4flxA:
13.49
3ag1J-4flxA:
6.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AG2_C_CHDC271_0
(CYTOCHROME C OXIDASE
SUBUNIT 3)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 7 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.95A 3ag2C-4flxA:
2.6		 3ag2C-4flxA:
13.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AG2_P_CHDP1271_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE 7A1
CYTOCHROME C OXIDASE
SUBUNIT 3)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 7 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.93A 3ag2P-4flxA:
2.6
3ag2W-4flxA:
undetectable		 3ag2P-4flxA:
13.49
3ag2W-4flxA:
6.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AG3_W_CHDW1059_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE 7A1
CYTOCHROME C OXIDASE
SUBUNIT 1)		 3h7a SHORT CHAIN
DEHYDROGENASE
(Rhodopseudomonas
palustris) 		4 / 8 ILE A 135
PHE A 137
THR A  70
LEU A  73
 ILE  A 135 ( 0.6A)
PHE  A 137 ( 1.3A)
THR  A  70 ( 0.8A)
LEU  A  73 ( 0.5A)
 0.89A 3ag3N-3h7aA:
undetectable
3ag3W-3h7aA:
undetectable		 3ag3N-3h7aA:
18.89
3ag3W-3h7aA:
11.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AG4_C_CHDC271_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE 7A1
CYTOCHROME C OXIDASE
SUBUNIT 3)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 8 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.90A 3ag4C-4flxA:
2.6
3ag4J-4flxA:
undetectable		 3ag4C-4flxA:
13.49
3ag4J-4flxA:
6.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AG4_P_CHDP1271_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE 7A1
CYTOCHROME C OXIDASE
SUBUNIT 3)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 7 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.89A 3ag4P-4flxA:
2.6
3ag4W-4flxA:
undetectable		 3ag4P-4flxA:
13.49
3ag4W-4flxA:
6.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AG4_W_CHDW1059_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE 7A1
CYTOCHROME C OXIDASE
SUBUNIT 1)		 3o96 RAC-ALPHA
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		4 / 7 LEU A 379
PHE A 407
ARG A 249
MET A 343
 LEU  A 379 ( 0.6A)
PHE  A 407 ( 1.3A)
ARG  A 249 ( 0.6A)
MET  A 343 ( 0.0A)
 1.04A 3ag4N-3o96A:
1.0
3ag4W-3o96A:
undetectable		 3ag4N-3o96A:
19.89
3ag4W-3o96A:
9.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AIA_B_SAMB206_0
(UPF0217 PROTEIN
MJ1640)		 1f2p AMINOPEPTIDASE
(Streptomyces
griseus) 		4 / 5 SER A 203
LEU A  86
GLY A 101
GLU A 131
 PHE  A 903 ( 3.9A)
None
None
PHE  A 903 (-2.8A)
 1.18A 3aiaA-1f2pA:
undetectable
3aiaB-1f2pA:
0.3		 3aiaA-1f2pA:
16.49
3aiaB-1f2pA:
16.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3APV_A_TP0A190_1
(ALPHA-1-ACID
GLYCOPROTEIN 2)		 3gnr OS03G0212800 PROTEIN
(Oryza
sativa) 		5 / 12 PHE A 301
LEU A 223
GLU A 305
ARG A 149
TYR A 286
 PHE  A 301 ( 1.3A)
LEU  A 223 ( 0.5A)
GLU  A 305 ( 0.6A)
ARG  A 149 ( 0.6A)
TYR  A 286 ( 1.3A)
 1.44A 3apvA-3gnrA:
undetectable		 3apvA-3gnrA:
16.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3APV_B_TP0B190_1
(ALPHA-1-ACID
GLYCOPROTEIN 2)		 3gnr OS03G0212800 PROTEIN
(Oryza
sativa) 		5 / 12 PHE A 301
LEU A 223
GLU A 305
ARG A 149
TYR A 286
 PHE  A 301 ( 1.3A)
LEU  A 223 ( 0.5A)
GLU  A 305 ( 0.6A)
ARG  A 149 ( 0.6A)
TYR  A 286 ( 1.3A)
 1.36A 3apvB-3gnrA:
undetectable		 3apvB-3gnrA:
16.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3APV_B_TP0B190_1
(ALPHA-1-ACID
GLYCOPROTEIN 2)		 3h8m EPHRIN TYPE-A
RECEPTOR 7
(Homo
sapiens) 		5 / 12 PHE A 944
TYR A 949
VAL A 928
LEU A 989
ARG A 957
 PHE  A 944 ( 1.4A)
TYR  A 949 ( 1.3A)
VAL  A 928 ( 0.6A)
LEU  A 989 ( 0.5A)
ARG  A 957 ( 0.6A)
 1.49A 3apvB-3h8mA:
undetectable		 3apvB-3h8mA:
17.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3APW_B_DP0B190_1
(ALPHA-1-ACID
GLYCOPROTEIN 2)		 3gnr OS03G0212800 PROTEIN
(Oryza
sativa) 		5 / 12 PHE A 301
LEU A 223
GLU A 305
ARG A 149
TYR A 286
 PHE  A 301 ( 1.3A)
LEU  A 223 ( 0.5A)
GLU  A 305 ( 0.6A)
ARG  A 149 ( 0.6A)
TYR  A 286 ( 1.3A)
 1.43A 3apwB-3gnrA:
undetectable		 3apwB-3gnrA:
16.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ARU_A_PNXA606_1
(CHITINASE A)		 1rrv GLYCOSYLTRANSFERASE
GTFD
(Amycolatopsis
orientalis) 		4 / 7 PHE A 232
GLY A 236
ASP A 287
ARG A 264
 PHE  A 232 ( 1.3A)
GLY  A 236 ( 0.0A)
ASP  A 287 ( 0.5A)
ARG  A 264 ( 0.6A)
 1.02A 3aruA-1rrvA:
undetectable		 3aruA-1rrvA:
22.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ARU_A_PNXA606_1
(CHITINASE A)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		7 / 7 PHE A 309
GLY A 359
LYS A 362
ASP A 384
TRP A 389
TYR A 411
ARG A 439
 PHE  A 309 ( 1.3A)
GLY  A 359 ( 0.0A)
LYS  A 362 ( 0.0A)
ASP  A 384 ( 0.5A)
TRP  A 389 (-0.5A)
TYR  A 411 ( 1.3A)
ARG  A 439 ( 0.6A)
 0.46A 3aruA-5gprA:
56.0		 3aruA-5gprA:
50.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ASN_C_CHDC271_0
(CYTOCHROME C OXIDASE
SUBUNIT 3
CYTOCHROME C OXIDASE
SUBUNIT 7A1)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 7 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.92A 3asnC-4flxA:
2.6
3asnJ-4flxA:
undetectable		 3asnC-4flxA:
13.49
3asnJ-4flxA:
6.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ASN_P_CHDP1271_0
(CYTOCHROME C OXIDASE
SUBUNIT 3
CYTOCHROME C OXIDASE
SUBUNIT 7A1)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 7 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.91A 3asnP-4flxA:
2.4
3asnW-4flxA:
undetectable		 3asnP-4flxA:
13.49
3asnW-4flxA:
6.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ASN_P_CHDP1271_0
(CYTOCHROME C OXIDASE
SUBUNIT 3
CYTOCHROME C OXIDASE
SUBUNIT 7A1)		 5d7w SERRALYSIN
(Serratia
marcescens) 		4 / 7 LYS A  57
LEU A  58
PHE A  60
LEU A 182
 LYS  A  57 ( 0.0A)
LEU  A  58 ( 0.6A)
PHE  A  60 ( 1.3A)
LEU  A 182 ( 0.6A)
 0.99A 3asnP-5d7wA:
undetectable
3asnW-5d7wA:
undetectable		 3asnP-5d7wA:
19.92
3asnW-5d7wA:
8.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ASO_P_CHDP1271_0
(CYTOCHROME C OXIDASE
SUBUNIT 3
CYTOCHROME C OXIDASE
SUBUNIT 7A1)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 7 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.91A 3asoP-4flxA:
2.6
3asoW-4flxA:
undetectable		 3asoP-4flxA:
13.49
3asoW-4flxA:
6.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ASO_P_CHDP1271_0
(CYTOCHROME C OXIDASE
SUBUNIT 3
CYTOCHROME C OXIDASE
SUBUNIT 7A1)		 5d7w SERRALYSIN
(Serratia
marcescens) 		4 / 7 LYS A  57
LEU A  58
PHE A  60
LEU A 182
 LYS  A  57 ( 0.0A)
LEU  A  58 ( 0.6A)
PHE  A  60 ( 1.3A)
LEU  A 182 ( 0.6A)
 0.99A 3asoP-5d7wA:
undetectable
3asoW-5d7wA:
undetectable		 3asoP-5d7wA:
19.92
3asoW-5d7wA:
8.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ASO_W_CHDW1059_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 7A1)		 3h7a SHORT CHAIN
DEHYDROGENASE
(Rhodopseudomonas
palustris) 		4 / 8 ILE A 135
PHE A 137
THR A  70
LEU A  73
 ILE  A 135 ( 0.6A)
PHE  A 137 ( 1.3A)
THR  A  70 ( 0.8A)
LEU  A  73 ( 0.5A)
 0.92A 3asoN-3h7aA:
1.0
3asoW-3h7aA:
undetectable		 3asoN-3h7aA:
18.89
3asoW-3h7aA:
11.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3B2R_A_VDNA1_1
(CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		6 / 12 TYR A 159
HIS A 160
LEU A 319
PHE A 340
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
LEU  A 319 ( 0.6A)
PHE  A 340 (-1.3A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.55A 3b2rA-3sl5A:
31.7		 3b2rA-3sl5A:
29.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3B2R_B_VDNB1_1
(CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		5 / 11 TYR A 159
HIS A 160
LEU A 319
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
LEU  A 319 ( 0.6A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.45A 3b2rB-3sl5A:
31.6		 3b2rB-3sl5A:
29.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3BBT_B_FMMB91_1
(RECEPTOR
TYROSINE-PROTEIN
KINASE ERBB-4)		 5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE
(Homo
sapiens) 		6 / 12 VAL A  39
ALA A  52
GLY A 111
LEU A 160
ASP A 171
PHE A 172
 VAL  A  39 (-0.6A)
ALA  A  52 (-0.0A)
GLY  A 111 (-0.0A)
LEU  A 160 (-0.6A)
ASP  A 171 ( 0.5A)
PHE  A 172 ( 1.3A)
 0.55A 3bbtB-5d7aA:
24.1		 3bbtB-5d7aA:
25.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3BBT_D_FMMD91_1
(RECEPTOR
TYROSINE-PROTEIN
KINASE ERBB-4)		 5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE
(Homo
sapiens) 		7 / 12 VAL A  39
ALA A  52
LEU A 103
GLY A 111
LEU A 160
ASP A 171
PHE A 172
 VAL  A  39 (-0.6A)
ALA  A  52 (-0.0A)
LEU  A 103 ( 0.6A)
GLY  A 111 (-0.0A)
LEU  A 160 (-0.6A)
ASP  A 171 ( 0.5A)
PHE  A 172 ( 1.3A)
 0.76A 3bbtD-5d7aA:
24.7		 3bbtD-5d7aA:
25.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3BCR_A_AZZA940_1
(GLYCOGEN
PHOSPHORYLASE,
MUSCLE FORM)		 1omo ALANINE
DEHYDROGENASE
(Archaeoglobus
fulgidus) 		4 / 5 ASN A 214
PHE A 288
ALA A 117
GLY A 114
 ASN  A 214 ( 0.6A)
PHE  A 288 ( 1.3A)
ALA  A 117 ( 0.0A)
GLY  A 114 ( 0.0A)
 1.11A 3bcrA-1omoA:
undetectable		 3bcrA-1omoA:
18.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3BCR_A_AZZA940_1
(GLYCOGEN
PHOSPHORYLASE,
MUSCLE FORM)		 1zef ALKALINE PHOSPHATASE
(Homo
sapiens) 		4 / 5 ASN A  84
PHE A 107
ALA A  94
GLY A  93
 None
PHE  A 802 (-4.4A)
None
SEP  A  92 ( 2.4A)
 0.99A 3bcrA-1zefA:
undetectable		 3bcrA-1zefA:
20.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3BJW_F_SVRF509_2
(PHOSPHOLIPASE A2)		 3gnr OS03G0212800 PROTEIN
(Oryza
sativa) 		4 / 8 TYR A 131
ASN A 177
PHE A 460
TRP A 444
 TYR  A 131 ( 1.3A)
ASN  A 177 (-0.6A)
PHE  A 460 (-1.3A)
TRP  A 444 (-0.5A)
 1.42A 3bjwD-3gnrA:
undetectable		 3bjwD-3gnrA:
12.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3BJW_G_SVRG506_3
(PHOSPHOLIPASE A2)		 1fgv H52 FV (LIGHT CHAIN)
(Homo
sapiens) 		3 / 3 PRO L   8
PHE L  83
LYS L 103
 PRO  L   8 ( 1.0A)
PHE  L  83 ( 1.3A)
LYS  L 103 ( 0.0A)
 1.25A 3bjwG-1fgvL:
0.0		 3bjwG-1fgvL:
20.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CZV_A_AZMA263_1
(CARBONIC ANHYDRASE
13)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		5 / 12 HIS A 164
HIS A 200
PHE A 372
THR A 271
VAL A 377
 HIS  A 164 (-1.0A)
HIS  A 200 (-1.0A)
PHE  A 372 (-1.3A)
THR  A 271 ( 0.8A)
VAL  A 377 ( 0.6A)
 1.20A 3czvA-3sl5A:
undetectable
3czvB-3sl5A:
undetectable		 3czvA-3sl5A:
20.73
3czvB-3sl5A:
20.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DD1_A_CFFA903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)		 1omo ALANINE
DEHYDROGENASE
(Archaeoglobus
fulgidus) 		4 / 6 ASN A 214
PHE A 288
ALA A 117
GLY A 114
 ASN  A 214 ( 0.6A)
PHE  A 288 ( 1.3A)
ALA  A 117 ( 0.0A)
GLY  A 114 ( 0.0A)
 1.06A 3dd1A-1omoA:
2.1		 3dd1A-1omoA:
17.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DD1_A_CFFA903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)		 1zef ALKALINE PHOSPHATASE
(Homo
sapiens) 		4 / 6 ASN A  84
PHE A 107
ALA A  94
GLY A  93
 None
PHE  A 802 (-4.4A)
None
SEP  A  92 ( 2.4A)
 1.01A 3dd1A-1zefA:
undetectable		 3dd1A-1zefA:
21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DD1_B_CFFB903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)		 1omo ALANINE
DEHYDROGENASE
(Archaeoglobus
fulgidus) 		4 / 6 ASN A 214
PHE A 288
ALA A 117
GLY A 114
 ASN  A 214 ( 0.6A)
PHE  A 288 ( 1.3A)
ALA  A 117 ( 0.0A)
GLY  A 114 ( 0.0A)
 1.04A 3dd1B-1omoA:
undetectable		 3dd1B-1omoA:
17.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DD1_B_CFFB903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)		 1zef ALKALINE PHOSPHATASE
(Homo
sapiens) 		4 / 6 ASN A  84
PHE A 107
ALA A  94
GLY A  93
 None
PHE  A 802 (-4.4A)
None
SEP  A  92 ( 2.4A)
 1.02A 3dd1B-1zefA:
undetectable		 3dd1B-1zefA:
21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DDS_A_CFFA904_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)		 1omo ALANINE
DEHYDROGENASE
(Archaeoglobus
fulgidus) 		4 / 6 ASN A 214
PHE A 288
ALA A 117
GLY A 114
 ASN  A 214 ( 0.6A)
PHE  A 288 ( 1.3A)
ALA  A 117 ( 0.0A)
GLY  A 114 ( 0.0A)
 1.07A 3ddsA-1omoA:
2.2		 3ddsA-1omoA:
17.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DDS_A_CFFA904_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)		 1zef ALKALINE PHOSPHATASE
(Homo
sapiens) 		4 / 6 ASN A  84
PHE A 107
ALA A  94
GLY A  93
 None
PHE  A 802 (-4.4A)
None
SEP  A  92 ( 2.4A)
 1.00A 3ddsA-1zefA:
0.1		 3ddsA-1zefA:
21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DDS_B_CFFB903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)		 1omo ALANINE
DEHYDROGENASE
(Archaeoglobus
fulgidus) 		4 / 6 ASN A 214
PHE A 288
ALA A 117
GLY A 114
 ASN  A 214 ( 0.6A)
PHE  A 288 ( 1.3A)
ALA  A 117 ( 0.0A)
GLY  A 114 ( 0.0A)
 1.05A 3ddsB-1omoA:
0.0		 3ddsB-1omoA:
17.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DDS_B_CFFB903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)		 1zef ALKALINE PHOSPHATASE
(Homo
sapiens) 		4 / 6 ASN A  84
PHE A 107
ALA A  94
GLY A  93
 None
PHE  A 802 (-4.4A)
None
SEP  A  92 ( 2.4A)
 1.00A 3ddsB-1zefA:
undetectable		 3ddsB-1zefA:
21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DDW_A_CFFA903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)		 1omo ALANINE
DEHYDROGENASE
(Archaeoglobus
fulgidus) 		4 / 6 ASN A 214
PHE A 288
ALA A 117
GLY A 114
 ASN  A 214 ( 0.6A)
PHE  A 288 ( 1.3A)
ALA  A 117 ( 0.0A)
GLY  A 114 ( 0.0A)
 1.06A 3ddwA-1omoA:
2.4		 3ddwA-1omoA:
17.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DDW_A_CFFA903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)		 1zef ALKALINE PHOSPHATASE
(Homo
sapiens) 		4 / 6 ASN A  84
PHE A 107
ALA A  94
GLY A  93
 None
PHE  A 802 (-4.4A)
None
SEP  A  92 ( 2.4A)
 0.99A 3ddwA-1zefA:
0.8		 3ddwA-1zefA:
21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DDW_B_CFFB903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)		 1omo ALANINE
DEHYDROGENASE
(Archaeoglobus
fulgidus) 		4 / 6 ASN A 214
PHE A 288
ALA A 117
GLY A 114
 ASN  A 214 ( 0.6A)
PHE  A 288 ( 1.3A)
ALA  A 117 ( 0.0A)
GLY  A 114 ( 0.0A)
 1.05A 3ddwB-1omoA:
undetectable		 3ddwB-1omoA:
17.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DDW_B_CFFB903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)		 1zef ALKALINE PHOSPHATASE
(Homo
sapiens) 		4 / 6 ASN A  84
PHE A 107
ALA A  94
GLY A  93
 None
PHE  A 802 (-4.4A)
None
SEP  A  92 ( 2.4A)
 1.00A 3ddwB-1zefA:
undetectable		 3ddwB-1zefA:
21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3E23_A_SAMA221_0
(UNCHARACTERIZED
PROTEIN RPA2492)		 4zke SUPERKILLER PROTEIN
7
(Saccharomyces
cerevisiae) 		5 / 12 PHE A 461
LEU A 422
TYR A 380
LEU A 273
LEU A 450
 PHE  A 461 ( 1.3A)
LEU  A 422 ( 0.6A)
TYR  A 380 ( 1.3A)
LEU  A 273 ( 0.6A)
LEU  A 450 ( 0.6A)
 1.15A 3e23A-4zkeA:
undetectable		 3e23A-4zkeA:
15.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ELZ_A_CHDA150_0
(ILEAL BILE
ACID-BINDING PROTEIN)		 2qj6 TOXIN A
(Clostridioides
difficile) 		5 / 12 PHE A 315
MET A 303
THR A 290
VAL A 289
ILE A 317
 PHE  A 315 ( 1.3A)
MET  A 303 ( 0.0A)
THR  A 290 ( 0.8A)
VAL  A 289 ( 0.6A)
ILE  A 317 ( 0.6A)
 1.40A 3elzA-2qj6A:
undetectable		 3elzA-2qj6A:
18.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FHX_B_PXLB313_1
(PYRIDOXAL KINASE)		 3wd7 TYPE III POLYKETIDE
SYNTHASES ACRIDONE
SYNTHASE
(Citrus
x
microcarpa) 		4 / 8 VAL A 342
VAL A 369
PHE A 371
HIS A 303
 VAL  A 342 ( 0.6A)
VAL  A 369 ( 0.6A)
PHE  A 371 ( 1.3A)
HIS  A 303 ( 1.0A)
 1.02A 3fhxB-3wd7A:
undetectable		 3fhxB-3wd7A:
21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FL9_G_TOPG200_1
(DIHYDROFOLATE
REDUCTASE (DHFR))		 3gle PILIN
(Streptococcus
pyogenes) 		6 / 12 LEU A 198
LEU A 175
VAL A 177
ILE A 212
PHE A 235
THR A 287
 LEU  A 198 ( 0.6A)
LEU  A 175 ( 0.5A)
VAL  A 177 ( 0.6A)
ILE  A 212 ( 0.7A)
PHE  A 235 ( 1.3A)
THR  A 287 ( 0.8A)
 1.42A 3fl9G-3gleA:
undetectable		 3fl9G-3gleA:
17.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FL9_H_TOPH200_1
(DIHYDROFOLATE
REDUCTASE (DHFR))		 3gle PILIN
(Streptococcus
pyogenes) 		5 / 9 LEU A 175
VAL A 177
ILE A 212
PHE A 235
THR A 287
 LEU  A 175 ( 0.5A)
VAL  A 177 ( 0.6A)
ILE  A 212 ( 0.7A)
PHE  A 235 ( 1.3A)
THR  A 287 ( 0.8A)
 1.28A 3fl9H-3gleA:
undetectable		 3fl9H-3gleA:
17.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FWF_A_CAMA420_0
(CAMPHOR
5-MONOOXYGENASE)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		4 / 7 PHE C 251
LEU C 280
VAL C 289
ASP C 273
 PHE  C 251 ( 1.3A)
LEU  C 280 ( 0.5A)
VAL  C 289 ( 0.5A)
ASP  C 273 ( 0.6A)
 1.01A 3fwfA-5lmxC:
undetectable		 3fwfA-5lmxC:
22.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FWF_B_CAMB420_0
(CAMPHOR
5-MONOOXYGENASE)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		4 / 7 PHE C 251
LEU C 280
VAL C 289
ASP C 273
 PHE  C 251 ( 1.3A)
LEU  C 280 ( 0.5A)
VAL  C 289 ( 0.5A)
ASP  C 273 ( 0.6A)
 1.03A 3fwfB-5lmxC:
undetectable		 3fwfB-5lmxC:
22.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FWG_A_CAMA420_0
(CAMPHOR
5-MONOOXYGENASE)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		4 / 6 PHE C 251
LEU C 280
VAL C 289
ASP C 273
 PHE  C 251 ( 1.3A)
LEU  C 280 ( 0.5A)
VAL  C 289 ( 0.5A)
ASP  C 273 ( 0.6A)
 1.03A 3fwgA-5lmxC:
undetectable		 3fwgA-5lmxC:
22.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FWG_B_CAMB420_0
(CAMPHOR
5-MONOOXYGENASE)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		4 / 7 PHE C 251
LEU C 280
VAL C 289
ASP C 273
 PHE  C 251 ( 1.3A)
LEU  C 280 ( 0.5A)
VAL  C 289 ( 0.5A)
ASP  C 273 ( 0.6A)
 1.00A 3fwgB-5lmxC:
undetectable		 3fwgB-5lmxC:
22.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FWJ_A_CAMA420_0
(CAMPHOR
5-MONOOXYGENASE)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		4 / 7 PHE C 251
LEU C 280
VAL C 289
ASP C 273
 PHE  C 251 ( 1.3A)
LEU  C 280 ( 0.5A)
VAL  C 289 ( 0.5A)
ASP  C 273 ( 0.6A)
 1.02A 3fwjA-5lmxC:
undetectable		 3fwjA-5lmxC:
22.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3G4L_A_ROFA901_0
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		11 / 12 TYR A 159
HIS A 160
MET A 273
ASN A 321
PRO A 322
TYR A 329
TRP A 332
THR A 333
ILE A 336
SER A 368
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 273 (-0.0A)
ASN  A 321 (-0.6A)
PRO  A 322 (-1.1A)
TYR  A 329 (-1.3A)
TRP  A 332 ( 0.5A)
THR  A 333 ( 0.8A)
ILE  A 336 ( 0.4A)
SER  A 368 (-0.0A)
PHE  A 372 (-1.3A)
 0.44A 3g4lA-3sl5A:
53.4		 3g4lA-3sl5A:
98.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3G4L_B_ROFB902_0
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		12 / 12 TYR A 159
HIS A 160
MET A 273
ASP A 318
LEU A 319
PRO A 322
TRP A 332
THR A 333
ILE A 336
MET A 337
MET A 357
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 273 (-0.0A)
ASP  A 318 (-0.5A)
LEU  A 319 ( 0.6A)
PRO  A 322 (-1.1A)
TRP  A 332 ( 0.5A)
THR  A 333 ( 0.8A)
ILE  A 336 ( 0.4A)
MET  A 337 ( 0.0A)
MET  A 357 (-0.0A)
PHE  A 372 (-1.3A)
 0.53A 3g4lB-3sl5A:
52.8		 3g4lB-3sl5A:
98.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3G4L_C_ROFC903_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		3 / 3 SER A 368
GLN A 369
PHE A 372
 SER  A 368 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.45A 3g4lC-3sl5A:
53.0		 3g4lC-3sl5A:
98.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G6M_A_CFFA1_1
(CHITINASE)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		11 / 11 TYR A 156
PHE A 184
GLY A 267
TRP A 268
ASP A 306
GLU A 308
MET A 381
TYR A 383
ASP A 384
TYR A 437
TRP A 532
 TYR  A 156 ( 1.3A)
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
TRP  A 268 ( 0.5A)
ASP  A 306 ( 0.5A)
GLU  A 308 ( 0.6A)
MET  A 381 ( 0.0A)
TYR  A 383 ( 1.3A)
ASP  A 384 ( 0.5A)
TYR  A 437 ( 1.3A)
TRP  A 532 ( 0.5A)
 0.49A 3g6mA-5gprA:
7.2		 3g6mA-5gprA:
25.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HS6_B_EPAB1_2
(PROSTAGLANDIN G/H
SYNTHASE 2)		 1c8x ENDO-BETA-N-ACETYLGL
UCOSAMINIDASE H
(Streptomyces
plicatus) 		4 / 7 PHE A 149
VAL A 153
LEU A 115
SER A 116
 PHE  A 149 ( 1.3A)
VAL  A 153 ( 0.6A)
LEU  A 115 ( 0.6A)
SER  A 116 ( 0.0A)
 0.92A 3hs6B-1c8xA:
0.0		 3hs6B-1c8xA:
19.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3I45_A_NIOA500_1
(TWIN-ARGININE
TRANSLOCATION
PATHWAY SIGNAL
PROTEIN)		 5x7y LIPOCALIN-CAN F 6
ALLERGEN
(Canis
lupus) 		4 / 8 PHE A  93
TYR A 123
PHE A  57
LEU A  72
 PHE  A  93 ( 1.3A)
TYR  A 123 ( 1.3A)
PHE  A  57 (-1.3A)
LEU  A  72 ( 0.6A)
 0.90A 3i45A-5x7yA:
undetectable		 3i45A-5x7yA:
11.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3I9J_B_NCAB302_0
(ADP-RIBOSYL CYCLASE)		 2b92 INTERFERON-INDUCED
GUANYLATE-BINDING
PROTEIN 1
(Homo
sapiens) 		4 / 6 LEU A  67
GLU A 251
SER A  52
PHE A  65
 LEU  A  67 (-0.6A)
GLU  A 251 ( 0.6A)
SER  A  52 ( 0.0A)
PHE  A  65 ( 1.3A)
 1.28A 3i9jB-2b92A:
3.2		 3i9jB-2b92A:
21.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3I9J_B_NCAB302_0
(ADP-RIBOSYL CYCLASE)		 4hne PHOSPHATIDYLINOSITOL
4-KINASE TYPE
2-ALPHA
(Homo
sapiens) 		4 / 6 GLU A 157
ASN A 187
SER A 259
PHE A 151
 GLU  A 157 ( 0.5A)
ASN  A 187 ( 0.6A)
SER  A 259 ( 0.0A)
PHE  A 151 ( 1.3A)
 1.49A 3i9jB-4hneA:
undetectable		 3i9jB-4hneA:
20.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3IA4_C_MTXC164_1
(DIHYDROFOLATE
REDUCTASE)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		5 / 12 ALA A 193
LEU A 260
PHE A 195
ILE A 248
LEU A 241
 ALA  A 193 ( 0.0A)
LEU  A 260 ( 0.6A)
PHE  A 195 ( 1.3A)
ILE  A 248 ( 0.7A)
LEU  A 241 ( 0.6A)
 1.31A 3ia4C-3sl5A:
undetectable		 3ia4C-3sl5A:
16.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3IAK_A_EV1A415_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		8 / 9 TYR A 159
ASN A 321
ILE A 336
PHE A 340
MET A 357
GLN A 369
PHE A 372
ILE A 376
 TYR  A 159 (-1.3A)
ASN  A 321 (-0.6A)
ILE  A 336 ( 0.4A)
PHE  A 340 (-1.3A)
MET  A 357 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
ILE  A 376 (-0.6A)
 0.53A 3iakA-3sl5A:
51.9		 3iakA-3sl5A:
94.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3IAK_A_EV1A415_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		8 / 9 TYR A 159
MET A 273
ASN A 321
ILE A 336
PHE A 340
MET A 357
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
MET  A 273 (-0.0A)
ASN  A 321 (-0.6A)
ILE  A 336 ( 0.4A)
PHE  A 340 (-1.3A)
MET  A 357 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.73A 3iakA-3sl5A:
51.9		 3iakA-3sl5A:
94.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3IV6_A_SAMA301_0
(PUTATIVE
ZN-DEPENDENT ALCOHOL
DEHYDROGENASE)		 5gru DIABODY PROTEIN
DIABODY PROTEIN
(Homo
sapiens;
Mus
musculus) 		5 / 12 TRP L  48
GLY H 225
THR H 227
PHE L 103
ILE L 101
 TRP  L  48 ( 0.5A)
GLY  H 225 ( 0.0A)
THR  H 227 ( 0.8A)
PHE  L 103 ( 1.3A)
ILE  L 101 ( 0.7A)
 1.22A 3iv6A-5gruL:
undetectable		 3iv6A-5gruL:
21.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3IV6_B_SAMB301_0
(PUTATIVE
ZN-DEPENDENT ALCOHOL
DEHYDROGENASE)		 5gru DIABODY PROTEIN
DIABODY PROTEIN
(Homo
sapiens;
Mus
musculus) 		5 / 12 TRP L  48
GLY H 225
THR H 227
PHE L 103
ILE L 101
 TRP  L  48 ( 0.5A)
GLY  H 225 ( 0.0A)
THR  H 227 ( 0.8A)
PHE  L 103 ( 1.3A)
ILE  L 101 ( 0.7A)
 1.20A 3iv6B-5gruL:
undetectable		 3iv6B-5gruL:
21.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3IV6_C_SAMC301_0
(PUTATIVE
ZN-DEPENDENT ALCOHOL
DEHYDROGENASE)		 5gru DIABODY PROTEIN
DIABODY PROTEIN
(Homo
sapiens;
Mus
musculus) 		5 / 12 TRP L  48
GLY H 225
THR H 227
PHE L 103
ILE L 101
 TRP  L  48 ( 0.5A)
GLY  H 225 ( 0.0A)
THR  H 227 ( 0.8A)
PHE  L 103 ( 1.3A)
ILE  L 101 ( 0.7A)
 1.28A 3iv6C-5gruL:
undetectable		 3iv6C-5gruL:
21.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3IV6_D_SAMD301_0
(PUTATIVE
ZN-DEPENDENT ALCOHOL
DEHYDROGENASE)		 5gru DIABODY PROTEIN
DIABODY PROTEIN
(Homo
sapiens;
Mus
musculus) 		5 / 12 TRP L  48
GLY H 225
THR H 227
PHE L 103
ILE L 101
 TRP  L  48 ( 0.5A)
GLY  H 225 ( 0.0A)
THR  H 227 ( 0.8A)
PHE  L 103 ( 1.3A)
ILE  L 101 ( 0.7A)
 1.24A 3iv6D-5gruL:
undetectable		 3iv6D-5gruL:
21.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3IX9_B_MTXB200_1
(DIHYDROFOLATE
REDUCTASE)		 1og0 PHOSPHO-2-DEHYDRO-3-
DEOXYHEPTONATE
ALDOLASE
(Saccharomyces
cerevisiae) 		5 / 12 ILE A  41
ALA A 141
GLN A 166
ARG A  55
VAL A 146
 None
None
PHE  A1012 (-3.4A)
None
None
 1.14A 3ix9B-1og0A:
undetectable		 3ix9B-1og0A:
19.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JWQ_A_VIAA901_1
(CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE
CATALYTIC DOMAIN,
CONE CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE
SUBUNIT ALPHA
CHIMERA)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		5 / 9 TYR A 159
HIS A 160
MET A 357
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 357 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 1.01A 3jwqA-3sl5A:
39.2		 3jwqA-3sl5A:
28.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JWQ_B_VIAB901_1
(CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE
CATALYTIC DOMAIN,
CONE CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE
SUBUNIT ALPHA
CHIMERA)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		5 / 11 TYR A 159
HIS A 160
MET A 357
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 357 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.94A 3jwqB-3sl5A:
39.0
3jwqC-3sl5A:
39.2		 3jwqB-3sl5A:
28.41
3jwqC-3sl5A:
28.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JWQ_C_VIAC901_1
(CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE
CATALYTIC DOMAIN,
CONE CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE
SUBUNIT ALPHA
CHIMERA)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		5 / 7 TYR A 159
HIS A 160
MET A 357
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 357 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.91A 3jwqC-3sl5A:
39.2		 3jwqC-3sl5A:
28.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JWQ_D_VIAD901_1
(CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE
CATALYTIC DOMAIN,
CONE CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE
SUBUNIT ALPHA
CHIMERA)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		6 / 11 TYR A 159
HIS A 160
PHE A 340
MET A 357
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
PHE  A 340 (-1.3A)
MET  A 357 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 1.01A 3jwqA-3sl5A:
39.2
3jwqD-3sl5A:
38.8		 3jwqA-3sl5A:
28.41
3jwqD-3sl5A:
28.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JZ0_B_CLYB900_1
(LINCOSAMIDE
NUCLEOTIDYLTRANSFERA
SE)		 5jja SERINE/THREONINE-PRO
TEIN PHOSPHATASE 2A
56 KDA REGULATORY
SUBUNIT GAMMA
ISOFORM
(Homo
sapiens) 		4 / 8 TYR A 263
TYR A 292
PHE A 211
ILE A 207
 TYR  A 263 ( 1.3A)
TYR  A 292 ( 1.3A)
PHE  A 211 ( 1.3A)
ILE  A 207 ( 0.7A)
 1.06A 3jz0B-5jjaA:
2.1		 3jz0B-5jjaA:
22.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K5V_B_STIB2_1
(TYROSINE-PROTEIN
KINASE ABL1)		 5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE
(Homo
sapiens) 		6 / 12 VAL A  39
ALA A  52
GLU A  69
PHE A 107
GLY A 111
LEU A 160
 VAL  A  39 (-0.6A)
ALA  A  52 (-0.0A)
GLU  A  69 ( 0.6A)
PHE  A 107 ( 1.3A)
GLY  A 111 (-0.0A)
LEU  A 160 (-0.6A)
 0.78A 3k5vB-5d7aA:
23.7		 3k5vB-5d7aA:
25.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KO0_A_TFPA201_1
(PROTEIN S100-A4)		 6cgu CADHERIN-6
(Mus
musculus) 		5 / 9 ILE A  96
PHE A   7
PHE A  92
PHE A  48
GLY A  43
 ILE  A  96 ( 0.7A)
PHE  A   7 ( 1.3A)
PHE  A  92 ( 1.3A)
PHE  A  48 ( 1.3A)
GLY  A  43 ( 0.0A)
 1.42A 3ko0A-6cguA:
undetectable
3ko0C-6cguA:
undetectable		 3ko0A-6cguA:
18.00
3ko0C-6cguA:
18.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KO0_B_TFPB202_2
(PROTEIN S100-A4)		 4g9k ROTENONE-INSENSITIVE
NADH-UBIQUINONE
OXIDOREDUCTASE
(Saccharomyces
cerevisiae) 		4 / 6 LEU A  69
SER A  67
PHE A  68
ILE A  58
 LEU  A  69 ( 0.6A)
SER  A  67 ( 0.0A)
PHE  A  68 ( 1.3A)
ILE  A  58 ( 0.7A)
 0.98A 3ko0B-4g9kA:
undetectable		 3ko0B-4g9kA:
12.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KO0_I_TFPI201_1
(PROTEIN S100-A4)		 6cgu CADHERIN-6
(Mus
musculus) 		5 / 9 PHE A  48
GLY A  43
ILE A  96
PHE A   7
PHE A  92
 PHE  A  48 ( 1.3A)
GLY  A  43 ( 0.0A)
ILE  A  96 ( 0.7A)
PHE  A   7 ( 1.3A)
PHE  A  92 ( 1.3A)
 1.39A 3ko0H-6cguA:
undetectable
3ko0I-6cguA:
undetectable		 3ko0H-6cguA:
18.00
3ko0I-6cguA:
18.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KO0_K_TFPK201_1
(PROTEIN S100-A4)		 1ted PKS18
(Mycobacterium
tuberculosis) 		4 / 8 GLY A 288
ILE A 304
PHE A 388
PHE A 375
 GLY  A 288 ( 0.0A)
ILE  A 304 ( 0.7A)
PHE  A 388 ( 1.3A)
PHE  A 375 ( 1.3A)
 0.95A 3ko0K-1tedA:
0.0
3ko0S-1tedA:
0.0		 3ko0K-1tedA:
11.96
3ko0S-1tedA:
11.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KO0_O_TFPO201_1
(PROTEIN S100-A4)		 5nks DIHYDROPYRIMIDINASE-
RELATED PROTEIN 4
(Homo
sapiens) 		4 / 8 GLY A  99
PHE A 392
PHE A 394
GLY A  68
 GLY  A  99 ( 0.0A)
PHE  A 392 ( 1.3A)
PHE  A 394 ( 1.3A)
GLY  A  68 ( 0.0A)
 0.90A 3ko0O-5nksA:
undetectable
3ko0Q-5nksA:
undetectable		 3ko0O-5nksA:
11.01
3ko0Q-5nksA:
11.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KO0_P_TFPP201_1
(PROTEIN S100-A4)		 5nks DIHYDROPYRIMIDINASE-
RELATED PROTEIN 4
(Homo
sapiens) 		4 / 7 GLY A  68
GLY A  99
PHE A 392
PHE A 394
 GLY  A  68 ( 0.0A)
GLY  A  99 ( 0.0A)
PHE  A 392 ( 1.3A)
PHE  A 394 ( 1.3A)
 0.96A 3ko0M-5nksA:
undetectable
3ko0P-5nksA:
undetectable		 3ko0M-5nksA:
11.01
3ko0P-5nksA:
11.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KO0_R_TFPR201_1
(PROTEIN S100-A4)		 6cgu CADHERIN-6
(Mus
musculus) 		5 / 10 ILE A  96
PHE A   7
PHE A  92
PHE A  48
GLY A  43
 ILE  A  96 ( 0.7A)
PHE  A   7 ( 1.3A)
PHE  A  92 ( 1.3A)
PHE  A  48 ( 1.3A)
GLY  A  43 ( 0.0A)
 1.40A 3ko0R-6cguA:
undetectable
3ko0T-6cguA:
undetectable		 3ko0R-6cguA:
18.00
3ko0T-6cguA:
18.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KO0_S_TFPS202_1
(PROTEIN S100-A4)		 4g9k ROTENONE-INSENSITIVE
NADH-UBIQUINONE
OXIDOREDUCTASE
(Saccharomyces
cerevisiae) 		4 / 6 LEU A  69
SER A  67
PHE A  68
ILE A  58
 LEU  A  69 ( 0.6A)
SER  A  67 ( 0.0A)
PHE  A  68 ( 1.3A)
ILE  A  58 ( 0.7A)
 1.01A 3ko0S-4g9kA:
undetectable		 3ko0S-4g9kA:
12.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KW4_A_TICA600_1
(CYTOCHROME P450 2B4)		 1txu RAB5 GDP/GTP
EXCHANGE FACTOR
(Homo
sapiens) 		5 / 11 ILE A 175
SER A 174
PHE A 341
ALA A 182
GLU A 180
 ILE  A 175 ( 0.3A)
SER  A 174 ( 0.0A)
PHE  A 341 ( 1.3A)
ALA  A 182 ( 0.0A)
GLU  A 180 ( 0.5A)
 0.95A 3kw4A-1txuA:
undetectable		 3kw4A-1txuA:
19.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3L4D_A_TPFA490_1
(STEROL 14-ALPHA
DEMETHYLASE)		 3ulk KETOL-ACID
REDUCTOISOMERASE
(Escherichia
coli) 		4 / 8 PHE A 210
ALA A 176
ALA A 191
LEU A 101
 PHE  A 210 ( 1.3A)
ALA  A 176 ( 0.0A)
ALA  A 191 ( 0.0A)
LEU  A 101 ( 0.6A)
 0.93A 3l4dA-3ulkA:
undetectable		 3l4dA-3ulkA:
21.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3L4D_D_TPFD490_1
(STEROL 14-ALPHA
DEMETHYLASE)		 1c8x ENDO-BETA-N-ACETYLGL
UCOSAMINIDASE H
(Streptomyces
plicatus) 		4 / 8 PHE A  38
TYR A  28
ALA A  13
THR A 221
 PHE  A  38 ( 1.3A)
TYR  A  28 ( 1.3A)
ALA  A  13 ( 0.0A)
THR  A 221 ( 0.8A)
 1.06A 3l4dD-1c8xA:
undetectable		 3l4dD-1c8xA:
19.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LN1_D_CELD682_2
(PROSTAGLANDIN G/H
SYNTHASE 2)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		4 / 5 ARG C 293
LEU C 280
ILE C 256
PHE C 251
 ARG  C 293 ( 0.6A)
LEU  C 280 ( 0.5A)
ILE  C 256 ( 0.7A)
PHE  C 251 ( 1.3A)
 1.25A 3ln1D-5lmxC:
undetectable		 3ln1D-5lmxC:
23.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LSL_G_PZIG801_0
(GLUTAMATE RECEPTOR 2)		 2qmx PREPHENATE
DEHYDRATASE
(Chlorobaculum
tepidum) 		3 / 3 PRO A 232
SER A 230
ASN A 206
 None
PHE  A 304 (-3.4A)
PHE  A 304 (-3.0A)
 0.78A 3lslG-2qmxA:
5.7		 3lslG-2qmxA:
19.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LW5_B_PQNB5002_1
(PHOTOSYSTEM I P700
CHLOROPHYLL A
APOPROTEIN A2)		 6c0w HISTONE H3-LIKE
CENTROMERIC PROTEIN
A
HISTONE H4
(Homo
sapiens) 		5 / 10 PHE A 106
ARG B  36
ALA B  33
LEU B  37
ALA B  38
 PHE  A 106 ( 1.3A)
ARG  B  36 ( 0.6A)
ALA  B  33 ( 0.0A)
LEU  B  37 ( 0.6A)
ALA  B  38 ( 0.0A)
 1.30A 3lw5B-6c0wA:
undetectable		 3lw5B-6c0wA:
7.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3M0W_E_P77E203_1
(PROTEIN S100-A4)		 2an1 PUTATIVE KINASE
(Salmonella
enterica) 		4 / 8 PHE A 170
SER A 173
LEU A 231
ASP A 257
 PHE  A 170 ( 1.3A)
SER  A 173 ( 0.0A)
LEU  A 231 ( 0.5A)
ASP  A 257 ( 0.6A)
 1.06A 3m0wE-2an1A:
undetectable
3m0wF-2an1A:
undetectable
3m0wG-2an1A:
undetectable
3m0wH-2an1A:
undetectable		 3m0wE-2an1A:
13.79
3m0wF-2an1A:
13.79
3m0wG-2an1A:
13.79
3m0wH-2an1A:
13.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MDT_B_VORB506_1
(CHOLESTEROL
24-HYDROXYLASE)		 3cb7 LYS-RICH LYSOZYME 2
(Musca
domestica) 		5 / 11 LEU A  12
PHE A   7
SER A  11
ILE A  57
ALA A  93
 LEU  A  12 ( 0.6A)
PHE  A   7 ( 1.3A)
SER  A  11 ( 0.0A)
ILE  A  57 ( 0.6A)
ALA  A  93 ( 0.0A)
 0.99A 3mdtB-3cb7A:
undetectable		 3mdtB-3cb7A:
13.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MNO_A_DEXA784_1
(GLUCOCORTICOID
RECEPTOR)		 5wo6 TRANSIENT RECEPTOR
POTENTIAL CATION
CHANNEL SUBFAMILY V
MEMBER 6
(Rattus
norvegicus) 		5 / 12 GLY A 448
VAL A 437
MET A 434
ILE A 556
PHE A 552
 GLY  A 448 ( 0.0A)
VAL  A 437 ( 0.6A)
MET  A 434 ( 0.0A)
ILE  A 556 ( 0.7A)
PHE  A 552 ( 1.3A)
 1.41A 3mnoA-5wo6A:
undetectable		 3mnoA-5wo6A:
15.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N0H_A_TOPA187_1
(DIHYDROFOLATE
REDUCTASE)		 2qvs CAMP-DEPENDENT
PROTEIN KINASE TYPE
II-ALPHA REGULATORY
SUBUNIT
(Mus
musculus) 		5 / 11 ILE B 163
ALA B 215
PHE B 202
LEU B 225
VAL B 162
 ILE  B 163 ( 0.7A)
ALA  B 215 ( 0.0A)
PHE  B 202 ( 1.3A)
LEU  B 225 ( 0.6A)
VAL  B 162 ( 0.6A)
 1.15A 3n0hA-2qvsB:
undetectable		 3n0hA-2qvsB:
18.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N9J_A_EAAA210_1
(GLUTATHIONE
S-TRANSFERASE P)		 1c1d L-PHENYLALANINE
DEHYDROGENASE
(Rhodococcus
sp.) 		4 / 8 PHE A 137
ILE A 106
TYR A 113
GLY A  39
 None
None
None
PHE  A 361 (-3.7A)
 0.96A 3n9jA-1c1dA:
undetectable		 3n9jA-1c1dA:
21.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NDI_A_SAMA601_0
(METHYLTRANSFERASE)		 5jja SERINE/THREONINE-PRO
TEIN PHOSPHATASE 2A
56 KDA REGULATORY
SUBUNIT GAMMA
ISOFORM
(Homo
sapiens) 		5 / 12 PHE A 246
GLU A 226
ILE A 227
ALA A 222
ILE A 204
 PHE  A 246 ( 1.3A)
GLU  A 226 ( 0.5A)
ILE  A 227 ( 0.6A)
ALA  A 222 ( 0.0A)
ILE  A 204 ( 0.7A)
 1.26A 3ndiA-5jjaA:
undetectable		 3ndiA-5jjaA:
21.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NMU_F_SAMF228_0
(FIBRILLARIN-LIKE
RRNA/TRNA
2'-O-METHYLTRANSFERA
SE
NOP5/NOP56 RELATED
PROTEIN)		 1zef ALKALINE PHOSPHATASE
(Homo
sapiens) 		5 / 12 GLU A 429
GLY A 318
GLU A 321
ALA A 324
ASP A 316
 PHE  A 802 ( 4.5A)
None
None
None
ZN  A 901 ( 1.9A)
 1.34A 3nmuA-1zefA:
undetectable
3nmuF-1zefA:
undetectable		 3nmuA-1zefA:
22.36
3nmuF-1zefA:
19.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OG7_A_032A1_1
(AKAP9-BRAF FUSION
PROTEIN)		 5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE
(Homo
sapiens) 		5 / 12 VAL A  39
ALA A  52
LYS A  54
LEU A  73
PHE A 172
 VAL  A  39 (-0.6A)
ALA  A  52 (-0.0A)
LYS  A  54 ( 0.0A)
LEU  A  73 ( 0.6A)
PHE  A 172 ( 1.3A)
 0.67A 3og7A-5d7aA:
25.5		 3og7A-5d7aA:
29.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OWX_B_XRAB233_1
(RIBOSYLDIHYDRONICOTI
NAMIDE DEHYDROGENASE
[QUINONE])		 3td9 BRANCHED CHAIN AMINO
ACID ABC
TRANSPORTER,
PERIPLASMIC AMINO
ACID-BINDING PROTEIN
(Thermotoga
maritima) 		5 / 11 VAL A 353
PHE A  36
GLY A 240
TYR A 166
ILE A 214
 None
PHE  A 400 (-3.7A)
None
PHE  A 400 (-3.8A)
None
 1.35A 3owxA-3td9A:
undetectable
3owxB-3td9A:
2.0		 3owxA-3td9A:
20.11
3owxB-3td9A:
20.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OZW_B_KKKB413_1
(FLAVOHEMOGLOBIN)		 3lkv UNCHARACTERIZED
CONSERVED DOMAIN
PROTEIN
(Vibrio
cholerae) 		5 / 12 ILE A 220
ALA A 218
LEU A 219
ILE A 255
GLY A 253
 PHE  A 601 (-4.0A)
None
None
None
None
 0.97A 3ozwB-3lkvA:
3.8		 3ozwB-3lkvA:
22.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3PCQ_B_PQNB842_1
(PHOTOSYSTEM I P700
CHLOROPHYLL A
APOPROTEIN A2)		 6c0w HISTONE H3-LIKE
CENTROMERIC PROTEIN
A
HISTONE H4
(Homo
sapiens) 		5 / 11 PHE A 106
ARG B  36
ALA B  33
LEU B  37
ALA B  38
 PHE  A 106 ( 1.3A)
ARG  B  36 ( 0.6A)
ALA  B  33 ( 0.0A)
LEU  B  37 ( 0.6A)
ALA  B  38 ( 0.0A)
 1.32A 3pcqB-6c0wA:
2.3		 3pcqB-6c0wA:
5.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3PGY_A_GLYA510_0
(SERINE
HYDROXYMETHYLTRANSFE
RASE)		 3ulk KETOL-ACID
REDUCTOISOMERASE
(Escherichia
coli) 		4 / 6 GLU A 383
ILE A 382
PHE A 373
ALA A 386
 GLU  A 383 ( 0.6A)
ILE  A 382 ( 0.7A)
PHE  A 373 ( 1.3A)
ALA  A 386 ( 0.0A)
 1.06A 3pgyA-3ulkA:
3.5
3pgyB-3ulkA:
3.6		 3pgyA-3ulkA:
23.61
3pgyB-3ulkA:
23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3PYY_A_STIA3_1
(V-ABL ABELSON MURINE
LEUKEMIA VIRAL
ONCOGENE HOMOLOG 1
ISOFORM B VARIANT)		 5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE
(Homo
sapiens) 		6 / 12 VAL A  39
ALA A  52
GLU A  69
PHE A 107
GLY A 111
LEU A 160
 VAL  A  39 (-0.6A)
ALA  A  52 (-0.0A)
GLU  A  69 ( 0.6A)
PHE  A 107 ( 1.3A)
GLY  A 111 (-0.0A)
LEU  A 160 (-0.6A)
 0.84A 3pyyA-5d7aA:
23.9		 3pyyA-5d7aA:
25.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QPS_A_CHDA211_0
(CMER)		 1ted PKS18
(Mycobacterium
tuberculosis) 		5 / 10 LEU A 281
ALA A 376
PHE A 377
GLY A 378
ILE A 264
 LEU  A 281 ( 0.6A)
ALA  A 376 ( 0.0A)
PHE  A 377 ( 1.3A)
GLY  A 378 ( 0.0A)
ILE  A 264 ( 0.7A)
 1.13A 3qpsA-1tedA:
undetectable		 3qpsA-1tedA:
18.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RV5_A_DXCA91_0
(TROPONIN C, SLOW
SKELETAL AND CARDIAC
MUSCLES)		 2ogs THERMOSTABLE
CARBOXYLESTERASE
EST50
(Geobacillus
stearothermophil
us) 		3 / 3 PHE A 371
GLN A 219
PHE A 314
 PHE  A 371 ( 1.3A)
GLN  A 219 ( 0.6A)
PHE  A 314 ( 1.3A)
 0.84A 3rv5A-2ogsA:
0.0		 3rv5A-2ogsA:
11.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RV5_A_DXCA91_0
(TROPONIN C, SLOW
SKELETAL AND CARDIAC
MUSCLES)		 5nks DIHYDROPYRIMIDINASE-
RELATED PROTEIN 4
(Homo
sapiens) 		3 / 3 PHE A 167
GLN A 180
PHE A 109
 PHE  A 167 ( 1.3A)
GLN  A 180 ( 0.6A)
PHE  A 109 ( 1.3A)
 0.80A 3rv5A-5nksA:
undetectable		 3rv5A-5nksA:
10.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RV5_C_DXCC92_0
(TROPONIN C, SLOW
SKELETAL AND CARDIAC
MUSCLES)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		4 / 4 VAL A 152
PHE A 379
PHE A 380
VAL A 417
 VAL  A 152 ( 0.6A)
PHE  A 379 ( 1.3A)
PHE  A 380 ( 1.3A)
VAL  A 417 ( 0.6A)
 1.27A 3rv5C-5gprA:
undetectable
3rv5D-5gprA:
undetectable		 3rv5C-5gprA:
9.96
3rv5D-5gprA:
9.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3S3V_A_TOPA187_1
(DIHYDROFOLATE
REDUCTASE)		 2qvs CAMP-DEPENDENT
PROTEIN KINASE TYPE
II-ALPHA REGULATORY
SUBUNIT
(Mus
musculus) 		5 / 12 ILE B 163
ALA B 215
PHE B 202
LEU B 225
VAL B 162
 ILE  B 163 ( 0.7A)
ALA  B 215 ( 0.0A)
PHE  B 202 ( 1.3A)
LEU  B 225 ( 0.6A)
VAL  B 162 ( 0.6A)
 1.14A 3s3vA-2qvsB:
undetectable		 3s3vA-2qvsB:
18.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3S8P_A_SAMA500_1
(HISTONE-LYSINE
N-METHYLTRANSFERASE
SUV420H1)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		3 / 3 HIS A 327
SER A 352
GLU A 374
 None
None
PHE  A 509 (-3.6A)
 0.68A 3s8pA-3l4gA:
undetectable		 3s8pA-3l4gA:
19.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SJ0_X_DXCX75_0
(CYTOCHROME C7)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		4 / 7 ILE A 185
PHE A 299
MET A 250
GLY A 247
 ILE  A 185 ( 0.7A)
PHE  A 299 ( 1.3A)
MET  A 250 ( 0.0A)
GLY  A 247 ( 0.0A)
 1.13A 3sj0X-5gprA:
undetectable		 3sj0X-5gprA:
9.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SMT_A_ACTA500_0
(HISTONE-LYSINE
N-METHYLTRANSFERASE
SETD3)		 1woj 2',3'-CYCLIC-NUCLEOT
IDE
3'-PHOSPHODIESTERASE
(Homo
sapiens) 		3 / 3 PHE A 262
SER A 283
GLN A 285
 PHE  A 262 ( 1.3A)
SER  A 283 ( 0.0A)
GLN  A 285 ( 0.6A)
 0.62A 3smtA-1wojA:
undetectable		 3smtA-1wojA:
18.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SMT_A_ACTA500_0
(HISTONE-LYSINE
N-METHYLTRANSFERASE
SETD3)		 5hiu GTPASE
ACTIVATOR-LIKE
PROTEIN
(Chaetomium
thermophilum) 		3 / 3 PHE A 359
SER A 324
GLN A 320
 PHE  A 359 ( 1.3A)
SER  A 324 ( 0.0A)
GLN  A 320 ( 0.6A)
 0.85A 3smtA-5hiuA:
undetectable		 3smtA-5hiuA:
22.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SNF_A_ACTA110_0
(PROTEIN P-30)		 6gef TYPE IV SECRETION
SYSTEM PROTEIN DOTB
(Yersinia
pseudotuberculos
is) 		4 / 5 ILE A 126
THR A 131
THR A 130
PHE A  68
 ILE  A 126 ( 0.7A)
THR  A 131 ( 0.8A)
THR  A 130 ( 0.8A)
PHE  A  68 ( 1.3A)
 0.89A 3snfA-6gefA:
undetectable		 3snfA-6gefA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SUD_A_SUEA1201_1
(NS3 PROTEASE, NS4A
PROTEIN)		 1xqw PROLINE
IMINOPEPTIDASE
(Thermoplasma
acidophilum) 		5 / 12 HIS A 271
ASP A 244
GLY A  36
ALA A 105
SER A  47
 LEU  A 301 (-3.4A)
None
LEU  A 301 (-3.2A)
PHE  A 300 ( 3.0A)
None
 1.06A 3sudA-1xqwA:
undetectable		 3sudA-1xqwA:
20.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SUD_B_SUEB1201_1
(NS3 PROTEASE, NS4A
PROTEIN)		 1xqw PROLINE
IMINOPEPTIDASE
(Thermoplasma
acidophilum) 		5 / 12 HIS A 271
ASP A 244
GLY A  36
ALA A 105
SER A  47
 LEU  A 301 (-3.4A)
None
LEU  A 301 (-3.2A)
PHE  A 300 ( 3.0A)
None
 0.91A 3sudB-1xqwA:
undetectable		 3sudB-1xqwA:
20.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SUE_D_SUED1201_1
(NS3 PROTEASE, NS4A
PROTEIN)		 1og0 PHOSPHO-2-DEHYDRO-3-
DEOXYHEPTONATE
ALDOLASE
(Saccharomyces
cerevisiae) 		5 / 12 GLY A 156
SER A 173
PHE A 196
ALA A 169
SER A 164
 None
None
None
PHE  A1012 (-3.2A)
None
 1.27A 3sueD-1og0A:
undetectable		 3sueD-1og0A:
20.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3T3S_B_9PLB1_1
(CYTOCHROME P450 2A13)		 6c0w CENTROMERE PROTEIN N
(Homo
sapiens) 		4 / 6 PHE K 108
PHE K 104
ALA K 161
THR K 163
 PHE  K 108 ( 1.3A)
PHE  K 104 ( 1.3A)
ALA  K 161 ( 0.0A)
THR  K 163 ( 0.8A)
 1.16A 3t3sB-6c0wK:
undetectable		 3t3sB-6c0wK:
10.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3T3S_F_9PLF1_1
(CYTOCHROME P450 2A13)		 2qv2 INOSITOL
POLYPHOSPHATE
5-PHOSPHATASE OCRL-1
(Homo
sapiens) 		4 / 8 PHE A  13
PHE A  15
PHE A  28
ALA A  58
 PHE  A  13 ( 1.3A)
PHE  A  15 ( 1.3A)
PHE  A  28 ( 1.3A)
ALA  A  58 ( 0.0A)
 0.95A 3t3sF-2qv2A:
undetectable		 3t3sF-2qv2A:
22.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TAJ_A_NBOA700_1
(LACTOTRANSFERRIN)		 1c1d L-PHENYLALANINE
DEHYDROGENASE
(Rhodococcus
sp.) 		5 / 7 THR A  41
GLY A 116
TYR A 113
GLY A  76
THR A  64
 None
PHE  A 361 ( 3.7A)
None
None
None
 1.31A 3tajA-1c1dA:
undetectable		 3tajA-1c1dA:
23.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TEG_A_DAHA416_1
(PHENYLALANYL-TRNA
SYNTHETASE,
MITOCHONDRIAL)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		7 / 12 ARG A 358
GLN A 372
GLU A 374
THR A 413
GLY A 436
ALA A 456
GLY A 458
 None
PHE  A 509 (-3.4A)
PHE  A 509 (-3.6A)
PHE  A 509 (-3.7A)
PHE  A 509 (-4.0A)
PHE  A 509 ( 4.1A)
PHE  A 509 (-3.6A)
 0.93A 3tegA-3l4gA:
20.8		 3tegA-3l4gA:
21.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TEG_A_DAHA416_1
(PHENYLALANYL-TRNA
SYNTHETASE,
MITOCHONDRIAL)		 3pco PHENYLALANYL-TRNA
SYNTHETASE, ALPHA
SUBUNIT
(Escherichia
coli) 		11 / 12 SER A 171
ARG A 195
GLN A 208
GLU A 210
PHE A 248
PHE A 250
THR A 251
GLY A 271
GLY A 273
ALA A 294
GLY A 296
 PHE  A 980 (-3.5A)
AMP  A 992 (-4.0A)
PHE  A 980 ( 3.6A)
PHE  A 980 (-3.0A)
PHE  A 980 (-3.6A)
PHE  A 980 (-4.5A)
PHE  A 980 ( 4.1A)
PHE  A 980 (-4.0A)
None
PHE  A 980 ( 4.0A)
PHE  A 980 (-3.6A)
 0.61A 3tegA-3pcoA:
25.1		 3tegA-3pcoA:
30.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TEG_A_DAHA416_1
(PHENYLALANYL-TRNA
SYNTHETASE,
MITOCHONDRIAL)		 3pco PHENYLALANYL-TRNA
SYNTHETASE, ALPHA
SUBUNIT
(Escherichia
coli) 		11 / 12 SER A 171
GLN A 174
ARG A 195
GLN A 208
PHE A 248
PHE A 250
THR A 251
GLY A 271
GLY A 273
ALA A 294
GLY A 296
 PHE  A 980 (-3.5A)
PHE  A 980 ( 4.5A)
AMP  A 992 (-4.0A)
PHE  A 980 ( 3.6A)
PHE  A 980 (-3.6A)
PHE  A 980 (-4.5A)
PHE  A 980 ( 4.1A)
PHE  A 980 (-4.0A)
None
PHE  A 980 ( 4.0A)
PHE  A 980 (-3.6A)
 0.65A 3tegA-3pcoA:
25.1		 3tegA-3pcoA:
30.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TEH_A_DAHA351_1
(PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		6 / 9 HIS A 327
ARG A 358
GLN A 372
GLU A 374
ALA A 456
GLY A 458
 None
None
PHE  A 509 (-3.4A)
PHE  A 509 (-3.6A)
PHE  A 509 ( 4.1A)
PHE  A 509 (-3.6A)
 0.97A 3tehA-3l4gA:
22.8		 3tehA-3l4gA:
27.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TEH_A_DAHA351_1
(PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN)		 3pco PHENYLALANYL-TRNA
SYNTHETASE, ALPHA
SUBUNIT
(Escherichia
coli) 		6 / 9 SER A 171
ARG A 195
GLN A 208
GLU A 210
ALA A 294
GLY A 296
 PHE  A 980 (-3.5A)
AMP  A 992 (-4.0A)
PHE  A 980 ( 3.6A)
PHE  A 980 (-3.0A)
PHE  A 980 ( 4.0A)
PHE  A 980 (-3.6A)
 0.58A 3tehA-3pcoA:
28.6		 3tehA-3pcoA:
45.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TGV_C_BEZC1_0
(HEME-BINDING PROTEIN
HUTZ)		 5nqf APICAL MEMBRANE
ANTIGEN 1
(Plasmodium
falciparum) 		4 / 5 TYR A 117
PHE A 312
PRO A 416
LEU A 419
 TYR  A 117 ( 1.3A)
PHE  A 312 ( 1.3A)
PRO  A 416 ( 1.1A)
LEU  A 419 ( 0.5A)
 1.48A 3tgvC-5nqfA:
undetectable		 3tgvC-5nqfA:
16.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TGV_D_BEZD1_0
(HEME-BINDING PROTEIN
HUTZ)		 5nqf APICAL MEMBRANE
ANTIGEN 1
(Plasmodium
falciparum) 		4 / 6 TYR A 117
PHE A 312
PRO A 416
LEU A 419
 TYR  A 117 ( 1.3A)
PHE  A 312 ( 1.3A)
PRO  A 416 ( 1.1A)
LEU  A 419 ( 0.5A)
 1.34A 3tgvD-5nqfA:
undetectable		 3tgvD-5nqfA:
16.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TMZ_A_06XA504_1
(CYTOCHROME P450 2B4)		 2vbf BRANCHED-CHAIN
ALPHA-KETOACID
DECARBOXYLASE
(Lactococcus
lactis) 		5 / 9 LEU A 359
LEU A 526
ILE A 498
GLU A 523
PHE A 505
 LEU  A 359 ( 0.5A)
LEU  A 526 ( 0.5A)
ILE  A 498 ( 0.7A)
GLU  A 523 ( 0.5A)
PHE  A 505 ( 1.3A)
 1.28A 3tmzA-2vbfA:
undetectable		 3tmzA-2vbfA:
20.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TVX_A_PNXA902_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4A)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		9 / 9 TYR A 159
LEU A 319
ASN A 321
PRO A 322
THR A 333
ILE A 336
MET A 357
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
LEU  A 319 ( 0.6A)
ASN  A 321 (-0.6A)
PRO  A 322 (-1.1A)
THR  A 333 ( 0.8A)
ILE  A 336 ( 0.4A)
MET  A 357 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.46A 3tvxA-3sl5A:
51.5		 3tvxA-3sl5A:
85.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TVX_B_PNXB902_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4A)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		7 / 7 TYR A 159
ASN A 321
ILE A 336
PHE A 340
MET A 357
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
ASN  A 321 (-0.6A)
ILE  A 336 ( 0.4A)
PHE  A 340 (-1.3A)
MET  A 357 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.52A 3tvxB-3sl5A:
51.6		 3tvxB-3sl5A:
85.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3U88_A_CHDA611_0
(MENIN)		 1ng0 COAT PROTEIN
(Cocksfoot
mottle
virus) 		3 / 3 SER A 246
PHE A  64
LYS A 244
 SER  A 246 ( 0.0A)
PHE  A  64 ( 1.3A)
LYS  A 244 ( 0.0A)
 1.02A 3u88A-1ng0A:
undetectable		 3u88A-1ng0A:
19.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3U9F_E_CLME221_1
(CHLORAMPHENICOL
ACETYLTRANSFERASE)		 3td9 BRANCHED CHAIN AMINO
ACID ABC
TRANSPORTER,
PERIPLASMIC AMINO
ACID-BINDING PROTEIN
(Thermotoga
maritima) 		3 / 3 PHE A 134
CYH A 133
HIS A 264
 None
None
PHE  A 400 ( 4.5A)
 1.24A 3u9fF-3td9A:
undetectable		 3u9fF-3td9A:
22.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3U9F_I_CLMI221_0
(CHLORAMPHENICOL
ACETYLTRANSFERASE)		 3td9 BRANCHED CHAIN AMINO
ACID ABC
TRANSPORTER,
PERIPLASMIC AMINO
ACID-BINDING PROTEIN
(Thermotoga
maritima) 		3 / 3 PHE A 134
CYH A 133
HIS A 264
 None
None
PHE  A 400 ( 4.5A)
 1.24A 3u9fG-3td9A:
undetectable		 3u9fG-3td9A:
22.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3U9F_K_CLMK221_1
(CHLORAMPHENICOL
ACETYLTRANSFERASE)		 3td9 BRANCHED CHAIN AMINO
ACID ABC
TRANSPORTER,
PERIPLASMIC AMINO
ACID-BINDING PROTEIN
(Thermotoga
maritima) 		3 / 3 PHE A 134
CYH A 133
HIS A 264
 None
None
PHE  A 400 ( 4.5A)
 1.22A 3u9fL-3td9A:
undetectable		 3u9fL-3td9A:
22.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3U9F_R_CLMR221_1
(CHLORAMPHENICOL
ACETYLTRANSFERASE)		 3td9 BRANCHED CHAIN AMINO
ACID ABC
TRANSPORTER,
PERIPLASMIC AMINO
ACID-BINDING PROTEIN
(Thermotoga
maritima) 		3 / 3 PHE A 134
CYH A 133
HIS A 264
 None
None
PHE  A 400 ( 4.5A)
 1.19A 3u9fS-3td9A:
undetectable		 3u9fS-3td9A:
22.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UA5_A_06XA501_1
(CYTOCHROME P450 2B6)		 1vho ENDOGLUCANASE
(Thermotoga
maritima) 		4 / 8 ILE A 222
PHE A  62
LEU A 271
VAL A 269
 ILE  A 222 ( 0.7A)
PHE  A  62 ( 1.3A)
LEU  A 271 ( 0.6A)
VAL  A 269 ( 0.6A)
 0.79A 3ua5A-1vhoA:
undetectable		 3ua5A-1vhoA:
25.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UCJ_A_AZMA229_2
(CARBONIC ANHYDRASE)		 1ryn PROTEIN CRS2
(Zea
mays) 		3 / 3 GLN A  44
PHE A  45
TYR A  82
 GLN  A  44 ( 0.6A)
PHE  A  45 ( 1.3A)
TYR  A  82 ( 1.3A)
 0.97A 3ucjB-1rynA:
undetectable		 3ucjB-1rynA:
22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UCJ_B_AZMB229_1
(CARBONIC ANHYDRASE)		 1ryn PROTEIN CRS2
(Zea
mays) 		3 / 3 GLN A  44
PHE A  45
TYR A  82
 GLN  A  44 ( 0.6A)
PHE  A  45 ( 1.3A)
TYR  A  82 ( 1.3A)
 0.97A 3ucjA-1rynA:
undetectable		 3ucjA-1rynA:
22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UQ6_A_ADNA401_2
(ADENOSINE KINASE,
PUTATIVE)		 2dj6 HYPOTHETICAL PROTEIN
PH0634
(Pyrococcus
horikoshii) 		4 / 5 LEU A  63
ALA A  13
PHE A  31
ASN A  69
 LEU  A  63 ( 0.5A)
ALA  A  13 ( 0.0A)
PHE  A  31 ( 1.3A)
ASN  A  69 ( 0.6A)
 1.44A 3uq6A-2dj6A:
undetectable		 3uq6A-2dj6A:
16.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3V3O_B_T1CB405_1
(TETX2 PROTEIN)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		5 / 12 PHE A 309
ASN A 316
GLY A 312
GLY A 266
MET A 381
 PHE  A 309 ( 1.3A)
ASN  A 316 ( 0.6A)
GLY  A 312 ( 0.0A)
GLY  A 266 ( 0.0A)
MET  A 381 ( 0.0A)
 1.11A 3v3oB-5gprA:
undetectable		 3v3oB-5gprA:
21.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3V3O_D_T1CD401_1
(TETX2 PROTEIN)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		5 / 10 PHE A 309
ASN A 316
GLY A 312
GLY A 266
MET A 381
 PHE  A 309 ( 1.3A)
ASN  A 316 ( 0.6A)
GLY  A 312 ( 0.0A)
GLY  A 266 ( 0.0A)
MET  A 381 ( 0.0A)
 1.18A 3v3oD-5gprA:
undetectable		 3v3oD-5gprA:
21.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3VAQ_A_ADNA401_2
(PUTATIVE ADENOSINE
KINASE)		 2dj6 HYPOTHETICAL PROTEIN
PH0634
(Pyrococcus
horikoshii) 		4 / 4 LEU A  63
ALA A  13
PHE A  31
ASN A  69
 LEU  A  63 ( 0.5A)
ALA  A  13 ( 0.0A)
PHE  A  31 ( 1.3A)
ASN  A  69 ( 0.6A)
 1.49A 3vaqA-2dj6A:
undetectable		 3vaqA-2dj6A:
16.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3VAS_B_ADNB401_1
(PUTATIVE ADENOSINE
KINASE)		 1c1d L-PHENYLALANINE
DEHYDROGENASE
(Rhodococcus
sp.) 		5 / 12 ILE A  81
LEU A  99
GLY A  39
GLY A  40
LEU A 129
 None
None
PHE  A 361 (-3.7A)
PHE  A 361 (-3.8A)
None
 1.11A 3vasB-1c1dA:
2.0		 3vasB-1c1dA:
22.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3VLN_A_ASCA904_0
(GLUTATHIONE
S-TRANSFERASE
OMEGA-1)		 3i4k MUCONATE LACTONIZING
ENZYME
(Corynebacterium
glutamicum) 		4 / 6 PHE A 331
LEU A 330
PRO A 333
GLU A 306
 PHE  A 331 ( 1.3A)
LEU  A 330 ( 0.6A)
PRO  A 333 ( 1.1A)
GLU  A 306 ( 0.5A)
 1.39A 3vlnA-3i4kA:
undetectable		 3vlnA-3i4kA:
20.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3VNS_A_DVAA602_0
(NRPS ADENYLATION
PROTEIN CYTC1)		 1amu GRAMICIDIN
SYNTHETASE 1
(Brevibacillus
brevis) 		5 / 7 PHE A 234
ASP A 235
GLY A 302
THR A 326
LYS A 517
 PHE  A 566 ( 4.5A)
PHE  A 566 (-2.8A)
PHE  A 566 ( 3.6A)
AMP  A 567 ( 3.9A)
AMP  A 567 ( 2.8A)
 0.52A 3vnsA-1amuA:
49.8		 3vnsA-1amuA:
31.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W1W_A_SALA1505_1
(FERROCHELATASE,
MITOCHONDRIAL)		 3td9 BRANCHED CHAIN AMINO
ACID ABC
TRANSPORTER,
PERIPLASMIC AMINO
ACID-BINDING PROTEIN
(Thermotoga
maritima) 		5 / 9 VAL A  40
PRO A 115
SER A 117
LEU A 293
SER A  98
 None
None
PHE  A 400 (-4.2A)
PHE  A 400 (-4.1A)
None
 1.28A 3w1wA-3td9A:
4.3
3w1wB-3td9A:
4.4		 3w1wA-3td9A:
21.98
3w1wB-3td9A:
21.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WDM_A_ADNA901_1
(4-PHOSPHOPANTOATE--B
ETA-ALANINE LIGASE)		 3td9 BRANCHED CHAIN AMINO
ACID ABC
TRANSPORTER,
PERIPLASMIC AMINO
ACID-BINDING PROTEIN
(Thermotoga
maritima) 		5 / 9 ALA A  35
ARG A  38
GLY A  37
LEU A 293
LEU A  27
 None
None
None
PHE  A 400 (-4.1A)
None
 1.47A 3wdmA-3td9A:
3.6		 3wdmA-3td9A:
22.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WG7_C_CHDC305_0
(CYTOCHROME C OXIDASE
SUBUNIT 3
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 6 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.92A 3wg7C-4flxA:
2.6
3wg7J-4flxA:
undetectable		 3wg7C-4flxA:
13.49
3wg7J-4flxA:
6.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WG7_P_CHDP306_0
(CYTOCHROME C OXIDASE
SUBUNIT 3
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 1woj 2',3'-CYCLIC-NUCLEOT
IDE
3'-PHOSPHODIESTERASE
(Homo
sapiens) 		4 / 6 LEU A 347
PHE A 189
LEU A 193
PHE A 199
 LEU  A 347 ( 0.6A)
PHE  A 189 ( 1.3A)
LEU  A 193 ( 0.6A)
PHE  A 199 ( 1.3A)
 0.99A 3wg7P-1wojA:
undetectable
3wg7W-1wojA:
undetectable		 3wg7P-1wojA:
21.91
3wg7W-1wojA:
15.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WG7_P_CHDP306_0
(CYTOCHROME C OXIDASE
SUBUNIT 3
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 2pk2 CYCLIN-T1, PROTEIN
TAT
(Homo
sapiens;
Equine
infectious
anemia
virus) 		4 / 6 LEU A  90
PHE A  89
LEU A 141
PHE A 146
 LEU  A  90 ( 0.6A)
PHE  A  89 ( 1.3A)
LEU  A 141 ( 0.6A)
PHE  A 146 ( 1.3A)
 1.04A 3wg7P-2pk2A:
undetectable
3wg7W-2pk2A:
undetectable		 3wg7P-2pk2A:
20.56
3wg7W-2pk2A:
11.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WG7_P_CHDP306_0
(CYTOCHROME C OXIDASE
SUBUNIT 3
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 6 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.89A 3wg7P-4flxA:
2.4
3wg7W-4flxA:
undetectable		 3wg7P-4flxA:
13.49
3wg7W-4flxA:
6.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WQV_A_GCSA501_1
(CHITINASE)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		7 / 11 PHE A 184
GLY A 267
ASP A 306
TYR A 383
ASP A 384
TYR A 437
TRP A 532
 PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
ASP  A 306 ( 0.5A)
TYR  A 383 ( 1.3A)
ASP  A 384 ( 0.5A)
TYR  A 437 ( 1.3A)
TRP  A 532 ( 0.5A)
 0.80A 3wqvA-5gprA:
43.0		 3wqvA-5gprA:
24.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WQV_A_GCSA501_1
(CHITINASE)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		10 / 11 PHE A 184
GLY A 267
TRP A 268
GLU A 308
MET A 381
TYR A 383
ASP A 384
TYR A 437
ARG A 439
TRP A 532
 PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
TRP  A 268 ( 0.5A)
GLU  A 308 ( 0.6A)
MET  A 381 ( 0.0A)
TYR  A 383 ( 1.3A)
ASP  A 384 ( 0.5A)
TYR  A 437 ( 1.3A)
ARG  A 439 ( 0.6A)
TRP  A 532 ( 0.5A)
 0.44A 3wqvA-5gprA:
43.0		 3wqvA-5gprA:
24.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WQW_A_GCSA501_1
(CHITINASE)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		7 / 11 PHE A 184
GLY A 267
ASP A 306
TYR A 383
ASP A 384
TYR A 437
TRP A 532
 PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
ASP  A 306 ( 0.5A)
TYR  A 383 ( 1.3A)
ASP  A 384 ( 0.5A)
TYR  A 437 ( 1.3A)
TRP  A 532 ( 0.5A)
 0.82A 3wqwA-5gprA:
43.0		 3wqwA-5gprA:
24.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WQW_A_GCSA501_1
(CHITINASE)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		10 / 11 PHE A 184
GLY A 267
TRP A 268
GLU A 308
MET A 381
TYR A 383
ASP A 384
TYR A 437
ARG A 439
TRP A 532
 PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
TRP  A 268 ( 0.5A)
GLU  A 308 ( 0.6A)
MET  A 381 ( 0.0A)
TYR  A 383 ( 1.3A)
ASP  A 384 ( 0.5A)
TYR  A 437 ( 1.3A)
ARG  A 439 ( 0.6A)
TRP  A 532 ( 0.5A)
 0.47A 3wqwA-5gprA:
43.0		 3wqwA-5gprA:
24.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WQW_A_GCSA502_1
(CHITINASE)		 5me6 EUKARYOTIC
TRANSCRIPTION
INITIATION FACTOR 4E
(Cucumis
melo) 		4 / 5 GLY A 172
TRP A 187
ALA A 173
PHE A 216
 GLY  A 172 ( 0.0A)
TRP  A 187 (-0.5A)
ALA  A 173 ( 0.0A)
PHE  A 216 ( 1.3A)
 1.26A 3wqwA-5me6A:
undetectable		 3wqwA-5me6A:
19.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WRH_A_CAMA503_0
(CAMPHOR
5-MONOOXYGENASE)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		4 / 7 PHE C 251
LEU C 280
VAL C 289
ASP C 273
 PHE  C 251 ( 1.3A)
LEU  C 280 ( 0.5A)
VAL  C 289 ( 0.5A)
ASP  C 273 ( 0.6A)
 1.01A 3wrhA-5lmxC:
undetectable		 3wrhA-5lmxC:
22.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WRH_E_CAME503_0
(CAMPHOR
5-MONOOXYGENASE)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		4 / 6 PHE C 251
LEU C 280
VAL C 289
ASP C 273
 PHE  C 251 ( 1.3A)
LEU  C 280 ( 0.5A)
VAL  C 289 ( 0.5A)
ASP  C 273 ( 0.6A)
 1.00A 3wrhE-5lmxC:
undetectable		 3wrhE-5lmxC:
22.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WRJ_A_CAMA503_0
(CAMPHOR
5-MONOOXYGENASE)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		4 / 7 PHE C 251
LEU C 280
VAL C 289
ASP C 273
 PHE  C 251 ( 1.3A)
LEU  C 280 ( 0.5A)
VAL  C 289 ( 0.5A)
ASP  C 273 ( 0.6A)
 1.00A 3wrjA-5lmxC:
undetectable		 3wrjA-5lmxC:
22.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WRJ_E_CAME503_0
(CAMPHOR
5-MONOOXYGENASE)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		4 / 6 PHE C 251
LEU C 280
VAL C 289
ASP C 273
 PHE  C 251 ( 1.3A)
LEU  C 280 ( 0.5A)
VAL  C 289 ( 0.5A)
ASP  C 273 ( 0.6A)
 1.01A 3wrjE-5lmxC:
undetectable		 3wrjE-5lmxC:
22.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WRL_A_CAMA503_0
(CAMPHOR
5-MONOOXYGENASE)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		4 / 7 PHE C 251
LEU C 280
VAL C 289
ASP C 273
 PHE  C 251 ( 1.3A)
LEU  C 280 ( 0.5A)
VAL  C 289 ( 0.5A)
ASP  C 273 ( 0.6A)
 1.02A 3wrlA-5lmxC:
undetectable		 3wrlA-5lmxC:
22.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WRM_A_CAMA503_0
(CAMPHOR
5-MONOOXYGENASE)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		4 / 7 PHE C 251
LEU C 280
VAL C 289
ASP C 273
 PHE  C 251 ( 1.3A)
LEU  C 280 ( 0.5A)
VAL  C 289 ( 0.5A)
ASP  C 273 ( 0.6A)
 1.03A 3wrmA-5lmxC:
undetectable		 3wrmA-5lmxC:
22.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WRM_F_CAMF503_0
(CAMPHOR
5-MONOOXYGENASE)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		4 / 7 PHE C 251
LEU C 280
VAL C 289
ASP C 273
 PHE  C 251 ( 1.3A)
LEU  C 280 ( 0.5A)
VAL  C 289 ( 0.5A)
ASP  C 273 ( 0.6A)
 1.00A 3wrmF-5lmxC:
undetectable		 3wrmF-5lmxC:
22.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WZE_A_BAXA1201_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE
(Homo
sapiens) 		8 / 12 VAL A  39
ALA A  52
LYS A  54
LEU A  73
PHE A 107
GLY A 111
LEU A 144
HIS A 151
 VAL  A  39 (-0.6A)
ALA  A  52 (-0.0A)
LYS  A  54 ( 0.0A)
LEU  A  73 ( 0.6A)
PHE  A 107 ( 1.3A)
GLY  A 111 (-0.0A)
LEU  A 144 ( 0.6A)
HIS  A 151 ( 1.0A)
 0.71A 3wzeA-5d7aA:
8.8		 3wzeA-5d7aA:
28.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3X2Q_C_CHDC304_0
(CYTOCHROME C OXIDASE
SUBUNIT 3
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 7 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.89A 3x2qC-4flxA:
2.7
3x2qJ-4flxA:
undetectable		 3x2qC-4flxA:
13.49
3x2qJ-4flxA:
6.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3X2Q_P_CHDP307_0
(CYTOCHROME C OXIDASE
SUBUNIT 3
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 7 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.90A 3x2qP-4flxA:
undetectable
3x2qW-4flxA:
undetectable		 3x2qP-4flxA:
13.49
3x2qW-4flxA:
6.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ZTV_A_ADNA1600_1
(NAD NUCLEOTIDASE)		 5xlu GAMMA GLUTAMYL
TRANSPEPTIDASE
(Bacillus
licheniformis) 		5 / 9 GLY A  89
GLY A  88
PHE A 236
SER A 108
GLY A  90
 GLY  A  89 ( 0.0A)
GLY  A  88 ( 0.0A)
PHE  A 236 ( 1.3A)
SER  A 108 ( 0.0A)
GLY  A  90 ( 0.0A)
 1.26A 3ztvA-5xluA:
undetectable		 3ztvA-5xluA:
7.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A6N_A_T1CA392_1
(TETX2 PROTEIN)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		5 / 11 GLN A 665
PHE A 152
GLY A 696
ALA A 215
GLY A 211
 GLN  A 665 ( 0.6A)
PHE  A 152 ( 1.3A)
GLY  A 696 ( 0.0A)
ALA  A 215 ( 0.0A)
GLY  A 211 ( 0.0A)
 1.24A 4a6nA-4flxA:
undetectable		 4a6nA-4flxA:
20.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A6N_A_T1CA392_1
(TETX2 PROTEIN)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		5 / 11 PHE A 309
ASN A 316
GLY A 312
GLY A 266
MET A 381
 PHE  A 309 ( 1.3A)
ASN  A 316 ( 0.6A)
GLY  A 312 ( 0.0A)
GLY  A 266 ( 0.0A)
MET  A 381 ( 0.0A)
 1.13A 4a6nA-5gprA:
undetectable		 4a6nA-5gprA:
20.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A6N_B_T1CB392_1
(TETX2 PROTEIN)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		5 / 11 PHE A 309
ASN A 316
GLY A 312
GLY A 266
MET A 381
 PHE  A 309 ( 1.3A)
ASN  A 316 ( 0.6A)
GLY  A 312 ( 0.0A)
GLY  A 266 ( 0.0A)
MET  A 381 ( 0.0A)
 1.13A 4a6nB-5gprA:
undetectable		 4a6nB-5gprA:
22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A6N_C_T1CC392_1
(TETX2 PROTEIN)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		5 / 11 PHE A 309
ASN A 316
GLY A 312
GLY A 266
MET A 381
 PHE  A 309 ( 1.3A)
ASN  A 316 ( 0.6A)
GLY  A 312 ( 0.0A)
GLY  A 266 ( 0.0A)
MET  A 381 ( 0.0A)
 1.13A 4a6nC-5gprA:
undetectable		 4a6nC-5gprA:
22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A97_D_ZPCD1318_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 2z3k LEUCYL/PHENYLALANYL-
TRNA-PROTEIN
TRANSFERASE
(Escherichia
coli) 		4 / 8 TYR A  87
VAL A  89
MET A 144
ILE A 132
 None
None
PHE  A 302 ( 3.6A)
None
 0.72A 4a97C-2z3kA:
undetectable		 4a97C-2z3kA:
20.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A97_E_ZPCE1318_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 2z3k LEUCYL/PHENYLALANYL-
TRNA-PROTEIN
TRANSFERASE
(Escherichia
coli) 		4 / 8 TYR A  87
VAL A  89
MET A 144
ILE A 132
 None
None
PHE  A 302 ( 3.6A)
None
 0.79A 4a97D-2z3kA:
undetectable		 4a97D-2z3kA:
20.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A97_H_ZPCH1318_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 2z3k LEUCYL/PHENYLALANYL-
TRNA-PROTEIN
TRANSFERASE
(Escherichia
coli) 		4 / 8 TYR A  87
VAL A  89
MET A 144
ILE A 132
 None
None
PHE  A 302 ( 3.6A)
None
 0.80A 4a97G-2z3kA:
undetectable		 4a97G-2z3kA:
20.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A97_J_ZPCJ1318_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 2z3k LEUCYL/PHENYLALANYL-
TRNA-PROTEIN
TRANSFERASE
(Escherichia
coli) 		4 / 8 TYR A  87
VAL A  89
MET A 144
ILE A 132
 None
None
PHE  A 302 ( 3.6A)
None
 0.86A 4a97I-2z3kA:
undetectable		 4a97I-2z3kA:
20.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A99_A_MIYA391_1
(TETX2 PROTEIN)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		5 / 10 PHE A 309
ASN A 316
GLY A 312
GLY A 266
MET A 381
 PHE  A 309 ( 1.3A)
ASN  A 316 ( 0.6A)
GLY  A 312 ( 0.0A)
GLY  A 266 ( 0.0A)
MET  A 381 ( 0.0A)
 1.22A 4a99A-5gprA:
undetectable		 4a99A-5gprA:
22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A99_B_MIYB391_1
(TETX2 PROTEIN)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		5 / 11 PHE A 309
ASN A 316
GLY A 312
GLY A 266
MET A 381
 PHE  A 309 ( 1.3A)
ASN  A 316 ( 0.6A)
GLY  A 312 ( 0.0A)
GLY  A 266 ( 0.0A)
MET  A 381 ( 0.0A)
 1.19A 4a99B-5gprA:
undetectable		 4a99B-5gprA:
22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A99_C_MIYC391_1
(TETX2 PROTEIN)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		5 / 11 PHE A 309
ASN A 316
GLY A 312
GLY A 266
MET A 381
 PHE  A 309 ( 1.3A)
ASN  A 316 ( 0.6A)
GLY  A 312 ( 0.0A)
GLY  A 266 ( 0.0A)
MET  A 381 ( 0.0A)
 1.21A 4a99C-5gprA:
undetectable		 4a99C-5gprA:
22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A99_D_MIYD391_1
(TETX2 PROTEIN)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		5 / 11 PHE A 309
ASN A 316
GLY A 312
GLY A 266
MET A 381
 PHE  A 309 ( 1.3A)
ASN  A 316 ( 0.6A)
GLY  A 312 ( 0.0A)
GLY  A 266 ( 0.0A)
MET  A 381 ( 0.0A)
 1.21A 4a99D-5gprA:
undetectable		 4a99D-5gprA:
22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ASD_A_BAXA1500_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE
(Homo
sapiens) 		9 / 12 VAL A  39
ALA A  52
LYS A  54
GLU A  69
LEU A  73
PHE A 107
GLY A 111
LEU A 144
HIS A 151
 VAL  A  39 (-0.6A)
ALA  A  52 (-0.0A)
LYS  A  54 ( 0.0A)
GLU  A  69 ( 0.6A)
LEU  A  73 ( 0.6A)
PHE  A 107 ( 1.3A)
GLY  A 111 (-0.0A)
LEU  A 144 ( 0.6A)
HIS  A 151 ( 1.0A)
 0.79A 4asdA-5d7aA:
10.1		 4asdA-5d7aA:
26.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4AWU_A_4CHA502_0
(OXIDOREDUCTASE,
FMN-BINDING)		 5ve2 ENOYL-COA HYDRATASE
(Pseudoalteromona
s
atlantica) 		4 / 7 THR A  61
TYR A  32
LEU A  35
PHE A  60
 THR  A  61 ( 0.8A)
TYR  A  32 ( 1.3A)
LEU  A  35 ( 0.6A)
PHE  A  60 ( 1.3A)
 1.33A 4awuA-5ve2A:
undetectable		 4awuA-5ve2A:
22.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4B9Z_A_ACRA1818_2
(ALPHA-GLUCOSIDASE,
PUTATIVE, ADG31B)		 5svd NUCLEOLAR PROTEIN 9
(Saccharomyces
cerevisiae) 		4 / 5 PHE A 351
PHE A 291
TRP A 321
GLN A 305
 PHE  A 351 ( 1.3A)
PHE  A 291 ( 1.3A)
TRP  A 321 ( 0.5A)
GLN  A 305 ( 0.6A)
 1.44A 4b9zA-5svdA:
0.0		 4b9zA-5svdA:
19.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4BB2_B_STRB1384_1
(CORTICOSTEROID-BINDI
NG GLOBULIN)		 4zke SUPERKILLER PROTEIN
7
(Saccharomyces
cerevisiae) 		5 / 11 GLN A 568
THR A 681
PHE A 715
ILE A 710
HIS A 678
 GLN  A 568 ( 0.6A)
THR  A 681 ( 0.8A)
PHE  A 715 ( 1.3A)
ILE  A 710 ( 0.7A)
HIS  A 678 ( 1.0A)
 1.03A 4bb2A-4zkeA:
undetectable
4bb2B-4zkeA:
undetectable		 4bb2A-4zkeA:
23.00
4bb2B-4zkeA:
5.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4BUP_B_SAMB500_0
(HISTONE-LYSINE
N-METHYLTRANSFERASE
SUV420H1)		 4kqn D-HYDANTOINASE
(Bacillus
sp.
AR9) 		5 / 12 SER A 148
GLY A 377
ALA A 373
HIS A  58
PHE A  92
 SER  A 148 ( 0.0A)
GLY  A 377 ( 0.0A)
ALA  A 373 ( 0.0A)
HIS  A  58 (-1.0A)
PHE  A  92 ( 1.3A)
 1.34A 4bupB-4kqnA:
undetectable		 4bupB-4kqnA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4BVA_A_T3A1314_1
(THIOMORPHOLINE-CARBO
XYLATE DEHYDROGENASE)		 5nks DIHYDROPYRIMIDINASE-
RELATED PROTEIN 4
(Homo
sapiens) 		5 / 12 VAL A 437
PHE A 434
GLY A 436
SER A 363
GLU A 367
 VAL  A 437 ( 0.6A)
PHE  A 434 ( 1.3A)
GLY  A 436 ( 0.0A)
SER  A 363 ( 0.0A)
GLU  A 367 ( 0.6A)
 1.36A 4bvaA-5nksA:
1.4		 4bvaA-5nksA:
21.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4BVA_B_T3B1314_1
(THIOMORPHOLINE-CARBO
XYLATE DEHYDROGENASE)		 1vho ENDOGLUCANASE
(Thermotoga
maritima) 		5 / 12 VAL A 252
PHE A 286
GLY A 249
VAL A 276
SER A 300
 VAL  A 252 ( 0.6A)
PHE  A 286 ( 1.3A)
GLY  A 249 ( 0.0A)
VAL  A 276 ( 0.6A)
SER  A 300 ( 0.0A)
 1.49A 4bvaB-1vhoA:
undetectable		 4bvaB-1vhoA:
24.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4BZ6_A_SHHA700_1
(HISTONE DEACETYLASE
8)		 1zef ALKALINE PHOSPHATASE
(Homo
sapiens) 		5 / 10 HIS A 317
HIS A 320
PRO A  90
HIS A 432
GLY A  43
 PHE  A 802 (-4.0A)
ZN  A 901 ( 3.3A)
None
ZN  A 901 ( 3.2A)
ZN  A 902 ( 4.9A)
 1.43A 4bz6A-1zefA:
2.6		 4bz6A-1zefA:
23.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4BZ6_B_SHHB700_1
(HISTONE DEACETYLASE
8)		 1zef ALKALINE PHOSPHATASE
(Homo
sapiens) 		5 / 12 HIS A 317
HIS A 320
PRO A  90
HIS A 432
GLY A  43
 PHE  A 802 (-4.0A)
ZN  A 901 ( 3.3A)
None
ZN  A 901 ( 3.2A)
ZN  A 902 ( 4.9A)
 1.43A 4bz6A-1zefA:
2.9
4bz6B-1zefA:
2.9		 4bz6A-1zefA:
23.51
4bz6B-1zefA:
23.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4BZ6_D_SHHD700_1
(HISTONE DEACETYLASE
8)		 1zef ALKALINE PHOSPHATASE
(Homo
sapiens) 		5 / 10 HIS A 317
HIS A 320
PRO A  90
HIS A 432
GLY A  43
 PHE  A 802 (-4.0A)
ZN  A 901 ( 3.3A)
None
ZN  A 901 ( 3.2A)
ZN  A 902 ( 4.9A)
 1.43A 4bz6D-1zefA:
2.3		 4bz6D-1zefA:
23.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C49_C_HCYC1384_1
(CORTICOSTEROID-BINDI
NG GLOBULIN)		 4zke SUPERKILLER PROTEIN
7
(Saccharomyces
cerevisiae) 		5 / 12 GLN A 568
THR A 681
PHE A 715
ILE A 710
HIS A 678
 GLN  A 568 ( 0.6A)
THR  A 681 ( 0.8A)
PHE  A 715 ( 1.3A)
ILE  A 710 ( 0.7A)
HIS  A 678 ( 1.0A)
 1.06A 4c49C-4zkeA:
undetectable		 4c49C-4zkeA:
23.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CLA_A_CLMA221_0
(TYPE III
CHLORAMPHENICOL
ACETYLTRANSFERASE)		 3ulk KETOL-ACID
REDUCTOISOMERASE
(Escherichia
coli) 		5 / 11 THR A 148
ALA A 127
LEU A 101
PHE A 210
ILE A 136
 THR  A 148 ( 0.8A)
ALA  A 127 ( 0.0A)
LEU  A 101 ( 0.6A)
PHE  A 210 ( 1.3A)
ILE  A 136 ( 0.7A)
 1.46A 4claA-3ulkA:
undetectable		 4claA-3ulkA:
17.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CLA_A_CLMA221_0
(TYPE III
CHLORAMPHENICOL
ACETYLTRANSFERASE)		 3whl PROTEASOME-ACTIVATIN
G NUCLEOTIDASE, 26S
PROTEASE REGULATORY
SUBUNIT 6A
(Pyrococcus
furiosus;
Saccharomyces
cerevisiae) 		5 / 11 THR A 276
ALA A 270
LEU A 266
PHE A 267
ILE A 197
 THR  A 276 ( 0.8A)
ALA  A 270 ( 0.0A)
LEU  A 266 ( 0.6A)
PHE  A 267 ( 1.3A)
ILE  A 197 ( 0.7A)
 1.33A 4claA-3whlA:
undetectable		 4claA-3whlA:
19.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTT_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 3r6y ASPARTASE
(Bacillus
sp.
YM55-1) 		4 / 7 MET A 298
VAL A 310
PHE A 178
GLU A 308
 MET  A 298 ( 0.0A)
VAL  A 310 ( 0.6A)
PHE  A 178 ( 1.3A)
GLU  A 308 ( 0.6A)
 1.43A 4cttA-3r6yA:
undetectable
4cttB-3r6yA:
undetectable		 4cttA-3r6yA:
22.39
4cttB-3r6yA:
22.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DM8_B_REAB1501_1
(RETINOIC ACID
RECEPTOR BETA)		 2pnn TRANSIENT RECEPTOR
POTENTIAL CATION
CHANNEL SUBFAMILY V
MEMBER 1
(Rattus
norvegicus) 		5 / 12 PHE A 189
LEU A 175
ALA A 174
LEU A 216
GLY A 168
 PHE  A 189 ( 1.3A)
LEU  A 175 ( 0.5A)
ALA  A 174 ( 0.0A)
LEU  A 216 ( 0.5A)
GLY  A 168 ( 0.0A)
 1.03A 4dm8B-2pnnA:
undetectable		 4dm8B-2pnnA:
21.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DRH_A_RAPA201_1
(PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP5)		 5wpi HSVA
(Erwinia
amylovora) 		5 / 12 TYR A 296
PHE A  58
VAL A  40
ILE A  38
PHE A 345
 TYR  A 296 ( 1.3A)
PHE  A  58 ( 1.3A)
VAL  A  40 ( 0.5A)
ILE  A  38 ( 0.7A)
PHE  A 345 ( 1.3A)
 1.34A 4drhA-5wpiA:
undetectable		 4drhA-5wpiA:
17.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DRH_D_RAPD201_1
(PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP5)		 5wpi HSVA
(Erwinia
amylovora) 		5 / 12 TYR A 296
PHE A  58
VAL A  40
ILE A  38
PHE A 345
 TYR  A 296 ( 1.3A)
PHE  A  58 ( 1.3A)
VAL  A  40 ( 0.5A)
ILE  A  38 ( 0.7A)
PHE  A 345 ( 1.3A)
 1.29A 4drhD-5wpiA:
undetectable		 4drhD-5wpiA:
17.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DRI_A_RAPA201_1
(PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP5)		 5wpi HSVA
(Erwinia
amylovora) 		5 / 11 TYR A 296
PHE A  58
VAL A  40
ILE A  38
PHE A 345
 TYR  A 296 ( 1.3A)
PHE  A  58 ( 1.3A)
VAL  A  40 ( 0.5A)
ILE  A  38 ( 0.7A)
PHE  A 345 ( 1.3A)
 1.29A 4driA-5wpiA:
undetectable		 4driA-5wpiA:
17.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DRJ_A_RAPA201_1
(PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP4)		 5wpi HSVA
(Erwinia
amylovora) 		5 / 11 TYR A 296
PHE A  58
VAL A  40
ILE A  38
PHE A 345
 TYR  A 296 ( 1.3A)
PHE  A  58 ( 1.3A)
VAL  A  40 ( 0.5A)
ILE  A  38 ( 0.7A)
PHE  A 345 ( 1.3A)
 1.33A 4drjA-5wpiA:
undetectable		 4drjA-5wpiA:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DUB_B_LDPB501_1
(CYTOCHROME P450 BM3
VARIANT 9D7)		 3r9r PHOSPHORIBOSYLAMINOI
MIDAZOLE-SUCCINOCARB
OXAMIDE SYNTHASE
(Mycobacteroides
abscessus) 		4 / 6 PHE A 289
ALA A  55
GLY A 294
PRO A 295
 PHE  A 289 ( 1.3A)
ALA  A  55 ( 0.0A)
GLY  A 294 ( 0.0A)
PRO  A 295 ( 1.1A)
 0.87A 4dubB-3r9rA:
undetectable		 4dubB-3r9rA:
21.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E1G_A_LNLA701_1
(PROSTAGLANDIN G/H
SYNTHASE 2)		 2ogs THERMOSTABLE
CARBOXYLESTERASE
EST50
(Geobacillus
stearothermophil
us) 		5 / 12 PHE A 213
TYR A 392
GLY A 196
ALA A 197
LEU A 204
 PHE  A 213 ( 1.3A)
TYR  A 392 ( 1.3A)
GLY  A 196 ( 0.0A)
ALA  A 197 ( 0.0A)
LEU  A 204 ( 0.6A)
 0.98A 4e1gA-2ogsA:
undetectable		 4e1gA-2ogsA:
20.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E1G_B_LNLB701_1
(PROSTAGLANDIN G/H
SYNTHASE 2)		 2ogs THERMOSTABLE
CARBOXYLESTERASE
EST50
(Geobacillus
stearothermophil
us) 		5 / 12 PHE A 213
TYR A 392
GLY A 196
ALA A 197
LEU A 204
 PHE  A 213 ( 1.3A)
TYR  A 392 ( 1.3A)
GLY  A 196 ( 0.0A)
ALA  A 197 ( 0.0A)
LEU  A 204 ( 0.6A)
 0.98A 4e1gB-2ogsA:
undetectable		 4e1gB-2ogsA:
20.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EAH_F_ACTF402_0
(ACTIN, ALPHA
SKELETAL MUSCLE)		 3ab7 PUTATIVE
UNCHARACTERIZED
PROTEIN TTHA0350
(Thermus
thermophilus) 		3 / 3 PHE A 126
ASP A 124
ARG A 258
 PHE  A 126 ( 1.3A)
ASP  A 124 ( 0.6A)
ARG  A 258 ( 0.6A)
 0.80A 4eahF-3ab7A:
undetectable		 4eahF-3ab7A:
20.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EAH_G_ACTG401_0
(ACTIN, ALPHA
SKELETAL MUSCLE)		 3ab7 PUTATIVE
UNCHARACTERIZED
PROTEIN TTHA0350
(Thermus
thermophilus) 		3 / 3 PHE A 126
ASP A 124
ARG A 258
 PHE  A 126 ( 1.3A)
ASP  A 124 ( 0.6A)
ARG  A 258 ( 0.6A)
 0.80A 4eahG-3ab7A:
undetectable		 4eahG-3ab7A:
20.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EB4_D_D16D402_1
(THYMIDYLATE SYNTHASE)		 2loe 6-CYSTEINE PROTEIN,
PUTATIVE
(Plasmodium
falciparum) 		5 / 10 PHE A  64
ILE A  48
ASP A 105
PHE A 109
LYS A  82
 PHE  A  64 ( 1.4A)
ILE  A  48 ( 0.7A)
ASP  A 105 ( 0.5A)
PHE  A 109 ( 1.4A)
LYS  A  82 ( 0.0A)
 1.47A 4eb4D-2loeA:
undetectable		 4eb4D-2loeA:
16.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EB6_C_VLBC503_1
(TUBULIN BETA CHAIN
TUBULIN ALPHA CHAIN)		 3td9 BRANCHED CHAIN AMINO
ACID ABC
TRANSPORTER,
PERIPLASMIC AMINO
ACID-BINDING PROTEIN
(Thermotoga
maritima) 		5 / 12 VAL A 168
ASP A 161
THR A 118
ILE A 221
ILE A  33
 None
None
PHE  A 400 (-2.8A)
None
None
 1.33A 4eb6B-3td9A:
3.7
4eb6C-3td9A:
2.8		 4eb6B-3td9A:
21.14
4eb6C-3td9A:
20.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EJ1_A_FOLA201_0
(DIHYDROFOLATE
REDUCTASE)		 3eqz RESPONSE REGULATOR
(Colwellia
psychrerythraea) 		5 / 12 LEU A 114
PHE A 117
ILE A  48
LEU A 121
ILE A 102
 LEU  A 114 ( 0.6A)
PHE  A 117 ( 1.3A)
ILE  A  48 ( 0.7A)
LEU  A 121 ( 0.6A)
ILE  A 102 ( 0.7A)
 0.82A 4ej1A-3eqzA:
undetectable		 4ej1A-3eqzA:
17.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EJG_B_NCTB501_1
(CYTOCHROME P450 2A13)		 6c0w CENTROMERE PROTEIN N
(Homo
sapiens) 		4 / 8 PHE K 104
ALA K 161
THR K 163
LEU K 175
 PHE  K 104 ( 1.3A)
ALA  K 161 ( 0.0A)
THR  K 163 ( 0.8A)
LEU  K 175 ( 0.5A)
 0.91A 4ejgB-6c0wK:
undetectable		 4ejgB-6c0wK:
10.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EJG_C_NCTC501_1
(CYTOCHROME P450 2A13)		 1szb MANNOSE BINDING
LECTIN-ASSOCIATED
SERINE PROTEASE-2
RELATED PROTEIN,
MAP19 (19KDA)
(Homo
sapiens) 		4 / 7 PHE A  49
PHE A  46
ALA A  72
LEU A  44
 PHE  A  49 ( 1.3A)
PHE  A  46 ( 1.3A)
ALA  A  72 ( 0.0A)
LEU  A  44 ( 0.6A)
 0.62A 4ejgC-1szbA:
undetectable		 4ejgC-1szbA:
16.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EJG_C_NCTC501_1
(CYTOCHROME P450 2A13)		 1szb MANNOSE BINDING
LECTIN-ASSOCIATED
SERINE PROTEASE-2
RELATED PROTEIN,
MAP19 (19KDA)
(Homo
sapiens) 		4 / 7 PHE A  49
PHE A  46
LEU A  98
LEU A  44
 PHE  A  49 ( 1.3A)
PHE  A  46 ( 1.3A)
LEU  A  98 ( 0.6A)
LEU  A  44 ( 0.6A)
 0.87A 4ejgC-1szbA:
undetectable		 4ejgC-1szbA:
16.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EJG_C_NCTC501_1
(CYTOCHROME P450 2A13)		 1szb MANNOSE BINDING
LECTIN-ASSOCIATED
SERINE PROTEASE-2
RELATED PROTEIN,
MAP19 (19KDA)
(Homo
sapiens) 		4 / 7 PHE A 115
PHE A  49
PHE A  46
LEU A  44
 PHE  A 115 ( 1.3A)
PHE  A  49 ( 1.3A)
PHE  A  46 ( 1.3A)
LEU  A  44 ( 0.6A)
 0.80A 4ejgC-1szbA:
undetectable		 4ejgC-1szbA:
16.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EJG_D_NCTD501_1
(CYTOCHROME P450 2A13)		 6c0w CENTROMERE PROTEIN N
(Homo
sapiens) 		4 / 6 PHE K 104
ALA K 161
THR K 163
LEU K 175
 PHE  K 104 ( 1.3A)
ALA  K 161 ( 0.0A)
THR  K 163 ( 0.8A)
LEU  K 175 ( 0.5A)
 0.89A 4ejgD-6c0wK:
undetectable		 4ejgD-6c0wK:
10.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EJJ_A_NCTA501_1
(CYTOCHROME P450 2A6)		 3whl PROTEASOME-ACTIVATIN
G NUCLEOTIDASE, 26S
PROTEASE REGULATORY
SUBUNIT 6A
(Pyrococcus
furiosus;
Saccharomyces
cerevisiae) 		4 / 7 PHE A 315
GLY A 217
ILE A 278
PHE A 267
 PHE  A 315 ( 1.3A)
GLY  A 217 ( 0.0A)
ILE  A 278 ( 0.7A)
PHE  A 267 ( 1.3A)
 0.81A 4ejjA-3whlA:
undetectable		 4ejjA-3whlA:
20.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EJJ_B_NCTB501_1
(CYTOCHROME P450 2A6)		 5svd NUCLEOLAR PROTEIN 9
(Saccharomyces
cerevisiae) 		4 / 7 VAL A 389
PHE A 338
GLY A 348
PHE A 325
 VAL  A 389 ( 0.6A)
PHE  A 338 ( 1.3A)
GLY  A 348 ( 0.0A)
PHE  A 325 ( 1.3A)
 0.94A 4ejjB-5svdA:
undetectable		 4ejjB-5svdA:
22.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EJJ_D_NCTD501_1
(CYTOCHROME P450 2A6)		 2qc5 STREPTOGRAMIN B
LACTONASE
(Staphylococcus
cohnii) 		4 / 7 ASN A 138
ILE A 122
LEU A 173
PHE A 156
 ASN  A 138 ( 0.6A)
ILE  A 122 ( 0.7A)
LEU  A 173 ( 0.6A)
PHE  A 156 ( 1.3A)
 0.80A 4ejjD-2qc5A:
undetectable		 4ejjD-2qc5A:
20.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EK1_A_CAMA502_0
(CAMPHOR
5-MONOOXYGENASE)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		4 / 6 PHE C 251
LEU C 280
VAL C 289
ASP C 273
 PHE  C 251 ( 1.3A)
LEU  C 280 ( 0.5A)
VAL  C 289 ( 0.5A)
ASP  C 273 ( 0.6A)
 1.03A 4ek1A-5lmxC:
undetectable		 4ek1A-5lmxC:
22.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)		 5ep8 PYRIMIDINE-NUCLEOSID
E PHOSPHORYLASE
(Bacillus
subtilis) 		5 / 12 PHE A 309
LEU A 329
ILE A 127
ALA A 256
GLY A 119
 PHE  A 309 ( 1.3A)
LEU  A 329 ( 0.6A)
ILE  A 127 ( 0.6A)
ALA  A 256 ( 0.0A)
GLY  A 119 ( 0.0A)
 1.03A 4enhA-5ep8A:
undetectable		 4enhA-5ep8A:
21.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FGK_A_0TXA302_0
(RIBOSYLDIHYDRONICOTI
NAMIDE DEHYDROGENASE
[QUINONE])		 5gpr CHITINASE
(Ostrinia
furnacalis) 		4 / 6 PHE A 286
ILE A 185
PRO A 186
PHE A 274
 PHE  A 286 ( 1.3A)
ILE  A 185 ( 0.7A)
PRO  A 186 ( 1.1A)
PHE  A 274 ( 1.3A)
 1.11A 4fgkA-5gprA:
undetectable		 4fgkA-5gprA:
17.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FGK_A_0TXA304_0
(RIBOSYLDIHYDRONICOTI
NAMIDE DEHYDROGENASE
[QUINONE])		 2hk0 D-PSICOSE
3-EPIMERASE
(Agrobacterium
tumefaciens) 		5 / 10 GLY A 106
GLY A 105
ASN A 157
VAL A 159
PHE A  89
 GLY  A 106 ( 0.0A)
GLY  A 105 ( 0.0A)
ASN  A 157 ( 0.6A)
VAL  A 159 ( 0.6A)
PHE  A  89 ( 1.3A)
 1.49A 4fgkA-2hk0A:
0.6
4fgkB-2hk0A:
undetectable		 4fgkA-2hk0A:
21.64
4fgkB-2hk0A:
21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FGL_C_CLQC303_1
(RIBOSYLDIHYDRONICOTI
NAMIDE DEHYDROGENASE
[QUINONE])		 5w0a GLUCANASE
(Trichoderma
harzianum) 		4 / 8 ASN A 142
GLY A 143
PHE A 130
ILE A 199
 ASN  A 142 ( 0.6A)
GLY  A 143 ( 0.0A)
PHE  A 130 ( 1.3A)
ILE  A 199 ( 0.7A)
 0.93A 4fglD-5w0aA:
undetectable		 4fglD-5w0aA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FHB_A_FOLA201_0
(DIHYDROFOLATE
REDUCTASE)		 3eqz RESPONSE REGULATOR
(Colwellia
psychrerythraea) 		5 / 12 LEU A 114
PHE A 117
ILE A  48
LEU A 121
ILE A 102
 LEU  A 114 ( 0.6A)
PHE  A 117 ( 1.3A)
ILE  A  48 ( 0.7A)
LEU  A 121 ( 0.6A)
ILE  A 102 ( 0.7A)
 0.84A 4fhbA-3eqzA:
undetectable		 4fhbA-3eqzA:
17.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FVQ_A_ACTA904_0
(TYROSINE-PROTEIN
KINASE JAK2)		 2grx PROTEIN TONB
(Escherichia
coli) 		3 / 3 PHE C 230
VAL C 176
GLU C 203
 PHE  C 230 ( 1.3A)
VAL  C 176 ( 0.6A)
GLU  C 203 ( 0.6A)
 0.58A 4fvqA-2grxC:
undetectable		 4fvqA-2grxC:
21.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4G3R_A_CAMA502_0
(CAMPHOR
5-MONOOXYGENASE)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		4 / 6 PHE C 251
LEU C 280
VAL C 289
ASP C 273
 PHE  C 251 ( 1.3A)
LEU  C 280 ( 0.5A)
VAL  C 289 ( 0.5A)
ASP  C 273 ( 0.6A)
 1.02A 4g3rA-5lmxC:
undetectable		 4g3rA-5lmxC:
22.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4G3R_B_CAMB502_0
(CAMPHOR
5-MONOOXYGENASE)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		4 / 6 PHE C 251
LEU C 280
VAL C 289
ASP C 273
 PHE  C 251 ( 1.3A)
LEU  C 280 ( 0.5A)
VAL  C 289 ( 0.5A)
ASP  C 273 ( 0.6A)
 1.02A 4g3rB-5lmxC:
undetectable		 4g3rB-5lmxC:
22.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4G5J_A_0WMA1102_1
(EPIDERMAL GROWTH
FACTOR RECEPTOR)		 3bpo INTERLEUKIN-13
RECEPTOR ALPHA-1
CHAIN
(Homo
sapiens) 		4 / 7 PHE C 183
TYR C 158
ILE C 213
PRO C 148
 PHE  C 183 ( 1.3A)
TYR  C 158 ( 1.3A)
ILE  C 213 ( 0.6A)
PRO  C 148 ( 1.1A)
 0.78A 4g5jA-3bpoC:
undetectable		 4g5jA-3bpoC:
20.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4G5J_A_0WMA1102_1
(EPIDERMAL GROWTH
FACTOR RECEPTOR)		 4non FERROUS IRON UPTAKE
TRANSPORTER PROTEIN
B
(Streptococcus
thermophilus) 		4 / 7 PHE A 250
TYR A 172
ILE A 201
PRO A 170
 PHE  A 250 ( 1.3A)
TYR  A 172 ( 1.3A)
ILE  A 201 ( 0.7A)
PRO  A 170 ( 1.1A)
 0.98A 4g5jA-4nonA:
undetectable		 4g5jA-4nonA:
24.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4GRQ_C_AVLC203_1
(MACROPHAGE MIGRATION
INHIBITORY FACTOR)		 3ghg FIBRINOGEN GAMMA
CHAIN
(Homo
sapiens) 		4 / 7 PHE C 215
TYR C 211
GLN C 195
PHE C 312
 PHE  C 215 ( 1.3A)
TYR  C 211 ( 1.3A)
GLN  C 195 ( 0.6A)
PHE  C 312 ( 1.3A)
 1.39A 4grqA-3ghgC:
undetectable
4grqC-3ghgC:
undetectable		 4grqA-3ghgC:
13.33
4grqC-3ghgC:
13.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4GRQ_C_AVLC203_1
(MACROPHAGE MIGRATION
INHIBITORY FACTOR)		 3ghg FIBRINOGEN GAMMA
CHAIN
(Homo
sapiens) 		4 / 7 PHE C 215
TYR C 211
TRP C 227
PHE C 312
 PHE  C 215 ( 1.3A)
TYR  C 211 ( 1.3A)
TRP  C 227 ( 0.5A)
PHE  C 312 ( 1.3A)
 1.29A 4grqA-3ghgC:
undetectable
4grqC-3ghgC:
undetectable		 4grqA-3ghgC:
13.33
4grqC-3ghgC:
13.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4I13_A_FOLA201_0
(DIHYDROFOLATE
REDUCTASE)		 3eqz RESPONSE REGULATOR
(Colwellia
psychrerythraea) 		5 / 12 LEU A 114
PHE A 117
ILE A  48
LEU A 121
ILE A 102
 LEU  A 114 ( 0.6A)
PHE  A 117 ( 1.3A)
ILE  A  48 ( 0.7A)
LEU  A 121 ( 0.6A)
ILE  A 102 ( 0.7A)
 0.93A 4i13A-3eqzA:
undetectable		 4i13A-3eqzA:
17.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4IAR_A_ERMA2001_1
(CHIMERA PROTEIN OF
HUMAN
5-HYDROXYTRYPTAMINE
RECEPTOR 1B AND E.
COLI SOLUBLE
CYTOCHROME B562)		 2ogs THERMOSTABLE
CARBOXYLESTERASE
EST50
(Geobacillus
stearothermophil
us) 		5 / 12 LEU A 411
ALA A 197
PHE A 371
PHE A 314
THR A 367
 LEU  A 411 ( 0.6A)
ALA  A 197 ( 0.0A)
PHE  A 371 ( 1.3A)
PHE  A 314 ( 1.3A)
THR  A 367 ( 0.8A)
 1.33A 4iarA-2ogsA:
undetectable		 4iarA-2ogsA:
21.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4IQQ_B_D16B402_1
(THYMIDYLATE SYNTHASE)		 5me6 EUKARYOTIC
TRANSCRIPTION
INITIATION FACTOR 4E
(Cucumis
melo) 		4 / 7 ILE A 186
ASP A 168
GLY A 167
PHE A 164
 ILE  A 186 ( 0.7A)
ASP  A 168 ( 0.6A)
GLY  A 167 ( 0.0A)
PHE  A 164 ( 1.3A)
 0.88A 4iqqB-5me6A:
undetectable		 4iqqB-5me6A:
19.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4J4V_A_SVRA301_1
(NUCLEOCAPSID PROTEIN)		 3i4k MUCONATE LACTONIZING
ENZYME
(Corynebacterium
glutamicum) 		5 / 11 GLY A 310
GLN A 316
PRO A 333
PHE A 345
ILE A 341
 GLY  A 310 ( 0.0A)
GLN  A 316 ( 0.6A)
PRO  A 333 ( 1.1A)
PHE  A 345 ( 1.3A)
ILE  A 341 ( 0.3A)
 1.13A 4j4vA-3i4kA:
undetectable		 4j4vA-3i4kA:
21.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4J4V_A_SVRA301_1
(NUCLEOCAPSID PROTEIN)		 5hxk ZINC-DEPENDENT
PEPTIDASE
(Thermus
thermophilus) 		5 / 11 GLY A 188
ALA A 353
VAL A 186
PRO A  91
PHE A  89
 GLY  A 188 ( 0.0A)
ALA  A 353 ( 0.0A)
VAL  A 186 ( 0.6A)
PRO  A  91 ( 1.1A)
PHE  A  89 ( 1.3A)
 1.48A 4j4vA-5hxkA:
undetectable		 4j4vA-5hxkA:
22.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4J4V_B_SVRB301_1
(NUCLEOCAPSID PROTEIN)		 5hxk ZINC-DEPENDENT
PEPTIDASE
(Thermus
thermophilus) 		5 / 10 GLY A 188
ALA A 353
VAL A 186
PRO A  91
PHE A  89
 GLY  A 188 ( 0.0A)
ALA  A 353 ( 0.0A)
VAL  A 186 ( 0.6A)
PRO  A  91 ( 1.1A)
PHE  A  89 ( 1.3A)
 1.44A 4j4vB-5hxkA:
0.7		 4j4vB-5hxkA:
22.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4J4V_D_SVRD301_1
(NUCLEOCAPSID PROTEIN)		 3i4k MUCONATE LACTONIZING
ENZYME
(Corynebacterium
glutamicum) 		5 / 11 ALA A 119
GLN A 316
PRO A 333
PHE A 345
ILE A 341
 ALA  A 119 ( 0.0A)
GLN  A 316 ( 0.6A)
PRO  A 333 ( 1.1A)
PHE  A 345 ( 1.3A)
ILE  A 341 ( 0.3A)
 1.43A 4j4vD-3i4kA:
undetectable
4j4vE-3i4kA:
undetectable		 4j4vD-3i4kA:
21.29
4j4vE-3i4kA:
21.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4J4V_D_SVRD301_1
(NUCLEOCAPSID PROTEIN)		 3i4k MUCONATE LACTONIZING
ENZYME
(Corynebacterium
glutamicum) 		5 / 11 GLY A 310
GLN A 316
PRO A 333
PHE A 345
ILE A 341
 GLY  A 310 ( 0.0A)
GLN  A 316 ( 0.6A)
PRO  A 333 ( 1.1A)
PHE  A 345 ( 1.3A)
ILE  A 341 ( 0.3A)
 1.27A 4j4vD-3i4kA:
undetectable
4j4vE-3i4kA:
undetectable		 4j4vD-3i4kA:
21.29
4j4vE-3i4kA:
21.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4J4V_E_SVRE301_1
(NUCLEOCAPSID PROTEIN)		 5hxk ZINC-DEPENDENT
PEPTIDASE
(Thermus
thermophilus) 		5 / 10 GLY A 188
ALA A 353
VAL A 186
PRO A  91
PHE A  89
 GLY  A 188 ( 0.0A)
ALA  A 353 ( 0.0A)
VAL  A 186 ( 0.6A)
PRO  A  91 ( 1.1A)
PHE  A  89 ( 1.3A)
 1.47A 4j4vA-5hxkA:
undetectable
4j4vE-5hxkA:
0.0		 4j4vA-5hxkA:
22.25
4j4vE-5hxkA:
22.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K87_A_ADNA602_1
(PROLINE--TRNA LIGASE)		 3c3n DIHYDROOROTATE
DEHYDROGENASE
(Trypanosoma
cruzi) 		4 / 8 PHE A  13
GLN A 271
GLY A 249
THR A 193
 PHE  A  13 ( 1.3A)
GLN  A 271 ( 0.6A)
GLY  A 249 ( 0.0A)
THR  A 193 ( 0.8A)
 0.99A 4k87A-3c3nA:
undetectable		 4k87A-3c3nA:
21.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KCN_B_MTLB806_0
(NITRIC OXIDE
SYNTHASE, BRAIN)		 4g9k ROTENONE-INSENSITIVE
NADH-UBIQUINONE
OXIDOREDUCTASE
(Saccharomyces
cerevisiae) 		4 / 7 ASN A 406
GLN A 371
PHE A 369
ASN A 434
 ASN  A 406 ( 0.6A)
GLN  A 371 ( 0.6A)
PHE  A 369 ( 1.3A)
ASN  A 434 ( 0.6A)
 1.36A 4kcnB-4g9kA:
undetectable		 4kcnB-4g9kA:
20.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KEB_B_FOLB202_0
(DIHYDROFOLATE
REDUCTASE)		 5fii PHENYLALANINE-4-HYDR
OXYLASE
(Homo
sapiens) 		5 / 12 ILE A  94
LEU A  41
PHE A  55
ILE A  65
LEU A  62
 None
None
None
PHE  A 901 ( 4.3A)
PHE  A 901 (-3.6A)
 1.10A 4kebB-5fiiA:
undetectable		 4kebB-5fiiA:
21.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KF9_A_ACTA408_0
(GLUTATHIONE
S-TRANSFERASE
PROTEIN)		 3i4k MUCONATE LACTONIZING
ENZYME
(Corynebacterium
glutamicum) 		4 / 6 TYR A 340
THR A 339
PRO A 333
PHE A 345
 TYR  A 340 ( 1.3A)
THR  A 339 ( 0.8A)
PRO  A 333 ( 1.1A)
PHE  A 345 ( 1.3A)
 1.30A 4kf9A-3i4kA:
undetectable		 4kf9A-3i4kA:
25.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KKY_X_CAMX503_0
(CAMPHOR
5-MONOOXYGENASE)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		4 / 6 PHE C 251
LEU C 280
VAL C 289
ASP C 273
 PHE  C 251 ( 1.3A)
LEU  C 280 ( 0.5A)
VAL  C 289 ( 0.5A)
ASP  C 273 ( 0.6A)
 0.96A 4kkyX-5lmxC:
undetectable		 4kkyX-5lmxC:
22.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4KS8_A_B49A701_1
(SERINE/THREONINE-PRO
TEIN KINASE PAK 6)		 5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE
(Homo
sapiens) 		6 / 10 ALA A  52
MET A 105
PHE A 107
GLY A 111
LEU A 160
ASP A 171
 ALA  A  52 (-0.0A)
MET  A 105 (-0.0A)
PHE  A 107 ( 1.3A)
GLY  A 111 (-0.0A)
LEU  A 160 (-0.6A)
ASP  A 171 ( 0.5A)
 1.03A 4ks8A-5d7aA:
29.9		 4ks8A-5d7aA:
37.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KSZ_A_CYSA620_0
(LACTOPEROXIDASE)		 2j5b TYROSYL-TRNA
SYNTHETASE
(Acanthamoeba
polyphaga
mimivirus) 		3 / 3 ARG A  92
GLU A  96
PHE A 318
 ARG  A  92 ( 0.6A)
GLU  A  96 ( 0.6A)
PHE  A 318 ( 1.3A)
 0.96A 4kszA-2j5bA:
undetectable		 4kszA-2j5bA:
20.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KSZ_A_CYSA620_0
(LACTOPEROXIDASE)		 5l5n PLEXIN-A4
(Mus
musculus) 		3 / 3 ARG A  69
GLU A  45
PHE A  42
 ARG  A  69 ( 0.6A)
GLU  A  45 ( 0.5A)
PHE  A  42 ( 1.3A)
 0.78A 4kszA-5l5nA:
undetectable		 4kszA-5l5nA:
18.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KYK_B_IMNB300_1
(LACTOYLGLUTATHIONE
LYASE)		 5w6l RTX
REPEAT-CONTAINING
CYTOTOXIN
(Vibrio
vulnificus) 		5 / 12 ALA A4009
LEU A3932
PHE A3968
GLY A3899
LEU A3909
 ALA  A4009 ( 0.0A)
LEU  A3932 ( 0.6A)
PHE  A3968 ( 1.3A)
GLY  A3899 ( 0.0A)
LEU  A3909 ( 0.6A)
 1.12A 4kykA-5w6lA:
undetectable
4kykB-5w6lA:
undetectable		 4kykA-5w6lA:
19.13
4kykB-5w6lA:
19.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4L4C_A_CAMA502_0
(CAMPHOR
5-MONOOXYGENASE)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		4 / 6 PHE C 251
LEU C 280
VAL C 289
ASP C 273
 PHE  C 251 ( 1.3A)
LEU  C 280 ( 0.5A)
VAL  C 289 ( 0.5A)
ASP  C 273 ( 0.6A)
 1.04A 4l4cA-5lmxC:
undetectable		 4l4cA-5lmxC:
23.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4L4G_A_CAMA503_0
(CAMPHOR
5-MONOOXYGENASE)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		4 / 7 PHE C 251
LEU C 280
VAL C 289
ASP C 273
 PHE  C 251 ( 1.3A)
LEU  C 280 ( 0.5A)
VAL  C 289 ( 0.5A)
ASP  C 273 ( 0.6A)
 0.97A 4l4gA-5lmxC:
undetectable		 4l4gA-5lmxC:
23.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LAX_A_FK5A301_1
(PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP4)		 5wpi HSVA
(Erwinia
amylovora) 		5 / 10 TYR A 296
PHE A  58
VAL A  40
ILE A  38
LYS A  74
 TYR  A 296 ( 1.3A)
PHE  A  58 ( 1.3A)
VAL  A  40 ( 0.5A)
ILE  A  38 ( 0.7A)
LYS  A  74 ( 0.0A)
 1.20A 4laxA-5wpiA:
undetectable		 4laxA-5wpiA:
23.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LAX_A_FK5A301_1
(PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP4)		 5wpi HSVA
(Erwinia
amylovora) 		5 / 10 TYR A 296
PHE A  58
VAL A  40
ILE A  38
PHE A 345
 TYR  A 296 ( 1.3A)
PHE  A  58 ( 1.3A)
VAL  A  40 ( 0.5A)
ILE  A  38 ( 0.7A)
PHE  A 345 ( 1.3A)
 1.43A 4laxA-5wpiA:
undetectable		 4laxA-5wpiA:
23.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LMN_A_EUIA503_1
(DUAL SPECIFICITY
MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE 1)		 5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE
(Homo
sapiens) 		5 / 12 LEU A  73
ASN A 158
ASP A 171
PHE A 172
GLY A 173
 LEU  A  73 ( 0.6A)
ASN  A 158 ( 0.6A)
ASP  A 171 ( 0.5A)
PHE  A 172 ( 1.3A)
GLY  A 173 ( 0.0A)
 0.72A 4lmnA-5d7aA:
29.6		 4lmnA-5d7aA:
30.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LMN_A_EUIA503_1
(DUAL SPECIFICITY
MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE 1)		 5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE
(Homo
sapiens) 		5 / 12 MET A 105
ASN A 158
ASP A 171
PHE A 172
GLY A 173
 MET  A 105 (-0.0A)
ASN  A 158 ( 0.6A)
ASP  A 171 ( 0.5A)
PHE  A 172 ( 1.3A)
GLY  A 173 ( 0.0A)
 1.00A 4lmnA-5d7aA:
29.6		 4lmnA-5d7aA:
30.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LTW_A_486A303_1
(ANCESTRAL STEROID
RECEPTOR 2)		 1c8x ENDO-BETA-N-ACETYLGL
UCOSAMINIDASE H
(Streptomyces
plicatus) 		5 / 9 ALA A  37
LEU A 262
PHE A 258
THR A 243
LEU A 246
 ALA  A  37 ( 0.0A)
LEU  A 262 ( 0.6A)
PHE  A 258 ( 1.3A)
THR  A 243 ( 0.8A)
LEU  A 246 ( 0.6A)
 1.34A 4ltwA-1c8xA:
undetectable		 4ltwA-1c8xA:
22.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LUF_A_ACTA605_0
(SERUM ALBUMIN)		 5hxk ZINC-DEPENDENT
PEPTIDASE
(Thermus
thermophilus) 		4 / 4 ALA A 251
HIS A 387
PHE A 383
LEU A 318
 ALA  A 251 ( 0.0A)
HIS  A 387 ( 1.0A)
PHE  A 383 ( 1.3A)
LEU  A 318 ( 0.6A)
 1.34A 4lufA-5hxkA:
0.0		 4lufA-5hxkA:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LUH_A_ACTA609_0
(SERUM ALBUMIN)		 5hxk ZINC-DEPENDENT
PEPTIDASE
(Thermus
thermophilus) 		4 / 4 ALA A 251
HIS A 387
PHE A 383
LEU A 318
 ALA  A 251 ( 0.0A)
HIS  A 387 ( 1.0A)
PHE  A 383 ( 1.3A)
LEU  A 318 ( 0.6A)
 1.36A 4luhA-5hxkA:
0.4		 4luhA-5hxkA:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4M11_C_MXMC606_2
(PROSTAGLANDIN G/H
SYNTHASE 2)		 2nvv ACETYL-COA
HYDROLASE/TRANSFERAS
E FAMILY PROTEIN
(Porphyromonas
gingivalis) 		3 / 3 LEU A 173
ARG A 331
MET A 281
 LEU  A 173 ( 0.6A)
ARG  A 331 ( 0.6A)
PHE  A 279 ( 3.6A)
 0.95A 4m11C-2nvvA:
undetectable		 4m11C-2nvvA:
21.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4M93_B_ACTB303_0
(S25-26 FAB (IGG1K)
HEAVY CHAIN
S25-26 FAB (IGG1K)
LIGHT CHAIN)		 3r64 NAD DEPENDENT
BENZALDEHYDE
DEHYDROGENASE
(Corynebacterium
glutamicum) 		4 / 5 SER A 233
ALA A 258
PHE A 234
GLU A 260
 SER  A 233 ( 0.0A)
ALA  A 258 ( 0.0A)
PHE  A 234 ( 1.3A)
GLU  A 260 ( 0.6A)
 1.04A 4m93B-3r64A:
undetectable
4m93C-3r64A:
undetectable		 4m93B-3r64A:
16.27
4m93C-3r64A:
19.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MMC_A_29JA604_1
(TRANSPORTER)		 5c05 PUTATIVE
GAMMA-TERPINENE
SYNTHASE
(Thymus
vulgaris) 		4 / 7 ILE A  92
PHE A 124
LEU A 276
ASP A 280
 ILE  A  92 ( 0.6A)
PHE  A 124 ( 1.3A)
LEU  A 276 ( 0.6A)
ASP  A 280 ( 0.5A)
 0.82A 4mmcA-5c05A:
undetectable		 4mmcA-5c05A:
22.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MUB_A_OAQA302_0
(SULFOTRANSFERASE)		 5xlu GAMMA GLUTAMYL
TRANSPEPTIDASE
(Bacillus
licheniformis) 		5 / 12 PRO A 338
VAL A 343
GLY A 373
ASP A 330
PHE A 293
 PRO  A 338 ( 1.1A)
VAL  A 343 ( 0.5A)
GLY  A 373 ( 0.0A)
ASP  A 330 ( 0.5A)
PHE  A 293 ( 1.3A)
 1.45A 4mubA-5xluA:
undetectable		 4mubA-5xluA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NX6_A_FOLA201_0
(DIHYDROFOLATE
REDUCTASE)		 3eqz RESPONSE REGULATOR
(Colwellia
psychrerythraea) 		5 / 12 LEU A 114
PHE A 117
ILE A  48
LEU A 121
ILE A 102
 LEU  A 114 ( 0.6A)
PHE  A 117 ( 1.3A)
ILE  A  48 ( 0.7A)
LEU  A 121 ( 0.6A)
ILE  A 102 ( 0.7A)
 0.88A 4nx6A-3eqzA:
undetectable		 4nx6A-3eqzA:
17.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NX7_A_FOLA202_0
(DIHYDROFOLATE
REDUCTASE)		 3eqz RESPONSE REGULATOR
(Colwellia
psychrerythraea) 		5 / 12 LEU A 114
PHE A 117
ILE A  48
LEU A 121
ILE A 102
 LEU  A 114 ( 0.6A)
PHE  A 117 ( 1.3A)
ILE  A  48 ( 0.7A)
LEU  A 121 ( 0.6A)
ILE  A 102 ( 0.7A)
 0.86A 4nx7A-3eqzA:
undetectable		 4nx7A-3eqzA:
17.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4O1Z_B_MXMB807_1
(PROSTAGLANDIN G/H
SYNTHASE 1)		 3ghg FIBRINOGEN GAMMA
CHAIN
(Homo
sapiens) 		6 / 12 MET C 384
VAL C 248
LEU C 246
LEU C 344
PHE C 295
ALA C 289
 MET  C 384 ( 0.0A)
VAL  C 248 ( 0.6A)
LEU  C 246 ( 0.6A)
LEU  C 344 ( 0.6A)
PHE  C 295 ( 1.3A)
ALA  C 289 ( 0.0A)
 1.50A 4o1zB-3ghgC:
undetectable		 4o1zB-3ghgC:
21.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4O7G_A_ASCA303_0
(PROBABLE
TRANSMEMBRANE
ASCORBATE
FERRIREDUCTASE 2)		 3pu5 EXTRACELLULAR
SOLUTE-BINDING
PROTEIN
(Bordetella
parapertussis) 		4 / 7 PHE A 159
ILE A 142
PHE A 173
ASN A 175
 PHE  A 159 ( 1.3A)
ILE  A 142 ( 0.6A)
PHE  A 173 ( 1.3A)
ASN  A 175 ( 0.6A)
 1.27A 4o7gA-3pu5A:
undetectable
4o7gB-3pu5A:
undetectable		 4o7gA-3pu5A:
21.96
4o7gB-3pu5A:
21.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4O7G_B_ASCB304_0
(PROBABLE
TRANSMEMBRANE
ASCORBATE
FERRIREDUCTASE 2)		 4hne PHOSPHATIDYLINOSITOL
4-KINASE TYPE
2-ALPHA
(Homo
sapiens) 		4 / 6 PHE A 221
ILE A 121
PHE A 260
ASN A 102
 PHE  A 221 ( 1.3A)
ILE  A 121 ( 0.7A)
PHE  A 260 ( 1.3A)
ASN  A 102 ( 0.6A)
 1.47A 4o7gB-4hneA:
undetectable		 4o7gB-4hneA:
18.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4O8F_A_BRLA501_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)		 3td9 BRANCHED CHAIN AMINO
ACID ABC
TRANSPORTER,
PERIPLASMIC AMINO
ACID-BINDING PROTEIN
(Thermotoga
maritima) 		4 / 5 GLY A 216
ILE A 224
LEU A 259
LEU A 293
 None
None
None
PHE  A 400 (-4.1A)
 0.79A 4o8fA-3td9A:
undetectable		 4o8fA-3td9A:
22.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4O8Z_A_BBIA402_1
(NAD-DEPENDENT
PROTEIN DEACETYLASE
SIRTUIN-3,
MITOCHONDRIAL)		 3o96 RAC-ALPHA
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		4 / 5 PHE A 408
PHE A 407
LEU A 384
PRO A 348
 PHE  A 408 ( 1.3A)
PHE  A 407 ( 1.3A)
LEU  A 384 ( 0.6A)
PRO  A 348 ( 1.1A)
 1.23A 4o8zA-3o96A:
undetectable		 4o8zA-3o96A:
21.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OBW_B_SAMB601_0
(2-METHOXY-6-POLYPREN
YL-1,4-BENZOQUINOL
METHYLASE,
MITOCHONDRIAL)		 1c1d L-PHENYLALANINE
DEHYDROGENASE
(Rhodococcus
sp.) 		5 / 12 ASN A 262
ALA A  38
GLY A  76
GLY A  77
PHE A 137
 PHE  A 361 ( 3.1A)
PHE  A 361 ( 4.2A)
None
None
None
 1.03A 4obwB-1c1dA:
6.0		 4obwB-1c1dA:
19.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OLB_A_TRPA901_0
(PROTEIN ARGONAUTE-2)		 3ulk KETOL-ACID
REDUCTOISOMERASE
(Escherichia
coli) 		3 / 3 VAL A 205
ALA A 203
PHE A  22
 VAL  A 205 ( 0.6A)
ALA  A 203 ( 0.0A)
PHE  A  22 ( 1.3A)
 0.84A 4olbA-3ulkA:
undetectable		 4olbA-3ulkA:
19.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4P3R_A_FOLA201_0
(DIHYDROFOLATE
REDUCTASE)		 3eqz RESPONSE REGULATOR
(Colwellia
psychrerythraea) 		5 / 12 LEU A 114
PHE A 117
ILE A  48
LEU A 121
ILE A 102
 LEU  A 114 ( 0.6A)
PHE  A 117 ( 1.3A)
ILE  A  48 ( 0.7A)
LEU  A 121 ( 0.6A)
ILE  A 102 ( 0.7A)
 0.84A 4p3rA-3eqzA:
undetectable		 4p3rA-3eqzA:
17.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4P6X_I_HCYI900_1
(GLUCOCORTICOID
RECEPTOR)		 4zke SUPERKILLER PROTEIN
7
(Saccharomyces
cerevisiae) 		5 / 12 LEU A 676
ASN A 683
LEU A 373
ILE A 710
PHE A 715
 LEU  A 676 ( 0.6A)
ASN  A 683 ( 0.6A)
LEU  A 373 ( 0.6A)
ILE  A 710 ( 0.7A)
PHE  A 715 ( 1.3A)
 1.47A 4p6xI-4zkeA:
undetectable		 4p6xI-4zkeA:
21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4PBH_A_BEZA401_0
(TRAP DICARBOXYLATE
TRANSPORTER, DCTP
SUBUNIT, PUTATIVE)		 2ogs THERMOSTABLE
CARBOXYLESTERASE
EST50
(Geobacillus
stearothermophil
us) 		5 / 12 ILE A 240
THR A 237
ALA A 159
LEU A 241
PHE A  39
 ILE  A 240 ( 0.7A)
THR  A 237 ( 0.8A)
ALA  A 159 ( 0.0A)
LEU  A 241 ( 0.6A)
PHE  A  39 ( 1.3A)
 0.85A 4pbhA-2ogsA:
undetectable		 4pbhA-2ogsA:
22.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4PEV_B_ADNB501_1
(MEMBRANE LIPOPROTEIN
FAMILY PROTEIN)		 3pu5 EXTRACELLULAR
SOLUTE-BINDING
PROTEIN
(Bordetella
parapertussis) 		5 / 12 VAL A 140
GLY A 242
PHE A  44
GLY A 268
ASP A 136
 VAL  A 140 ( 0.6A)
GLY  A 242 ( 0.0A)
PHE  A  44 ( 1.3A)
GLY  A 268 ( 0.0A)
ASP  A 136 ( 0.6A)
 1.19A 4pevB-3pu5A:
3.1		 4pevB-3pu5A:
23.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4PQA_A_X8ZA401_1
(SUCCINYL-DIAMINOPIME
LATE DESUCCINYLASE)		 1f2p AMINOPEPTIDASE
(Streptomyces
griseus) 		5 / 11 HIS A  85
ASP A  97
GLU A 131
GLU A 132
HIS A 247
 ZN  A 901 ( 3.3A)
ZN  A 902 (-2.5A)
PHE  A 903 (-2.8A)
ZN  A 902 ( 2.2A)
ZN  A 902 ( 3.3A)
 0.38A 4pqaA-1f2pA:
22.8		 4pqaA-1f2pA:
22.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4PSS_A_FOLA201_0
(DIHYDROFOLATE
REDUCTASE)		 3eqz RESPONSE REGULATOR
(Colwellia
psychrerythraea) 		5 / 12 LEU A 114
PHE A 117
ILE A  48
LEU A 121
ILE A 102
 LEU  A 114 ( 0.6A)
PHE  A 117 ( 1.3A)
ILE  A  48 ( 0.7A)
LEU  A 121 ( 0.6A)
ILE  A 102 ( 0.7A)
 0.89A 4pssA-3eqzA:
undetectable		 4pssA-3eqzA:
17.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4PST_A_FOLA201_0
(DIHYDROFOLATE
REDUCTASE)		 3eqz RESPONSE REGULATOR
(Colwellia
psychrerythraea) 		5 / 12 LEU A 114
PHE A 117
ILE A  48
LEU A 121
ILE A 102
 LEU  A 114 ( 0.6A)
PHE  A 117 ( 1.3A)
ILE  A  48 ( 0.7A)
LEU  A 121 ( 0.6A)
ILE  A 102 ( 0.7A)
 0.96A 4pstA-3eqzA:
undetectable		 4pstA-3eqzA:
17.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QB9_D_PARD500_1
(ENHANCED
INTRACELLULAR
SURVIVAL PROTEIN)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 8 PHE A 283
THR A 319
GLU A 143
ASP A 141
 PHE  A 283 ( 1.3A)
THR  A 319 ( 0.8A)
GLU  A 143 (-0.6A)
ASP  A 141 (-0.5A)
 0.94A 4qb9D-4flxA:
undetectable		 4qb9D-4flxA:
21.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QB9_F_PARF500_1
(ENHANCED
INTRACELLULAR
SURVIVAL PROTEIN)		 5lmx DNA-DIRECTED RNA
POLYMERASE I SUBUNIT
RPA49
(Saccharomyces
cerevisiae) 		5 / 11 PHE M  30
GLU M  50
ASP M  39
TYR M  65
GLY M  64
 PHE  M  30 ( 1.3A)
GLU  M  50 ( 0.6A)
ASP  M  39 ( 0.5A)
TYR  M  65 ( 1.3A)
GLY  M  64 ( 0.0A)
 1.31A 4qb9F-5lmxM:
undetectable		 4qb9F-5lmxM:
20.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOG_B_ML1B302_1
(RIBOSYLDIHYDRONICOTI
NAMIDE DEHYDROGENASE
[QUINONE])		 5nqf APICAL MEMBRANE
ANTIGEN 1
RHOPTRY NECK PROTEIN
2
(Plasmodium
falciparum;
Plasmodium
vivax) 		4 / 6 GLY B2044
PHE A 276
ILE A 252
PHE A 274
 GLY  B2044 ( 0.0A)
PHE  A 276 ( 1.3A)
ILE  A 252 ( 0.7A)
PHE  A 274 ( 1.3A)
 1.05A 4qogA-5nqfB:
undetectable
4qogB-5nqfB:
undetectable		 4qogA-5nqfB:
10.67
4qogB-5nqfB:
10.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOI_B_ML1B303_1
(RIBOSYLDIHYDRONICOTI
NAMIDE DEHYDROGENASE
[QUINONE])		 1ng0 COAT PROTEIN
(Cocksfoot
mottle
virus) 		5 / 11 GLY A 161
GLY A 162
GLY A 127
PHE A  76
ILE A 129
 GLY  A 161 ( 0.0A)
GLY  A 162 ( 0.0A)
GLY  A 127 ( 0.0A)
PHE  A  76 ( 1.3A)
ILE  A 129 ( 0.7A)
 1.16A 4qoiA-1ng0A:
undetectable
4qoiB-1ng0A:
undetectable		 4qoiA-1ng0A:
20.99
4qoiB-1ng0A:
20.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOI_B_ML1B303_1
(RIBOSYLDIHYDRONICOTI
NAMIDE DEHYDROGENASE
[QUINONE])		 3wd7 TYPE III POLYKETIDE
SYNTHASES ACRIDONE
SYNTHASE
(Citrus
x
microcarpa) 		5 / 11 GLY A 305
GLY A 306
GLY A 163
ILE A 254
PHE A 275
 GLY  A 305 (-0.0A)
GLY  A 306 (-0.0A)
GLY  A 163 ( 0.0A)
ILE  A 254 ( 0.7A)
PHE  A 275 ( 1.3A)
 1.09A 4qoiA-3wd7A:
undetectable
4qoiB-3wd7A:
undetectable		 4qoiA-3wd7A:
22.31
4qoiB-3wd7A:
22.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_A_HQEA503_1
(CATALASE)		 2vbf BRANCHED-CHAIN
ALPHA-KETOACID
DECARBOXYLASE
(Lactococcus
lactis) 		5 / 9 ILE A 453
PHE A 408
LEU A 432
LEU A 439
PHE A 487
 ILE  A 453 ( 0.4A)
PHE  A 408 ( 1.3A)
LEU  A 432 ( 0.5A)
LEU  A 439 ( 0.5A)
PHE  A 487 ( 1.3A)
 1.06A 4qopA-2vbfA:
undetectable		 4qopA-2vbfA:
22.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_B_HQEB503_1
(CATALASE)		 2vbf BRANCHED-CHAIN
ALPHA-KETOACID
DECARBOXYLASE
(Lactococcus
lactis) 		5 / 9 ILE A 453
PHE A 408
LEU A 432
LEU A 439
PHE A 487
 ILE  A 453 ( 0.4A)
PHE  A 408 ( 1.3A)
LEU  A 432 ( 0.5A)
LEU  A 439 ( 0.5A)
PHE  A 487 ( 1.3A)
 1.08A 4qopB-2vbfA:
undetectable		 4qopB-2vbfA:
22.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 8 ILE A 567
PHE A 406
LEU A 577
LEU A 544
 ILE  A 567 ( 0.4A)
PHE  A 406 ( 1.3A)
LEU  A 577 ( 0.5A)
LEU  A 544 ( 0.6A)
 0.90A 4qopC-4flxA:
undetectable		 4qopC-4flxA:
21.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QT2_A_RAPA202_1
(FK506-BINDING
PROTEIN (FKBP)-TYPE
PEPTIDYL-PROPYL
ISOMERASE)		 5wpi HSVA
(Erwinia
amylovora) 		5 / 10 TYR A 296
PHE A  58
VAL A  40
ILE A  38
PHE A 345
 TYR  A 296 ( 1.3A)
PHE  A  58 ( 1.3A)
VAL  A  40 ( 0.5A)
ILE  A  38 ( 0.7A)
PHE  A 345 ( 1.3A)
 1.37A 4qt2A-5wpiA:
undetectable		 4qt2A-5wpiA:
17.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QT3_A_RAPA202_1
(FK506-BINDING
PROTEIN (FKBP)-TYPE
PEPTIDYL-PROPYL
ISOMERASE)		 5wpi HSVA
(Erwinia
amylovora) 		5 / 10 TYR A 296
PHE A  58
VAL A  40
ILE A  38
PHE A 345
 TYR  A 296 ( 1.3A)
PHE  A  58 ( 1.3A)
VAL  A  40 ( 0.5A)
ILE  A  38 ( 0.7A)
PHE  A 345 ( 1.3A)
 1.35A 4qt3A-5wpiA:
undetectable		 4qt3A-5wpiA:
19.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QTU_B_SAMB301_1
(PUTATIVE
METHYLTRANSFERASE
BUD23)		 3td9 BRANCHED CHAIN AMINO
ACID ABC
TRANSPORTER,
PERIPLASMIC AMINO
ACID-BINDING PROTEIN
(Thermotoga
maritima) 		4 / 5 TYR A 217
GLN A 164
ASP A 136
ASP A 343
 PHE  A 400 (-4.8A)
None
None
None
 1.08A 4qtuB-3td9A:
3.1		 4qtuB-3td9A:
20.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R1Z_A_AERA601_1
(CYP17A1 PROTEIN)		 3td9 BRANCHED CHAIN AMINO
ACID ABC
TRANSPORTER,
PERIPLASMIC AMINO
ACID-BINDING PROTEIN
(Thermotoga
maritima) 		5 / 9 ALA A 292
ASP A 244
GLY A 242
THR A 118
VAL A  93
 EDO  A 403 (-3.5A)
EDO  A 403 ( 2.8A)
PHE  A 400 ( 4.2A)
PHE  A 400 (-2.8A)
PHE  A 400 (-4.7A)
 1.12A 4r1zA-3td9A:
undetectable		 4r1zA-3td9A:
22.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R38_C_RBFC201_2
(BLUE-LIGHT-ACTIVATED
HISTIDINE KINASE 2)		 3rab PROTEIN (RAB3A)
(Rattus
norvegicus) 		5 / 9 ILE A  71
LEU A  39
LEU A 179
ILE A  99
PHE A  23
 ILE  A  71 ( 0.7A)
LEU  A  39 ( 0.6A)
LEU  A 179 ( 0.6A)
ILE  A  99 ( 0.7A)
PHE  A  23 ( 1.3A)
 0.94A 4r38C-3rabA:
undetectable		 4r38C-3rabA:
25.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R82_A_ACTA205_0
(OXIDOREDUCTASE)		 1ryn PROTEIN CRS2
(Zea
mays) 		4 / 5 GLY A 138
ARG A  21
GLU A 158
PHE A 154
 GLY  A 138 ( 0.0A)
ARG  A  21 ( 0.6A)
GLU  A 158 ( 0.6A)
PHE  A 154 ( 1.3A)
 1.02A 4r82A-1rynA:
undetectable
4r82B-1rynA:
undetectable		 4r82A-1rynA:
24.19
4r82B-1rynA:
24.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RET_A_DGXA1107_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		 1c8x ENDO-BETA-N-ACETYLGL
UCOSAMINIDASE H
(Streptomyces
plicatus) 		5 / 12 ASP A 128
LEU A 167
PHE A 111
ALA A 173
LEU A  91
 ASP  A 128 ( 0.5A)
LEU  A 167 ( 0.5A)
PHE  A 111 ( 1.3A)
ALA  A 173 ( 0.0A)
LEU  A  91 ( 0.6A)
 1.19A 4retA-1c8xA:
undetectable		 4retA-1c8xA:
13.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RJD_A_TFPA203_1
(CALMODULIN)		 4gow CALMODULIN
(Homo
sapiens) 		4 / 8 PHE D  19
ILE D  27
LEU D  32
MET D  51
 PHE  D  19 ( 1.3A)
ILE  D  27 ( 0.7A)
LEU  D  32 ( 0.6A)
MET  D  51 ( 0.0A)
 0.56A 4rjdA-4gowD:
12.6		 4rjdA-4gowD:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RJD_A_TFPA203_1
(CALMODULIN)		 4gow CALMODULIN
(Homo
sapiens) 		7 / 8 PHE D  92
ILE D 100
LEU D 105
MET D 109
MET D 124
ALA D 128
VAL D 136
 PHE  D  92 ( 1.3A)
ILE  D 100 ( 0.7A)
LEU  D 105 ( 0.6A)
MET  D 109 ( 0.0A)
MET  D 124 ( 0.0A)
ALA  D 128 ( 0.0A)
VAL  D 136 ( 0.6A)
 0.65A 4rjdA-4gowD:
12.6		 4rjdA-4gowD:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RJD_B_TFPB203_1
(CALMODULIN)		 4gow CALMODULIN
(Homo
sapiens) 		5 / 7 PHE D  19
LEU D  32
MET D  36
MET D  71
MET D  72
 PHE  D  19 ( 1.3A)
LEU  D  32 ( 0.6A)
MET  D  36 ( 0.0A)
MET  D  71 ( 0.0A)
MET  D  72 ( 0.0A)
 1.16A 4rjdB-4gowD:
12.6		 4rjdB-4gowD:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RJD_B_TFPB203_1
(CALMODULIN)		 4gow CALMODULIN
(Homo
sapiens) 		5 / 7 PHE D  19
LEU D  32
MET D  51
MET D  71
MET D  72
 PHE  D  19 ( 1.3A)
LEU  D  32 ( 0.6A)
MET  D  51 ( 0.0A)
MET  D  71 ( 0.0A)
MET  D  72 ( 0.0A)
 0.67A 4rjdB-4gowD:
12.6		 4rjdB-4gowD:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RJD_B_TFPB203_1
(CALMODULIN)		 4gow CALMODULIN
(Homo
sapiens) 		7 / 7 PHE D  92
LEU D 105
MET D 109
MET D 124
ALA D 128
MET D 144
MET D 145
 PHE  D  92 ( 1.3A)
LEU  D 105 ( 0.6A)
MET  D 109 ( 0.0A)
MET  D 124 ( 0.0A)
ALA  D 128 ( 0.0A)
MET  D 144 ( 0.0A)
MET  D 145 ( 0.0A)
 0.93A 4rjdB-4gowD:
12.6		 4rjdB-4gowD:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RKU_A_PQNA5001_1
(PHOTOSYSTEM I P700
CHLOROPHYLL A
APOPROTEIN A1
PHOTOSYSTEM I
REACTION CENTER
SUBUNIT IX)		 1c8x ENDO-BETA-N-ACETYLGL
UCOSAMINIDASE H
(Streptomyces
plicatus) 		4 / 8 PHE A 102
SER A 104
ALA A 155
LEU A 152
 PHE  A 102 ( 1.3A)
SER  A 104 ( 0.0A)
ALA  A 155 ( 0.0A)
LEU  A 152 ( 0.6A)
 1.02A 4rkuA-1c8xA:
undetectable
4rkuJ-1c8xA:
0.0		 4rkuA-1c8xA:
16.15
4rkuJ-1c8xA:
13.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RMJ_A_NCAA402_0
(NAD-DEPENDENT
PROTEIN DEACETYLASE
SIRTUIN-2)		 1amu GRAMICIDIN
SYNTHETASE 1
(Brevibacillus
brevis) 		4 / 7 ILE A 352
PHE A 214
LEU A 218
ILE A 330
 None
None
None
PHE  A 566 (-4.6A)
 0.63A 4rmjA-1amuA:
undetectable		 4rmjA-1amuA:
20.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RTR_A_SAMA301_0
(DNA ADENINE
METHYLASE)		 3gnr OS03G0212800 PROTEIN
(Oryza
sativa) 		5 / 11 GLY A 396
PHE A 442
ILE A 174
ASN A 177
TYR A 127
 GLY  A 396 ( 0.0A)
PHE  A 442 ( 1.3A)
ILE  A 174 ( 0.6A)
ASN  A 177 (-0.6A)
TYR  A 127 ( 1.3A)
 1.22A 4rtrA-3gnrA:
undetectable		 4rtrA-3gnrA:
19.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RVD_A_SAMA502_0
(D-MYCAROSE
3-C-METHYLTRANSFERAS
E)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		5 / 12 ILE A  44
GLY A   4
ALA A 182
PHE A  66
HIS A  41
 ILE  A  44 ( 0.5A)
GLY  A   4 ( 0.0A)
ALA  A 182 ( 0.0A)
PHE  A  66 ( 1.3A)
HIS  A  41 ( 1.0A)
 0.95A 4rvdA-4g41A:
undetectable		 4rvdA-4g41A:
22.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RZV_A_032A801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 3ulk KETOL-ACID
REDUCTOISOMERASE
(Escherichia
coli) 		6 / 12 LEU A 423
SER A 314
SER A 313
PHE A 312
GLY A 420
GLY A 227
 LEU  A 423 ( 0.6A)
SER  A 314 ( 0.0A)
SER  A 313 ( 0.0A)
PHE  A 312 ( 1.3A)
GLY  A 420 ( 0.0A)
GLY  A 227 ( 0.0A)
 1.41A 4rzvA-3ulkA:
undetectable		 4rzvA-3ulkA:
20.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RZV_B_032B801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE
(Homo
sapiens) 		5 / 12 VAL A  39
ALA A  52
LYS A  54
SER A 112
PHE A 172
 VAL  A  39 (-0.6A)
ALA  A  52 (-0.0A)
LYS  A  54 ( 0.0A)
SER  A 112 (-0.0A)
PHE  A 172 ( 1.3A)
 0.65A 4rzvB-5d7aA:
25.4		 4rzvB-5d7aA:
31.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4TWD_A_377A402_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 3td9 BRANCHED CHAIN AMINO
ACID ABC
TRANSPORTER,
PERIPLASMIC AMINO
ACID-BINDING PROTEIN
(Thermotoga
maritima) 		5 / 9 ALA A 100
ALA A  96
ALA A  94
SER A 117
ALA A  73
 None
None
PHE  A 400 (-4.3A)
PHE  A 400 (-4.2A)
None
 1.14A 4twdA-3td9A:
undetectable
4twdB-3td9A:
undetectable
4twdC-3td9A:
undetectable
4twdD-3td9A:
undetectable
4twdE-3td9A:
undetectable		 4twdA-3td9A:
20.11
4twdB-3td9A:
20.11
4twdC-3td9A:
20.11
4twdD-3td9A:
20.11
4twdE-3td9A:
20.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4U15_A_0HKA2001_2
(MUSCARINIC
ACETYLCHOLINE
RECEPTOR
M3,LYSOZYME,MUSCARIN
IC ACETYLCHOLINE
RECEPTOR M3)		 2b92 INTERFERON-INDUCED
GUANYLATE-BINDING
PROTEIN 1
(Homo
sapiens) 		3 / 3 ASN A 111
PHE A 116
TYR A 144
 ASN  A 111 ( 0.6A)
PHE  A 116 ( 1.3A)
TYR  A 144 ( 1.3A)
 0.58A 4u15A-2b92A:
undetectable		 4u15A-2b92A:
21.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4U15_A_0HKA2001_2
(MUSCARINIC
ACETYLCHOLINE
RECEPTOR
M3,LYSOZYME,MUSCARIN
IC ACETYLCHOLINE
RECEPTOR M3)		 3gnr OS03G0212800 PROTEIN
(Oryza
sativa) 		3 / 3 ASN A 177
PHE A 442
TYR A  87
 ASN  A 177 (-0.6A)
PHE  A 442 ( 1.3A)
TYR  A  87 ( 1.3A)
 0.68A 4u15A-3gnrA:
undetectable		 4u15A-3gnrA:
21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UCI_B_ADNB2415_1
(RNA-DIRECTED RNA
POLYMERASE L)		 1txu RAB5 GDP/GTP
EXCHANGE FACTOR
(Homo
sapiens) 		4 / 7 PHE A 145
PHE A 142
LYS A 213
TYR A 214
 PHE  A 145 ( 1.3A)
PHE  A 142 ( 1.3A)
LYS  A 213 ( 0.0A)
TYR  A 214 ( 1.3A)
 1.42A 4uciB-1txuA:
0.0		 4uciB-1txuA:
20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UCI_B_ADNB2415_1
(RNA-DIRECTED RNA
POLYMERASE L)		 5hfi UNCHARACTERIZED
PROTEIN, CYTOSOLIC
DISULFIDE REDUCTASE
DSBM
(Pseudomonas
aeruginosa) 		4 / 7 PHE A  79
PHE A  74
TYR A  18
HIS A 120
 PHE  A  79 ( 1.3A)
PHE  A  74 ( 1.3A)
TYR  A  18 ( 1.3A)
HIS  A 120 ( 1.0A)
 1.12A 4uciB-5hfiA:
undetectable		 4uciB-5hfiA:
20.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4UIL_H_QI9H1223_0
(FAB 314.1)		 1fgv H52 FV (HEAVY CHAIN)
H52 FV (LIGHT CHAIN)
(Homo
sapiens;
Homo
sapiens) 		8 / 12 HIS H  35
GLY H 101
PHE H 111
GLN L  89
GLN L  90
GLY L  91
LEU L  94
PRO L  96
 HIS  H  35 ( 1.0A)
GLY  H 101 ( 0.0A)
PHE  H 111 ( 1.3A)
GLN  L  89 ( 0.6A)
GLN  L  90 ( 0.6A)
GLY  L  91 ( 0.0A)
LEU  L  94 ( 0.6A)
PRO  L  96 ( 1.1A)
 0.85A 4uilH-1fgvH:
20.2
4uilL-1fgvH:
5.2		 4uilH-1fgvH:
53.23
4uilL-1fgvH:
19.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4UIL_H_QI9H1223_0
(FAB 314.1)		 1fgv H52 FV (HEAVY CHAIN)
H52 FV (LIGHT CHAIN)
(Homo
sapiens;
Homo
sapiens) 		8 / 12 HIS H  35
SER H  59
PHE H 111
GLN L  89
GLN L  90
GLY L  91
LEU L  94
PRO L  96
 HIS  H  35 ( 1.0A)
SER  H  59 ( 0.0A)
PHE  H 111 ( 1.3A)
GLN  L  89 ( 0.6A)
GLN  L  90 ( 0.6A)
GLY  L  91 ( 0.0A)
LEU  L  94 ( 0.6A)
PRO  L  96 ( 1.1A)
 1.00A 4uilH-1fgvH:
20.2
4uilL-1fgvH:
5.2		 4uilH-1fgvH:
53.23
4uilL-1fgvH:
19.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4UIL_H_QI9H1223_0
(FAB 314.1)		 5gru DIABODY PROTEIN
DIABODY PROTEIN
(Homo
sapiens;
Mus
musculus) 		5 / 12 PHE L 103
GLN H 223
GLN H 224
GLY H 225
LEU H 228
 PHE  L 103 ( 1.3A)
GLN  H 223 ( 0.6A)
GLN  H 224 ( 0.6A)
GLY  H 225 ( 0.0A)
LEU  H 228 ( 0.6A)
 0.62A 4uilH-5gruL:
18.6
4uilL-5gruL:
19.3		 4uilH-5gruL:
35.54
4uilL-5gruL:
66.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4UIN_H_QI9H1226_0
(FAB 314.3)		 1fgv H52 FV (HEAVY CHAIN)
H52 FV (LIGHT CHAIN)
(Homo
sapiens;
Homo
sapiens) 		6 / 12 HIS H  35
GLY H 101
PHE H 111
GLY L  91
LEU L  94
PRO L  96
 HIS  H  35 ( 1.0A)
GLY  H 101 ( 0.0A)
PHE  H 111 ( 1.3A)
GLY  L  91 ( 0.0A)
LEU  L  94 ( 0.6A)
PRO  L  96 ( 1.1A)
 0.84A 4uinH-1fgvH:
21.2
4uinL-1fgvH:
13.6		 4uinH-1fgvH:
52.42
4uinL-1fgvH:
20.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4UIN_H_QI9H1226_0
(FAB 314.3)		 1fgv H52 FV (HEAVY CHAIN)
H52 FV (LIGHT CHAIN)
(Homo
sapiens;
Homo
sapiens) 		6 / 12 HIS H  35
TRP H  47
PHE H 111
GLY L  91
LEU L  94
PRO L  96
 HIS  H  35 ( 1.0A)
TRP  H  47 ( 0.4A)
PHE  H 111 ( 1.3A)
GLY  L  91 ( 0.0A)
LEU  L  94 ( 0.6A)
PRO  L  96 ( 1.1A)
 0.73A 4uinH-1fgvH:
21.2
4uinL-1fgvH:
13.6		 4uinH-1fgvH:
52.42
4uinL-1fgvH:
20.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4UIN_H_QI9H1226_0
(FAB 314.3)		 1fgv H52 FV (HEAVY CHAIN)
H52 FV (LIGHT CHAIN)
(Homo
sapiens;
Homo
sapiens) 		6 / 12 TRP H  47
SER H  59
PHE H 111
GLY L  91
LEU L  94
PRO L  96
 TRP  H  47 ( 0.4A)
SER  H  59 ( 0.0A)
PHE  H 111 ( 1.3A)
GLY  L  91 ( 0.0A)
LEU  L  94 ( 0.6A)
PRO  L  96 ( 1.1A)
 0.91A 4uinH-1fgvH:
21.2
4uinL-1fgvH:
13.6		 4uinH-1fgvH:
52.42
4uinL-1fgvH:
20.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UPN_A_H4BA760_1
(NEURONAL NITRIC
OXIDE SYNTHASE)		 3r6y ASPARTASE
(Bacillus
sp.
YM55-1) 		4 / 7 MET A 298
VAL A 310
PHE A 178
GLU A 308
 MET  A 298 ( 0.0A)
VAL  A 310 ( 0.6A)
PHE  A 178 ( 1.3A)
GLU  A 308 ( 0.6A)
 1.39A 4upnA-3r6yA:
undetectable
4upnB-3r6yA:
1.3		 4upnA-3r6yA:
22.39
4upnB-3r6yA:
22.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V1F_A_BQ1A1087_0
(F0F1 ATP SYNTHASE
SUBUNIT C)		 5c05 PUTATIVE
GAMMA-TERPINENE
SYNTHASE
(Thymus
vulgaris) 		3 / 3 GLU A 255
ALA A 256
PHE A 259
 GLU  A 255 ( 0.5A)
ALA  A 256 ( 0.0A)
PHE  A 259 (-1.3A)
 0.54A 4v1fA-5c05A:
undetectable		 4v1fA-5c05A:
9.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V1F_C_BQ1C1087_0
(F0F1 ATP SYNTHASE
SUBUNIT C)		 5c05 PUTATIVE
GAMMA-TERPINENE
SYNTHASE
(Thymus
vulgaris) 		3 / 3 GLU A 255
ALA A 256
PHE A 259
 GLU  A 255 ( 0.5A)
ALA  A 256 ( 0.0A)
PHE  A 259 (-1.3A)
 0.58A 4v1fC-5c05A:
undetectable		 4v1fC-5c05A:
9.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4W5N_A_IPHA901_0
(PROTEIN ARGONAUTE-2)		 3ulk KETOL-ACID
REDUCTOISOMERASE
(Escherichia
coli) 		3 / 3 VAL A 205
ALA A 203
PHE A  22
 VAL  A 205 ( 0.6A)
ALA  A 203 ( 0.0A)
PHE  A  22 ( 1.3A)
 0.85A 4w5nA-3ulkA:
undetectable		 4w5nA-3ulkA:
19.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)		 2qv2 INOSITOL
POLYPHOSPHATE
5-PHOSPHATASE OCRL-1
(Homo
sapiens) 		5 / 9 LEU A 173
LEU A 213
GLU A 178
VAL A 183
PHE A 235
 LEU  A 173 ( 0.6A)
LEU  A 213 ( 0.6A)
GLU  A 178 ( 0.5A)
VAL  A 183 ( 0.6A)
PHE  A 235 ( 1.3A)
 1.44A 4wnvB-2qv2A:
undetectable		 4wnvB-2qv2A:
21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNW_A_RTZA602_1
(CYTOCHROME P450 2D6)		 5hiu GTPASE
ACTIVATOR-LIKE
PROTEIN
(Chaetomium
thermophilum) 		5 / 12 LEU A 212
LEU A 173
GLN A 185
THR A 193
PHE A 170
 LEU  A 212 ( 0.6A)
LEU  A 173 ( 0.5A)
GLN  A 185 ( 0.6A)
THR  A 193 ( 0.8A)
PHE  A 170 ( 1.3A)
 1.22A 4wnwA-5hiuA:
undetectable		 4wnwA-5hiuA:
22.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNW_B_RTZB602_1
(CYTOCHROME P450 2D6)		 1og0 PHOSPHO-2-DEHYDRO-3-
DEOXYHEPTONATE
ALDOLASE
(Saccharomyces
cerevisiae) 		5 / 12 LEU A 186
GLY A 193
LEU A 194
ALA A 217
VAL A 198
 None
None
PHE  A1012 (-4.2A)
None
None
 1.09A 4wnwB-1og0A:
0.0		 4wnwB-1og0A:
21.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4X5I_A_FOLA201_0
(DIHYDROFOLATE
REDUCTASE)		 3eqz RESPONSE REGULATOR
(Colwellia
psychrerythraea) 		5 / 12 LEU A 114
PHE A 117
ILE A  48
LEU A 121
ILE A 102
 LEU  A 114 ( 0.6A)
PHE  A 117 ( 1.3A)
ILE  A  48 ( 0.7A)
LEU  A 121 ( 0.6A)
ILE  A 102 ( 0.7A)
 0.82A 4x5iA-3eqzA:
undetectable		 4x5iA-3eqzA:
17.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XK8_A_PQNA844_1
(PHOTOSYSTEM I P700
CHLOROPHYLL A
APOPROTEIN A1)		 1c8x ENDO-BETA-N-ACETYLGL
UCOSAMINIDASE H
(Streptomyces
plicatus) 		4 / 7 PHE A 102
SER A 104
ALA A 155
LEU A 152
 PHE  A 102 ( 1.3A)
SER  A 104 ( 0.0A)
ALA  A 155 ( 0.0A)
LEU  A 152 ( 0.6A)
 1.09A 4xk8A-1c8xA:
undetectable		 4xk8A-1c8xA:
16.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XK8_A_PQNA844_1
(PHOTOSYSTEM I P700
CHLOROPHYLL A
APOPROTEIN A1)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		4 / 7 MET A 122
PHE A 126
ALA A 192
LEU A 191
 MET  A 122 ( 0.0A)
PHE  A 126 ( 1.3A)
ALA  A 192 ( 0.0A)
LEU  A 191 ( 0.6A)
 1.12A 4xk8A-3sl5A:
undetectable		 4xk8A-3sl5A:
18.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XNX_A_41XA707_1
(TRANSPORTER)		 3ulk KETOL-ACID
REDUCTOISOMERASE
(Escherichia
coli) 		5 / 11 PHE A  28
ALA A 203
GLY A  24
VAL A 205
GLY A 200
 PHE  A  28 ( 1.3A)
ALA  A 203 ( 0.0A)
GLY  A  24 ( 0.0A)
VAL  A 205 ( 0.6A)
GLY  A 200 ( 0.0A)
 1.25A 4xnxA-3ulkA:
undetectable		 4xnxA-3ulkA:
20.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XP1_A_LDPA708_1
(DOPAMINE
TRANSPORTER, ISOFORM
B)		 5w0a GLUCANASE
(Trichoderma
harzianum) 		5 / 10 VAL A 132
ASP A 133
PHE A 249
SER A 204
SER A 135
 VAL  A 132 ( 0.6A)
ASP  A 133 ( 0.6A)
PHE  A 249 ( 1.3A)
SER  A 204 ( 0.0A)
SER  A 135 ( 0.0A)
 1.39A 4xp1A-5w0aA:
undetectable		 4xp1A-5w0aA:
9.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XR4_B_AG2B511_1
(HOMOSPERMIDINE
SYNTHASE)		 5c6d UBIQUITIN
CARBOXYL-TERMINAL
HYDROLASE 7
(Homo
sapiens) 		3 / 3 VAL A 685
PHE A 688
ARG A 634
 VAL  A 685 ( 0.6A)
PHE  A 688 ( 1.3A)
ARG  A 634 ( 0.6A)
 0.71A 4xr4B-5c6dA:
undetectable		 4xr4B-5c6dA:
20.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XUM_A_IMNA501_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)		 4mwt LYSOSOMAL PROTECTIVE
PROTEIN
(Homo
sapiens) 		5 / 12 ILE A   7
PHE A 106
LEU A 313
LEU A  67
TYR A 312
 ILE  A   7 ( 0.7A)
PHE  A 106 ( 1.3A)
LEU  A 313 ( 0.6A)
LEU  A  67 ( 0.5A)
TYR  A 312 ( 1.3A)
 1.26A 4xumA-4mwtA:
undetectable		 4xumA-4mwtA:
21.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XV2_A_P06A801_2
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 4kqn D-HYDANTOINASE
(Bacillus
sp.
AR9) 		4 / 4 GLY A  84
LEU A  61
PHE A  74
ILE A  89
 GLY  A  84 ( 0.0A)
LEU  A  61 ( 0.6A)
PHE  A  74 ( 1.3A)
ILE  A  89 ( 0.6A)
 0.83A 4xv2A-4kqnA:
undetectable		 4xv2A-4kqnA:
21.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XV2_A_P06A801_2
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 4kqn D-HYDANTOINASE
(Bacillus
sp.
AR9) 		4 / 4 GLY A  85
LEU A  61
PHE A  74
ILE A  89
 GLY  A  85 ( 0.0A)
LEU  A  61 ( 0.6A)
PHE  A  74 ( 1.3A)
ILE  A  89 ( 0.6A)
 0.92A 4xv2A-4kqnA:
undetectable		 4xv2A-4kqnA:
21.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YB6_A_HISA302_0
(ATP
PHOSPHORIBOSYLTRANSF
ERASE)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 VAL A 376
GLU A 374
THR A 413
VAL A 454
SER A 332
 None
PHE  A 509 (-3.6A)
PHE  A 509 (-3.7A)
None
None
 1.25A 4yb6A-3l4gA:
undetectable
4yb6E-3l4gA:
undetectable		 4yb6A-3l4gA:
20.63
4yb6E-3l4gA:
20.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YB6_A_HISA302_0
(ATP
PHOSPHORIBOSYLTRANSF
ERASE)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 VAL A 376
GLU A 374
VAL A 454
SER A 332
LEU A 336
 None
PHE  A 509 (-3.6A)
None
None
None
 1.14A 4yb6A-3l4gA:
undetectable
4yb6E-3l4gA:
undetectable		 4yb6A-3l4gA:
20.63
4yb6E-3l4gA:
20.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YB6_B_HISB302_0
(ATP
PHOSPHORIBOSYLTRANSF
ERASE)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 VAL A 376
GLU A 374
THR A 413
VAL A 454
SER A 332
 None
PHE  A 509 (-3.6A)
PHE  A 509 (-3.7A)
None
None
 1.24A 4yb6B-3l4gA:
undetectable
4yb6C-3l4gA:
undetectable		 4yb6B-3l4gA:
20.63
4yb6C-3l4gA:
20.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YB6_B_HISB302_0
(ATP
PHOSPHORIBOSYLTRANSF
ERASE)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 VAL A 376
GLU A 374
VAL A 454
SER A 332
LEU A 336
 None
PHE  A 509 (-3.6A)
None
None
None
 1.13A 4yb6B-3l4gA:
undetectable
4yb6C-3l4gA:
undetectable		 4yb6B-3l4gA:
20.63
4yb6C-3l4gA:
20.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YB6_C_HISC302_0
(ATP
PHOSPHORIBOSYLTRANSF
ERASE)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 VAL A 376
GLU A 374
THR A 413
VAL A 454
SER A 332
 None
PHE  A 509 (-3.6A)
PHE  A 509 (-3.7A)
None
None
 1.26A 4yb6C-3l4gA:
undetectable
4yb6F-3l4gA:
undetectable		 4yb6C-3l4gA:
20.63
4yb6F-3l4gA:
20.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YB6_C_HISC302_0
(ATP
PHOSPHORIBOSYLTRANSF
ERASE)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 VAL A 376
GLU A 374
VAL A 454
SER A 332
LEU A 336
 None
PHE  A 509 (-3.6A)
None
None
None
 1.14A 4yb6C-3l4gA:
undetectable
4yb6F-3l4gA:
undetectable		 4yb6C-3l4gA:
20.63
4yb6F-3l4gA:
20.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YB6_D_HISD302_0
(ATP
PHOSPHORIBOSYLTRANSF
ERASE)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 SER A 332
LEU A 336
VAL A 376
GLU A 374
VAL A 454
 None
None
None
PHE  A 509 (-3.6A)
None
 1.12A 4yb6A-3l4gA:
undetectable
4yb6D-3l4gA:
undetectable		 4yb6A-3l4gA:
20.63
4yb6D-3l4gA:
20.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YB6_D_HISD302_0
(ATP
PHOSPHORIBOSYLTRANSF
ERASE)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 SER A 332
VAL A 376
GLU A 374
THR A 413
VAL A 454
 None
None
PHE  A 509 (-3.6A)
PHE  A 509 (-3.7A)
None
 1.27A 4yb6A-3l4gA:
undetectable
4yb6D-3l4gA:
undetectable		 4yb6A-3l4gA:
20.63
4yb6D-3l4gA:
20.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YB6_E_HISE302_0
(ATP
PHOSPHORIBOSYLTRANSF
ERASE)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 SER A 332
LEU A 336
VAL A 376
GLU A 374
VAL A 454
 None
None
None
PHE  A 509 (-3.6A)
None
 1.13A 4yb6D-3l4gA:
undetectable
4yb6E-3l4gA:
undetectable		 4yb6D-3l4gA:
20.63
4yb6E-3l4gA:
20.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YB6_E_HISE302_0
(ATP
PHOSPHORIBOSYLTRANSF
ERASE)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 SER A 332
VAL A 376
GLU A 374
THR A 413
VAL A 454
 None
None
PHE  A 509 (-3.6A)
PHE  A 509 (-3.7A)
None
 1.25A 4yb6D-3l4gA:
undetectable
4yb6E-3l4gA:
undetectable		 4yb6D-3l4gA:
20.63
4yb6E-3l4gA:
20.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YB6_F_HISF302_0
(ATP
PHOSPHORIBOSYLTRANSF
ERASE)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 SER A 332
LEU A 336
VAL A 376
GLU A 374
VAL A 454
 None
None
None
PHE  A 509 (-3.6A)
None
 1.16A 4yb6B-3l4gA:
undetectable
4yb6F-3l4gA:
undetectable		 4yb6B-3l4gA:
20.63
4yb6F-3l4gA:
20.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YFB_F_PACF601_0
(PROTEIN RELATED TO
PENICILLIN ACYLASE)		 4hne PHOSPHATIDYLINOSITOL
4-KINASE TYPE
2-ALPHA
(Homo
sapiens) 		5 / 12 PHE A 416
PHE A 405
GLN A 419
ILE A 420
VAL A 199
 PHE  A 416 ( 1.3A)
PHE  A 405 ( 1.3A)
GLN  A 419 ( 0.6A)
ILE  A 420 ( 0.7A)
VAL  A 199 ( 0.6A)
 1.50A 4yfbF-4hneA:
undetectable		 4yfbF-4hneA:
21.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YFB_I_PACI601_0
(PROTEIN RELATED TO
PENICILLIN ACYLASE)		 4hne PHOSPHATIDYLINOSITOL
4-KINASE TYPE
2-ALPHA
(Homo
sapiens) 		5 / 12 PHE A 416
PHE A 405
GLN A 419
ILE A 420
VAL A 199
 PHE  A 416 ( 1.3A)
PHE  A 405 ( 1.3A)
GLN  A 419 ( 0.6A)
ILE  A 420 ( 0.7A)
VAL  A 199 ( 0.6A)
 1.49A 4yfbI-4hneA:
undetectable		 4yfbI-4hneA:
21.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YFB_L_PACL601_0
(PROTEIN RELATED TO
PENICILLIN ACYLASE)		 4hne PHOSPHATIDYLINOSITOL
4-KINASE TYPE
2-ALPHA
(Homo
sapiens) 		5 / 12 PHE A 416
PHE A 405
GLN A 419
ILE A 420
VAL A 199
 PHE  A 416 ( 1.3A)
PHE  A 405 ( 1.3A)
GLN  A 419 ( 0.6A)
ILE  A 420 ( 0.7A)
VAL  A 199 ( 0.6A)
 1.48A 4yfbL-4hneA:
undetectable		 4yfbL-4hneA:
21.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YSH_B_GLYB401_0
(GLYCINE OXIDASE)		 3kbb PHOSPHORYLATED
CARBOHYDRATES
PHOSPHATASE TM_1254
(Thermotoga
maritima) 		4 / 6 PHE A 163
GLY A 183
TYR A 182
ALA A 201
 PHE  A 163 ( 1.3A)
GLY  A 183 ( 0.0A)
TYR  A 182 ( 1.3A)
ALA  A 201 ( 0.0A)
 1.22A 4yshB-3kbbA:
undetectable		 4yshB-3kbbA:
22.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Z4I_A_IPHA903_0
(PROTEIN ARGONAUTE-2)		 3ulk KETOL-ACID
REDUCTOISOMERASE
(Escherichia
coli) 		3 / 3 VAL A 205
ALA A 203
PHE A  22
 VAL  A 205 ( 0.6A)
ALA  A 203 ( 0.0A)
PHE  A  22 ( 1.3A)
 0.87A 4z4iA-3ulkA:
undetectable		 4z4iA-3ulkA:
19.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Z4I_A_IPHA903_0
(PROTEIN ARGONAUTE-2)		 5ve2 ENOYL-COA HYDRATASE
(Pseudoalteromona
s
atlantica) 		3 / 3 VAL A 106
ALA A 138
PHE A 129
 VAL  A 106 ( 0.6A)
ALA  A 138 ( 0.0A)
PHE  A 129 ( 1.3A)
 0.82A 4z4iA-5ve2A:
undetectable		 4z4iA-5ve2A:
15.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Z69_A_DIFA1008_1
(SERUM ALBUMIN)		 4kqn D-HYDANTOINASE
(Bacillus
sp.
AR9) 		5 / 9 SER A 233
ALA A 178
PHE A 458
VAL A 182
LEU A 170
 SER  A 233 ( 0.0A)
ALA  A 178 ( 0.0A)
PHE  A 458 ( 1.3A)
VAL  A 182 ( 0.6A)
LEU  A 170 ( 0.5A)
 1.27A 4z69A-4kqnA:
undetectable		 4z69A-4kqnA:
22.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZDY_A_1YNA602_1
(LANOSTEROL 14-ALPHA
DEMETHYLASE)		 5nqf APICAL MEMBRANE
ANTIGEN 1
(Plasmodium
falciparum) 		5 / 12 GLY A 179
PHE A 342
ILE A 127
GLY A 153
THR A 164
 GLY  A 179 ( 0.0A)
PHE  A 342 ( 1.3A)
ILE  A 127 ( 0.7A)
GLY  A 153 ( 0.0A)
THR  A 164 ( 0.8A)
 1.19A 4zdyA-5nqfA:
undetectable		 4zdyA-5nqfA:
21.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZDZ_A_TPFA602_1
(LANOSTEROL 14-ALPHA
DEMETHYLASE)		 3o96 RAC-ALPHA
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		4 / 7 PHE A 408
ILE A 402
GLY A 254
MET A 343
 PHE  A 408 ( 1.3A)
ILE  A 402 ( 0.4A)
GLY  A 254 ( 0.0A)
MET  A 343 ( 0.0A)
 0.93A 4zdzA-3o96A:
undetectable		 4zdzA-3o96A:
21.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZE0_A_VORA602_1
(LANOSTEROL 14-ALPHA
DEMETHYLASE)		 3pco PHENYLALANYL-TRNA
SYNTHETASE, ALPHA
SUBUNIT
(Escherichia
coli) 		5 / 9 THR A 251
PHE A 250
PHE A 248
LEU A 270
LEU A 227
 PHE  A 980 ( 4.1A)
PHE  A 980 (-4.5A)
PHE  A 980 (-3.6A)
None
None
 1.43A 4ze0A-3pcoA:
undetectable		 4ze0A-3pcoA:
21.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZE2_A_1YNA602_1
(LANOSTEROL 14-ALPHA
DEMETHYLASE)		 5nqf APICAL MEMBRANE
ANTIGEN 1
(Plasmodium
falciparum) 		5 / 12 GLY A 179
PHE A 342
ILE A 127
GLY A 153
THR A 164
 GLY  A 179 ( 0.0A)
PHE  A 342 ( 1.3A)
ILE  A 127 ( 0.7A)
GLY  A 153 ( 0.0A)
THR  A 164 ( 0.8A)
 1.16A 4ze2A-5nqfA:
undetectable		 4ze2A-5nqfA:
21.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZVM_A_DM2A303_1
(RIBOSYLDIHYDRONICOTI
NAMIDE DEHYDROGENASE
[QUINONE])		 2qj6 TOXIN A
(Clostridioides
difficile) 		5 / 12 GLY A 108
THR A 107
PHE A 138
ILE A 133
PHE A 140
 GLY  A 108 ( 0.0A)
THR  A 107 ( 0.8A)
PHE  A 138 ( 1.3A)
ILE  A 133 ( 0.7A)
PHE  A 140 ( 1.3A)
 1.09A 4zvmA-2qj6A:
undetectable
4zvmB-2qj6A:
undetectable		 4zvmA-2qj6A:
21.45
4zvmB-2qj6A:
21.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZXI_A_GLYA1402_0
(TYROCIDINE
SYNTHETASE 3)		 1amu GRAMICIDIN
SYNTHETASE 1
(Brevibacillus
brevis) 		5 / 7 PHE A 234
ASP A 235
GLY A 302
THR A 326
LYS A 517
 PHE  A 566 ( 4.5A)
PHE  A 566 (-2.8A)
PHE  A 566 ( 3.6A)
AMP  A 567 ( 3.9A)
AMP  A 567 ( 2.8A)
 0.27A 4zxiA-1amuA:
49.6		 4zxiA-1amuA:
19.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AJQ_B_DB8B800_1
(SERINE/THREONINE-PRO
TEIN KINASE 10)		 2nvv ACETYL-COA
HYDROLASE/TRANSFERAS
E FAMILY PROTEIN
(Porphyromonas
gingivalis) 		5 / 10 ILE A 423
PHE A 391
GLY A 360
LEU A 431
ALA A 429
 ILE  A 423 ( 0.7A)
PHE  A 391 ( 1.3A)
GLY  A 360 ( 0.0A)
LEU  A 431 ( 0.6A)
ALA  A 429 ( 0.0A)
 1.41A 5ajqB-2nvvA:
undetectable		 5ajqB-2nvvA:
20.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ALB_L_TIQL1210_2
(MEDI2452 LIGHT CHAIN)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		4 / 8 SER C  90
TYR C 163
ALA C 164
PHE C  85
 SER  C  90 ( 0.0A)
TYR  C 163 ( 1.3A)
ALA  C 164 ( 0.0A)
PHE  C  85 ( 1.3A)
 0.85A 5albL-5lmxC:
undetectable		 5albL-5lmxC:
21.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5B1B_P_CHDP306_0
(CYTOCHROME C OXIDASE
SUBUNIT 3
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 7 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.95A 5b1bP-4flxA:
2.7
5b1bW-4flxA:
undetectable		 5b1bP-4flxA:
13.49
5b1bW-4flxA:
6.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5B1B_W_CHDW101_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 3h7a SHORT CHAIN
DEHYDROGENASE
(Rhodopseudomonas
palustris) 		4 / 7 ILE A 135
PHE A 137
THR A  70
LEU A  73
 ILE  A 135 ( 0.6A)
PHE  A 137 ( 1.3A)
THR  A  70 ( 0.8A)
LEU  A  73 ( 0.5A)
 0.86A 5b1bN-3h7aA:
undetectable
5b1bW-3h7aA:
undetectable		 5b1bN-3h7aA:
18.89
5b1bW-3h7aA:
11.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5B3S_W_CHDW101_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 3h7a SHORT CHAIN
DEHYDROGENASE
(Rhodopseudomonas
palustris) 		4 / 7 ILE A 135
PHE A 137
THR A  70
LEU A  73
 ILE  A 135 ( 0.6A)
PHE  A 137 ( 1.3A)
THR  A  70 ( 0.8A)
LEU  A  73 ( 0.5A)
 0.88A 5b3sN-3h7aA:
undetectable
5b3sW-3h7aA:
undetectable		 5b3sN-3h7aA:
18.89
5b3sW-3h7aA:
11.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5B8I_C_FK5C201_1
(SERINE/THREONINE-PRO
TEIN PHOSPHATASE
PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE)		 2vbf BRANCHED-CHAIN
ALPHA-KETOACID
DECARBOXYLASE
(Lactococcus
lactis) 		4 / 6 LEU A 359
TRP A 360
SER A 380
PHE A 381
 LEU  A 359 ( 0.5A)
TRP  A 360 ( 0.5A)
SER  A 380 ( 0.0A)
PHE  A 381 ( 1.3A)
 1.29A 5b8iA-2vbfA:
undetectable		 5b8iA-2vbfA:
23.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CDN_G_EVPG2101_1
(DNA GYRASE SUBUNIT A
DNA GYRASE SUBUNIT
B,DNA GYRASE SUBUNIT
B)		 3td9 BRANCHED CHAIN AMINO
ACID ABC
TRANSPORTER,
PERIPLASMIC AMINO
ACID-BINDING PROTEIN
(Thermotoga
maritima) 		5 / 6 SER A  68
GLU A  69
GLY A 242
ASP A 241
GLY A 216
 None
None
PHE  A 400 ( 4.2A)
PHE  A 400 (-2.7A)
None
 1.35A 5cdnA-3td9A:
undetectable
5cdnB-3td9A:
4.2		 5cdnA-3td9A:
20.12
5cdnB-3td9A:
21.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CXV_A_0HKA501_2
(MUSCARINIC
ACETYLCHOLINE
RECEPTOR
M1,ENDOLYSIN,MUSCARI
NIC ACETYLCHOLINE
RECEPTOR M1)		 5ep8 PYRIMIDINE-NUCLEOSID
E PHOSPHORYLASE
(Bacillus
subtilis) 		3 / 3 THR A 210
THR A 202
PHE A 207
 THR  A 210 ( 0.8A)
THR  A 202 ( 0.8A)
PHE  A 207 ( 1.3A)
 0.83A 5cxvA-5ep8A:
undetectable		 5cxvA-5ep8A:
21.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5D4N_C_ACTC201_0
(NITROGEN REGULATORY
PROTEIN P-II)		 3qvi HISTO-ASPARTIC
PROTEASE
(Plasmodium
falciparum) 		4 / 5 VAL A 197
VAL A 205
GLY A 201
PHE A 227
 VAL  A 197 ( 0.5A)
VAL  A 205 ( 0.6A)
GLY  A 201 ( 0.0A)
PHE  A 227 ( 1.4A)
 0.92A 5d4nA-3qviA:
undetectable
5d4nC-3qviA:
undetectable		 5d4nA-3qviA:
12.42
5d4nC-3qviA:
12.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5DLV_A_5D5A930_0
(ECTONUCLEOTIDE
PYROPHOSPHATASE/PHOS
PHODIESTERASE FAMILY
MEMBER 2)		 4rhy HYPOXANTHINE-GUANINE
PHOSPHORIBOSYLTRANSF
ERASE
(Mycobacterium
tuberculosis) 		5 / 12 PHE A 169
LEU A 152
ILE A 120
PHE A  71
TYR A 179
 PHE  A 169 ( 1.3A)
LEU  A 152 ( 0.6A)
ILE  A 120 ( 0.7A)
PHE  A  71 ( 1.3A)
TYR  A 179 ( 1.3A)
 1.44A 5dlvA-4rhyA:
undetectable		 5dlvA-4rhyA:
13.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5DSG_B_0HKB1201_2
(MUSCARINIC
ACETYLCHOLINE
RECEPTOR
M4,ENDOLYSIN,ENDOLYS
IN,MUSCARINIC
ACETYLCHOLINE
RECEPTOR M4)		 5l5n PLEXIN-A4
(Mus
musculus) 		3 / 3 ASP A 368
ASN A 363
PHE A 357
 ASP  A 368 ( 0.5A)
ASN  A 363 ( 0.6A)
PHE  A 357 ( 1.3A)
 0.66A 5dsgB-5l5nA:
undetectable		 5dsgB-5l5nA:
17.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5DZK_P_BEZP801_1
(ATP-DEPENDENT CLP
PROTEASE PROTEOLYTIC
SUBUNIT 2
BEZ-LEU-LEU)		 3h7a SHORT CHAIN
DEHYDROGENASE
(Rhodopseudomonas
palustris) 		4 / 6 PHE A 158
ALA A 162
HIS A 180
LEU A 160
 PHE  A 158 ( 1.3A)
ALA  A 162 ( 0.0A)
HIS  A 180 ( 1.0A)
LEU  A 160 ( 0.6A)
 1.25A 5dzkB-3h7aA:
3.1
5dzkP-3h7aA:
undetectable		 5dzkB-3h7aA:
23.99
5dzkP-3h7aA:
0.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5E4D_B_BEZB201_0
(HYDROXYNITRILE LYASE)		 3sag EXOSOME COMPONENT 10
(Homo
sapiens) 		5 / 11 VAL A 469
PHE A 387
ILE A 447
TYR A 410
LEU A 396
 VAL  A 469 ( 0.6A)
PHE  A 387 ( 1.3A)
ILE  A 447 ( 0.7A)
TYR  A 410 ( 1.3A)
LEU  A 396 ( 0.6A)
 1.10A 5e4dB-3sagA:
undetectable		 5e4dB-3sagA:
16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5E72_A_SAMA400_0
(N2,
N2-DIMETHYLGUANOSINE
TRNA
METHYLTRANSFERASE)		 3gnr OS03G0212800 PROTEIN
(Oryza
sativa) 		5 / 12 ILE A 392
PHE A 248
MET A 378
ALA A 278
LEU A 313
 ILE  A 392 ( 0.7A)
PHE  A 248 ( 1.3A)
MET  A 378 ( 0.0A)
ALA  A 278 ( 0.0A)
LEU  A 313 ( 0.5A)
 1.07A 5e72A-3gnrA:
undetectable		 5e72A-3gnrA:
21.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EAJ_A_FOLA201_0
(DIHYDROFOLATE
REDUCTASE)		 3eqz RESPONSE REGULATOR
(Colwellia
psychrerythraea) 		5 / 12 LEU A 114
PHE A 117
ILE A  48
LEU A 121
ILE A 102
 LEU  A 114 ( 0.6A)
PHE  A 117 ( 1.3A)
ILE  A  48 ( 0.7A)
LEU  A 121 ( 0.6A)
ILE  A 102 ( 0.7A)
 0.88A 5eajA-3eqzA:
undetectable		 5eajA-3eqzA:
17.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEI_A_SHHA2004_1
(HDAC6 PROTEIN)		 2nvv ACETYL-COA
HYDROLASE/TRANSFERAS
E FAMILY PROTEIN
(Porphyromonas
gingivalis) 		5 / 12 PRO A  36
GLY A  22
PHE A  23
ASP A  68
LEU A  71
 PRO  A  36 ( 1.1A)
GLY  A  22 ( 0.0A)
PHE  A  23 ( 1.3A)
ASP  A  68 ( 0.5A)
LEU  A  71 ( 0.6A)
 1.24A 5eeiA-2nvvA:
undetectable		 5eeiA-2nvvA:
20.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEI_B_SHHB801_1
(HDAC6 PROTEIN)		 2nvv ACETYL-COA
HYDROLASE/TRANSFERAS
E FAMILY PROTEIN
(Porphyromonas
gingivalis) 		5 / 12 PRO A  36
GLY A  22
PHE A  23
ASP A  68
LEU A  71
 PRO  A  36 ( 1.1A)
GLY  A  22 ( 0.0A)
PHE  A  23 ( 1.3A)
ASP  A  68 ( 0.5A)
LEU  A  71 ( 0.6A)
 1.23A 5eeiB-2nvvA:
2.1		 5eeiB-2nvvA:
20.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEU_A_TRPA101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.41A 5eeuA-3l4gA:
undetectable
5eeuB-3l4gA:
undetectable		 5eeuA-3l4gA:
9.81
5eeuB-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEU_B_TRPB101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5eeuB-3l4gA:
undetectable
5eeuC-3l4gA:
undetectable		 5eeuB-3l4gA:
9.81
5eeuC-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEU_C_TRPC101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5eeuC-3l4gA:
undetectable
5eeuD-3l4gA:
undetectable		 5eeuC-3l4gA:
9.81
5eeuD-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEU_E_TRPE101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.41A 5eeuE-3l4gA:
undetectable
5eeuF-3l4gA:
undetectable		 5eeuE-3l4gA:
9.81
5eeuF-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEU_H_TRPH101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5eeuH-3l4gA:
undetectable
5eeuI-3l4gA:
undetectable		 5eeuH-3l4gA:
9.81
5eeuI-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEU_K_TRPK101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.42A 5eeuA-3l4gA:
undetectable
5eeuK-3l4gA:
undetectable		 5eeuA-3l4gA:
9.81
5eeuK-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEU_O_TRPO101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.45A 5eeuN-3l4gA:
undetectable
5eeuO-3l4gA:
undetectable		 5eeuN-3l4gA:
9.81
5eeuO-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEU_V_TRPV101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.43A 5eeuU-3l4gA:
undetectable
5eeuV-3l4gA:
undetectable		 5eeuU-3l4gA:
9.81
5eeuV-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEV_B_TRPB101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5eevB-3l4gA:
undetectable
5eevC-3l4gA:
undetectable		 5eevB-3l4gA:
9.81
5eevC-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEV_C_TRPC101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5eevC-3l4gA:
undetectable
5eevD-3l4gA:
undetectable		 5eevC-3l4gA:
9.81
5eevD-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEV_E_TRPE101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.41A 5eevE-3l4gA:
undetectable
5eevF-3l4gA:
undetectable		 5eevE-3l4gA:
9.81
5eevF-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEV_H_TRPH101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5eevH-3l4gA:
undetectable
5eevI-3l4gA:
undetectable		 5eevH-3l4gA:
9.81
5eevI-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEV_K_TRPK101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.42A 5eevA-3l4gA:
undetectable
5eevK-3l4gA:
undetectable		 5eevA-3l4gA:
9.81
5eevK-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEV_O_TRPO101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.45A 5eevN-3l4gA:
undetectable
5eevO-3l4gA:
undetectable		 5eevN-3l4gA:
9.81
5eevO-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEV_U_TRPU101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.45A 5eevT-3l4gA:
undetectable
5eevU-3l4gA:
undetectable		 5eevT-3l4gA:
9.81
5eevU-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEV_V_TRPV101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.42A 5eevU-3l4gA:
undetectable
5eevV-3l4gA:
undetectable		 5eevU-3l4gA:
9.81
5eevV-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEW_B_TRPB101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5eewB-3l4gA:
undetectable
5eewC-3l4gA:
undetectable		 5eewB-3l4gA:
9.81
5eewC-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEW_C_TRPC101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5eewC-3l4gA:
undetectable
5eewD-3l4gA:
undetectable		 5eewC-3l4gA:
9.81
5eewD-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEW_E_TRPE101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.41A 5eewE-3l4gA:
undetectable
5eewF-3l4gA:
undetectable		 5eewE-3l4gA:
9.81
5eewF-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEW_G_TRPG101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.45A 5eewG-3l4gA:
undetectable
5eewH-3l4gA:
undetectable		 5eewG-3l4gA:
9.81
5eewH-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEW_K_TRPK101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.42A 5eewA-3l4gA:
undetectable
5eewK-3l4gA:
undetectable		 5eewA-3l4gA:
9.81
5eewK-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEW_O_TRPO101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.45A 5eewN-3l4gA:
undetectable
5eewO-3l4gA:
undetectable		 5eewN-3l4gA:
9.81
5eewO-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEW_U_TRPU101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.45A 5eewT-3l4gA:
undetectable
5eewU-3l4gA:
undetectable		 5eewT-3l4gA:
9.81
5eewU-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEX_B_TRPB101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5eexB-3l4gA:
undetectable
5eexC-3l4gA:
undetectable		 5eexB-3l4gA:
9.81
5eexC-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEX_C_TRPC101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5eexC-3l4gA:
undetectable
5eexD-3l4gA:
undetectable		 5eexC-3l4gA:
9.81
5eexD-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEX_D_TRPD101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5eexD-3l4gA:
undetectable
5eexE-3l4gA:
undetectable		 5eexD-3l4gA:
9.81
5eexE-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEX_E_TRPE101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.41A 5eexE-3l4gA:
undetectable
5eexF-3l4gA:
undetectable		 5eexE-3l4gA:
9.81
5eexF-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEX_G_TRPG101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.46A 5eexG-3l4gA:
undetectable
5eexH-3l4gA:
undetectable		 5eexG-3l4gA:
9.81
5eexH-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEX_K_TRPK101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.42A 5eexA-3l4gA:
undetectable
5eexK-3l4gA:
undetectable		 5eexA-3l4gA:
9.81
5eexK-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEX_O_TRPO101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.44A 5eexN-3l4gA:
undetectable
5eexO-3l4gA:
undetectable		 5eexN-3l4gA:
9.81
5eexO-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEX_R_TRPR101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.45A 5eexQ-3l4gA:
undetectable
5eexR-3l4gA:
undetectable		 5eexQ-3l4gA:
9.81
5eexR-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEX_U_TRPU101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.45A 5eexT-3l4gA:
undetectable
5eexU-3l4gA:
undetectable		 5eexT-3l4gA:
9.81
5eexU-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEX_V_TRPV101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.42A 5eexU-3l4gA:
undetectable
5eexV-3l4gA:
undetectable		 5eexU-3l4gA:
9.81
5eexV-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEY_B_TRPB101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5eeyB-3l4gA:
undetectable
5eeyC-3l4gA:
undetectable		 5eeyB-3l4gA:
9.81
5eeyC-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEY_C_TRPC101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5eeyC-3l4gA:
undetectable
5eeyD-3l4gA:
undetectable		 5eeyC-3l4gA:
9.81
5eeyD-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEY_D_TRPD101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5eeyD-3l4gA:
undetectable
5eeyE-3l4gA:
undetectable		 5eeyD-3l4gA:
9.81
5eeyE-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEY_E_TRPE101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.41A 5eeyE-3l4gA:
undetectable
5eeyF-3l4gA:
undetectable		 5eeyE-3l4gA:
9.81
5eeyF-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEY_G_TRPG101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.46A 5eeyG-3l4gA:
undetectable
5eeyH-3l4gA:
undetectable		 5eeyG-3l4gA:
9.81
5eeyH-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEY_H_TRPH101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5eeyH-3l4gA:
undetectable
5eeyI-3l4gA:
undetectable		 5eeyH-3l4gA:
9.81
5eeyI-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEY_K_TRPK101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.42A 5eeyA-3l4gA:
undetectable
5eeyK-3l4gA:
undetectable		 5eeyA-3l4gA:
9.81
5eeyK-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEY_O_TRPO101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.45A 5eeyN-3l4gA:
undetectable
5eeyO-3l4gA:
undetectable		 5eeyN-3l4gA:
9.81
5eeyO-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEY_R_TRPR101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.45A 5eeyQ-3l4gA:
undetectable
5eeyR-3l4gA:
undetectable		 5eeyQ-3l4gA:
9.81
5eeyR-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEY_U_TRPU101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.45A 5eeyT-3l4gA:
undetectable
5eeyU-3l4gA:
undetectable		 5eeyT-3l4gA:
9.81
5eeyU-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEZ_B_TRPB101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5eezB-3l4gA:
undetectable
5eezC-3l4gA:
undetectable		 5eezB-3l4gA:
9.81
5eezC-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEZ_C_TRPC101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5eezC-3l4gA:
undetectable
5eezD-3l4gA:
undetectable		 5eezC-3l4gA:
9.81
5eezD-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEZ_D_TRPD101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.43A 5eezD-3l4gA:
undetectable
5eezE-3l4gA:
undetectable		 5eezD-3l4gA:
9.81
5eezE-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEZ_E_TRPE101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.41A 5eezE-3l4gA:
undetectable
5eezF-3l4gA:
undetectable		 5eezE-3l4gA:
9.81
5eezF-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEZ_G_TRPG101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.46A 5eezG-3l4gA:
undetectable
5eezH-3l4gA:
undetectable		 5eezG-3l4gA:
9.81
5eezH-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEZ_H_TRPH101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5eezH-3l4gA:
undetectable
5eezI-3l4gA:
undetectable		 5eezH-3l4gA:
9.81
5eezI-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEZ_J_TRPJ101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.41A 5eezJ-3l4gA:
undetectable
5eezK-3l4gA:
undetectable		 5eezJ-3l4gA:
9.81
5eezK-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEZ_K_TRPK101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.42A 5eezA-3l4gA:
undetectable
5eezK-3l4gA:
undetectable		 5eezA-3l4gA:
9.81
5eezK-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEZ_O_TRPO101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.45A 5eezN-3l4gA:
undetectable
5eezO-3l4gA:
undetectable		 5eezN-3l4gA:
9.81
5eezO-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEZ_R_TRPR101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.44A 5eezQ-3l4gA:
undetectable
5eezR-3l4gA:
undetectable		 5eezQ-3l4gA:
9.81
5eezR-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEZ_U_TRPU101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.45A 5eezT-3l4gA:
undetectable
5eezU-3l4gA:
undetectable		 5eezT-3l4gA:
9.81
5eezU-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF0_B_TRPB101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5ef0B-3l4gA:
undetectable
5ef0C-3l4gA:
undetectable		 5ef0B-3l4gA:
9.81
5ef0C-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF0_C_TRPC101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5ef0C-3l4gA:
undetectable
5ef0D-3l4gA:
undetectable		 5ef0C-3l4gA:
9.81
5ef0D-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF0_D_TRPD101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.43A 5ef0D-3l4gA:
undetectable
5ef0E-3l4gA:
undetectable		 5ef0D-3l4gA:
9.81
5ef0E-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF0_E_TRPE101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5ef0E-3l4gA:
undetectable
5ef0F-3l4gA:
undetectable		 5ef0E-3l4gA:
9.81
5ef0F-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF0_G_TRPG101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.46A 5ef0G-3l4gA:
undetectable
5ef0H-3l4gA:
undetectable		 5ef0G-3l4gA:
9.81
5ef0H-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF0_H_TRPH101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5ef0H-3l4gA:
undetectable
5ef0I-3l4gA:
undetectable		 5ef0H-3l4gA:
9.81
5ef0I-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF0_J_TRPJ101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5ef0J-3l4gA:
undetectable
5ef0K-3l4gA:
undetectable		 5ef0J-3l4gA:
9.81
5ef0K-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF0_K_TRPK101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.42A 5ef0A-3l4gA:
undetectable
5ef0K-3l4gA:
undetectable		 5ef0A-3l4gA:
9.81
5ef0K-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF0_O_TRPO101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.44A 5ef0N-3l4gA:
undetectable
5ef0O-3l4gA:
undetectable		 5ef0N-3l4gA:
9.81
5ef0O-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF0_R_TRPR101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.44A 5ef0Q-3l4gA:
undetectable
5ef0R-3l4gA:
undetectable		 5ef0Q-3l4gA:
9.81
5ef0R-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF0_U_TRPU101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.45A 5ef0T-3l4gA:
undetectable
5ef0U-3l4gA:
undetectable		 5ef0T-3l4gA:
9.81
5ef0U-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF0_V_TRPV101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.42A 5ef0U-3l4gA:
undetectable
5ef0V-3l4gA:
undetectable		 5ef0U-3l4gA:
9.81
5ef0V-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF1_B_TRPB101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5ef1B-3l4gA:
undetectable
5ef1C-3l4gA:
undetectable		 5ef1B-3l4gA:
9.81
5ef1C-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF1_C_TRPC101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5ef1C-3l4gA:
undetectable
5ef1D-3l4gA:
undetectable		 5ef1C-3l4gA:
9.81
5ef1D-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF1_D_TRPD101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.43A 5ef1D-3l4gA:
undetectable
5ef1E-3l4gA:
undetectable		 5ef1D-3l4gA:
9.81
5ef1E-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF1_E_TRPE101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5ef1E-3l4gA:
undetectable
5ef1F-3l4gA:
undetectable		 5ef1E-3l4gA:
9.81
5ef1F-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF1_G_TRPG101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.46A 5ef1G-3l4gA:
undetectable
5ef1H-3l4gA:
undetectable		 5ef1G-3l4gA:
9.81
5ef1H-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF1_H_TRPH101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5ef1H-3l4gA:
undetectable
5ef1I-3l4gA:
undetectable		 5ef1H-3l4gA:
9.81
5ef1I-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF1_J_TRPJ101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5ef1J-3l4gA:
undetectable
5ef1K-3l4gA:
undetectable		 5ef1J-3l4gA:
9.81
5ef1K-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF1_K_TRPK101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.42A 5ef1A-3l4gA:
undetectable
5ef1K-3l4gA:
undetectable		 5ef1A-3l4gA:
9.81
5ef1K-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF1_O_TRPO101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.45A 5ef1N-3l4gA:
undetectable
5ef1O-3l4gA:
undetectable		 5ef1N-3l4gA:
9.81
5ef1O-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF1_R_TRPR101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.45A 5ef1Q-3l4gA:
undetectable
5ef1R-3l4gA:
undetectable		 5ef1Q-3l4gA:
9.81
5ef1R-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF1_U_TRPU101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.45A 5ef1T-3l4gA:
undetectable
5ef1U-3l4gA:
undetectable		 5ef1T-3l4gA:
9.81
5ef1U-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF2_B_TRPB101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5ef2B-3l4gA:
undetectable
5ef2C-3l4gA:
undetectable		 5ef2B-3l4gA:
9.81
5ef2C-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF2_C_TRPC101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5ef2C-3l4gA:
undetectable
5ef2D-3l4gA:
undetectable		 5ef2C-3l4gA:
9.81
5ef2D-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF2_D_TRPD101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.43A 5ef2D-3l4gA:
undetectable
5ef2E-3l4gA:
undetectable		 5ef2D-3l4gA:
9.81
5ef2E-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF2_E_TRPE101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5ef2E-3l4gA:
undetectable
5ef2F-3l4gA:
undetectable		 5ef2E-3l4gA:
9.81
5ef2F-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF2_G_TRPG101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.46A 5ef2G-3l4gA:
undetectable
5ef2H-3l4gA:
undetectable		 5ef2G-3l4gA:
9.81
5ef2H-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF2_H_TRPH101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5ef2H-3l4gA:
undetectable
5ef2I-3l4gA:
undetectable		 5ef2H-3l4gA:
9.81
5ef2I-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF2_J_TRPJ101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5ef2J-3l4gA:
undetectable
5ef2K-3l4gA:
undetectable		 5ef2J-3l4gA:
9.81
5ef2K-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF2_K_TRPK101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.43A 5ef2A-3l4gA:
undetectable
5ef2K-3l4gA:
undetectable		 5ef2A-3l4gA:
9.81
5ef2K-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF2_O_TRPO101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.44A 5ef2N-3l4gA:
undetectable
5ef2O-3l4gA:
undetectable		 5ef2N-3l4gA:
9.81
5ef2O-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF2_R_TRPR101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.44A 5ef2Q-3l4gA:
undetectable
5ef2R-3l4gA:
undetectable		 5ef2Q-3l4gA:
9.81
5ef2R-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF2_U_TRPU101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.45A 5ef2T-3l4gA:
undetectable
5ef2U-3l4gA:
undetectable		 5ef2T-3l4gA:
9.81
5ef2U-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF3_B_TRPB101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.43A 5ef3B-3l4gA:
undetectable
5ef3C-3l4gA:
undetectable		 5ef3B-3l4gA:
9.81
5ef3C-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF3_C_TRPC101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5ef3C-3l4gA:
undetectable
5ef3D-3l4gA:
undetectable		 5ef3C-3l4gA:
9.81
5ef3D-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF3_D_TRPD101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.43A 5ef3D-3l4gA:
undetectable
5ef3E-3l4gA:
undetectable		 5ef3D-3l4gA:
9.81
5ef3E-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF3_E_TRPE101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5ef3E-3l4gA:
undetectable
5ef3F-3l4gA:
undetectable		 5ef3E-3l4gA:
9.81
5ef3F-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF3_G_TRPG101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.46A 5ef3G-3l4gA:
undetectable
5ef3H-3l4gA:
undetectable		 5ef3G-3l4gA:
9.81
5ef3H-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF3_H_TRPH101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5ef3H-3l4gA:
undetectable
5ef3I-3l4gA:
undetectable		 5ef3H-3l4gA:
9.81
5ef3I-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF3_J_TRPJ101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 SER A 332
GLY A 458
THR A 328
HIS A 327
ILE A 373
 None
PHE  A 509 (-3.6A)
None
None
None
 1.42A 5ef3J-3l4gA:
undetectable
5ef3K-3l4gA:
undetectable		 5ef3J-3l4gA:
9.81
5ef3K-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF3_K_TRPK101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.43A 5ef3A-3l4gA:
undetectable
5ef3K-3l4gA:
undetectable		 5ef3A-3l4gA:
9.81
5ef3K-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF3_O_TRPO101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.44A 5ef3N-3l4gA:
undetectable
5ef3O-3l4gA:
undetectable		 5ef3N-3l4gA:
9.81
5ef3O-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF3_R_TRPR101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 9 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.45A 5ef3Q-3l4gA:
undetectable
5ef3R-3l4gA:
undetectable		 5ef3Q-3l4gA:
9.81
5ef3R-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF3_U_TRPU101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)		 3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
(Homo
sapiens) 		5 / 10 GLY A 458
THR A 328
HIS A 327
ILE A 373
SER A 332
 PHE  A 509 (-3.6A)
None
None
None
None
 1.45A 5ef3T-3l4gA:
undetectable
5ef3U-3l4gA:
undetectable		 5ef3T-3l4gA:
9.81
5ef3U-3l4gA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ERG_B_SAMB401_0
(TRNA
(ADENINE(58)-N(1))-M
ETHYLTRANSFERASE
CATALYTIC SUBUNIT
TRM61)		 3s2w TRANSCRIPTIONAL
REGULATOR, MARR
FAMILY
(Methanosarcina
mazei) 		5 / 12 GLY A  46
SER A  47
PHE A  50
VAL A 105
LEU A  67
 GLY  A  46 (-0.0A)
SER  A  47 (-0.0A)
PHE  A  50 ( 1.3A)
VAL  A 105 ( 0.6A)
LEU  A  67 ( 0.6A)
 1.04A 5ergB-3s2wA:
undetectable		 5ergB-3s2wA:
18.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ESJ_A_TPFA602_1
(LANOSTEROL 14-ALPHA
DEMETHYLASE)		 3o96 RAC-ALPHA
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		4 / 8 PHE A 408
ILE A 402
GLY A 254
MET A 343
 PHE  A 408 ( 1.3A)
ILE  A 402 ( 0.4A)
GLY  A 254 ( 0.0A)
MET  A 343 ( 0.0A)
 0.92A 5esjA-3o96A:
undetectable		 5esjA-3o96A:
21.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ESL_A_1YNA701_1
(LANOSTEROL 14-ALPHA
DEMETHYLASE)		 5nqf APICAL MEMBRANE
ANTIGEN 1
(Plasmodium
falciparum) 		5 / 12 GLY A 179
PHE A 342
ILE A 127
GLY A 153
THR A 164
 GLY  A 179 ( 0.0A)
PHE  A 342 ( 1.3A)
ILE  A 127 ( 0.7A)
GLY  A 153 ( 0.0A)
THR  A 164 ( 0.8A)
 1.20A 5eslA-5nqfA:
undetectable		 5eslA-5nqfA:
21.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ESM_A_TPFA602_1
(LANOSTEROL 14-ALPHA
DEMETHYLASE)		 5d7w SERRALYSIN
(Serratia
marcescens) 		4 / 7 ILE A 303
PHE A 281
GLY A 260
THR A 272
 ILE  A 303 ( 0.7A)
PHE  A 281 ( 1.3A)
GLY  A 260 ( 0.0A)
THR  A 272 ( 0.8A)
 1.03A 5esmA-5d7wA:
undetectable		 5esmA-5d7wA:
19.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F9Z_B_HFGB703_0
(AMINOACYL-TRNA
SYNTHETASE)		 5svd NUCLEOLAR PROTEIN 9
(Saccharomyces
cerevisiae) 		5 / 12 LEU A 213
PHE A 258
SER A 257
PHE A 126
GLY A 131
 LEU  A 213 ( 0.6A)
PHE  A 258 ( 1.3A)
SER  A 257 ( 0.0A)
PHE  A 126 ( 1.3A)
GLY  A 131 ( 0.0A)
 1.08A 5f9zB-5svdA:
undetectable		 5f9zB-5svdA:
22.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FSA_A_X2NA590_1
(CYP51 VARIANT1)		 5svd NUCLEOLAR PROTEIN 9
(Saccharomyces
cerevisiae) 		5 / 12 TYR A 497
LEU A 494
PHE A 490
PHE A 501
GLY A 424
 TYR  A 497 ( 1.3A)
LEU  A 494 ( 0.6A)
PHE  A 490 ( 1.3A)
PHE  A 501 ( 1.3A)
GLY  A 424 ( 0.0A)
 1.11A 5fsaA-5svdA:
undetectable		 5fsaA-5svdA:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G08_A_Z80A1187_1
(FREQUENIN 2)		 3pco PHENYLALANYL-TRNA
SYNTHETASE, ALPHA
SUBUNIT
(Escherichia
coli) 		4 / 6 ILE A 175
PHE A 250
THR A 157
TRP A 159
 None
PHE  A 980 (-4.5A)
None
None
 1.36A 5g08A-3pcoA:
undetectable		 5g08A-3pcoA:
17.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G08_A_Z80A1187_1
(FREQUENIN 2)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		4 / 6 ILE A 336
PHE A 341
THR A 409
TRP A 405
 ILE  A 336 ( 0.4A)
PHE  A 341 ( 1.3A)
THR  A 409 ( 0.8A)
TRP  A 405 ( 0.5A)
 1.14A 5g08A-3sl5A:
undetectable		 5g08A-3sl5A:
19.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5GPG_A_RAPA301_1
(PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP3)		 1vho ENDOGLUCANASE
(Thermotoga
maritima) 		5 / 11 LEU A  12
VAL A  32
ILE A  33
ALA A 322
PHE A 198
 LEU  A  12 ( 0.6A)
VAL  A  32 ( 0.5A)
ILE  A  33 ( 0.6A)
ALA  A 322 ( 0.0A)
PHE  A 198 ( 1.3A)
 1.11A 5gpgA-1vhoA:
undetectable		 5gpgA-1vhoA:
18.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5GQB_A_GCSA603_1
(CHITINASE)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		8 / 8 PHE A 184
GLY A 267
TRP A 268
GLU A 308
TYR A 383
ASP A 384
ARG A 439
TRP A 532
 PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
TRP  A 268 ( 0.5A)
GLU  A 308 ( 0.6A)
TYR  A 383 ( 1.3A)
ASP  A 384 ( 0.5A)
ARG  A 439 ( 0.6A)
TRP  A 532 ( 0.5A)
 0.27A 5gqbA-5gprA:
67.9		 5gqbA-5gprA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5H3A_A_D16A401_1
(ORF70)		 1omo ALANINE
DEHYDROGENASE
(Archaeoglobus
fulgidus) 		4 / 7 PHE A 288
ILE A 268
ASP A 277
GLY A 278
 PHE  A 288 ( 1.3A)
ILE  A 268 ( 0.3A)
ASP  A 277 ( 0.5A)
GLY  A 278 ( 0.0A)
 0.86A 5h3aA-1omoA:
undetectable		 5h3aA-1omoA:
20.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5H3A_A_D16A401_1
(ORF70)		 2qj6 TOXIN A
(Clostridioides
difficile) 		4 / 7 PHE A 138
ILE A 133
GLY A 129
PHE A 140
 PHE  A 138 ( 1.3A)
ILE  A 133 ( 0.7A)
GLY  A 129 ( 0.0A)
PHE  A 140 ( 1.3A)
 0.87A 5h3aA-2qj6A:
undetectable		 5h3aA-2qj6A:
18.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5H3A_B_D16B401_1
(ORF70)		 1omo ALANINE
DEHYDROGENASE
(Archaeoglobus
fulgidus) 		4 / 7 PHE A 288
ILE A 268
ASP A 277
GLY A 278
 PHE  A 288 ( 1.3A)
ILE  A 268 ( 0.3A)
ASP  A 277 ( 0.5A)
GLY  A 278 ( 0.0A)
 0.84A 5h3aB-1omoA:
0.0		 5h3aB-1omoA:
20.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5H8T_A_RTLA201_0
(RETINOL-BINDING
PROTEIN 1)		 4ikn AP-3 COMPLEX SUBUNIT
MU-1
(Rattus
norvegicus) 		5 / 12 PHE A 222
LEU A 387
ILE A 210
ARG A 258
LEU A 392
 PHE  A 222 ( 1.3A)
LEU  A 387 ( 0.6A)
ILE  A 210 ( 0.7A)
ARG  A 258 ( 0.6A)
LEU  A 392 ( 0.5A)
 1.17A 5h8tA-4iknA:
undetectable		 5h8tA-4iknA:
20.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HI2_A_BAXA801_2
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 1omo ALANINE
DEHYDROGENASE
(Archaeoglobus
fulgidus) 		5 / 8 ILE A 175
VAL A 207
ILE A 285
ASP A 189
PHE A 128
 ILE  A 175 ( 0.6A)
VAL  A 207 ( 0.6A)
ILE  A 285 ( 0.7A)
ASP  A 189 ( 0.6A)
PHE  A 128 ( 1.3A)
 1.49A 5hi2A-1omoA:
undetectable		 5hi2A-1omoA:
20.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HIE_A_P06A801_2
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 3c3n DIHYDROOROTATE
DEHYDROGENASE
(Trypanosoma
cruzi) 		4 / 7 ILE A 227
GLY A 224
PHE A  17
ASP A 258
 ILE  A 227 (-0.4A)
GLY  A 224 (-0.0A)
PHE  A  17 ( 1.3A)
ASP  A 258 ( 0.5A)
 0.98A 5hieA-3c3nA:
undetectable		 5hieA-3c3nA:
21.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HIE_C_P06C801_2
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 4kqn D-HYDANTOINASE
(Bacillus
sp.
AR9) 		4 / 7 ILE A 348
VAL A 438
ASN A 416
PHE A  83
 ILE  A 348 ( 0.4A)
VAL  A 438 ( 0.6A)
ASN  A 416 ( 0.6A)
PHE  A  83 ( 1.3A)
 0.96A 5hieC-4kqnA:
undetectable		 5hieC-4kqnA:
20.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HIE_D_P06D801_2
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 8 ILE A 228
GLY A 227
PHE A 152
PHE A 214
 ILE  A 228 ( 0.7A)
GLY  A 227 ( 0.0A)
PHE  A 152 ( 1.3A)
PHE  A 214 ( 1.3A)
 0.94A 5hieD-4flxA:
undetectable		 5hieD-4flxA:
16.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HS1_A_VORA602_1
(LANOSTEROL 14-ALPHA
DEMETHYLASE)		 4yzr POLYKETIDE
BIOSYNTHESIS
CYTOCHROME P450 PKSS
(Bacillus
subtilis) 		4 / 8 PHE A 168
ILE A 160
PHE A 193
LEU A 216
 PHE  A 168 ( 1.3A)
ILE  A 160 ( 0.6A)
PHE  A 193 ( 1.3A)
LEU  A 216 ( 0.6A)
 0.85A 5hs1A-4yzrA:
29.2		 5hs1A-4yzrA:
21.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I73_A_68PA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)		 2ogs THERMOSTABLE
CARBOXYLESTERASE
EST50
(Geobacillus
stearothermophil
us) 		5 / 12 ASP A 380
ILE A 304
PHE A 488
LEU A 204
VAL A 306
 ASP  A 380 ( 0.6A)
ILE  A 304 ( 0.7A)
PHE  A 488 ( 1.3A)
LEU  A 204 ( 0.6A)
VAL  A 306 ( 0.6A)
 0.95A 5i73A-2ogsA:
undetectable		 5i73A-2ogsA:
21.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I9Y_A_1N1A1001_2
(EPHRIN TYPE-A
RECEPTOR 2)		 3icc PUTATIVE
3-OXOACYL-(ACYL
CARRIER PROTEIN)
REDUCTASE
(Bacillus
anthracis) 		3 / 3 ILE A 127
ILE A 181
MET A 168
 ILE  A 127 ( 0.7A)
ILE  A 181 ( 0.7A)
PHE  A 124 ( 3.8A)
 0.67A 5i9yA-3iccA:
undetectable		 5i9yA-3iccA:
23.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IGI_A_ZITA402_1
(MACROLIDE
2'-PHOSPHOTRANSFERAS
E)		 4g9k ROTENONE-INSENSITIVE
NADH-UBIQUINONE
OXIDOREDUCTASE
(Saccharomyces
cerevisiae) 		5 / 12 ILE A 298
VAL A 277
GLY A 470
THR A 474
PHE A 475
 ILE  A 298 ( 0.7A)
VAL  A 277 ( 0.6A)
GLY  A 470 ( 0.0A)
THR  A 474 ( 0.8A)
PHE  A 475 ( 1.3A)
 1.22A 5igiA-4g9kA:
undetectable		 5igiA-4g9kA:
20.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IGJ_A_CTYA402_2
(MACROLIDE
2'-PHOSPHOTRANSFERAS
E)		 1gc7 RADIXIN
(Mus
musculus) 		4 / 5 PRO A 154
LEU A 234
TYR A 201
PHE A  85
 PRO  A 154 ( 1.1A)
LEU  A 234 ( 0.6A)
TYR  A 201 ( 1.3A)
PHE  A  85 ( 1.3A)
 1.26A 5igjA-1gc7A:
undetectable		 5igjA-1gc7A:
23.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IL1_A_SAMA601_0
(METTL3)		 2rci TYPE-2BA CYTOLYTIC
DELTA-ENDOTOXIN
(Bacillus
thuringiensis) 		5 / 12 ILE A  83
PRO A 188
LEU A 220
PHE A  64
GLY A  66
 ILE  A  83 ( 0.7A)
PRO  A 188 ( 1.1A)
LEU  A 220 ( 0.6A)
PHE  A  64 ( 1.3A)
GLY  A  66 ( 0.0A)
 0.91A 5il1A-2rciA:
undetectable		 5il1A-2rciA:
21.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IY5_P_CHDP307_0
(CYTOCHROME C OXIDASE
SUBUNIT 3
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 5 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.94A 5iy5P-4flxA:
2.6
5iy5W-4flxA:
undetectable		 5iy5P-4flxA:
13.43
5iy5W-4flxA:
6.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IY5_W_CHDW101_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 3h7a SHORT CHAIN
DEHYDROGENASE
(Rhodopseudomonas
palustris) 		4 / 7 ILE A 135
PHE A 137
THR A  70
LEU A  73
 ILE  A 135 ( 0.6A)
PHE  A 137 ( 1.3A)
THR  A  70 ( 0.8A)
LEU  A  73 ( 0.5A)
 0.91A 5iy5N-3h7aA:
undetectable
5iy5W-3h7aA:
undetectable		 5iy5N-3h7aA:
18.89
5iy5W-3h7aA:
11.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5J7W_C_MTXC402_1
(THYMIDYLATE SYNTHASE)		 1xqw PROLINE
IMINOPEPTIDASE
(Thermoplasma
acidophilum) 		5 / 12 LEU A 284
ASP A 244
GLY A 241
PHE A 266
ALA A 105
 None
None
None
None
PHE  A 300 ( 3.0A)
 1.30A 5j7wC-1xqwA:
undetectable		 5j7wC-1xqwA:
23.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JGL_B_SAMB301_1
(UBIE/COQ5 FAMILY
METHYLTRANSFERASE,
PUTATIVE)		 3pu5 EXTRACELLULAR
SOLUTE-BINDING
PROTEIN
(Bordetella
parapertussis) 		3 / 3 ASP A 136
ASN A  47
PHE A  92
 ASP  A 136 ( 0.6A)
ASN  A  47 ( 0.6A)
PHE  A  92 ( 1.3A)
 0.92A 5jglB-3pu5A:
undetectable		 5jglB-3pu5A:
24.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JS1_A_IPHA902_0
(PROTEIN ARGONAUTE-2)		 3ulk KETOL-ACID
REDUCTOISOMERASE
(Escherichia
coli) 		3 / 3 VAL A 205
ALA A 203
PHE A  22
 VAL  A 205 ( 0.6A)
ALA  A 203 ( 0.0A)
PHE  A  22 ( 1.3A)
 0.86A 5js1A-3ulkA:
undetectable		 5js1A-3ulkA:
19.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JS1_A_IPHA902_0
(PROTEIN ARGONAUTE-2)		 5ve2 ENOYL-COA HYDRATASE
(Pseudoalteromona
s
atlantica) 		3 / 3 VAL A 106
ALA A 138
PHE A 129
 VAL  A 106 ( 0.6A)
ALA  A 138 ( 0.0A)
PHE  A 129 ( 1.3A)
 0.83A 5js1A-5ve2A:
undetectable		 5js1A-5ve2A:
15.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5K7U_A_SAMA601_0
(N6-ADENOSINE-METHYLT
RANSFERASE 70 KDA
SUBUNIT)		 2nvv ACETYL-COA
HYDROLASE/TRANSFERAS
E FAMILY PROTEIN
(Porphyromonas
gingivalis) 		5 / 12 ILE A 358
PRO A 469
LEU A 460
PHE A 359
HIS A 417
 ILE  A 358 ( 0.7A)
PRO  A 469 ( 1.1A)
LEU  A 460 ( 0.6A)
PHE  A 359 ( 1.3A)
HIS  A 417 (-1.0A)
 1.34A 5k7uA-2nvvA:
undetectable		 5k7uA-2nvvA:
17.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5K7U_A_SAMA601_0
(N6-ADENOSINE-METHYLT
RANSFERASE 70 KDA
SUBUNIT)		 2rci TYPE-2BA CYTOLYTIC
DELTA-ENDOTOXIN
(Bacillus
thuringiensis) 		5 / 12 ILE A  83
PRO A 188
LEU A 220
PHE A  64
GLY A  66
 ILE  A  83 ( 0.7A)
PRO  A 188 ( 1.1A)
LEU  A 220 ( 0.6A)
PHE  A  64 ( 1.3A)
GLY  A  66 ( 0.0A)
 0.90A 5k7uA-2rciA:
undetectable		 5k7uA-2rciA:
22.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5KLA_A_ACTA1505_0
(MATERNAL PROTEIN
PUMILIO)		 1aoa T-FIMBRIN
(Homo
sapiens) 		3 / 3 HIS A 304
LYS A 300
PHE A 328
 HIS  A 304 ( 1.0A)
LYS  A 300 ( 0.0A)
PHE  A 328 ( 1.3A)
 1.45A 5klaA-1aoaA:
undetectable		 5klaA-1aoaA:
20.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5KMD_C_6UBC1304_1
(ION TRANSPORT
PROTEIN)		 2j5b TYROSYL-TRNA
SYNTHETASE
(Acanthamoeba
polyphaga
mimivirus) 		4 / 5 ILE A  67
LEU A  90
GLY A  91
PHE A  94
 ILE  A  67 ( 0.7A)
LEU  A  90 ( 0.6A)
GLY  A  91 ( 0.0A)
PHE  A  94 ( 1.3A)
 0.87A 5kmdC-2j5bA:
undetectable
5kmdD-2j5bA:
undetectable		 5kmdC-2j5bA:
22.87
5kmdD-2j5bA:
22.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5KMD_C_6UBC1304_1
(ION TRANSPORT
PROTEIN)		 3s2w TRANSCRIPTIONAL
REGULATOR, MARR
FAMILY
(Methanosarcina
mazei) 		4 / 5 ILE A  25
LEU A 153
GLY A 152
PHE A 149
 ILE  A  25 ( 0.7A)
LEU  A 153 ( 0.6A)
GLY  A 152 ( 0.0A)
PHE  A 149 ( 1.3A)
 0.90A 5kmdC-3s2wA:
undetectable
5kmdD-3s2wA:
2.3		 5kmdC-3s2wA:
17.02
5kmdD-3s2wA:
17.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L6E_A_SAMA601_0
(N6-ADENOSINE-METHYLT
RANSFERASE 70 KDA
SUBUNIT)		 2rci TYPE-2BA CYTOLYTIC
DELTA-ENDOTOXIN
(Bacillus
thuringiensis) 		5 / 12 ILE A  83
PRO A 188
LEU A 220
PHE A  64
GLY A  66
 ILE  A  83 ( 0.7A)
PRO  A 188 ( 1.1A)
LEU  A 220 ( 0.6A)
PHE  A  64 ( 1.3A)
GLY  A  66 ( 0.0A)
 0.92A 5l6eA-2rciA:
undetectable		 5l6eA-2rciA:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5LG3_F_Z80F401_1
(GAMMA-AMINOBUTYRIC-A
CID RECEPTOR SUBUNIT
BETA-1)		 4g9k ROTENONE-INSENSITIVE
NADH-UBIQUINONE
OXIDOREDUCTASE
(Saccharomyces
cerevisiae) 		5 / 10 ILE A 336
PHE A 208
VAL A 233
ASP A 249
ILE A 268
 ILE  A 336 ( 0.7A)
PHE  A 208 ( 1.3A)
VAL  A 233 ( 0.6A)
ASP  A 249 ( 0.6A)
ILE  A 268 ( 0.7A)
 1.25A 5lg3F-4g9kA:
undetectable		 5lg3F-4g9kA:
20.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5LG3_G_Z80G401_1
(GAMMA-AMINOBUTYRIC-A
CID RECEPTOR SUBUNIT
BETA-1)		 4g9k ROTENONE-INSENSITIVE
NADH-UBIQUINONE
OXIDOREDUCTASE
(Saccharomyces
cerevisiae) 		5 / 10 ILE A 336
PHE A 208
VAL A 233
ASP A 249
ILE A 268
 ILE  A 336 ( 0.7A)
PHE  A 208 ( 1.3A)
VAL  A 233 ( 0.6A)
ASP  A 249 ( 0.6A)
ILE  A 268 ( 0.7A)
 1.24A 5lg3G-4g9kA:
undetectable		 5lg3G-4g9kA:
20.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5LG3_H_Z80H401_1
(GAMMA-AMINOBUTYRIC-A
CID RECEPTOR SUBUNIT
BETA-1)		 4g9k ROTENONE-INSENSITIVE
NADH-UBIQUINONE
OXIDOREDUCTASE
(Saccharomyces
cerevisiae) 		5 / 10 ILE A 336
PHE A 208
VAL A 233
ASP A 249
ILE A 268
 ILE  A 336 ( 0.7A)
PHE  A 208 ( 1.3A)
VAL  A 233 ( 0.6A)
ASP  A 249 ( 0.6A)
ILE  A 268 ( 0.7A)
 1.25A 5lg3H-4g9kA:
undetectable		 5lg3H-4g9kA:
20.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5LRB_A_ACRA1003_1
(ALPHA-1,4 GLUCAN
PHOSPHORYLASE)		 5xlu GAMMA GLUTAMYL
TRANSPEPTIDASE
(Bacillus
licheniformis) 		4 / 6 GLU A 151
PHE A 225
THR A 224
TYR A 237
 GLU  A 151 ( 0.6A)
PHE  A 225 ( 1.3A)
THR  A 224 ( 0.8A)
TYR  A 237 ( 1.3A)
 1.29A 5lrbA-5xluA:
undetectable		 5lrbA-5xluA:
6.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5M0O_C_EPAC502_1
(TERMINAL
OLEFIN-FORMING FATTY
ACID DECARBOXYLASE)		 4hne PHOSPHATIDYLINOSITOL
4-KINASE TYPE
2-ALPHA
(Homo
sapiens) 		4 / 8 PHE A 110
ARG A 115
ALA A 117
PHE A 260
 PHE  A 110 ( 1.3A)
ARG  A 115 ( 0.6A)
ALA  A 117 ( 0.0A)
PHE  A 260 ( 1.3A)
 1.05A 5m0oC-4hneA:
undetectable		 5m0oC-4hneA:
21.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MSD_A_BEZA1202_0
(CARBOXYLIC ACID
REDUCTASE)		 4yba REGULATORY PROTEIN C
(Klebsiella
pneumoniae) 		4 / 5 ILE A  57
PHE A  68
SER A  17
ALA A  60
 ILE  A  57 ( 0.7A)
PHE  A  68 ( 1.3A)
SER  A  17 ( 0.0A)
ALA  A  60 ( 0.0A)
 1.25A 5msdA-4ybaA:
undetectable		 5msdA-4ybaA:
6.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MUE_A_VIVA302_0
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)		 2rci TYPE-2BA CYTOLYTIC
DELTA-ENDOTOXIN
(Bacillus
thuringiensis) 		6 / 12 ILE A 205
VAL A 195
ILE A 189
PHE A 143
ILE A 101
ILE A 139
 ILE  A 205 ( 0.7A)
VAL  A 195 ( 0.5A)
ILE  A 189 ( 0.7A)
PHE  A 143 ( 1.3A)
ILE  A 101 ( 0.7A)
ILE  A 139 ( 0.7A)
 1.49A 5mueA-2rciA:
undetectable		 5mueA-2rciA:
20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MUE_A_VIVA302_0
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)		 2rci TYPE-2BA CYTOLYTIC
DELTA-ENDOTOXIN
(Bacillus
thuringiensis) 		6 / 12 ILE A 205
VAL A 195
ILE A 189
PHE A 143
VAL A 100
ILE A 139
 ILE  A 205 ( 0.7A)
VAL  A 195 ( 0.5A)
ILE  A 189 ( 0.7A)
PHE  A 143 ( 1.3A)
VAL  A 100 ( 0.6A)
ILE  A 139 ( 0.7A)
 1.47A 5mueA-2rciA:
undetectable		 5mueA-2rciA:
20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MUG_A_VIVA301_1
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)		 5svd NUCLEOLAR PROTEIN 9
(Saccharomyces
cerevisiae) 		3 / 3 SER A 295
SER A 301
PHE A 325
 SER  A 295 ( 0.0A)
SER  A 301 ( 0.0A)
PHE  A 325 ( 1.3A)
 0.90A 5mugA-5svdA:
undetectable		 5mugA-5svdA:
18.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5N5D_A_SAMA306_0
(METHYLTRANSFERASE)		 1wqa PHOSPHO-SUGAR MUTASE
(Pyrococcus
horikoshii) 		5 / 12 VAL A 268
GLY A 342
PHE A 333
ALA A 343
TYR A 157
 VAL  A 268 ( 0.6A)
GLY  A 342 ( 0.0A)
PHE  A 333 ( 1.3A)
ALA  A 343 ( 0.0A)
TYR  A 157 ( 1.3A)
 1.11A 5n5dA-1wqaA:
undetectable		 5n5dA-1wqaA:
20.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5N5D_B_SAMB303_0
(METHYLTRANSFERASE)		 3td9 BRANCHED CHAIN AMINO
ACID ABC
TRANSPORTER,
PERIPLASMIC AMINO
ACID-BINDING PROTEIN
(Thermotoga
maritima) 		5 / 12 TYR A 166
ILE A  26
GLU A  69
ALA A  77
ALA A 100
 PHE  A 400 (-3.8A)
None
None
None
None
 1.08A 5n5dB-3td9A:
undetectable		 5n5dB-3td9A:
22.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5N9X_A_THRA601_0
(ADENYLATION DOMAIN)		 1amu GRAMICIDIN
SYNTHETASE 1
(Brevibacillus
brevis) 		5 / 7 PHE A 234
ASP A 235
GLY A 302
GLY A 324
LYS A 517
 PHE  A 566 ( 4.5A)
PHE  A 566 (-2.8A)
PHE  A 566 ( 3.6A)
PHE  A 566 (-4.7A)
AMP  A 567 ( 2.8A)
 0.65A 5n9xA-1amuA:
50.1		 5n9xA-1amuA:
30.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5NOO_A_D16A402_1
(THYMIDYLATE SYNTHASE)		 5me6 EUKARYOTIC
TRANSCRIPTION
INITIATION FACTOR 4E
(Cucumis
melo) 		4 / 7 ILE A 186
ASP A 168
GLY A 167
PHE A 164
 ILE  A 186 ( 0.7A)
ASP  A 168 ( 0.6A)
GLY  A 167 ( 0.0A)
PHE  A 164 ( 1.3A)
 0.87A 5nooA-5me6A:
undetectable		 5nooA-5me6A:
19.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5NOO_B_D16B402_1
(THYMIDYLATE SYNTHASE)		 5me6 EUKARYOTIC
TRANSCRIPTION
INITIATION FACTOR 4E
(Cucumis
melo) 		4 / 7 ILE A 186
ASP A 168
GLY A 167
PHE A 164
 ILE  A 186 ( 0.7A)
ASP  A 168 ( 0.6A)
GLY  A 167 ( 0.0A)
PHE  A 164 ( 1.3A)
 0.88A 5nooB-5me6A:
undetectable		 5nooB-5me6A:
19.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5NZY_A_CE3A1102_1
(DNA CROSS-LINK
REPAIR 1A PROTEIN)		 5w6l RTX
REPEAT-CONTAINING
CYTOTOXIN
(Vibrio
vulnificus) 		4 / 7 PHE A3696
ARG A3629
ILE A3632
GLY A3628
 PHE  A3696 ( 1.3A)
ARG  A3629 ( 0.6A)
ILE  A3632 ( 0.7A)
GLY  A3628 ( 0.0A)
 0.99A 5nzyA-5w6lA:
undetectable		 5nzyA-5w6lA:
14.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5OM3_B_DXTB501_1
(ALPHA-1-ANTICHYMOTRY
PSIN)		 5hiu GTPASE
ACTIVATOR-LIKE
PROTEIN
(Chaetomium
thermophilum) 		4 / 6 LEU A 251
SER A 252
PHE A 255
HIS A 299
 LEU  A 251 ( 0.5A)
SER  A 252 ( 0.0A)
PHE  A 255 ( 1.3A)
HIS  A 299 ( 1.0A)
 1.09A 5om3A-5hiuA:
undetectable
5om3B-5hiuA:
undetectable		 5om3A-5hiuA:
11.93
5om3B-5hiuA:
9.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ONL_A_010A302_0
(YNDL)		 2bzt PROTEIN ISCX
(Escherichia
coli) 		4 / 5 GLU A  55
LYS A  52
GLU A  51
PHE A  29
 GLU  A  55 ( 0.6A)
LYS  A  52 ( 0.0A)
GLU  A  51 ( 0.6A)
PHE  A  29 ( 1.3A)
 1.37A 5onlA-2bztA:
undetectable		 5onlA-2bztA:
16.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TE0_A_XINA401_1
(AP2-ASSOCIATED
PROTEIN KINASE 1)		 5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE
(Homo
sapiens) 		6 / 12 GLU A  29
ALA A  52
GLU A  69
PHE A 107
GLY A 111
LEU A 160
 GLU  A  29 ( 0.6A)
ALA  A  52 (-0.0A)
GLU  A  69 ( 0.6A)
PHE  A 107 ( 1.3A)
GLY  A 111 (-0.0A)
LEU  A 160 (-0.6A)
 0.65A 5te0A-5d7aA:
24.8		 5te0A-5d7aA:
26.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TL8_A_X2NA502_1
(PROTEIN CYP51)		 1k5d RAN-SPECIFIC
GTPASE-ACTIVATING
PROTEIN
(Homo
sapiens) 		5 / 12 PHE B 142
ALA B 148
ALA B  85
MET B  90
THR B 153
 PHE  B 142 ( 1.3A)
ALA  B 148 ( 0.0A)
ALA  B  85 ( 0.0A)
MET  B  90 ( 0.0A)
THR  B 153 ( 0.8A)
 1.25A 5tl8A-1k5dB:
undetectable		 5tl8A-1k5dB:
17.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UHB_C_RFPC1201_2
(DNA-DIRECTED RNA
POLYMERASE SUBUNIT
BETA)		 1aoa T-FIMBRIN
(Homo
sapiens) 		3 / 3 PHE A 369
ASP A 357
LEU A 231
 PHE  A 369 ( 1.3A)
ASP  A 357 ( 0.6A)
LEU  A 231 ( 0.6A)
 0.77A 5uhbC-1aoaA:
0.0		 5uhbC-1aoaA:
13.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UHC_C_RFPC1201_2
(DNA-DIRECTED RNA
POLYMERASE SUBUNIT
BETA)		 1aoa T-FIMBRIN
(Homo
sapiens) 		3 / 3 PHE A 369
ASP A 357
LEU A 231
 PHE  A 369 ( 1.3A)
ASP  A 357 ( 0.6A)
LEU  A 231 ( 0.6A)
 0.68A 5uhcC-1aoaA:
0.0		 5uhcC-1aoaA:
13.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UHD_C_RFPC1201_2
(DNA-DIRECTED RNA
POLYMERASE SUBUNIT
BETA)		 5w0a GLUCANASE
(Trichoderma
harzianum) 		4 / 4 ARG A 271
PHE A 209
ASP A 198
LEU A 137
 ARG  A 271 ( 0.6A)
PHE  A 209 ( 1.3A)
ASP  A 198 (-0.6A)
LEU  A 137 ( 0.6A)
 1.45A 5uhdC-5w0aA:
0.3		 5uhdC-5w0aA:
4.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UJX_A_FOLA201_0
(DIHYDROFOLATE
REDUCTASE)		 3eqz RESPONSE REGULATOR
(Colwellia
psychrerythraea) 		5 / 12 LEU A 114
PHE A 117
ILE A  48
LEU A 121
ILE A 102
 LEU  A 114 ( 0.6A)
PHE  A 117 ( 1.3A)
ILE  A  48 ( 0.7A)
LEU  A 121 ( 0.6A)
ILE  A 102 ( 0.7A)
 0.90A 5ujxA-3eqzA:
undetectable		 5ujxA-3eqzA:
17.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UXC_A_ZITA306_1
(PREDICTED
AMINOGLYCOSIDE
PHOSPHOTRANSFERASE)		 5jja SERINE/THREONINE-PRO
TEIN PHOSPHATASE 2A
56 KDA REGULATORY
SUBUNIT GAMMA
ISOFORM
(Homo
sapiens) 		4 / 7 THR A 282
PHE A 274
ASP A 278
LEU A 239
 THR  A 282 ( 0.8A)
PHE  A 274 ( 1.3A)
ASP  A 278 ( 0.6A)
LEU  A 239 ( 0.6A)
 1.25A 5uxcA-5jjaA:
undetectable		 5uxcA-5jjaA:
20.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UXD_A_ZITA501_1
(MACROLIDE
2'-PHOSPHOTRANSFERAS
E MPHH)		 2ogs THERMOSTABLE
CARBOXYLESTERASE
EST50
(Geobacillus
stearothermophil
us) 		4 / 7 GLU A 310
PHE A 314
ALA A 109
GLY A 107
 GLU  A 310 ( 0.6A)
PHE  A 314 ( 1.3A)
ALA  A 109 ( 0.0A)
GLY  A 107 ( 0.0A)
 1.05A 5uxdA-2ogsA:
undetectable		 5uxdA-2ogsA:
21.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V5Z_A_1YNA602_1
(LANOSTEROL 14-ALPHA
DEMETHYLASE)		 3pu5 EXTRACELLULAR
SOLUTE-BINDING
PROTEIN
(Bordetella
parapertussis) 		5 / 12 PHE A 219
PHE A 216
GLY A 239
THR A 244
LEU A 229
 PHE  A 219 ( 1.3A)
PHE  A 216 ( 1.3A)
GLY  A 239 ( 0.0A)
THR  A 244 ( 0.8A)
LEU  A 229 ( 0.5A)
 1.23A 5v5zA-3pu5A:
undetectable		 5v5zA-3pu5A:
21.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VEU_H_RITH602_1
(CYTOCHROME P450 3A5)		 1wqa PHOSPHO-SUGAR MUTASE
(Pyrococcus
horikoshii) 		5 / 12 LEU A 194
PHE A 360
GLY A 235
PHE A 353
ALA A 354
 LEU  A 194 ( 0.6A)
PHE  A 360 ( 1.3A)
GLY  A 235 ( 0.0A)
PHE  A 353 ( 1.3A)
ALA  A 354 ( 0.0A)
 0.95A 5veuH-1wqaA:
undetectable		 5veuH-1wqaA:
23.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VKQ_A_PCFA1805_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)		 3eqz RESPONSE REGULATOR
(Colwellia
psychrerythraea) 		4 / 7 PHE A  38
VAL A  63
ILE A  77
SER A  72
 PHE  A  38 ( 1.3A)
VAL  A  63 ( 0.6A)
ILE  A  77 ( 0.7A)
SER  A  72 ( 0.0A)
 1.02A 5vkqA-3eqzA:
undetectable
5vkqD-3eqzA:
undetectable		 5vkqA-3eqzA:
5.66
5vkqD-3eqzA:
5.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VKQ_B_PCFB1802_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)		 5cdn DNA GYRASE SUBUNIT A
(Staphylococcus
aureus) 		4 / 7 THR A 486
PHE A 218
HIS A 186
ILE A 213
 THR  A 486 ( 0.8A)
PHE  A 218 ( 1.3A)
HIS  A 186 ( 1.0A)
ILE  A 213 ( 0.6A)
 1.15A 5vkqA-5cdnA:
3.2
5vkqB-5cdnA:
3.2		 5vkqA-5cdnA:
14.36
5vkqB-5cdnA:
14.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VKQ_B_PCFB1806_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)		 3ik5 PROTEIN NEF
(Simian
immunodeficiency
virus) 		4 / 6 ILE A 153
ILE A 123
LEU A 142
PHE A 215
 ILE  A 153 ( 0.7A)
ILE  A 123 ( 0.7A)
LEU  A 142 ( 0.6A)
PHE  A 215 ( 1.3A)
 0.88A 5vkqB-3ik5A:
undetectable
5vkqC-3ik5A:
undetectable		 5vkqB-3ik5A:
6.00
5vkqC-3ik5A:
6.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VKQ_C_PCFC1803_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)		 3eqz RESPONSE REGULATOR
(Colwellia
psychrerythraea) 		4 / 8 SER A 120
PHE A  26
VAL A 113
ILE A  50
 SER  A 120 ( 0.0A)
PHE  A  26 ( 1.3A)
VAL  A 113 ( 0.6A)
ILE  A  50 ( 0.7A)
 1.11A 5vkqB-3eqzA:
undetectable
5vkqC-3eqzA:
undetectable		 5vkqB-3eqzA:
5.66
5vkqC-3eqzA:
5.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VKQ_C_PCFC1803_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)		 5cdn DNA GYRASE SUBUNIT A
(Staphylococcus
aureus) 		4 / 8 THR A 486
PHE A 218
HIS A 186
ILE A 213
 THR  A 486 ( 0.8A)
PHE  A 218 ( 1.3A)
HIS  A 186 ( 1.0A)
ILE  A 213 ( 0.6A)
 1.15A 5vkqB-5cdnA:
3.2
5vkqC-5cdnA:
3.2		 5vkqB-5cdnA:
14.36
5vkqC-5cdnA:
14.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VKQ_C_PCFC1807_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)		 3ik5 PROTEIN NEF
(Simian
immunodeficiency
virus) 		4 / 6 ILE A 153
ILE A 123
LEU A 142
PHE A 215
 ILE  A 153 ( 0.7A)
ILE  A 123 ( 0.7A)
LEU  A 142 ( 0.6A)
PHE  A 215 ( 1.3A)
 0.90A 5vkqC-3ik5A:
undetectable
5vkqD-3ik5A:
undetectable		 5vkqC-3ik5A:
6.00
5vkqD-3ik5A:
6.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VKQ_D_PCFD1803_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)		 5cdn DNA GYRASE SUBUNIT A
(Staphylococcus
aureus) 		4 / 7 THR A 486
PHE A 218
HIS A 186
ILE A 213
 THR  A 486 ( 0.8A)
PHE  A 218 ( 1.3A)
HIS  A 186 ( 1.0A)
ILE  A 213 ( 0.6A)
 1.12A 5vkqC-5cdnA:
3.2
5vkqD-5cdnA:
3.2		 5vkqC-5cdnA:
14.36
5vkqD-5cdnA:
14.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUS_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 3r6y ASPARTASE
(Bacillus
sp.
YM55-1) 		4 / 7 MET A 298
VAL A 310
PHE A 178
GLU A 308
 MET  A 298 ( 0.0A)
VAL  A 310 ( 0.6A)
PHE  A 178 ( 1.3A)
GLU  A 308 ( 0.6A)
 1.40A 5vusA-3r6yA:
undetectable
5vusB-3r6yA:
undetectable		 5vusA-3r6yA:
22.39
5vusB-3r6yA:
22.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5W97_C_CHDC306_0
(CYTOCHROME C OXIDASE
SUBUNIT 3
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 6 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.95A 5w97C-4flxA:
undetectable
5w97J-4flxA:
undetectable		 5w97C-4flxA:
13.49
5w97J-4flxA:
6.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5W97_C_CHDC306_0
(CYTOCHROME C OXIDASE
SUBUNIT 3
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 5d7w SERRALYSIN
(Serratia
marcescens) 		4 / 6 LYS A  57
LEU A  58
PHE A  60
LEU A 182
 LYS  A  57 ( 0.0A)
LEU  A  58 ( 0.6A)
PHE  A  60 ( 1.3A)
LEU  A 182 ( 0.6A)
 0.93A 5w97C-5d7wA:
undetectable
5w97J-5d7wA:
undetectable		 5w97C-5d7wA:
19.92
5w97J-5d7wA:
8.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5WK9_A_CAMA503_0
(CAMPHOR
5-MONOOXYGENASE)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		4 / 7 PHE C 251
LEU C 280
VAL C 289
ASP C 273
 PHE  C 251 ( 1.3A)
LEU  C 280 ( 0.5A)
VAL  C 289 ( 0.5A)
ASP  C 273 ( 0.6A)
 1.02A 5wk9A-5lmxC:
undetectable		 5wk9A-5lmxC:
23.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5WM2_A_SALA601_1
(SALICYLATE-AMP
LIGASE)		 3wd7 TYPE III POLYKETIDE
SYNTHASES ACRIDONE
SYNTHASE
(Citrus
x
microcarpa) 		5 / 9 PHE A 373
GLY A 372
VAL A 379
GLY A 374
LEU A 377
 PHE  A 373 ( 1.3A)
GLY  A 372 ( 0.0A)
VAL  A 379 ( 0.6A)
GLY  A 374 ( 0.0A)
LEU  A 377 ( 0.6A)
 1.33A 5wm2A-3wd7A:
0.0		 5wm2A-3wd7A:
14.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X19_P_CHDP305_0
(CYTOCHROME C OXIDASE
SUBUNIT 3)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 6 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.90A 5x19P-4flxA:
2.7		 5x19P-4flxA:
13.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X19_P_CHDP305_0
(CYTOCHROME C OXIDASE
SUBUNIT 3)		 5d7w SERRALYSIN
(Serratia
marcescens) 		4 / 6 LYS A  57
LEU A  58
PHE A  60
LEU A 182
 LYS  A  57 ( 0.0A)
LEU  A  58 ( 0.6A)
PHE  A  60 ( 1.3A)
LEU  A 182 ( 0.6A)
 0.91A 5x19P-5d7wA:
undetectable		 5x19P-5d7wA:
19.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X1B_P_CHDP305_0
(CYTOCHROME C OXIDASE
SUBUNIT 3)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 5 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.92A 5x1bP-4flxA:
1.3		 5x1bP-4flxA:
13.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X1F_C_CHDC304_0
(CYTOCHROME C OXIDASE
SUBUNIT 3
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 5 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.95A 5x1fC-4flxA:
undetectable
5x1fJ-4flxA:
undetectable		 5x1fC-4flxA:
13.49
5x1fJ-4flxA:
6.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X1F_C_CHDC304_0
(CYTOCHROME C OXIDASE
SUBUNIT 3
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 5c6d UBIQUITIN
CARBOXYL-TERMINAL
HYDROLASE 7
(Homo
sapiens) 		4 / 5 LEU A 622
PHE A 661
LEU A 609
PHE A 594
 LEU  A 622 ( 0.6A)
PHE  A 661 ( 1.3A)
LEU  A 609 ( 0.6A)
PHE  A 594 ( 1.3A)
 1.19A 5x1fC-5c6dA:
undetectable
5x1fJ-5c6dA:
undetectable		 5x1fC-5c6dA:
19.21
5x1fJ-5c6dA:
11.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X1F_P_CHDP304_0
(CYTOCHROME C OXIDASE
SUBUNIT 3
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 7 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.91A 5x1fP-4flxA:
undetectable
5x1fW-4flxA:
undetectable		 5x1fP-4flxA:
13.49
5x1fW-4flxA:
6.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X1F_P_CHDP304_0
(CYTOCHROME C OXIDASE
SUBUNIT 3
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 5d7w SERRALYSIN
(Serratia
marcescens) 		4 / 7 LYS A  57
LEU A  58
PHE A  60
LEU A 182
 LYS  A  57 ( 0.0A)
LEU  A  58 ( 0.6A)
PHE  A  60 ( 1.3A)
LEU  A 182 ( 0.6A)
 0.90A 5x1fP-5d7wA:
undetectable
5x1fW-5d7wA:
undetectable		 5x1fP-5d7wA:
19.92
5x1fW-5d7wA:
8.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X23_A_LSNA504_1
(CYTOCHROME P450 2C9)		 2qc5 STREPTOGRAMIN B
LACTONASE
(Staphylococcus
cohnii) 		4 / 8 PHE A 198
ILE A 230
PRO A 221
PRO A 227
 PHE  A 198 ( 1.3A)
ILE  A 230 ( 0.6A)
PRO  A 221 ( 1.1A)
PRO  A 227 ( 1.1A)
 1.08A 5x23A-2qc5A:
undetectable		 5x23A-2qc5A:
20.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X66_A_MTXA402_1
(THYMIDYLATE SYNTHASE)		 2vbf BRANCHED-CHAIN
ALPHA-KETOACID
DECARBOXYLASE
(Lactococcus
lactis) 		5 / 12 LEU A  69
GLY A  22
PHE A  21
ASN A  46
ASP A  40
 LEU  A  69 ( 0.5A)
GLY  A  22 ( 0.0A)
PHE  A  21 ( 1.3A)
ASN  A  46 ( 0.6A)
ASP  A  40 ( 0.6A)
 1.13A 5x66A-2vbfA:
undetectable
5x66B-2vbfA:
undetectable		 5x66A-2vbfA:
19.89
5x66B-2vbfA:
19.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XDX_C_CHDC308_0
(CYTOCHROME C OXIDASE
SUBUNIT 3
CYTOCHROME C OXIDASE
SUBUNIT VIIA-HEART)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 5 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.93A 5xdxC-4flxA:
2.6
5xdxJ-4flxA:
undetectable		 5xdxC-4flxA:
13.37
5xdxJ-4flxA:
6.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XDX_P_CHDP306_0
(CYTOCHROME C OXIDASE
SUBUNIT 3
CYTOCHROME C OXIDASE
SUBUNIT VIIA-HEART)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 5 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.95A 5xdxP-4flxA:
2.6
5xdxW-4flxA:
undetectable		 5xdxP-4flxA:
13.37
5xdxW-4flxA:
6.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XV7_A_EMHA705_1
(SERINE-ARGININE (SR)
PROTEIN KINASE 1)		 3ulk KETOL-ACID
REDUCTOISOMERASE
(Escherichia
coli) 		5 / 12 ARG A  76
GLY A  44
ALA A  82
PHE A  87
GLY A  90
 ARG  A  76 (-0.6A)
GLY  A  44 (-0.0A)
ALA  A  82 ( 0.0A)
PHE  A  87 ( 1.3A)
GLY  A  90 ( 0.0A)
 0.83A 5xv7A-3ulkA:
undetectable		 5xv7A-3ulkA:
12.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y2O_A_8N6A501_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)		 5ec3 4-HYDROXYPHENYLPYRUV
ATE DIOXYGENASE
(Homo
sapiens) 		5 / 12 PHE A  42
LEU A 346
PHE A  69
LEU A 178
LEU A 286
 PHE  A  42 ( 1.3A)
LEU  A 346 ( 0.6A)
PHE  A  69 ( 1.3A)
LEU  A 178 ( 0.6A)
LEU  A 286 ( 0.6A)
 1.35A 5y2oA-5ec3A:
undetectable		 5y2oA-5ec3A:
9.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y2T_B_8LXB501_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)		 5ec3 4-HYDROXYPHENYLPYRUV
ATE DIOXYGENASE
(Homo
sapiens) 		4 / 8 HIS A  20
PHE A  69
PHE A  42
LEU A 348
 HIS  A  20 ( 1.0A)
PHE  A  69 ( 1.3A)
PHE  A  42 ( 1.3A)
LEU  A 348 ( 0.6A)
 1.11A 5y2tB-5ec3A:
undetectable		 5y2tB-5ec3A:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YSI_A_NCAA1001_0
(UBIQUITINATING/DEUBI
QUITINATING ENZYME
SDEA)		 1xqw PROLINE
IMINOPEPTIDASE
(Thermoplasma
acidophilum) 		4 / 6 GLY A 129
SER A 132
THR A 137
VAL A 246
 None
None
PHE  A 300 (-3.9A)
None
 1.21A 5ysiA-1xqwA:
0.0		 5ysiA-1xqwA:
17.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Z6J_A_FOLA201_0
(DIHYDROFOLATE
REDUCTASE)		 3eqz RESPONSE REGULATOR
(Colwellia
psychrerythraea) 		5 / 12 LEU A 114
PHE A 117
ILE A  48
LEU A 121
ILE A 102
 LEU  A 114 ( 0.6A)
PHE  A 117 ( 1.3A)
ILE  A  48 ( 0.7A)
LEU  A 121 ( 0.6A)
ILE  A 102 ( 0.7A)
 0.90A 5z6jA-3eqzA:
undetectable		 5z6jA-3eqzA:
17.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Z6K_A_FOLA201_0
(DIHYDROFOLATE
REDUCTASE)		 3eqz RESPONSE REGULATOR
(Colwellia
psychrerythraea) 		5 / 12 LEU A 114
PHE A 117
ILE A  48
LEU A 121
ILE A 102
 LEU  A 114 ( 0.6A)
PHE  A 117 ( 1.3A)
ILE  A  48 ( 0.7A)
LEU  A 121 ( 0.6A)
ILE  A 102 ( 0.7A)
 0.90A 5z6kA-3eqzA:
undetectable		 5z6kA-3eqzA:
17.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Z6M_A_FOLA201_0
(DIHYDROFOLATE
REDUCTASE)		 2qvs CAMP-DEPENDENT
PROTEIN KINASE TYPE
II-ALPHA REGULATORY
SUBUNIT
(Mus
musculus) 		5 / 11 ASP B 229
LEU B 228
PHE B 233
LEU B 139
ILE B 237
 ASP  B 229 ( 0.5A)
LEU  B 228 ( 0.6A)
PHE  B 233 ( 1.3A)
LEU  B 139 ( 0.6A)
ILE  B 237 ( 0.6A)
 1.07A 5z6mA-2qvsB:
undetectable		 5z6mA-2qvsB:
18.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Z85_C_CHDC306_0
(CYTOCHROME C OXIDASE
SUBUNIT 3
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 7 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.93A 5z85C-4flxA:
undetectable
5z85J-4flxA:
undetectable		 5z85C-4flxA:
13.49
5z85J-4flxA:
6.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ZCO_C_CHDC306_0
(CYTOCHROME C OXIDASE
SUBUNIT 3
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 7 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.88A 5zcoC-4flxA:
2.6
5zcoJ-4flxA:
undetectable		 5zcoC-4flxA:
13.49
5zcoJ-4flxA:
6.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ZCP_W_CHDW101_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 3h7a SHORT CHAIN
DEHYDROGENASE
(Rhodopseudomonas
palustris) 		4 / 8 ILE A 135
PHE A 137
THR A  70
LEU A  73
 ILE  A 135 ( 0.6A)
PHE  A 137 ( 1.3A)
THR  A  70 ( 0.8A)
LEU  A  73 ( 0.5A)
 0.89A 5zcpN-3h7aA:
undetectable
5zcpW-3h7aA:
undetectable		 5zcpN-3h7aA:
18.89
5zcpW-3h7aA:
11.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ZCQ_C_CHDC306_0
(CYTOCHROME C OXIDASE
SUBUNIT 3
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 7 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.91A 5zcqC-4flxA:
undetectable
5zcqJ-4flxA:
undetectable		 5zcqC-4flxA:
13.49
5zcqJ-4flxA:
6.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ZCQ_P_CHDP306_0
(CYTOCHROME C OXIDASE
SUBUNIT 3
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		4 / 7 ARG A 266
LEU A 352
PHE A 356
LEU A 333
 ARG  A 266 ( 0.6A)
LEU  A 352 ( 0.6A)
PHE  A 356 ( 1.3A)
LEU  A 333 ( 0.6A)
 0.93A 5zcqP-4flxA:
2.6
5zcqW-4flxA:
undetectable		 5zcqP-4flxA:
13.49
5zcqW-4flxA:
6.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ZW4_A_SAMA302_0
(PUTATIVE
O-METHYLTRANSFERASE
YRRM)		 6c0w HISTONE H3-LIKE
CENTROMERIC PROTEIN
A
HISTONE H4
(Homo
sapiens;
Homo
sapiens) 		5 / 12 TYR B  88
ASN B  64
ALA A  71
ALA A  98
PHE A  67
 TYR  B  88 ( 1.3A)
ASN  B  64 ( 0.6A)
ALA  A  71 ( 0.0A)
ALA  A  98 ( 0.0A)
PHE  A  67 ( 1.3A)
 1.05A 5zw4A-6c0wB:
undetectable		 5zw4A-6c0wB:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ZWR_B_9KLB402_0
(EST-Y29)		 3c3n DIHYDROOROTATE
DEHYDROGENASE
(Trypanosoma
cruzi) 		5 / 12 TYR A 159
PHE A  78
ILE A 100
LEU A  98
ALA A 116
 TYR  A 159 ( 1.3A)
PHE  A  78 ( 1.3A)
ILE  A 100 ( 0.6A)
LEU  A  98 ( 0.6A)
ALA  A 116 ( 0.0A)
 1.37A 5zwrB-3c3nA:
undetectable		 5zwrB-3c3nA:
21.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6A7P_B_9SCB601_0
(SERUM ALBUMIN)		 4ikn AP-3 COMPLEX SUBUNIT
MU-1
(Rattus
norvegicus) 		5 / 12 VAL A 183
LEU A 220
ARG A 246
PHE A 222
LEU A 387
 VAL  A 183 ( 0.6A)
LEU  A 220 ( 0.6A)
ARG  A 246 ( 0.6A)
PHE  A 222 ( 1.3A)
LEU  A 387 ( 0.6A)
 1.45A 6a7pB-4iknA:
undetectable		 6a7pB-4iknA:
18.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6A7P_B_9SCB601_1
(SERUM ALBUMIN)		 5nks DIHYDROPYRIMIDINASE-
RELATED PROTEIN 4
(Homo
sapiens) 		4 / 6 ASN A  26
PHE A  31
LEU A 409
SER A 405
 ASN  A  26 ( 0.6A)
PHE  A  31 ( 1.3A)
LEU  A 409 ( 0.5A)
SER  A 405 ( 0.0A)
 1.25A 6a7pB-5nksA:
undetectable		 6a7pB-5nksA:
21.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6A93_B_8NUB3001_0
(5-HYDROXYTRYPTAMINE
RECEPTOR 2A,SOLUBLE
CYTOCHROME B562)		 1szb MANNOSE BINDING
LECTIN-ASSOCIATED
SERINE PROTEASE-2
RELATED PROTEIN,
MAP19 (19KDA)
(Homo
sapiens) 		5 / 12 TYR A  92
THR A  82
LEU A  71
PHE A  49
LEU A  44
 TYR  A  92 ( 1.3A)
THR  A  82 ( 0.8A)
LEU  A  71 ( 0.6A)
PHE  A  49 ( 1.3A)
LEU  A  44 ( 0.6A)
 1.31A 6a93B-1szbA:
undetectable		 6a93B-1szbA:
19.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6A94_B_ZOTB3001_0
(5-HYDROXYTRYPTAMINE
RECEPTOR 2A,SOLUBLE
CYTOCHROME B562)		 4gow POTASSIUM
VOLTAGE-GATED
CHANNEL SUBFAMILY
KQT MEMBER 4
CALMODULIN
(Homo
sapiens;
Homo
sapiens) 		5 / 12 VAL A 533
THR A 532
LEU D 112
PHE D  92
VAL D  91
 VAL  A 533 ( 0.6A)
THR  A 532 ( 0.8A)
LEU  D 112 ( 0.6A)
PHE  D  92 ( 1.3A)
VAL  D  91 ( 0.6A)
 1.08A 6a94B-4gowA:
undetectable		 6a94B-4gowA:
14.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV1_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 3r6y ASPARTASE
(Bacillus
sp.
YM55-1) 		4 / 7 MET A 298
VAL A 310
PHE A 178
GLU A 308
 MET  A 298 ( 0.0A)
VAL  A 310 ( 0.6A)
PHE  A 178 ( 1.3A)
GLU  A 308 ( 0.6A)
 1.43A 6av1A-3r6yA:
undetectable
6av1B-3r6yA:
undetectable		 6av1A-3r6yA:
12.98
6av1B-3r6yA:
12.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWT_D_BEZD202_0
(PR 10 PROTEIN)		 4ov1 PUTATIVE FERREDOXIN
(Rhodopseudomonas
palustris) 		3 / 3 PHE A  28
ASP A  29
LYS A  39
 PHE  A  28 ( 1.3A)
ASP  A  29 ( 0.6A)
LYS  A  39 ( 0.0A)
 0.75A 6awtD-4ov1A:
undetectable		 6awtD-4ov1A:
20.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AY4_A_TPFA506_1
(CYP51, STEROL
14ALPHA-DEMETHYLASE)		 1rrv GLYCOSYLTRANSFERASE
GTFD
(Amycolatopsis
orientalis) 		5 / 10 TYR A 188
ALA A 159
PHE A 162
ALA A 163
LEU A 170
 TYR  A 188 ( 1.3A)
ALA  A 159 ( 0.0A)
PHE  A 162 ( 1.3A)
ALA  A 163 ( 0.0A)
LEU  A 170 ( 0.6A)
 1.26A 6ay4A-1rrvA:
undetectable		 6ay4A-1rrvA:
22.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B89_B_NOVB403_1
(LIPOPOLYSACCHARIDE
EXPORT SYSTEM
ATP-BINDING PROTEIN
LPTB)		 2jrs RNA-BINDING PROTEIN
39
(Homo
sapiens) 		4 / 7 PHE A  75
ARG A  28
ALA A  84
GLN A  57
 PHE  A  75 ( 1.3A)
ARG  A  28 ( 0.6A)
ALA  A  84 ( 0.0A)
GLN  A  57 ( 0.6A)
 1.31A 6b89A-2jrsA:
undetectable		 6b89A-2jrsA:
25.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6BQG_A_ERMA1201_1
(5-HYDROXYTRYPTAMINE
RECEPTOR 2C,SOLUBLE
CYTOCHROME B562)		 5ep8 PYRIMIDINE-NUCLEOSID
E PHOSPHORYLASE
(Bacillus
subtilis) 		5 / 12 SER A 110
GLY A 192
ALA A 191
PHE A 139
ASN A 315
 SER  A 110 (-0.0A)
GLY  A 192 ( 0.0A)
ALA  A 191 ( 0.0A)
PHE  A 139 ( 1.3A)
ASN  A 315 ( 0.6A)
 1.19A 6bqgA-5ep8A:
undetectable		 6bqgA-5ep8A:
9.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CE2_B_SVRB202_2
(-)		 3pco PHENYLALANYL-TRNA
SYNTHETASE, ALPHA
SUBUNIT
PHENYLALANYL-TRNA
SYNTHETASE, BETA
CHAIN
(Escherichia
coli) 		5 / 12 LEU A 227
LEU A 223
GLY A 296
GLY A 271
ASN B 472
 None
None
PHE  A 980 (-3.6A)
PHE  A 980 (-4.0A)
None
 0.89A 6ce2B-3pcoA:
undetectable		 6ce2B-3pcoA:
16.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CP4_A_CAMA422_0
(CYTOCHROME P450CAM)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		4 / 8 PHE C 251
LEU C 280
VAL C 289
ASP C 273
 PHE  C 251 ( 1.3A)
LEU  C 280 ( 0.5A)
VAL  C 289 ( 0.5A)
ASP  C 273 ( 0.6A)
 0.97A 6cp4A-5lmxC:
undetectable		 6cp4A-5lmxC:
22.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6E43_A_BEZA502_0
(INDOLEAMINE
2,3-DIOXYGENASE 1)		 3c3n DIHYDROOROTATE
DEHYDROGENASE
(Trypanosoma
cruzi) 		4 / 6 PHE A 306
VAL A 270
LEU A   6
LEU A 303
 PHE  A 306 ( 1.3A)
VAL  A 270 ( 0.6A)
LEU  A   6 ( 0.6A)
LEU  A 303 ( 0.6A)
 1.03A 6e43A-3c3nA:
undetectable		 6e43A-3c3nA:
23.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6E43_C_BEZC502_0
(INDOLEAMINE
2,3-DIOXYGENASE 1)		 3c3n DIHYDROOROTATE
DEHYDROGENASE
(Trypanosoma
cruzi) 		4 / 6 PHE A 306
VAL A 270
LEU A   6
LEU A 303
 PHE  A 306 ( 1.3A)
VAL  A 270 ( 0.6A)
LEU  A   6 ( 0.6A)
LEU  A 303 ( 0.6A)
 1.02A 6e43C-3c3nA:
undetectable		 6e43C-3c3nA:
23.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EBP_B_DAHB123_0
(RIBONUCLEOSIDE-DIPHO
SPHATE REDUCTASE,
BETA SUBUNIT)		 5hiu GTPASE
ACTIVATOR-LIKE
PROTEIN
(Chaetomium
thermophilum) 		5 / 10 PHE A 207
LEU A 210
THR A 211
GLY A 276
ILE A 274
 PHE  A 207 ( 1.3A)
LEU  A 210 ( 0.5A)
THR  A 211 ( 0.8A)
GLY  A 276 ( 0.0A)
ILE  A 274 ( 0.7A)
 0.87A 6ebpB-5hiuA:
undetectable		 6ebpB-5hiuA:
9.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EBP_C_DAHC123_0
(RIBONUCLEOSIDE-DIPHO
SPHATE REDUCTASE,
BETA SUBUNIT)		 5hiu GTPASE
ACTIVATOR-LIKE
PROTEIN
(Chaetomium
thermophilum) 		5 / 10 PHE A 207
LEU A 210
THR A 211
GLY A 276
ILE A 274
 PHE  A 207 ( 1.3A)
LEU  A 210 ( 0.5A)
THR  A 211 ( 0.8A)
GLY  A 276 ( 0.0A)
ILE  A 274 ( 0.7A)
 0.89A 6ebpC-5hiuA:
undetectable		 6ebpC-5hiuA:
9.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EBP_D_DAHD123_0
(RIBONUCLEOSIDE-DIPHO
SPHATE REDUCTASE,
BETA SUBUNIT)		 5hiu GTPASE
ACTIVATOR-LIKE
PROTEIN
(Chaetomium
thermophilum) 		6 / 10 PHE A 207
LEU A 210
THR A 211
GLY A 276
ILE A 274
ILE A 262
 PHE  A 207 ( 1.3A)
LEU  A 210 ( 0.5A)
THR  A 211 ( 0.8A)
GLY  A 276 ( 0.0A)
ILE  A 274 ( 0.7A)
ILE  A 262 ( 0.7A)
 0.97A 6ebpD-5hiuA:
undetectable		 6ebpD-5hiuA:
9.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EBZ_A_DAHA123_0
(RIBONUCLEOSIDE-DIPHO
SPHATE REDUCTASE,
BETA SUBUNIT)		 5hiu GTPASE
ACTIVATOR-LIKE
PROTEIN
(Chaetomium
thermophilum) 		6 / 11 PHE A 207
LEU A 210
THR A 211
GLY A 276
ILE A 274
ILE A 262
 PHE  A 207 ( 1.3A)
LEU  A 210 ( 0.5A)
THR  A 211 ( 0.8A)
GLY  A 276 ( 0.0A)
ILE  A 274 ( 0.7A)
ILE  A 262 ( 0.7A)
 0.98A 6ebzA-5hiuA:
undetectable		 6ebzA-5hiuA:
9.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EBZ_B_DAHB123_0
(RIBONUCLEOSIDE-DIPHO
SPHATE REDUCTASE,
BETA SUBUNIT)		 5hiu GTPASE
ACTIVATOR-LIKE
PROTEIN
(Chaetomium
thermophilum) 		6 / 11 PHE A 207
LEU A 210
THR A 211
GLY A 276
ILE A 274
ILE A 262
 PHE  A 207 ( 1.3A)
LEU  A 210 ( 0.5A)
THR  A 211 ( 0.8A)
GLY  A 276 ( 0.0A)
ILE  A 274 ( 0.7A)
ILE  A 262 ( 0.7A)
 1.01A 6ebzB-5hiuA:
undetectable		 6ebzB-5hiuA:
9.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EBZ_C_DAHC123_0
(RIBONUCLEOSIDE-DIPHO
SPHATE REDUCTASE,
BETA SUBUNIT)		 5hiu GTPASE
ACTIVATOR-LIKE
PROTEIN
(Chaetomium
thermophilum) 		6 / 11 PHE A 207
LEU A 210
THR A 211
GLY A 276
ILE A 274
ILE A 262
 PHE  A 207 ( 1.3A)
LEU  A 210 ( 0.5A)
THR  A 211 ( 0.8A)
GLY  A 276 ( 0.0A)
ILE  A 274 ( 0.7A)
ILE  A 262 ( 0.7A)
 1.04A 6ebzC-5hiuA:
undetectable		 6ebzC-5hiuA:
9.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EBZ_D_DAHD123_0
(RIBONUCLEOSIDE-DIPHO
SPHATE REDUCTASE,
BETA SUBUNIT)		 5hiu GTPASE
ACTIVATOR-LIKE
PROTEIN
(Chaetomium
thermophilum) 		6 / 11 PHE A 207
LEU A 210
THR A 211
GLY A 276
ILE A 274
ILE A 262
 PHE  A 207 ( 1.3A)
LEU  A 210 ( 0.5A)
THR  A 211 ( 0.8A)
GLY  A 276 ( 0.0A)
ILE  A 274 ( 0.7A)
ILE  A 262 ( 0.7A)
 0.99A 6ebzD-5hiuA:
undetectable		 6ebzD-5hiuA:
9.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6ECE_C_DVAC3010_0
(VLM2
DODECADEPSIPEPTIDE)		 3td9 BRANCHED CHAIN AMINO
ACID ABC
TRANSPORTER,
PERIPLASMIC AMINO
ACID-BINDING PROTEIN
(Thermotoga
maritima) 		3 / 3 ALA A 116
PHE A 134
GLN A 139
 PHE  A 400 (-3.6A)
None
None
 0.81A 6eceA-3td9A:
3.1		 6eceA-3td9A:
24.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6FGD_A_ACTA821_0
(GEPHYRIN)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		3 / 3 ARG A 165
PHE A 167
GLY A 161
 ARG  A 165 ( 0.6A)
PHE  A 167 ( 1.3A)
GLY  A 161 ( 0.0A)
 0.73A 6fgdA-5gprA:
undetectable		 6fgdA-5gprA:
21.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6GP2_A_DAHA126_0
(RIBONUCLEOSIDE-DIPHO
SPHATE REDUCTASE
BETA CHAIN)		 5hiu GTPASE
ACTIVATOR-LIKE
PROTEIN
(Chaetomium
thermophilum) 		6 / 11 PHE A 207
LEU A 210
THR A 211
GLY A 276
ILE A 274
ILE A 262
 PHE  A 207 ( 1.3A)
LEU  A 210 ( 0.5A)
THR  A 211 ( 0.8A)
GLY  A 276 ( 0.0A)
ILE  A 274 ( 0.7A)
ILE  A 262 ( 0.7A)
 0.95A 6gp2A-5hiuA:
undetectable		 6gp2A-5hiuA:
10.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6GP2_B_DAHB126_0
(RIBONUCLEOSIDE-DIPHO
SPHATE REDUCTASE
BETA CHAIN)		 5hiu GTPASE
ACTIVATOR-LIKE
PROTEIN
(Chaetomium
thermophilum) 		6 / 11 PHE A 207
LEU A 210
THR A 211
GLY A 276
ILE A 274
ILE A 262
 PHE  A 207 ( 1.3A)
LEU  A 210 ( 0.5A)
THR  A 211 ( 0.8A)
GLY  A 276 ( 0.0A)
ILE  A 274 ( 0.7A)
ILE  A 262 ( 0.7A)
 0.86A 6gp2B-5hiuA:
undetectable		 6gp2B-5hiuA:
10.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6H7L_A_Y00A406_1
(BETA-1 ADRENERGIC
RECEPTOR)		 5svd NUCLEOLAR PROTEIN 9
(Saccharomyces
cerevisiae) 		4 / 6 GLY A 348
LEU A 352
PHE A 291
PHE A 273
 GLY  A 348 ( 0.0A)
LEU  A 352 ( 0.6A)
PHE  A 291 ( 1.3A)
PHE  A 273 ( 1.3A)
 1.04A 6h7lA-5svdA:
undetectable		 6h7lA-5svdA:
10.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6H7L_B_Y00B405_1
(BETA-1 ADRENERGIC
RECEPTOR)		 5svd NUCLEOLAR PROTEIN 9
(Saccharomyces
cerevisiae) 		4 / 6 GLY A 348
LEU A 352
PHE A 291
PHE A 273
 GLY  A 348 ( 0.0A)
LEU  A 352 ( 0.6A)
PHE  A 291 ( 1.3A)
PHE  A 273 ( 1.3A)
 1.04A 6h7lB-5svdA:
undetectable		 6h7lB-5svdA:
10.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HD4_A_STIA604_1
(TYROSINE-PROTEIN
KINASE ABL1)		 1v0f ENDO-ALPHA-SIALIDASE
(Enterobacteria
phage
K1F) 		4 / 5 TYR A 278
VAL A 267
PHE A 311
GLY A 275
 TYR  A 278 ( 1.3A)
VAL  A 267 ( 0.5A)
PHE  A 311 ( 1.3A)
GLY  A 275 ( 0.0A)
 1.32A 6hd4A-1v0fA:
undetectable		 6hd4A-1v0fA:
8.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HD4_A_STIA604_1
(TYROSINE-PROTEIN
KINASE ABL1)		 5nks DIHYDROPYRIMIDINASE-
RELATED PROTEIN 4
(Homo
sapiens) 		4 / 5 VAL A  70
PHE A 460
MET A 459
GLY A 457
 VAL  A  70 ( 0.6A)
PHE  A 460 ( 1.3A)
MET  A 459 ( 0.0A)
GLY  A 457 ( 0.0A)
 1.40A 6hd4A-5nksA:
undetectable		 6hd4A-5nksA:
10.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HRJ_A_010A302_0
(YNDL)		 2bzt PROTEIN ISCX
(Escherichia
coli) 		4 / 5 GLU A  55
LYS A  52
GLU A  51
PHE A  29
 GLU  A  55 ( 0.6A)
LYS  A  52 ( 0.0A)
GLU  A  51 ( 0.6A)
PHE  A  29 ( 1.3A)
 1.38A 6hrjA-2bztA:
undetectable		 6hrjA-2bztA:
15.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HU9_I_PCFI101_0
(CYTOCHROME B-C1
COMPLEX SUBUNIT 1,
MITOCHONDRIAL
CYTOCHROME B-C1
COMPLEX SUBUNIT 9
CYTOCHROME B-C1
COMPLEX SUBUNIT
RIESKE,
MITOCHONDRIAL)		 3lkv UNCHARACTERIZED
CONSERVED DOMAIN
PROTEIN
(Vibrio
cholerae) 		5 / 11 TYR A 272
VAL A 113
GLY A  94
ALA A  77
VAL A 117
 None
None
None
None
PHE  A 601 (-3.7A)
 1.17A 6hu9A-3lkvA:
undetectable
6hu9E-3lkvA:
undetectable
6hu9I-3lkvA:
undetectable		 6hu9A-3lkvA:
23.83
6hu9E-3lkvA:
21.74
6hu9I-3lkvA:
13.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HU9_T_PCFT101_0
(CYTOCHROME B-C1
COMPLEX SUBUNIT 1,
MITOCHONDRIAL
CYTOCHROME B-C1
COMPLEX SUBUNIT 9
CYTOCHROME B-C1
COMPLEX SUBUNIT
RIESKE,
MITOCHONDRIAL)		 3lkv UNCHARACTERIZED
CONSERVED DOMAIN
PROTEIN
(Vibrio
cholerae) 		5 / 10 TYR A 272
VAL A 113
GLY A  94
ALA A  77
VAL A 117
 None
None
None
None
PHE  A 601 (-3.7A)
 1.19A 6hu9L-3lkvA:
undetectable
6hu9P-3lkvA:
undetectable
6hu9T-3lkvA:
undetectable		 6hu9L-3lkvA:
23.83
6hu9P-3lkvA:
21.74
6hu9T-3lkvA:
13.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6IEY_A_CLMA401_0
(ESTERASE)		 2rci TYPE-2BA CYTOLYTIC
DELTA-ENDOTOXIN
(Bacillus
thuringiensis) 		5 / 11 ILE A 186
ALA A  90
GLY A  86
PHE A  64
ALA A  80
 ILE  A 186 ( 0.7A)
ALA  A  90 ( 0.0A)
GLY  A  86 ( 0.0A)
PHE  A  64 ( 1.3A)
ALA  A  80 ( 0.0A)
 1.03A 6ieyA-2rciA:
undetectable
6ieyB-2rciA:
undetectable		 6ieyA-2rciA:
19.93
6ieyB-2rciA:
19.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6MB7_A_PARA900_0
(AAC(3)-IIIB PROTEIN)		 3td9 BRANCHED CHAIN AMINO
ACID ABC
TRANSPORTER,
PERIPLASMIC AMINO
ACID-BINDING PROTEIN
(Thermotoga
maritima) 		5 / 10 ASP A 241
THR A 215
GLY A 216
ASP A 161
GLU A 220
 PHE  A 400 (-2.7A)
None
None
None
None
 1.36A 6mb7A-3td9A:
2.0		 6mb7A-3td9A:
13.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6MB9_A_NMYA303_0
(AAC(3)-IIIB PROTEIN)		 3td9 BRANCHED CHAIN AMINO
ACID ABC
TRANSPORTER,
PERIPLASMIC AMINO
ACID-BINDING PROTEIN
(Thermotoga
maritima) 		5 / 10 ASP A 241
THR A 215
GLY A 216
ASP A 161
GLU A 220
 PHE  A 400 (-2.7A)
None
None
None
None
 1.37A 6mb9A-3td9A:
undetectable		 6mb9A-3td9A:
13.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6MB9_B_NMYB302_0
(AAC(3)-IIIB PROTEIN)		 3td9 BRANCHED CHAIN AMINO
ACID ABC
TRANSPORTER,
PERIPLASMIC AMINO
ACID-BINDING PROTEIN
(Thermotoga
maritima) 		5 / 10 ASP A 241
THR A 215
GLY A 216
ASP A 161
GLU A 220
 PHE  A 400 (-2.7A)
None
None
None
None
 1.35A 6mb9B-3td9A:
undetectable		 6mb9B-3td9A:
13.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6MB9_C_NMYC302_0
(AAC(3)-IIIB PROTEIN)		 3td9 BRANCHED CHAIN AMINO
ACID ABC
TRANSPORTER,
PERIPLASMIC AMINO
ACID-BINDING PROTEIN
(Thermotoga
maritima) 		5 / 10 ASP A 241
THR A 215
GLY A 216
ASP A 161
GLU A 220
 PHE  A 400 (-2.7A)
None
None
None
None
 1.33A 6mb9C-3td9A:
undetectable		 6mb9C-3td9A:
13.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6MB9_D_NMYD302_0
(AAC(3)-IIIB PROTEIN)		 3td9 BRANCHED CHAIN AMINO
ACID ABC
TRANSPORTER,
PERIPLASMIC AMINO
ACID-BINDING PROTEIN
(Thermotoga
maritima) 		5 / 10 ASP A 241
THR A 215
GLY A 216
ASP A 161
GLU A 220
 PHE  A 400 (-2.7A)
None
None
None
None
 1.32A 6mb9D-3td9A:
undetectable		 6mb9D-3td9A:
13.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6NKN_W_CHDW101_0
(CYTOCHROME C OXIDASE
SUBUNIT 3
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 1wqa PHOSPHO-SUGAR MUTASE
(Pyrococcus
horikoshii) 		3 / 3 ARG A  36
LEU A 131
PHE A 132
 ARG  A  36 ( 0.6A)
LEU  A 131 ( 0.6A)
PHE  A 132 ( 1.3A)
 0.80A 6nknP-1wqaA:
0.0		 6nknP-1wqaA:
21.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6NKN_W_CHDW101_0
(CYTOCHROME C OXIDASE
SUBUNIT 3
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 4hne PHOSPHATIDYLINOSITOL
4-KINASE TYPE
2-ALPHA
(Homo
sapiens) 		3 / 3 ARG A 210
LEU A 262
PHE A 263
 ARG  A 210 ( 0.6A)
LEU  A 262 (-0.5A)
PHE  A 263 (-1.3A)
 0.61A 6nknP-4hneA:
undetectable		 6nknP-4hneA:
18.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6NMP_P_CHDP307_0
(CYTOCHROME C OXIDASE
SUBUNIT 3
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 1aoa T-FIMBRIN
(Homo
sapiens) 		4 / 5 LEU A 281
GLN A 308
PHE A 279
PHE A 292
 LEU  A 281 ( 0.6A)
GLN  A 308 ( 0.6A)
PHE  A 279 ( 1.3A)
PHE  A 292 ( 1.3A)
 1.29A 6nmpP-1aoaA:
0.1
6nmpW-1aoaA:
0.0		 6nmpP-1aoaA:
19.49
6nmpW-1aoaA:
15.94